Vital and

Health Statistics

Serum Lipids of

Adults 20–74 Years:

United States,

1976-80

Series 11:

Data From the National Health Survey

Not 242

This report presents descriptive and analytic data for serum total cholesterol,

cholesterol lipoproteins, and triglycerides for adults 20–74 years of age by age,

sex, and selected subgroups of the population at risk of developing coronary

heart disease, This information is frorm the second National Health and Nutrition

Examination Survey, which was conducted during the years 1976-80,

US. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Public Health Service

Centers for Disease Control and Prevention

National Center for Health Statistics

Hyaitsville, Maryland

March 1993

DHHS Publication No. [PHS) 93-1692
Trade Name Diecleimer

The use of trade names is for identiicetion onfy and does not imply

endorsement by the Public Health Service, U.S. Department of Health and

Human Sewices.

Copyright information

All material appearing in this report is in the public domain and may be

reproduced or copied without permission: citation as to source, however, is

appreciated.

Suggeeted Cftetlon

Carroll M, Sempos C, Briefel R, et al. Serum lipids of adults 2G74 years,

United States, 1976-60. National Center for Health Statistics. Vital Health Stat

11(242). 1S93.

Library of Congrese Cataloging-in-Publication Data

Serum lipids and lipoproteins of adults, 1976-60.

p. cm. – (Vkel and health statistics. Series 11, Data from the National

Health Survefi no. 242) (DHHS publication: no. (PHS) 93–1 692)

Authors, Margaret Carroll... [et al.].

“From the second National Health and Nutriion Examination Survey.”

Includes bibliographical references.

ISBN O-640WJ462-9

1. Blood lipids– United States-Statistics. 2. Blood cholesterol- United

*

States- Statistics. 3. Blood lipoproteins – United States – Statistics. 4. Coronary

heart disease–United States– Risk factors -Statistics. L Carroll, Margaret T. Il.

National Center for Health Statistics (U.S.) Ill. National Health and Nutrition

Examination Survey (U.S.) IV. Series. V. Series: DHHS publication no. (PHS)

93-1692.

[DNLM: 1. Cholesterol– blood –sbtisfics. W2 A N146vk: no. 242]

RA407.3.A347 no. 242

[QP99.3.L5]

362.1 ‘0S73’021 s–dc20

[614.5’9123’00973]

DNLM/DLC 92–1 6913

for Library of Congress CIP
National Center for Health Statistics

Manning Feinleib, M.D., Dr. P.H., Director

Jack R, Anderson, Acting Depu@ Director

Jacob J. Feldman, Ph. D., Associate Direc/or for Analysis

and Epidemiology

Gail F. Fisher, Ph. D., Associate Director for Planning and

Extramural Program

Peter L. Hurley, Associate Director for Vital and Health

Statistics Systems

Robert A. Israel, Associate Director for International Statistics

Stephen E. Nieberding, Associate Direcrorfor Management

Charles J. Rothwell, Associate Director for Data Processing

and Services

Monroe G. Sirken, Ph. D., Associate Director for Research

and Methodology

David L. Larson, Assistant Director, Atlanta

Division of Health Examination Statistics

Robert S. Murphy, M.S.P.H., Direc(or

Kurt R, Maurer, Ph. D., Depufy Director

Ronette R. Briefel, Dr. P.H,, R.D., Direc[or, Nutrition

Monitoring and Related Research Program

Clifford L. Johnson, M.S.P.H., Special Assistant of

Analysis and Information Managenvmt

Vicki L. Burt, SC.M,, R.N., Chief Survey Planning and

Development Branch

Jean Findlay, M.S., ChieJ Survey Operations Branch

Katherine M. Flegal, Ph. D., Chiej Medical Statistics

Branch

Anne C. Looker, Ph. D., ChieJ Nutrition Statistics Branch

Robert S. Krasowski, M.A., M.S., ChieJ Computer

Systems and Programming Branch

Christopher T. Sempos, Ph. D., Chief Longitudinal

Statistics Branch
Contents

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Source of data and analytic issues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Source of data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Methods of measurement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Analytic issues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Selected tindings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Total cholesterol (TC) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

High density lipoprotein (HDL) cholesterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Non-high density lipoprotein (non-HDL) cholesterol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Ratio of TCto HDL-C . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Serum triglyceride . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Low density lipoprotein (LDL-C)cholesteroI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

LDL-C:HDL-C ratio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

The National Cholesterol Education Program Adult Treatment Panel Guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . .

References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

List of detailed tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Appendixes

1, Statistical notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...4....

1

3

3

3

5

8

8

8

8

8

9

g

9

9

10

12

97

H. Data presentation and reliability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104

III. Definition ofvariables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...105

W. Definitions of risk factorvariables. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...106

Text tables

A.

B.

c.

D,

Health examination surveys conducted by the National Center for Health Statistics, by years ofsurvey, ages

of target population, and lipid determinations: 1960–80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2

Number and percent ofpersons20–74 years ofagewlm wereinterviewed and examinedby age, sex,and

race: Second National Health and Nutrition Examination Survey, 1976–80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3

Number and percent of persons 20-74 years of age interviewed and examined inthe fasting sample, by age,

sex, and race: Second National Health an dNutritio nExamination Survey, 1976–S0 . . . . . . . . . . . . . . . . . . . . . . . . 4

Number ofpersons ages 20–74 years with known serum lipid determinationsby race: Second National

Health and Nutrition Examination Survey, 1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4

...

Ill
Serum Lipids of Adults

Margaret Carroll, M.S.P.H., Christopher Sempos, Ph. D.,

Ronette Briefel, Dr. P.H., R.D., Shirley Gray, M.B.A., and

Clifford Johnson, M.S.P.H., Division of Health

Examination Statistics

Introduction

Serum total cholesterol (TC), the cholesterol lipoproteins, and serum triglyceride are all associated with the

development of coronary heart disease (CHD) (l-3). Both

TC and low density lipoprotein cholesterol (LDL-C) are

directly related to the development of CHD (1,2). High

density lipoprotein cholesterol (HDL-C) is inversely associated with CHD development and high levels of HDL

cholesterol may be protective (4,5). Serum triglyceride,

although directly associated with CHD, has not consistently been shown to be an independent CHD risk factor

(6,7).

This report presents basic reference data on serum

lipids and lipoproteins for adults 20-74 years of age,

including TC, HDL-C, the difference between TC and

HDL-C or non-HDL-C, TC:HDL-C ratio, serum triglyceride, calculated LDL-C, LDL-C.HDL-C ratio, and detailed

estimates of the percent of persons with high blood

cholesterol as defined by the Adult Treatment Panel of

the National Cholesterol Education Program (2).

The data were collected by the National Center for

Health Statistics (NCHS) through the second National

Health and Nutrition Examination Survey (NHANES II),

conducted during the years 1976–SO (S). NHANES II

included a variety of measures of nutritional status and

related health information.

The NHANES is an expansion of the National Health

Examination Survey (NHES). The surveys are designed to

collect data by direct standardized examinaticm of a sample of the population. Direct examinations, coupled with

cIinical tests and measurements, are the ordy source of

prevalence data regarding previously undiagnosed and

The authors acknovdcdgc with apprcciatimr the contributions to the

]abordtory analysis, data collection, datti processing ami editing, and

manuscript review made by the following individuals from various Government and non-Govcmmcnt agcncics:

The George Washington University Lipid Research Clinic:

John C. La Rosa, M.D.

Richard Mucsing, Ph.D.

The National Heart Lung mrd Blood lnstitutc, Nation:ll Institutes of

Health:

Basil Rifkind, M.D.

Kenneth Lippcl, Ph.D.

Robinson Fuhvood, M. S.P.H.

The National Center for Health Statistics:

Robert S. Murphy, M.S.P.H.

untreated diseases. They are the best source of standardized clinical, physical, and physiological data on the subject.

The three programs of the NHES (1959-70) (9-11)

focused on selected aspects of illness and health, each

targeting a particular age group of the population.

In 1971, responsibility for monitoring the nutritional

status of the population was added to the National Health

Examination Survey, which then became the first National

Health and Nutrition Examination Survey (NHANES I).

Conducted from April 1971-June 1974, NHANES I was

designed to assess overall health status, with particular

emphasis on dental health, skin problems, eye conditions,

and the nutritional status of the population 1–74 years of

age (12).

Adults 25–74 years of age were examined to determine the prevalence of chronic lung disease; disabling

arthritis of the hip, knee, or Iower spine; cardiovascular

disease; and hearing levels. In addition, information was

obtained on health care needs and general well-being.

This segment of the NHANES I program was followed by

a 15-month period (July 1974-October 1975) during which

an additional national sample of persons 25–74 years of

age \vas examined in order to augment thesizeof the

original NHANES I sample. This study is referred to as

the National Health and Nutrition Examination Survey,

Augmentation Cycle (13).

NHANES II, the source of data for this report,

provides an opportunity to assess the population’s health

and nutritional status cross-sectionally and to assess some

aspects of change over time (14), Components of nutritional status measurement were included in a physician’s

examination, a medical history questionnaire, body measurements, laboratory assessments of blood samples, and a

dietary interview’.

Also included in NHANES II were tests and procedures that provided data on diabetes, kidney and heart

disease, hypertension, certain allergies, disc degeneration,

pulmonary function, hearing and speech problems, and

exposure to certain potentiality toxic substances.

TotaI serum cholesterol has been determined from

sera collected in each health examination survey except

the second National Health Examination Survey (NHES

II) (table A). During NHANES H, the NCHS and the

National Heart, Lung and Blood Institute of the National

Institutes of Health collected and analytically processed

1
Table A: Health examination surveys conducted by the National

Center for Health Statistics, by years of survey, age of target

population, and lipid determinations: 1960-60

Age of

Years target Lipid

Survey conducted popu/afion determinations

First National Health Examination

Survey ...,,........,,.. 1960-62 18-79 years TC

Second National Health

Examination Survey. 1963-65 6-11 years none

Third National Health

Examination Survey, 1966-70 12-17 years TC

First National Health and Nutrition

Examination Survey. . 1971-74 1-74 years TC

Second National Health TC

and Nutrition Examination 6 months– HDL-C serum

Survey . . . . . . . . . . . . . . . . . 1976-80 74 years triglyceride

(for the first time) serum specimens for HDL-C and

triglycerides in addition to TC.

Lipid analyses for NHANES H were performed at the

George Washington University according to protocol used

by the Lipid Research Clinic Program (LRC). The blood

determinations underwent numerous quality control and

editing procedures in both the data collection and data

processing phases of the survey. All unusual values were

checked and verified by the laboratory.

Data for TC, HDL-C, and serum triglyceride were

determined only for adults ages 20-74 years in NHANES

11,TC and HDL-C were scheduled to be measured in all

adults 20–74 years old who were examined in NHANES II

and serum triglyceride was scheduled to be measured only

in the randomly selected half of the examined adults 20-74

years old who were to receive the oral glucose tolerance test

(OGTT). The “half sample” was also designed to represent

the adult population of the United States.

Estimates of the mean, standard error of the mean,

and selected percentiles are shown for serum lipid and

lipoprotein determinations by race, sex, and age, and

for women 20-44 years of age by race, age, and use of

oral contraceptives. These include TC, HDL-C, nonHDL-C, and the TC:HDL-C ratio. This latter composite variable, first used in the Framingham Study, is a

useful measure of the joint contribution of TC and

HDL-C to CHD risk (15).

In addition, estimates are presented for persons

20-74 years old who fasted at least 12 hours prior to venipuncture for serum triglyceride, calculated values of LDL-C

(16) and the LDL-C:HDL-C ratio by race, sex, and age.

Cumulative percent distributions for these seven

variables are also presented by race, sex, and age. Selected

results from these tables are highlighted in other tables

showing the percent distributions by selected cutpoints of

importance to CHD. These results include:

. The percent with HDL–C less than 35 mg/dl

. The percent with a TC:HDL–C ratio greater

equal to 4.5 (17)

than or

The percent of persons with serum triglyceride levels between

250 and 500 mg/dl and the percent with serum triglyceride

levels of 500 mg/dl or more (6) are not highlighted in a special

table. However, these percents can be obtained from the

tables showing cumulative percents (18).

In addition, the guidelines proposed by the National

Cholesterol Education Program’s (2) Expert Panel on

Detection, Evaluation, and Treatment of High Blood

Cholesterol in Adults or Adult Treatment Panel (ATP)

are applied to all adults 20–74 years, to women 20–44

years, to hypertensives, and to normotensives in summary

tables showing:

. The percent with desirable, borderline-high and high

serum TC

. The percent referred for lipoprotein analysis with

desirable, borderline-high risk and high risk LDL-C

(not presented for women 20-44 years)

The percent of hypertensives and normotensives with

desirable, borderline-high, and high TC as well as the

percent of hypertensive and normotensives referred for

lipoprotein analysis with desirable, borderline-high-risk,

and high-risk LDL-C are also presented. Moreover, the

percent of hypertensives and normotensives within the

desirable, borderline-high-risk, and high-risk TC categories, and the percent referred for lipoprotein analysis

within the desirable, borderline-high-risk, and high-risk

LDL-C categories are presented. Similar tables are presented for percent with HDL-C less than 35 mgldl and

persons with a ratio of TC to HDL-C greater than, or

equal to 4.5 in the various categories of the guidelines,

Two additional tables show the percent with desirable,, borderline-high-risk, and high-risk LDL-C for adults

20-74 years–one as a percent of the total population and

one as a percent of those not needing treatment for high

blood cholesterol. Important findings derived from these

tables have been published (19), as are other important

findings concerning NHANES II lipid data (19-23).

All serum lipid and lipoprotein determinations are

shown in milligrams per deciliters (mg/dl). To convert TC,

HDL-C, non-HDL-C, and LDL-C to rnillimoles per liter

(mmol/L), multiply the value expressed in milligrams per

deciliters by .02586. To convert serum triglyceride to

mmol/L, multiply the value expressed in milligrams per

deciliters by .01129.

Sample sizes for most subgroups are large enough to

meet NCHS requirements for statistically reliable results (see

appendix II). In instances where these requirements are not

satisfied, an asterisk (*) is shown instead of the estimates.

The lipid data from this survey have been coded,

edited, and released on microdata tape (PB. No.

PB90-500943). Persons interested in more detailed analyses can purchase this tape from the National Technical

Information Service, 5285 Port Royal Road, Springfield,

Virginia (24),
Source of data and

analytical issues

Source of data

The second National Health and Nutrition Examination Survey (NHANES) was conducted February 1976-February 1980 by NCHS. The study population for the survey

was the civilian noninstitutionalized population 20–74 years

of age in the United States. The NHANES II sample

consisted of 17,390 persons 20-74 years of age, SS percent

of whom were interviewed. Of these, 11,S64 were interviewed and examined, resulting in a response rate of

68 percent. The sampIe sizes and response rates for adults

20-74 years by race, sex, and age in NHANES II are

shown in tables B and C; sample sizes available for each

lipid determination are shown in table D. More detail on

the sample design and conduct of the survey is shown in

appendix L Other data collection and analytic issues are

described in appendixes II-IV.

All interviews, examinations, tests, procedures, and

laboratory determinations followed standardized protocol.

NHANES II, like previous examination surveys, consisted

of two components. The first component consisted of

household interviews and the second component consisted

of physical examinations and additional interviews in mobile examination centers.

The househoId interview component involved collecting socioeconomic and demographic information from the

family and sample persons within the family and completing a medical history questionnaire for sample persons.

Staff from the U.S. Bureau of the Census performed the

initial household interviews and assisted in scheduling

appointments for examinations.

The examination component was performed in mobile

examination centers specially designed for this study. The

examination, environment, and equipment were standardized to minimize differences in findings among sample

locations. Examination teams were trained to follow the

study protocol, which in turn provided for standardization

and evaluation of their performance. The examination

consisted of:

. A general medical examination and screening by a

physician and additional medical histo~

. Laboratory tests of whole blood, serum and urine

specimens, and lipid determinations

. Body measurements

. A dietary interview

. Selected diagnostic tests, such as electrocardiogranls

and x rays, and tests on speech and hearing, allergies,

and pulmonary function

Thus, NHANES II provided the opportunity to assess key

aspects of the population’s health and nutritional status

during a 4-year period, and to assess changes in the U.S.

population over time by comparison with other NHANES.

Table B. Number and percent of persons 20-74 years of age who

were intewiewed and examined by age, sex, and race: Second

National Health and Nutrition Examination Survey, “[976-S0

Interviewed Examined

Total

Age, sex, and race sample Number Percent Number Percent

Methods of measurement Total . . . . . . . . . . 17,390 15,364 86.35 11,864 68.22

NHANES H was staffed by two trained examination

teams and equipped with three mobile examination centers which could be moved to a central location in each of

the examination sites or primary sampling units. At the

mobile examination center, examinees changed from their

street clothing to disposable paper examination uniforms

and foam rubber slippers designed to facilitate and standardize various elements of the examination.

Age

20-24 years. . . . . .

25-34 years. . . . . .

35-44 years.. . . .

45-54 years. . . . . .

55–64 years. . . . . .

65-74 years. . . . . .

92.82

91.49

89.67

66.83

86.09

86.23

1,414

2,237

1,589

“1,453

2,556

2,615

74.66

73.80

71.06

67.61

66.08

62.08

1,894

3,031

2,236

2,149

3,868

4,212

1,758

2,773

2,005

1,866

3,330

3,632

Sex

67.20

69.41

Female . . . . . . . . .

Male . . . . . . . . . .

9,316

8,074

8,286

7,078

68.94

87.66

6,260

EI,604

Serum lipid determinations

Race

White . . . . . . . . . .

Black, ,,, . . . . . .

Other . . . . . . . . . .

Blood samples were obtained by venipuncture from

both fasting and nonfasting subjects. The cells were allowed to clot and the samples were then centrifuged. The

15,103

1,955

332

13,316

1,764

284

88.17

90.23

85.54

10,301

1,336

227

68.20

68.34

68.37

3
serum

plastic

was recovered, and an a[iquot was placed in a

screw-capped vial and placed in a freezer within 3

hours of collection, At approximately 2-week intervals,

serum specimens collected over the preceding period were

placed in a styrofoam shipping container with dry ice.

Specimens were shipped to George Washington University Lipid Research Clinic Laboratory for analysis of

serum cholesterol, triglyceride, and high density lipoprotein (HDL) cholesterol.

When they arrived at the laboratory, samples were

placed in a freezer at -15° C until they were analyzed –

usually within 2 weeks of receipt. Specimens were allowed

to thaw at room temperature, then mixed thoroughly by

vortexing. All measurements were performed according to

the protocol described for the Lipid Research Clinics

(LRC) program (25).

Total serum cholesterol and serum triglycerides

Analyses were performed on zeolite-treated isopropanol extracts using an Auto-Analyzer II (AAII) (Technicon Instruments, Tarrytown, N,Y.) (a), The AAII uses a

Lieberman-Burchard reagent for cholesterol and a flourimetric measurement of triglycerides, Instrumental process

was established at the beginning of each analytical run

with. cholesterol/triglyceride standards in isopropanol

(100/50, 200/100, 300/200, and 400/300 mg/dl) provided by

the Clinical Chemistry Standardization Section of the

Centers for Disease Control and Prevention (CDC).

A serum calibrator was used to automatically adjust

instrumental response to reference AbelI-Kendall values

(26), Extracts of a high or low serum cholesterol/triglyceride internal pool were positioned in each tray; results from

out-of-control analyses were rejected and the analyses

repeated. The serum calibrator and internal control pools

Table C. Number and percent of persons 20-74 years of age

interviewed and examined in the fasting sample, by age, sex, and

race: Second National Health and Nutrition Examination Survey,

1976-80

hfervie wed Examined

Total

Age, sex, and race samp/e Number Percent Number Percent

Total . . . . . . . . . .

Age

20-24 years,

25–34 years, . .

35-44 years. .

45–54 years.

55–64 years.

65–74 years.

Sex

Female, . . . . . . . .

Male, . . . . . . . . .

Race

White, . . . . . . . . .

Black, .,..,..,,

Other, . . . . . . . . .

8,686

914

1,520

1,135

1,075

1,909

2,133

4,572

4,114

7,555

962

169

7,691

837

1,390

1,025

926

1,651

1,862

4,073

3,618

6,673

871

147

88.54

91.58

91.45

90.31

66.14

86.49

87,29

89,09

87.94

88.33

90.54

86.98

5,903

650

1,129

795

706

1,261

1,340

3,057

1,016

5,145

646

112

67.96

71,12

74,28

70,04

65.86

67.10

6262

66.86

24.70

68.10

67.15

66.27

Table [). Number of persons ages 20-74 years with known serum

serum lipid determinations by race: Second National Health and

Nutrition Examination Survey, 1976-80

—

Lipid determjnaticm Total White Black

Total serum cholesterol (TC) . . 11,864 10,301 1,336

High density lipoprotein cholesterol

(HDL-C). . .,, ,,, ,,, . . . . . . . . . . 9,797 8,562 1,043

Ratio of TC/HDL-C. ,, . . . . . . . . . . . . 9,797 8,582 1,043

Serum triglyceride, . . . . . . . . . . . . . 2,753 2,401 299

Low delwity lipoprotein cholesterol. 2,283 1,990 251

with assigned cholesterol/triglyceride target values were

provided by the CDC, Serum triglyceride values are for

the fasting sample only. There were 5,903 sample persons

in the fasting sample (table C ),

The fasting time in hours was calculated in the mobile

examination center from the Glucose Challenge and Related Diabetes Data questionnaire (24), Only the triglyceride values for those sample persons who fasted 12 hours

or more were used for this report (n= 2,753).

High density lipoprotein cholesterol

HDL cholesterol was determined by the beta quantification procedure, which involves a combination of preparative ultracentrifugation and heparin-manganese

precipitation. The determination was made on a supernatant fraction obtained after treatment of the sera with

heparin and manganese chloride, to precipitate apo B

containing lipoproteins. The precipitate was sedimented

by centrifugation for 30 minutes at 1,500 x g, and an

a]iquot of the clear supernatant was extracted with, 9.5

volumes of 99 percent isopropanol, The extract was treated

with a zeolite-containing mixture to remove interfering

substances. The solids were sedimented by centrifuging

for 30 minutes at 1,500 x g. The cholesterol content of

the extract was measured on the AAII as described in the

LRC program operations manual.

Non-HDL cholesterol

For each sample person 20-74 years of age for whom

TC and HDL cholesterol were determined, the non-HDL

cholesterol was determined by subtracting the HDIL-C

from the TC. The non-HDL cholesterol is an estimate of

the sum of LDL-C and very low density lipoprotein

cholesterol (VLDL-C).

Ratio of TC to HDL-C

For each sample person 20–74 years of age for whom

TC and HDL cholesterol were determined, the ratio was

obtained by dividing the TC by the HDL-C.

Low-density lipoprotein cholesterol

For persons fasting 12 hours or more prior to venipuncture, serum LDL was calculated using the Friedewald

equation (16) as follows:

4
LDL-C = TC-(HDL-C+ serum triglyceride/5).

All values are expressed in mg/dl.

LDL-C was not calculated for individuals with a serum

triglyceride value greater than 400 mg/dl because the

equation is not accurate beyond this valua (16). LDL-C

data in this report are based on the values for 2,2S3

sample persons.

Ratio of LDL-C to HDL-C

The LDL-C to HDL-C ratio for persons fasting 12

hours or more prior to venipuncture with known HDL-C

and serum triglyceride not exceeding 400 mg/dI was calculated by dividing the LDL-C value by the HDL-C value.

Analytic issues

Weighting procedures

The estimates are weighted to be national population

estimates. Weighting was accomplished by inflating examination findings for each examined person by the reciprocal of selection probabilities adjusted to account for persons

who were not examined and poststratifying by race, sex,

and age. As a result of poststratification adjustments, the

population estimates closely approximate the independent

U.S. Bureau of the Census estimates for the civilian

noninstitutionalized population of the United States at the

midpoint of the survey (March 1, 197S).

Estimates of TC, HDL-C, non-HDL cholesterol and

the ratio of TC to HDL-C are based on the examined

weights found in tape position 2S2–2S7 (24) of all NHANES

II data release tapes.

Estimates of serum triglyceride, LDL-C and the ratio

of LDL-C to HDL-C are based on the OGTT weights

found in tape positions 294-299 of all NHANES II data

release tapes. These weights account for the fact that ordy

half the adults examined in NHANES II received the

OGTT test.

A more detailed discussion of the calculation of sample weights is in appendk I.

Population estimates

The 19S6 U.S. population estimates are presented

by age, sex, and race in table VI of appendix I. The

prevalence estimates shown in tables 32-4S can be

applied to these population estimates to obtain corresponding estimates of the number of U.S. adults affected.

For example, 26.S percent of all persons had a high TC

(TC >240 mg/dl) value (2) (table 34); multiplying that

figure by the number of persons 20-74 years old

(15S,639,000) from table VI results in an estimate of

42,515,000 persons with high TC in 19S6.

Reliability of estimates

Estimates of percents, means, standard errors of the

percents and means, and nine selected percentiles (5th,

10th, 15th, 25th, 50th, 75th, S5th, 90th, and 95th) are

presented for each lipid variable. These estimates are

stable only if the sample size is sufficiently large. The

sample size is sufficiently large for most subgroups; the

exceptions are indicated with an asterisk. (See appendix II

for further discussion of data presentation and reliabili~.)

The number of black adults fasting 12 hours or more

was too small to present statistically reliable sex- and

age-specific estimates of serum triglyceride and LDL-C.

Therefore, only unadjusted or crude estimates and ageadjusted estimates of these lipid variables are presented

for black men and women. Because the number of women

20-44 years old who fasted 12 hours or more prior to

examination was insufficient to further strati~ by oral

contraceptive use, age, and race, estimates of serum triglyceride and LDL-C are not presented for these subgroups

(table D).

The reliability of an estimated mean or percent depends not only on the number of people upon which it is

based but also on its relative standard error, defined as the

ratio of the standard error of the estimate to the estimate

times 100. The larger the relative standard error of the

estimate the less reliable is the estimate. In the past,

NCHS has recommended that the relative standard error

of an estimate not exceed 25 percent.

Percent needing lipoprotein analysis

The National Cholesterol Education Program’s Expert Committee on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults has

recommended a two-step process (2). This committee is

also referred to as the Adult Treatment Panel or ATP.

The first step in the ATP guidelines is based on the

measurement of total cholesterol and an evaluation of

CHD risk factor load. Adults with a high blood TC level of

greater than or equal to 240 m@dl (6.21 mmol/L) are

referred for lipoprotein analysis. Those with borderlinehigh TC values of 200 and 239 m#dl (5.17-6.20 mmol/L)

and two or more CHD risk factors were also referred for

lipoprotein analysis. Those in the borderline-high group

who did not also have two or more CHD risk factors

should be reevaluated yearly. Adults with TC values in the

desirable range of less than 200 mg/dl (5.17 mmol/L)

should be reevaluated every 5 years. The CHD risk factors, identified by the ATP for evaluating borderline-high

TC values, are:

● Male sex;

. Family history of premature CHD;

● Smoking more than 10 cigarettes per day;

. Hypertension;

. Diabetes mellitus;

. History of definite cerebrovascuIar disease or occlusive

peripheral vascular disease; and

5
● Severe obesity (greater than or equal to 30 percent

overweight).

The second step in the ATP guidelines is based on

LDL-C and on an evaluation of risk factor load. Adults

with high-risk LDL-C levels of greater than or equal to

160 mg/dl (4.14 mmol/L) are candidates for medical advice

and intervention using diet as the primary mode of treatment. Additionally, adults with borderline-high-risk LDL-C

levels of 130-159 mg/dl (3.36-4.13) and two or more CHD

risk factors are also candidates for treatment. Those in the

borderline-high-risk group who did not have two or more

CHD risk factors should be reevaluated yearly. Adults

with LDL-C values in the desirable range of less than 130

mg/dI (3.36 mmol/L) should be reevaluated every 5 years.

An additional risk factor used in evaluating borderlinehigh-risk LDL-C levels is an HDL-C level less than 35

m~dl (0.91 mmol/L).

The percent of individuals who need treatment for

high cholesterol may be determined as follows:

Let

and

Then

and

If

B1 represent the event that an individual has a TC

level of at least 240 m#dl

Bz represent the event that an individual has a TC

level of 200-239 mg/dl and CHD or 2 CHD risk

factors

C, represent the event that an individual has an

LDL-C level of at least 160 mgJdl

Cz represent the event that an individual has an

LDL-C level of 130-159 mg/dl and CHD or 2 CHD

risk factors.

B = BIU Bz represents the event that an individual

would be referred for lipoprotein analysis

C= CIU Cz represents the event that an individual

has an LDL-C level of at least 160 mg/dl or an

LDL-C level 130-159 mg!dl and CHD or 2 CHD

risk factors.

T represents the event that an individual needs

treatment for high blood cholesterol, then

T=131’lC and

P(T) = P(13J3C) (where P denotes the

probability of an event) (1)

=P(B)P(C/B) (2)

= P(BIU BZJP(C1 U CJBIU BJ (3)

= [p(B,)+p(BJ] [P(C,/B,U B,)

+ P(CJBIU BJ] (,4)

NOTE: P(BIU Bz) = P(B1) + P(BZ) because B1 and Bz are

disjoint events (that is, events that cannot occur simultaneously).

that is, B, IIBz =0

P(CI U CJBIU Bz) = P(C1/BIUBJ +P(CJBIUBJ

because Cl and Cz are

disjoint events,

Therefore, P(C/B) represents the conditional probability that individuals need treatment for high blood cholesterol given that they are referred for lipoprotein analysis.

6

The percent of persons in a specified subgroup who

need treatment for high blood cholesterol can be obtained

by applying (4) to the appropriate percentages in the

tables. (The probability of an event may be converted to a

percent by multiplying it by 100. Conversely, a percent

may be converted to a probability by dividing it by 100.)

For example, to determine the percent of hypertensive who need treatment for high blood cholesterol,

consicler: the percent of hypertensives 20–74 years of age

with a TC level of at least 240 mg/dl is 40.1 (row 1 and

column 8 of table 41) and the percent with a TC value

200-239 mg/dl and CHD or two CHD risk factors is 27.2

(row 1 and column 6 of table 41). Therefore, the percent

of hypertensive 20–74 years of age who would be referred

for lipoprotein analysis is 67.3(=40.1+27.2) and the corresponding probability, .673( =67.3/100).

The percent of hypertensives 20-74 years of age with

an LI)L-C level of at least 160 mg/dl, given that they have

been referred for lipoprotein analysis, is 56.0 percent (row

1 and column 8 of table 43), and the percent with LDL-C

130–159 mg/dl and CHD or two CHD risk factors, given

that they have been referred for lipoprotein analysis, is

33.8 (row 1 and column 6 of table 43), Therefore, the

percent of hypertensives who need treatment for high

cholesterol, given that they are referred for lipoprotein

analysis, is 89.8(=56+33,8) and the corresponding probability is .898(= 89.8/100).

Therefore, the total percent of hypertensives 20.-74

years of age who need treatment for high cholesterol is

60.4( = .673x .898x 100). The percent of adults 20-74 years

of age who need treatment for high blood cholesterol can

also be determined directly from table 37 by the following

method: add the percent for a given race, sex, and age

subgroup with high-risk LDL-C to the corresponding percent with borderline-high risk LDL-C and CHD or two

CHD risk factors. For example, the percent of white

women 20–74 years of age who need treatment for high

blood cholesterol is 31.2(=24.3+ 6,9),

Perc:ent not needing lipoprotein analysis

An individual with a TC level less than 200 mg/dl is

defined as one who has desirable serum cholesterol. Such

individuals, as well as those with borderline-high TC and

CHD and no two CHD risk factors, would not need

lipoprotein analysis. The percent of adults with desirable,

borderline-high risk, and high-risk LDL-C as a percent of

those who do not need lipoprotein analysis is shown in

tab[a 38.

Age of examinees

The chronological age at the time of interview was the

age criterion for inclusion in the sample. The value used

as a label for each age group in the tables is the integer

referring to age at last birthday at the time of interview,

Hence, “10 years” refers to all children 10.00–10,99 years,

with an approximate mean value of 10.50 years.
Hypertension

Hypertension is defined as (1) a systolic blood pressure of 140 mmHg or more, or (2) diastotic blood pressure

of 90 mmHg or more, or (3) currently taking medication

for high blood pressure. Normotension is defined as not

hypertensive, that is, systolic blood pressure is less than

140, diastolic blood pressure is less than 90 mmHg, and

the subject is not currently taking medication for high

blood pressure.

Oral contraceptive use

Women ages 20-44 years are classified as users, recent

discontinues, and nonusers of oral contraceptives. Women

who responded “yes” to the question “Are you now taking

birth control pills?” are classified as oral contraceptive

users. Women who responded “yes” to the question “Have

you taken birth control pills during the past six months?”

and “no” to the question “Are you taking them now?” are

classified as recent discontinues. Women who responded

“no” to the question “Have you taken birth control pills

during the past six months?” are classified as nonusers of

oral contraceptives. Nonpregnant and nonlactating women

were excluded from the estimates of TC, HDL-C, and the

ratio of TC to HDL-C. Estimates of mean TC and the

percent with desirable, borderline-high, and high TC were

based on 504 birth control users. Estimates of mean

HDL-C and ratio were based on 436 such women.

For a more detailed discussion of the variables, see

appendix HI.

7
Selected findings

Some findings concerning serum lipids and lipoproteins analyzed in the second National Health and Nutrition Examination Survey (NHANES H, 1976–80) are

summarized below. These include comparisons of estimated means and percents above or below specified cutpoints that are important to coronary heart disease (CHD)

by demographic (sex, race, and age) variables. Comparisons of lipid levels by oral contraceptive use in women and

by hypertensive status are also shown.

Statistically significant differences in these estimates

are presented. A noninsignificant result does not necessarily mean a real difference does not exist. For a given

difference, the probability of detecting a difference when

it exists is directly related to the sample size. Thus, if the

sample size is small, one is less likely to detect a difference

when it exists. Observed differences (that may be of

interest although they are not statistically significant), as

well as descriptive statements about the distribution of

serum lipids are also presented.

Many of the important findings concerning these

NHANES II data have been presented eIsewhere (19-23).

Total cholesterol (TC)

Many of the important tindings concerning mean total

cholesterol (TC) (tables 1 and 29) have been described

elsewhere (20, 21).

These findings include:

. The mean TC levels of both men and women generally

increase with age.

● The age-adjusted mean TC level of oral contraceptive

users is significantly higher than that of nonusers

among females 20-44 years of age.

High density lipoprotein (HDL) cholesterol

Many of the important findings concerning mean

HDL-C (table 2) have already been presenteci (22). These

findings include:

. Mean HDL-C levels are higher in

a. women compared with men

b. black adults compared with white adults.

. The age-adjusted mean HDL-C level of adults 20-74

years of age is 45.2 for men and 53.6 for women (table 2).

. Approximately 17.8 million adults 20–74 years of age

(1 1.2 percent)– 15.S milIion white adults (11.6 per8

cent) and 1,3 million black adults (7.3 percent)have an

HDL-C level less than 35 mg/dl (table 33).

White men have consistently higher percents of HDL-C

less than 35 mg/dl than white women of the same age

group (table 33) and this relationship persists for those

with desirable TC levels (TC <200 mg/dl) (2) as well

as those with high TC levels (table 45).

The age-adjusted percent of black men with HDLC leveIs

less than 35 n-@di is significantly Iower than that of white

men —a difference of 8.2 percent (table 33). This relationship persists for men with desirable, borderline-high, and

high total serum cholesterol (table 45),

Non-high density lipoprotein (non-HDL)

cholesterol

● The age-adjusted mean non-HDL cholesterol is 165

mg/dl for men and 160 mg/dl for women, For white

adults, the corresponding values are 166 mgldl for men

and 161 mg/dl for women and for black adults, it is 156

rmg/dl and 157 mg/dl for men and women respectively

(table 3),

. white men have consistently higher non-HDL cholesterol

Ievels than black men of the same age group (table 3).

Ratio of TC to HDL-C

Many findings concerning the ratio of TC to HDL-C

have been published (22). These include:

. The age-adjusted mean TC:HDL-C ratio is higher in

a. men compared with women

b. white adults compared with black adults (table 4).

. These relationships remained after stratification by

selected correlates such as body mass index and reported alcohol consumption.

. White adults have consistently higher mean ratios of

TC to HDL-C than black adults of the same sex and

age group (table 4).

● ‘White oral contraceptive users have higher mean ratios of TC to HDL-C than white nonusers have (table

31). Results are significant for the younger but not the

older age group,

. Approximately 72 million persons (45.6 percent) –64

million white adults (47.0 percent) and 5.6 million

black adults (31.8 percent) have a ratio of TC to

HDL-C of 4.5 (17) or more (table 32).
Serum triglyceride

The age-adjusted mean serum triglyceride levels of

adults 20–74 years of age are 141 mg/di for men and

121 m#dl for women. The corresponding values are

144 m~dl and 122 mg/dl for white men and white

women respectively, and 116 and 105 for black men

and black women, respectively (table 5).

Approximately 7 percent of all adults 20-74 years of

age- have fasting- triglyceride levels greater than or

equal to 250 mg/dl (men have 9.3 percent and women

have 5.6 percent). Approximately 1 percent have values greater than or equal to 500 mg/dl (men have

1.5 percent, women have 0.3 percent) (table 20).

Low density lipoprotein cholesterol (LDL-C)

● The age-adjusted mean LDL-C of adults 20–74 years

of age is 137 mg/dl for both men and women. The

corresponding level is 13S mg/dl for both white men

and women and 12S for black men and 132 for black

women (table 6).

. The percent of persons with LDL-C levels of 160 mg/dl

or more was highest among black women (34.S percent), followed by white men (29.S percent), white

women (27.S percent), and lowest among black men

(17 percent) (table 23).

LDL-C:HDL-C ratio

● Men have consistently higher mean LDL-C:HDL-C

ratios than their female counterparts.

. The age-adjusted mean LDL-C:HDL-C ratio is higher

among white adults than among black adults—a difference of 0.65 among men and 0.3 among women.

The National Cholesterol Education

Program Adult Treatment Panel Guidelines

Persons who need treatment for high blood cholesterol:

. An estimated 42.5 million adults 20–74 years of age

(26.8 percent) –37.1 million white adults (27.2 percent) and 4.2 million black adults (23.S percent) —have

high serum cholesterol (TC > 240 mg/dI) (2). An additional 22 mil[ion persons (13.9 percent) – 19 million

white adults (13.9 percent) and 2.7 million black adults

(15.5 percent) have borderline-high TC (TC greater

than or equal to 200 but less than 240 n@dl) (2) and

CHD or 2 CHD risk factors. Therefore, an estimated

64.5 million adults 20–74 years of age ( =42.5 miIlion

+22 million), 56.1 million white adults and 6.9 million

black adults, would be referred for lipopro~ein analysis

(table 34).

. Of the 42.5 million persons 20–74 years of age with

high TC, 20 million (47.1 percent) are hypertensive

and 22.5 million (52.9 = (100-47.1) percent) are normotensive. Of the 22 million persons 20-74 years of

age with borderline-high TC and CHD O:Ctwo CHD

risk factors, 13.4 miliion (60.S percent) are hyperten-

●

●

●

●

●

●

●

●

●

●

sive and 8.6 million (39.2 percent) are normotensive.

Therefore, 33.4 million hypertensive adults and 31.1

million norrnotensive aduIts 20–74 years of age would

be referred for lipoprotein analysis (table 39).

Among women 20-44 years of age, the percent of oral

contraceptive users, nonusers, and recent discontinues who would be referred for lipoprotein analysis

because of high blood cholesterol is 18.2, 15, and 15,

respectively (table 35). Additional findings on TC have

been published (20,21).

Of the 42.5 milIion adults 20–74 years of age with high

TC, an estimated 4.6 million persons (10,9 percent)

also have an HDL-C level less than 35 m~dl. Of the 22

million adults 20–74 years of age with borderline-high

TC and CHD or two CHD risk factors, 3.6 million

(16.2 percent) also have an HDL-C level <35 mgjdl.

Therefore, an estimated 8.2 million persons with HDLC< 35 mg/dl wouId be referred for lipoprotein analysis

(table 45).

Of the 42.5 million adults 20-74 years of age with high

TC, 33.2 million (78.1 percent) have a ratio of TC to

HDL-C greater than or equal to 4.5. Of the 22 million

adults with borderline-high TC and CHD or two CHD

risk factors 14 million (63.5 percent) have a ratio of

TC to HDL-C of 4.5 or more. Therefore, 47.2 million

adults 20–74 years of age referred for lipoprotein

analysis also have a ratio of TC to HDL-C 2- 4.

(table 47).

Of those adults referred for lipoprotein analysis

8S.2 percent, 62.7 percent with high-risk LDL-C (LDLC> 160 mgldl) and 25.5 percent with borderline-high

risk LDL-C(LDL-C 2 130 but <160 mg/dl) and CHI

or two CHD risk factors, wouId need treatment for

high bIood cholesterol (tabIe 36).

Approximately 56.9 million adults 20–74 years of

age (35.9 percent), 40.4 milIion (25.5 percent) with

high-risk LDL-C and 16.5 (10.4 percent) with

borderline-high-risk LDL-C and CHD or two CHD

risk factors, need treatment for high blood cholesterol (table 37).

Of the 33.2 million hypertensive who would be referred for lipoprotein analysis (see above results in TC

section), an estimated 29.8 million (S9.S percent of

hypertensives referred for lipoprotein analysis) need

treatment for high blood cholesterol (table 43).

Only S.1 percent (3.5+4.6) of adults 20–74 years who

do not need lipoprotein analysis would need treatment

for high bIood cholesterol levels (table 38).

The percent of hypertensive who need treatment for

high blood cholesterol is 60.4 (tables 41 and 43).

The percent of normotensives who need treatment for

high blood cholesterol is:

24,S = (0.0S +0.207) x (0.169+ 0.695) X 100

(tables 42 and 44).

A higher percent of hypertensive persons than normotensive persons of the same race, sex, and age

group have high TC levels (tables 41 and 42).

9
References

1. Consensus Development Conference, Lowering blood cholesterol to prevent heart disease. JAMA 253:2080-86.1985.

2. Report of the National Cholesterol Education Program

Expert Panel on Detection, Evaluation, and Treatment of

High Blood Cholesterol in Adults. Arch Intern Med

148:36-69.

3. Stamler J. Lifestyles, major risk factors. Proof and Public

Policy Circulation 58(1):3-19. 197S.

4. Grundy SM, Goodman DS, Rifkind B, Cleeman JI. The

place of LDL in cholesterol management. Arch Intern Med

149:505-10.1989.

5. Castelli WP. Epidemiology of coronary heart disease: The

Framingham Study, Am J Med 76(2A): 4-12.1984.

6. Consensus Development Conference on treatment of hypertriglyceridemia. JAMA 251(9): 1196-1200.1984.

7. Grundy SM. Cholesterol and Coronary Heart Disease, “Future Directions. JAMA 264:3053–59. 1990.

8. McDowell A, Engel A, Massey JT, Maurer K. Plan and

operation of the second National Health and Nutrition

Examination Survey, 1976-S0. National Center for Health

Statistics. Vital Health Stat 1(15). 1981.

9. National Center for Health Statistics. Plan and initial program of the Health Examination Survey. National Center

for Health Statistics. Vital Health Stat 1(4). 1965.

10. National Center for Health Statistics. Plan and operation

and response results of a program of children’s examinations. National Center for Health Statistics. Vital Health

Stat 1(5). 1967.

11. National Center for Health Statistics. Plan and operation of

a health examination survey of U.S. youths 12–17 years of

age. National Center for Health Statistics. Vital Health Stat

1(8). 1969.

12. Miller HW, Plan and operation of the Health and Nutrition

Examination Survey, United States, 1971–1973, National

Center for Health Statistics. Vital Health Stat l(lOa). 1978,

13. Engel A, Murphy RS, Maurer K, Collins E. Plan and

operation of the NHANES I Augmentation Survey of Adults

25-74 years, United States, 1974–75. National Center for

Health Statistics. Vital Health Stat 1(14). 197S.

14. Murphy RS, Michael CA, Methodology and considerations

of the National Health and Nutrition Examination Survey.

Am J Clin Nutr 3571:1255-5S,

15. CastelIi WP, Abbott RD, McNamara PS. Summary estimates used to predict coronary heart disease. Circulation

67(4):730-34. 19S3.

16. Friedewald WT, Le~ RI, Fredrickson DS, Estimation of

the concentration of low density lipoprotein cholesterol in

plasma without use of the preparative ultracentrifuge. Clin

Chem 18:499-502.1972.

17. Grundy SM, Greenland P, Herd A, et al. Position statement, American Heart Association. Cardiovascular and risk

factor evaluation of healthy American adults, Circulation

75(6): 1339A-62A. 1987.

18. Carroll MD, Sempos CT, Fulwood RF, et al. Serum Lipids

and Lipoproteins of Hispanics, 1982-84. National Center

for Health Statistics, Vital Health Stat 11(240). 1990.

19. Sempos C, Fulwood R, Haines C, et al. The prevalence of

high blood cholesterol in adults in the United States. JAMA

262(1):45-52. 1989.

20. Fulwood R, Kalsbeek W, Rifkind B, et al. Total serum

cholesterol levels of adults 20–74 years of age, United

States, 1976-80. National Center for Health Statistics. Vital

Health Stat 11(236). 1986.

21. Russell-Briefel R, Ezzati TM, Hyg MS, et al, Cardiovascular

risk status and oral contraceptive use: United States, 197680.

Prev Med 15:352-62, 1986,

22. Linn S, Fulwood R, Rifkind B, et al. High density lipoprotein cholesterol levels among US. adults by selected demographic and socioeconomic variables: The Second National

Health and Nutrition Examination Survey, 1976-90. Am J

Epidemiol 129(2):281-94. 1989.

23. Linn S, Ftdwood R, Carroll MD, et al. Serum total cholesterol: HDL cholesterol ratios in U.S. white and black adults

by selected demographic and socioeconomic variables. ,4JPH

S1:1038-43. 1991.

24. National Center for Health Statistics. Hematology and biochemistry ages 6 months-74 years, Tape No. 5411-NHANES

II, 1976-80. Public use data documentation. Public Health

Service. 1989.

25. Manual of Laboratory Operations, vol 1, Lipid Research

Clinics Program, Lipid and Lipoprotein Analysis, DHEW

Publication no. (NIH) 75-628.1974.

26. Bachorik PS, Wood PDS, Williams J, et al. Automated

determinations of total plasma cholesterol. A serum calibration technique. Clin Chim Acts 96:145.1979.

27. National Center for Health Statistics. The National Health

Interview Survey design, 1973-84, and procedures, 1975-83.

National Center for Health Statistics. Vital Health Stat

1(18). 1985.

2S. Goodman R, Kish L. Controlled selection – a technique in

prob:ibility sampling. J Am Stat Assoc 45:350-72.1950,

29. Kish L. Survey Sampling. New York: John Wiley and Sons,

Inc. 1965.

30. Forthofer RN. Investigation of nonresponse bias in NHANES

11,Am J Epidemiol 117(4):507-15. 1983,

31, Chapman D. A comparison and analysis of examined and

unexamined persons on medical history characteristics for

the first round of the Health and Nutrition Examination

10
Survey. Contract No. HSM-1 10-73-371. Health Services

and Mental Health Administmtion, Roch_ville, Maryland:

Westat, Inc. 1974.

32. Institute for Survey Research. The HANES study final

report. Contract No. HSM-11O-73-376. Health Services and

Mental Health Administmtion. Philtidelphia: Temple University. 1975.

33. Miller H, Williams P. Factors related to response in a health

examination survey, United States, 1960-62. National Center for Health Statistics. Vital Health Stat 2(36). 1969.

34. Schaible WL. Memorandum to Arthur J. McDowell. Division of Health Examination Statistics. June 21, 1974.

35. Hadden WC, Harris MI. Prevalence of diagnosed diabetes,

undiagnosed diabetes, and impaired glucose tolerance in

adults 20-74 years of age. National Center for Health

Statistics. Vital and Health Stat 11(237). 19S7.

36. Bryant E, Baird JT. Cooperation in health examination

surveys. National Center for Health Statistics. Vital Health

Stat 2(9). 1965.

37. Schaible WL. Quality control in a national health emmination survey. National Center for Health Statistics. Vital and

Health Stat 2(44). 1972.

3S. Brymt EE, Kowr MG, Miller H. A study of the effect of

remuneration upon response in the Health tmd Nutrition

Examination Survey, United States. National Center for

Health Statistics. Vital and Health Stat 2(67). 1975.

39. U.S. National Health Survey. Attitudes towarcs coopemtion

in a health examination survey. Health Statistics. Series D,

No. 6. Public Health Service. 1961.

40. Woodruff RS. Simple method for approximating wriance of

a complicated estimate. J Am Stat Assoc 66:411-14.1971.

41. Shah BV. SESUDA4N: Standard errors program for computing standardized rates from sample survey data. Contract

No. RTI/5250,00-OlS. Research Triangle Park, NC: Research Triangle Institute. 19S1.

42. Holt M. SURREGR: Standard errors of regression coefficients from sample survey data. Research Triangle Park,

NC Research Triangle Institute. May 1977: revised Apr

19S2.

43. Landis JR, Stanish W, Freeman JL, et al. A computer

program for the generalized chi-square analysis of categorical data using weighted least squares (GENCAT). Comput

Methods Programs Biomed 6:196-231.1976.

44. Rose GA, Blackburn H, Gillam RF, et al. Cardiovascular

Survey Methods 2nd ed. Geneva, Switzerland. World Health

Organization. 1982.

45. National Center for Health Statistics. Medical history, ages

12-74 years. Tape No. 5020 -NHANES II 1976-S0. Public

use data documentation. Public Health Service. 19S5.

46. National Center for Health Statistics. Health history supplement ages 12-74 years. Tape No. 5305-NHANES II 1976-S0.

Public use data documentation. Public Health Service. 19S3.

47. National Center for Health Statistics. Body measures ages 6

months-74 years. Tape No. 5301-NHANES H 1976-S0.

Public use data documentation. Public Health Service. 19S4.

4S. Metropolitan Life Insurance Company: New weight standards for men and women. Stat Bull Metrop Insur Co

40:1-4.1959.

11
List of detailed tables

1.

2,

3.

4.

5.

6.

7.

8.

9.

10.

11.

12

Serum total cholesterol levels for persons 20-74 years

of age, number of examined persons, mean, standard

error of the mean, and selected percentiles, by sex,

race, arrd age: United States, 1976–S0.. . . . . . . . . . . .

Serum high density lipoprotein (HDL) cholesterol

levels for persons 20-74 years of age, number of

examined persons, mean, standard error of the mean,

and selected percentiles, by sex, ruce, and :ige: United

States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Serum non-high density lipoprotein (non-HDL) cholesterol levels forpcrsons 20-74 years of age, number

of examined persons, mean, standard error of the

mean, and selected percentiles, by sex, race, and age:

United States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . .

Ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol levels for persons 20–74 years

of age, number of examined persons, mean, standard

error of the mean, and selected percentiles, by sex,

rtice, imdage: United States, 1976-S0 . . . . . . . . . . . . .

Serum triglyceride levels for persons 20–74 years of

age fasting 12 hours or more, number of examined

persons, mean, standard error of the mean, and selected percentiles, by sex, race, und age: United States,

1976-80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Calculated serum low density lipoprotein (LDL) cholesterol levels for persons 20-74 years of age fasting 12

hours or more, number of examined persons, mean,

standard error of the mean, and selected percentiles,

by sex, race, and age: United States, 1976-SO. . . . . . .

Ratio of calculated serum low density lipoprotein

(LDL) cholesterol to high density lipoprotein (HDL)

cholesterol levels for persons 20–74 years, number of

examined persons, mean, standard error of the mean,

and selected percentiles, by sex, race, and age: United

States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of serum total cholesterol levels for persons 20-74 years of age, and number

of examined persons, by race, selected cholesterol

level cutoffs, andsex: United Sta[es. 1976-80 . . . . . . .

Cumulative percent distribution of serum total cholesterol levels for men 20-74 years of ageancl number of

examined persons, by race, selected cholesterol level

cutoffs, and age: United States, 1976–S0 . . . . . . . .

Cumulative percent distribution of serum total cholesterol levels for women 20–74 years of age and number

of examined persons, by race, selected cholesterol

level cutotYs, an dage:Un]tedStates, 1976-80. .,....

Cumulative percent distribution ofhigh densitylipoprotein (HDL) cholesterol levels for persons 20–74 years

of age and number of examined persons, by race,

15

16

17

1s

19

20

21

22

24

26

I ~,

13.

14.

15.

16.

17.

1s.

19.

20.

21.

selected HDL cholesterol level cutoffs, and sex: United

States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of high density lipoprotein (HDL) cholesterol levels for men 20-74 years of

:age and number of examined persons, by race, HDL

cholesterol level cutoffs, and age: United States,

1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

(Cumulative percent distribution of high density lipoprotein (HDL) cholesterol levels for women 20–74 years

of age and number of examined persons, by race, HDL

cholesterol level cutoffs, and age: United States,

1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of serum non-high

density lipoprotein (non-HDL) cholesterol for persons

20-74 years of age by race and selected cholesterol

level cutoffs, according to sex: United States, 1976-S0

Cumulative percent distribution of serum non-high

density lipoprotein (non-HDL) cholesterol for men

20-74 years of age and number of examined persons

by race and selected cholesterol level cutoffs, accordingtoage: United States, 1976–S0 . . . . . . . . . . . . . . .

Cumulative percent distribution of serum non-high

density lipoprotein (non-HDL) cholesterol for women

20-74 years of age and number of examined persons

by race and selected cholesterol level cutoffs, accordingtoage: United States, 1976–S0 . . . . . . . . . . . . . . .

Cumulative percent distribution of the ratio of serum

total cholesterol to high density lipoprotein (HDL)

cholesterol forpersons 20-74 year so fageand number

of examined persons by race and selected ratio cutoffs,

according to sex: United States, 1976–S0 . . . . . . . . . .

Cumulative percent distribution of the ratio of serum

total cholesterol to high density lipoprotein (HDL)

cholesterol for men 20–74 yearsof agc and number of

examined persons, by race, selected ratio cutoffs, and

age: United States, 1976-SO. . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of the ratio of serum

total cholesterol to high density lipoprotein (HDL)

cholesterol for women 20-74 years ofage and number

of examined persons by race and selected ratio cutoffs,

according toage: United States, 1976-S0 . . . . . . . . . .

Cumulative percent distribution of serum triglycerides

for persons 20-74 years of age fasting 12 hours or

more and number of examined persons by race and

selected serum triglyceride cutoffs, according to sex:

United States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of serum triglycerides

for men 20–74 years of age fasting 12 hours or more

and number ofexamined persons byrace and selected

triglyceride cutoffs, according to age: United States,

1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2s

30

32

34

36

3s

40

42

44

46

4s
22.

23.

24.

25.

26.

27,

~s,

29.

30.

31.

32.

33.

Cumulative percent distribution of serum triglycerides

for women 20-74 years of age t%ting 12 hours or more.

and number of examined persons by race arid selected

serum triglyceride cutoffs, according to age: United

States, 1976-80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of calculated values of low density lipoprotein (LDL) cholesterol

for persons 20-74 years of age Fasting 12 hours or

more and number of examined persons by race and

selected LDL cutoffs, according to sex: United

States, 1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of calculated wdlues of low density lipoprotein (LDL) cholesterol

for men 20-74 years of age fasting 12 hours or more

and number of examined persons by race and

selected LDL cutoffs, according to age: United

States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of calculated values

of low density lipoprotein (LDL) cholesterol for men

ZO-74 years of age fmting 12 hours or more and

number of exzzmined persons by race and selected

LDL cutoffs, according to sex: United States,

1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of the ratio of calculatedvduesof Iow density lipoprotein (LDL) cholesterol to high density lipoprotein (HDL) cholesterol for

persons 20-74 years of age fmting 12 hours or more

and number of examined persons by mce and sex:

United States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . .

Cumulative percent distribution of the ratio of calculated values of low density lipoprotein (LDL) cholesterol to high density lipoprotein (HDL) cholesterol for

women 20-74 years of age Pasting 12 hours or more

and number of examined persons by race and LDL

cutoffs, according to age: United States, 1976-S0 . . . .

Cumulative percent distribution of the ratio of calcuhtedvalues oflowdensilyl ipoprotein (LDL)cholesterol to high density lipoprotein (HDL) cholesterol for

women 20-74 years of age fasting 12 hours or more

and number of examined persons by mce and selected

ratio cutoffs, ticcording to age: United States,

1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Serum total cholesterol levels for women 20-44

years of age, number of examined persons, mean,

standard error of the mean, and selected percentiles, by race, oral contraceptive use, and age:

United States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . .

Serum high density lipoprotein (HDL) cholesterol for

women 20-44 years of age, number ofexmnined persons, mean, sttindard error of the mean, and selected

percentiles, by race, oral contraceptive use, and age:

United States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . .

Ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol for women 20-44 ye~rs of age,

number of examined persons, mean, standard error of

the mean, and selected percentiles, by race, oral contraceptiveuse, and age: United States, 1976-S0 . . . . .

Percent of persons 20-74 years of age with ratio of

serum total cholesterol to high density lipoprotein

(HDL) cholesterol greater than or equal to 4.5,

number of examined persons, and standard error of

the percent, by race, age, and sex: United States,

1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Percent of persons 20-74 years of age with high

density lipoprotein (HDL) cholesterol less than 35

milligrams per deciliter, number of e~~minedpersons,

50

52

54

56

5s

60

62

64

65

66

67

34.

35.

36.

37.

3s.

39.

40.

41.

42.

43.

44,

45.

and standard error of the percent, by race, age, and

sex United States, 1976-SO.. . . . . . . . . . . . . . . . . . . .

Percent ofpersons 20-74 yearsof age with desirable,

borderline-high and high serum total cholesterol levels, number of e~dmined persons, and standard error

of the percent, by sex, race, and age: United States,

1976-s0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Percent of women 20J14 years of age with desirable,

borderline-high and high serum total cholesterol levels, number of examined persons, and standard error

of percent, by race, oral contraceptive use, and age:

United States, 1976-S0 . . . . . . . . . . . . . . . . . . . . . . . .

Percent of persons 20-74 years of age with desirable,

borderline-high-risk, and high-risk low density Lipoprotein (LDL) cholesterol levels values as a percentage of

the total number needing lipoprotein analysis, number

of examined persons, and standard error of the percent,

by sex, mce, and age United States, 1976-S0. . . . . . ., .

Percent of persons 20-74 years of age with desirable,

borderline-high-risk, and high-risk low density lipoprotein (LDL) cholesterol levels as a percentage of the total

U.S.populationand number-c-examined persons,bysex,

race, and age United States, 1976-SO . . . . . . . . . . . . . .

Percent of persons 20-74 years of age who did not

need lipoprotein analysis with desirable, borderlinehigh-risk, and high-risk low density lipoprotein (LDL)

cholesterol levels, and number of examined persons,

by sex, race, and age: United States, 1976-S0. . . . . . .

Percent of persons 20-74 years of age in the desirable,

borderline-high, and high serum total cholesterol categories with hypertension, number of examined persons, and standard error of the percent, by sex, race,

andage: United States, 1976-S0 . . . . . . . . . . . . . . . . .

Percent of persons 20-74 years of age in the desirable,

borderline-high-risk, and high-risk low density lipoprotein (LDL) cholesterol categories with hypertension,

as a percentage of the total number needing lipoprotein analysis, number of examined persons, and standard error of the percent, by sex, race, and age: United

States, 1976-S0 . . . .. c . . . . . . . . . . . . . . . . . . . . . . . .

Percent of hypertensive persons 20-74 years of age

with desirable, borderline-high, and high serum total

cholesterol levels, number of examined persons, and

standard error of the percent, by sex, race, and age:

lJnited States, 1976-SO . . . . . . . . . . . . . . . . . . . . . . . .

Percent of normotensive persons 20-74 years of age

with desirable, borderline-high, and high serum total

cholesterol levels, number of examined persons, and

standard error of the percent, by sex, race, and age:

United States, 1976-S0 . . . . . . . . . . . . . . . . . . . . . . . .

Percent of hypertensive persons 20-74 years of age

with desirable, borderline-high-risk, and high-risk low

density lipoprotein (LDL) cholesterol levels, number

of examined persons, and standard error of the percent,

by sex, race, and age: United States, 1976-S0. , . . . . . . .

Percent of normotensive persons 20-74 years of age

with desirable, borderline-high-risk, and high-risk low

density lipoprotein (LDL) cholesterol levels, number

of examined persons, and standard error of the percent,

by sex, race, and age: United States, 197&S0. . . . . . . . .

Percent of persons in the desirable, borderline-high,

and high serum total cholesterol categories with a

value for high density lipoprotein (HDL) cholesterol

less than 35 milligrams per deciliter (mg/dl), number of

6S

70

72

73

75

77

79

S1

S2

84

S5

Ss

13
examined persons, smcistandard error of the percent, by

sex, race, andage: United States, 1976-80. . . . . . . . . . .

46. Percent of persons in the desirable, borderline-highrisk, and high-risk low density lipoprotein (LDL)choIesterol categories with a value for high cfensjty

lipoprotein (HDL)cholesteroI iessthan 35mil[igrams

per deciliter (mg/d[), number of examined persons,

and standard error of the percent, by sex, race, and

age: United States, 1976-80 . . . . . . . . . . . . . . . . . . . .

47. Percent of persons in the desirable, borderline-high,

and high serum total cholesterol categories with a

value for the ratio of serum total cholesterol to high

density lipoprotein cholesterol greater than or equal to

4.5, number ofexamined persons, and standard error

90 of the percent, by sex, race, and age: United States,

19:7&80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93

48. Pe:rcent of persons in the desirable, borderline-highrisk, and high-risk serum low density lipoprotein (LDL)

cholesterol categories with a value for the ratio of

serum total cholesterol to high density lipoprotein

(HDL) cholesterol greater than or equal to 4.5, num92 ber of examined persons, and standard error of the

percent, bysex, race, andage: United States, 1976-80 95

14
Table 1. Serum total cholesterol levels for persons 20-74 years of age, number of examined persons, mean, standard error of the mean,

and selected percentiles, by sex, race, and age: United States, 1976-80

Number of Standard Percentile

examined error of

Sex, race, and age persons Mean the mean 5th loth 15th 25th 50th 75th 85th 90th 95th

Men

All races:2

20-74 years . . . . . . . . . . . . . . .

20-74 years, age adjusted. .

20-24 years . . . . . . . . . . . . . .

25–34years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . . . .

20-74 yeara, age adjusted. . . . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years, . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . . .

20–74 years, age adjusted. . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65–74 years...........,,,

Women

All races:2

20-74 years, . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . .

20-24 years,.........,,..

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years, . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . . . .

20-74 yeare, age adjusted. .

20-24 years . . . . . . . . . . . . . .

25-34 years, . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years, . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . .

20-24 yeare . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55–84years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

Serum total cholesterol in milligrams per deciliter (mg/dl)l

5,604

.

676

1,067

745

690

1,227

1,199

4,883

,..

581

901

653

617

1,086

1,045

607

. . .

79

139

70

62

129

128

6,260

. .

738

1,170

844

763

1,329

1,416

5,418

. . .

624

1,000

726

647

1,176

1,245

729

. . .

94

145

103

100

135

152

211

211

1.30

199

217

227

1.2

1.1

1.7

1.5

2.0

1.8

1,8

1.8

1.2

1.1

1.8

1.7

1.8

1.8

2.0

2.0

2.5

2,4

‘3,7

‘4.1

*8.3

*7.1

‘4.8

4.2

1.2

1,2

1.9

i .4

1.8

2.2

2.0

1.6

1.3

1.2

2.1

1.5

1.9

2.6

1.7

1.7

3.1

2.7

*4.9

*4.1

*4,5

*7.2

*8.O

4.2

144

. . .

129

141

153

159

164

153

145

. . .

131

144

153

160

164

153

133

156

. . .

136

152

166

176

176

167

157

. .

138

153

166

177

178

167

146

. . .

128

136

156

374

168

163

156

!..

140

145

165

. . .

145

159

173

182

184

175

166

. . .

146

161

173

181

185

175

156

.,.

134

144

168

184

172

173

166

. .

145

154

164

188

203

198

166

179

. . .

155

206

. . .

176

194

215

223

239

. . .

258

215

240

262

271

277

265

258

. . .

216

239

260

271

278

266

260

. . .

210

248

275

268

271

261

266

. . .

216

233

248

275

299

295

267

. . .

215

235

248

274

298

296

263

. . .

220

226

254

277

318

290

271

. . .

227

254

275

291

. . .

246

275

293

303

307

301

291

. . .

244

273

291

303

307

301

301

. . .

●

301

*

●

312

299

305

. . .

250

263

276

306

336

327

305

.,.

249

261

277

308

330

328

308

,..

*

267

279

306

345

323

202

172 220

187 244

197 255 283

198 225 254

249

288

279

271

. . .

221

211

211

191

179

. . .

155

172

187

217

207 239

180 176 202 229

199

217

194

214

220 254

272

283

289

281

273

. . .

211

259

283

279

244

198 222 254

230 199 225 255

191

171

. . .

149

163

176

195

183

183

179

. . .

157

164

177

199

215

214

179

. . .

159

164

t 77

199

215

214

176

. . .

156

167

175

200

211

211

217 250 222

208 200 238

208 . . .

170 171 *

129

*

*

157

149

143

,.,

132

135

147

164

180

173

143

. . .

133

135

147

166

180

174

140

. . .

*

129

143

150

178

173

193

199 192 226

218 202

232

218

216

210

. . .

180

188

202

228

242

241

210

238

229 261

223

2“’ 7

2<5

214

184

192

207

232

249

2Z6

216

214

1E4

1$2

2C17

222

249

246

212

214

185

191

206

230

251

243

254

244

245

. . .

299

277

282

. . .

230

243

260

204

215

231

257

277

274

248

. . .

204

215

231

257

277

275

237

. . .

204

212

233

263

280

269

158

178 290

193

189

314

309

156 282

. . .

230

244

. .

140

145

157

179

193

190

154

. . .

136

144

158

172

185

189

?47

153

184

188

203

199

166

. . .

144

156

170

181

198

198

181

188

203

228

244

242

205

. . .

178

190

194

226

233

237

259

290

312

309

279

. . .

237

235

274

291

336

308

1To convert to m!lhmoles per liter (mmol/L), multiply by 0.02586,

21ncludes data for races not shown SeParatehf.

15
Table 2. Serum high density lipoprotein (HDL) cholesterol levels for persons 20-74 years of age, number of examined persons, mean,

standard error of the mean, and selected percentiles, by sex, race, and age: United States, 1976-80

Number of Standard Percentile

examined error of —

Sex, race, and age persons Mean the mean 5th 10th 15th 25th 50th 75th 85th 90th 95th

Men

All races:2

20–74 years . . . . . . . . . . . . . . ,.

20–74 years, age adjusted.

20-24 years.,,..,.....,.,

25–34years .,.........,..

35-44 years . . . . . . . . . . . . . .

45–54 years, . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65–74 years . . . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . . .

20-74 years, age adjusted.

20–24 years . . . . . . . . . . . . . .

25–34 years . . . . . . . . . . . . . .

35-44 years....,,.....,,.

45-54 years.,,..,.....,..

55–64 years.........,.,..

65-74 years,.......,..,..

Black:

20–74 years . . . . . . . . . . . . . . .

20-74 years, age adjusted. .

20-24 years . ., . . . . . . . . . . .

25-34 years . ., . .,, ,. .,..,

35-44 years . . . . . . . . . . . . . .

45–54 years . ., ., . . . . . . . . .

55-64 years...........,..

65-74 years . ., . . . . . . . . . . .

Women

All races:z

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. .

20–24 years, ., .,, ,., . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45–54 years,,,..,.,,.,,,,

55-64 years, . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

White:

2G74 years, . . . . . ...,,,...

20-74 years, age adjusted.

20-24 years . ., . .,, ,,, . . . .

25–34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45–54 years..,.,....,.,,,

55–64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . . .

20-74 years, age adjusted.

20-24 yaars . . . . . . . . . . . . . .

25–34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

4,562

.

570

885

611

559

964

973

4,019

494

751

545

506

865

858

462

,,.

65

112

54

47

92

92

5,235

.

634

1,017

722

641

1,086

1,135

4,563

.

542

875

626

546

973

1,001

581

.

77

122

84

81

99

118

45.2

45,2

46.7

45.0

44.2

44,1

46,0

45,7

44,4

44,5

45.9

44.4

43.4

43.3

45,4

44,6

51.8

51.9

53.0

49.9

50.8

53.3

52.9

53.5

53.7

53.6

53.1

52.5

52.7

55.1

55.9

53.2

53.4

53.4

52.8

52.2

52.4

55.1

55.7

52.6

56.2

56.3

56.6

55.4

55.1

56.2

58.3

57.1

Serum HDL cholesterol in milligrams per deciliter (mg/dl)l

0,4

0,4

0,6

0.5

0.7

0.7

0.5

0.7

0.4

0.4

0.7

0.5

0.7

0.7

0.6

0,7

0.7

0.7

*1,7

*1,6

‘2.0

‘3.0

*1,9

*2.1

0.4

0.4

0,7

0.5

0.6

0,7

0.9

0.6

0.4

0.4

0,7

0,5

0.6

0.8

0.8

0.6

0.9

0.9

*1.8

“1.6

“1.9

‘1,8

‘2,8

*1,8

29.0

.,.

32.0

29.0

28.0

26.0

28.0

29,0

28.0

. . .

31,0

29,0

26.0

28.0

27,0

29.0

33,0

,..

*

31.0

*

*

*

*

33.1

. . .

34.0

33,0

34.0

34.0

33.0

33.1

34.0

. .

33.1

33.1

34,0

34.0

33.0

33.0

34,0

. .

*

32.0

*

*

*

38,0

32.0

. .

34.0

32,0

32,0

32,0

32.0

32.0

32,0

. . .

34.0

32.0

32.0

31,0

31,0

32.0

35.1

. .

39.0

35.0

34.0

*

36.0

35.0

37.0

. . .

37.0

36.0

37.0

38.0

37.1

37.0

37.0

.,.

37.0

37.0

37.0

38.0

37.0

36.1

38.0

. .

41.0

35.0

36.0

39.0

38.1

40.0

34.0

,.,

36.0

34.0

34.0

34.0

34.0

33.0

34.0

. .

36.0

34.0

33.1

33.1

33.1

33.0

38.0

. .

40.0

37.0

37.0

36.0

39.0

39.0

39.0

,..

39.0

39.0

39.0

40.0

39.0

39,0

39,0

.,.

39.0

39.0

39.0

40,0

39.0

39.0

41.0

. . .

43,0

41.0

38.0

41.0

40.0

41.0

37.0

. .

39.0

37.0

36.0

36.0

36,0

36,0

36.0

. . .

36,0

37.0

36.0

36.0

36.0

36,0

40.1

. . .

45,0

40.0

39.0

41.0

40.1

43,0

44.0

. . .

44,0

44.0

43.0

45.0

45.0

43,0

44.0

. . .

43.1

44,0

43.0

45.0

45.0

43.0

45,0

. . .

48.0

45.0

44.0

43,0

43.0

43.0

44,0

. .

45.0

44.0

41.1

41,1

44.1

44.0

43.0

. .

44.1

43.0

41.0

41.0

44,0

43.1

49.0

. . .

51.0

46.1

49.0

48.J

49,0

50.0

52.0

. . .

51.0

51.0

51.0

63.0

53.0

51.0

51.1

. .

51.0

51.0

50.0

52.1

53.0

51.0

53.1

. .

55.0

52.1

53.0

56.0

55.0

56.0

51.0

. . .

52.0

51.0

50.0

50.0

52.1

52.1

50.1

. .

51.0

50.0

49.0

49.0

52.0

51.1

59.0

. .

56.0

58.0

60.0

57.1

61.0

62.0

62.0

. . .

61.0

60.0

60.0

63.0

66.0

61.0

61.1

. . .

61.0

60.0

60,0

63.0

65.1

60.0

65.0

. .

64,n

63.0

62.0

65.0

74.0

65.1

57.0

.,.

57.1

56.0

56.0

56.0

58.1

56.0

56,0

.,.

57.0

55,0

53.0

55.0

58.0

57.0

64.0

.,.

64.0

63.0

63.1

74.1

68.0

72.0

68.1

. .

65.1

65.1

66.1

70.1

72.1

68.0

68.0

. . .

65.1

65.0

66.0

70.1

71.1

66.1

72.1

. .

70.1

70.1

69.1

70.1

76,0

76.0

6041

. . .

61.0

59.0

60.0

59.0

63.0

62.0

59.0

. . .

60.0

58.1

56.0

58.0

62.1

60.0

72.1

. .

65.1

70.0

66.1

*

71.1

77.0

72.1

. . .

71.0

70.1

71,1

75,1

77.1

73.1

72.1

. . .

70.0

69.1

71.1

76.1

77.1

72.1

76.1

. .

76.0

77.1

72.1

74.0

60.0

80.0

68.1

. . .

70.1

66.1

65.1

66.0

71.0

71.0

66.0

.,.

69.1

64.1

64.1

65.0

89.0

66.1

80.1

. .

*

73.0

*

*

*

*

80.1

,..

77.0

75.1

77.0

84.1

66.1

61.1

80.0

. .

77.0

75.0

76.1

65.0

66.0

81.0

84.1

. . .

*

68.1

*

*

*

83.1

lTOconverl to mlllimoles per liter (mmol/L), multlply by 0.02586

‘Includes data for races not shown separately.

16
Table 3. Serum non-high density lipoprotein (norl-HDL) cholesterol levels for persons 20-74 years of age, number of examined persons,

mean, standard error of the mean, and selected percentiles, by sex, race, and age: United States, 1976-80

Number of Standard Percentile

examined error of

Sex, race, and age persons Mean the mean 5th 10th 15th 25th 50th 75th 85th 90th 95th

All races:2

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years..........,,,,

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35+44 yes.rs . . . . . . . . . . . . . .

45–54 years, . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20-24 years . . . . . . . . . . . . . .

25–34yesrs, . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-84 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

Women

All races:2

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . .

20-24 years, . . . . . . . . . . . . .

25-34 years..........,,.,

35-44 years . . . . . . . . . . . . . .

45-54 years, . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65–74 years . . . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . .

20–24years . . . . . . . . . . . . . .

25–34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55–64years . . . . . . . . . . . . . .

65-74 years, . . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . ...”

4,562

. . .

570

885

611

559

964

973

4,019

. . .

494

751

545

506

865

858

462

. . .

65

112

54

47

92

92

5.235

. .

634

1,017

722

641

1,086

1,135

4,563

. .

542

875

626

546

973

1,001

581

. .

77

122

84

81

99

118

165

165

132

154

173

182

183

175

167

166

133

155

174

183

185

177

154

156

119

145

172

174

169

164

161

160

130

140

154

178

191

192

162

161

130

141

154

179

191

194

155

157

131

137

152

171

192

185

Non-HDL cholesterol in milligrams per deciliter (mg/dl)l

1,4

1.2

1.9

2.0

2.3

1.8

1.8

2.2

1,4

1.3

2.1

2.2

2.3

2.0

1,9

2,3

3.4

3.2

*3.7

*6. 1

*7,2

*8.5

*6.4

*5.8

1.5

1.4

2.1

1.8

2.1

2.7

2.3

2.0

1.5

1.4

2.2

2.0

2.3

3.2

1.9

1.9

3.4

3.3

‘5.1

*4.9

*4.3

*7.3

‘11.2

●4.9

97

. . .

81

93

106

116

117

107

99

. . .

84

95

107

118

119

108

82

. . .

*

79

*

*

109

91

90

. .

77

85

91

104

118

121

91

. . .

76

85

90

104

119

121

85

. . .

*

81

94

100

112

116

109

. . .

90

104

120

129

128

119

110

. . .

91

107

121

130

130

i 20

93

. . .

73

85

104

113

117

97

101

. .

87

94

101

121

133

134

101

. .

88

94

102

121

133

136

97

. . .

84

69

98

121

123

131

118

98

111

129

137

138

128

119

. . .

99

113

129

138

140

128

lot

.,.

85

97

119

128

117

114

110

. . .

95

100

109

129

140

145

111

. . .

95

100

109

130

140

145

108

. . .

67

97

110

129

140

139

131

. . .

107

125

142

i 52

153

145

133

. . .

108

126

142

154

155

147

117

. . .

96

105

142

138

129

130

124

. .

105

112

121

143

156

156

124

. . .

106

112

121

145

156

159

119

. . .

104

111

119

134

154

151

161

. . .

127

149

170

182

179

172

163

. . .

128

150

171

182

180

173

149

. . .

122

140

160

169

163

161

154

. .

126

135

151

175

187

189

155

.,.

126

134

151

175

188

190

149

. . .

124

139

148

165

172

186

195

. . .

153

176

202

210

210

203

196

. . .

154

178

202

210

211

205

185

. . .

135

168

205

195

204

192

193

. . .

151

163

179

206

221

222

194

. . .

150

164

181

209

220

223

180

. . .

156

154

176

201

213

211

214

. . .

169

199

218

228

232

219

214

. . .

169

200

218

229

232

220

205

. . .

154

198

224

218

227

211

213

. .

166

182

197

226

240

242

214

. . .

164

184

198

227

240

244

204

. . .

170

173

183

222

270

228

229

. . .

179

212

234

237

245

234

230

. . .

179

213

234

237

245

236

222

. .

161

204

236

224

246

227

227

. . .

176

200

210

239

256

255

228

. . .

173

200

210

240

255

258

222

. . .

190

177

201

229

292

249

245

. . .

199

232

246

258

265

253

246

. . .

198

233

246

258

264

254

247

. . .

*

240

*

*

270

250

250

. . .

197

217

229

257

281

279

250

. . .

192

216

227

260

276

281

249

. . .

*

227

245

247

305

263

1Non-HDLcholesterol= totalcholesterol- HDLcholesterol.To convertto m!llimolesper Ihter(mmol/L),mu!t!plyby 0,025a6.

21ncludesdataforracesnotshownSeparately.

17
Table 4. Ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol levels for persons 20-74 years of age, number of

examined persons, mean, standard error of the mean, and selected percentiles., by sex, race, and age: United States, 1976-80

Number of Sfandard Percent//e

examirred error of

Sex, race, and age persons Mean the mean 5th 10th 15th 25th 50th 75fh 85th 90th !75th

Men

All races: 1

20–74 years,,,,,...,,,,,,..

20–74 years, age adjusted.

20–24years, ,, ...,,,,,,..

25–34 years, . . . . . . . . . . . . .

35-44 years.,...,,,...,.,

45-54 years .,, . .,, ,,, . . . .

55-64 years . . . . . . . . . . . . . .

65–74 years . . . . . . . . . . . . . .

White:

20-74 years .,, . . . . . . . . . . . . .

20–74 years, age adjusted,

20–24 years..,,,,.....,,,

25–34 years.,,,,.....,,,,

35–44 years,,,,,.....,,,,

45–54 years . ., .,, . . . . . . . .

55–64 years,,,......,,,..

65–74 years,...,,.....,.,

Black:

20–74 years,,,,....,,,.,,..

20-74 years, age adjusted,

20–24 years . . . . . . . . . . . . . .

25534 years,,...,,..,.,..

35-44 years,,,..,..,.,,,,

45–54 years.,,.,,.,.,.,.,

55–64 years,,,.....,.,,,,

65–74 years...........,..

Women

All races:l

20–74 years,...,,.,.,...,.,

20-74 years, age adjusted,

20–24 years, ., . ., ...,,.,,

25–34 years...,.,.....,..

35–44 years . . . . . . . . . . . . . .

45–54 years . . . . . . . . . . . . . .

55-64 years.,,,,....,.,,,

65–74years, ,,, . . . . . . . . . .

White:

20-74 years .,, , . . . . . . . . . . .

20-74 years, age adjusted.

20-24 years....,,,,,,.,..

25-34 years . . . . . . . . . . . . . .

35–44 years ., . .,, ,. .,,...

45–54 years . . . . . . . . . . . . . .

55–64 years, ., .,, ..,...,,

65-74 years.,,,,.....,,,,

Black:

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted.

20-24 years,,.......,,,..

25-34 years..,.,,,,,,,,..

35=14 years . . . . . . . . . . . . . .

45–54 years . .,, ,, .,,,....

55–64 years, .,, ,,, ,,, . . . .

65–74 years, ., .,, ,,, . . . . .

4,562

570

885

611

559

964

973

4,019

494

751

545

506

865

858

462

65

112

54

47

92

92

5,235

634

1,017

722

641

1,086

1,135

4,563

542

875

626

546

973

1,001

581

. .

77

122

84

81

99

118

4.96

4,96

4,05

4.69

5.24

5.48

5.38

5.22

5.06

5.05

4,11

4,75

5,31

5,55

5.47

5.30

4.28

4,33

3.43

4,16

4.69

4.75

4,50

4,49

4.27

4.27

3.64

3.69

4.19

4,56

4,82

4,94

4.30

4,28

3.66

3.90

4,20

4.57

4.61

5,00

4,06

4.10

3,45

3.76

4.12

4.35

4.78

4.50

0.05

0,05

0.07

0.07

0.10

0.09

0.07

0.10

0.06

0.06

0.06

0.06

0.10

0.09

0.08

0.10

0.10

0.10

‘0.1 1

‘0,16

“0.23

‘0,37

‘0.18

*0.28

0.05

0.04

0.06

0.06

0,07

0.08

0.09

0.07

0,05

0.05

0.06

0.06

0.08

0.10

0.07

0.07

0.10

0.10

“0.14

“0.15

‘0.14

‘0.23

‘0.37

‘0.19

2.67

2.27

2.53

3.13

3.09

3,00

2.82

2.79

.,.

2.39

2.58

3.14

3.14

3.08

2,86

2.24

,..

*

2.37

*

*

*

*

2.40

2.23

2.36

2.43

2.46

2.60

2.66

2.42

2.23

2.40

2.45

2.45

2.63

2.88

2.30

*

2.22

*

*

*

2.52

:3.08

.

2,63

2,94

:3.40

:3.46

:3.40

3.26

3.17

2,72

3.05

3,41

3.50

3.47

3.32

2.59

2.24

2.59

2.91

*

2.79

2.67

2,66

.

2.43

2,57

2,66

2,82

2,89

3.11

2.68

.,.

2.43

2.58

2,66

2,80

2.91

3.16

2,51

.

2.39

2.38

2.45

3.00

2.60

2.97

3.35

.,.

2.85

3.20

3.57

3.79

3.70

3.49

3,43

. .

2.95

3.32

3.62

3.86

3.60

3.55

2,77

. .

2.44

2.74

3.34

2.83

3.00

2.64

2,86

,..

2,59

2.72

2.62

3.02

3.11

3.33

2.68

2,59

2,74

2.86

3,00

3.12

3.36

2.69

2.57

2.52

2.69

3.07

2.96

3,23

3.81

. .

3.16

3.68

3.96

4,28

4,09

3.93

3.88

3.25

3.74

4.06

4.35

4,17

4.03

3.08

,..

2,64

3.06

3.53

3.54

3,38

3.32

3.16

. .

2.88

2.96

3.16

3.33

3.56

3.82

3.18

2.90

2.98

3.19

3.33

3.57

3.83

2.98

. .

2,67

2,84

2,96

3.19

3.11

3.59

4,73

. .

3,93

4.46

4.91

5.34

5.07

5.00

4.81

. .

3,98

4,51

4,97

5.39

5.19

5.11

4.00

. .

3,22

3,91

4,45

4.17

4.28

4.13

3.96

3.42

3.60

3,97

4,30

4.51

4.69

3.98

3.42

3.63

3.98

4,35

4,52

4,75

3.70

. .

3.22

3.41

3.87

3.96

4.21

4.32

5.91

4.71

5.52

6.17

6.41

6.44

6.15

5.98

.,.

4.75

5.53

6.26

6.49

6.51

6,24

5.11

.

4.20

5.04

5.26

5.44

5.47

5.18

5.02

. .

4.20

4,49

4.94

5.45

5.72

5.80

5.04

4,20

4,51

4.97

5.47

5.67

5.89

4.70

. .

4.13

4.47

4.68

5.16

5,95

5.15

6.62

.

5.26

6,16

6.92

7,16

7.17

6.77

6.72

. .

5.31

6.22

6,97

7,24

7,25

6.84

5.69

4.41

5.64

6.07

6.09

6.30

5,69

5.77

. .

4.65

5.12

5.54

6.05

6.58

6,61

5.79

4.64

5.07

5.56

6.05

6.56

6.73

5.60

.

4,68

5.45

5.39

6.42

7.19

5.78

7,21

. . .

5.66

6.59

7.48

7.78

7.76

7.34

7,29

. . .

5.67

6.72

7.79

7.78

7.82

7.39

6,22

. .

4.70

6.06

6.75

*

6.89

6.64

6.30

5.05

5.65

6.07

6,61

7.21

7.09

6.30

. .

5.14

5.58

6.06

6,60

7,18

7,16

6.26

.

4.95

5.86

6.52

6.64

7.64

5.81

8.07

. .

6.51

7.51

8.15

8.79

8.42

8.21

13.13

. .

6.51

7.57

13,21

8.79

i3,54

8.25

7.36

. .

*

7.00

*

*

*

*

7.19

. .

5.70

6.61

6.87

7.50

8.28

7.97

7,24

,.,

5,72

6.61

6,74

7.60

8.17

6.03

7.05

*

6.47

*

*

*

7,07

1Includes data for races not shown separately

18
Table 5. Serum triglyceride levels for persons 20-74 years of age fasting 12 hours or more, number of examined persons, mean,

standard error of the mean, and selected percentiles, by sex, race, and age: United States, 1976-60

Number of Standard Percentile

examined error of

Sex, race, and age persons Mean the mean 5th 10th 15th 25th 50th 75th 85th 90th 95th

Men

All races:z

20–74years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55–64years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

White:

20-74 years, . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

3544 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years..........,,..

Black:3

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . .

Women

All races:2

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35–44years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-64 years..........,,,,

65-74 years . . . . . . . . . . . . . .

White:

20-74 years, . . . . . . . . . . . . . . .

20–74 years, age adjusted. . . . . .

20-24 years, . . . . . . . . . . . . .

25-34 years, . . . . . . . . . . . . .

3544years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-64 years, . . . . . . . . . . . . .

65-74 years . .,, . . . . . . . . . .

Black:3

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

1,269

. . .

83

206

150

132

352

346

1,111

. . .

86

174

133

119

312

307

133

. . .

1,484

. . .

123

230

194

193

332

412

1,290

. . .

104

208

161

166

266

365

166

,..

145

141

100

124

151

176

160

145

149

144

103

124

15?

164

159

148

116

116

124

121

1OL

1r)c.

107

129

149

154.

126

122

I oe

102

107

130

155

157

104

105

2.9

2.5

*6.3

5.8

10.0

12.5

7.4

5.7

3.3

2.7

*7.5

5.7

10,5

13.8

6,6

5.6

*6.8

*7.2

2.3

2.1

4.6

4.7

4.1

5,5

7.5

5.1

2.4

2.2

5.2

4.6

4.3

6.4

8.5

5.3

*4.2

*7.1

Serum triglyceride in milligrams per deciliter (mg/dl)l

55

...

*

48

60

60

65

62

58

...

*

46

60

60

68

64

43

...

49

...

46

44

51

59

53

70

49

...

47

44

51

59

53

74

47

...

65

...

51

59

65

74

76

69

66

51

59

69

80

77

74

54

...

56

...

51

50

54

67

68

83

56

..

55

50

54

64

71

65

51

...

72

...

60

85

72

82

83

79

73

...

59

64

73

83

83

83

64

.,.

64

...

54

55

57

72

74

91

66

...

63

54

56

70

78

91

56

...

84

...

67

79

81

93

91

91

85

...

69

77

87

95

92

93

74

...

74

...

66

67

67

81

92

104

75

...

69

66

67

81

99

104

66

...

116

...

85

105

119

136

126

128

120

...

91

105

129

145

126

131

99

. . .

107

...

91

87

92

115

125

134

108

...

94

86

93

117

128

135

89

. . .

166

...

116

149

178

203

186

167

173

...

116

149

189

211

188

166

132

...

149

...

127

123

123

159

178

184

151

...

128

123

127

164

182

185

120

...

203

...

140

182

202

248

240

203

210

...

160

185

208

255

240

205

145

.!.

185

...

153

147

160

181

226

221

187

. .

173

146

160

181

237

228

163

. .

240

...

168

197

245

299

295

237

250

. . .

200

202

245

302

294

239

159

. . .

211

. . .

187

176

188

218

272

243

214

. . .

187

174

168

207

277

247

180

...

312

...

*

280

310

350

346

285

316

,..

*

284

350

351

346

286

203

...

263

..

207

215

242

275

336

293

265

. . .

197

215

211

245

355

298

226

. .

i To COnverl to mdhmoles per liter (mmol/L), mulhply by 0.01129,

21ncludes data for races not shown Separately.

3rjata nOt give” by age because of small sample size.

19
Table 6. Calculated serum low density lipoprotein (LDL) cholesterol levels fc)r persons 20-74 years of age fasting 12 hours or more,

number of examined persons, mean, standard error of the mean, and selected percentiles, bv sex, race, and age: United States, 1976-80

Number of Standard Percer7ti/e

examined error of

Sex, race, and age persons Mean the mean 5th 10th 15th 25th 50th 75th 85th 90th 95th

Men

All races:z

20-74 years...,,..,....,.,

2D-74years, age adjusted.

2D-24 yeara, ,, . . . . . . . . . . .

25–34years, . . . . . . . . . . . . .

35-44 yaars, . . . . . . . . . . . . .

45-54 years, . . . . . . . . . . . . .

55-64 years, . . . . . . . . . . . . .

65–74 years . . . . . . . . . . . . . .

White:

20–74years, . . . . . . . . . . . . . . .

20-74 years, age adjusted.

20–24 years.,.,.,,....,..

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45–54 years . . . . . . . . . . . . . .

55–64 years...,,,..,..,,,

65-74 years . .,, ,, . . . . . . . .

Black:3

20-74 yaars. ., . . . . . . . . . . . .

20–74years, age adjusted, .

Women

All races:2

20-74 years,,,,....,,,.,..

20-74 years, age adjusted, .

20–24 years, . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years.,..,....,.,..

45–54 years . . . . . . . . . . . . . .

55–64 years . .,, , . . . . . . . . .

65-74 yaars .,,........,,,

White:

20-74 years . . . . . . . . . . . . . . .

20-74 years, age adjusted. ,

20-24 years . . . . . . . . . . . . . .

25-34 years ., . . . . . . . . . . . .

35-44 years.,.....,,..,..

45-54 years . . . . . . . . . . . . . .

55-64 years, ., ., .,.,.,.,,

65–74 years.,...,,..,.,..

i31ack:3

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. .

1,037

72

174

130

106

267

288

906

57

146

115

96

236

256

114

.

1,246

. .

105

194

166

166

282

331

1,084

89

177

142

143

244

289

137

,..

140

137

109

126

145

150

146

149

141

136

109

130

147

150

149

150

127

128

141

137

114

121

129

157

159

162

141

136

115

121

129

157

161

162

139

132

Serum LDL cholesterol in milligrams per deciliter (mg/dl)l

1.6

1.5

*5.4

2.7

3.0

2.6

3.1

2.6

1.6

1.5

●6.7

2,6

2.9

2.6

3.2

3.0

‘4,6

*4,7

1,6

1,4

3.4

2.3

3.2

2.7

3.8

3.1

1.5

1.3

3.4

2.1

3.2

2,6

4,1

2.9

*4.2

*4.3

80

*

76

81

99

64

87

63

.

*

76

90

*

84

67

70

61

69

72

76

94

101

96

62

.,,

*

76

78

96

101

95

70

,..

92 100

70

67

96

103

101

105

94

,..

57

89

100

105

104

105

76

. .

91

.

74

83

90

104

113

109

91

. .

76

85

90

104

113

109

75

,,.

74

94

105

112

108

109

103

,..

75

95

110

113

110

110

87

98

.,.

63

90

97

116

118

122

99

,..

84

90

97

117

119

122

94

. .

113

.

86

108

118

119

116

120

114

. .

86

111

120

120

121

121

98

. .

110

. . .

94

98

107

125

129

135

110

.,.

94

98

107

125

126

134

109

. .

136

. .

104

126

138

146

147

144

136

. .

102

129

141

148

146

145

123

. . .

136

. .

106

116

126

156

150

158

135

. .

106

116

124

151

151

156

140

. .

164

129

146

176

171

171

174

166

. . .

127

149

176

170

172

175

151

. .

164

. .

136

139

150

164

166

166

163

136

137

149

163

193

185

166

. .

161

. . .

149

161

192

169

191

166

183

. . .

149

162

192

169

191

166

172

. . .

166

. .

149

154

163

200

205

207

166

.,.

146

153

163

206

209

207

184

. .

194

. . .

154

171

203

195

206

199

194

. .

169

171

203

202

206

199

195

. .

199

. .

155

166

171

213

219

226

201

. . .

155

163

170

216

221

226

194

.,.

206

. . .

*

169

206

211

217

217

206

. . .

*

169

205

*

216

216

204

. .

220

. . .

179

187

191

226

237

245

221

*

186

191

226

237

247

206

. . .

‘To convsrt to mlllimoles per liter (mmollL), multiply by 0.025&36.

21ncludes data for rsces not shown separately.

3Data “Ot given by age because of small sample sze.

NOTES: LDLcholesterol = lotalcholesterol -HDLcholesterol -trlglyceride15, Equallollfrom Friedewald, 'W, etal, Ckn Chem:l849%5O2, 1972. Persons with aserumtriglycerlde va[ue

greater than 400 mgldl were excluded,

20
Table 7. Ratio of calculated serum low density lipoprotein (LDL) cholesterol to high density lipoprotein (HDL) cholesterol levels for

persons 20–74 years of age, number of examined persons, mean, standard error of the mean, and selected percentiles, by sex, race, and

age: United States, 1976-60

Number of Standard Percentile

examined error of

Sex, race, and age persons Wean the mean 5th 10th 15th 25th 50th 75th 85th 90th 95th

Men

All races:l

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted.

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45–54years . . . . . . . . . . . . . .

55-84 years . . . . . . . . . . . . . .

65–74years . . . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . . . .

20–74years, age adjusted. . . . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-84 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

Black:2

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . .

Women

All races: 1

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . ...<.....

55–64years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . .

20-24 years . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . . .

Black:2

20–74years . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . .

1,037

. . .

72

174

130

106

267

266

906

57

146

115

96

236

256

114

. .

1,246

105

194

166

166

282

331

1,084

. . .

89

177

142

143

244

289

137

. . .

3.31

3.25

2.53

3.14

3.43

3.66

3.32

3.52

3.39

3.32

2.61

3.20

3.52

3.74

3,38

3,57

2.66

2.67

2.79

2.74

2.35

2.47

2.61

:.02

3.06

3.25

2.82

2.77

2.40

2.48

2.63

3.06

3.11

327

2.56

2.47

0.06

0.06

‘0.20

0.10

0.12

0.13

0.10

0.12

0.07

0,07

‘0.24

0.10

0.12

0.14

0.10

0.12

‘0.14

‘0.1 4

0.05

0.04

0.10

0.08

0.09

0.09

0.10

0.10

0.05

0.04

0.11

0.07

0.09

0.10

0.10

0.10

‘0.12

‘0.12

1.46

. . .

*

1.46

1.75

1.51

1.75

1.74

1.59

. . .

*

1.46

1.97

●

1.76

1.81

1.08

. . .

1.22

. .

1.18

1.20

1.31

1.40

1.15

1.55

1,29

. . .

*

1.30

1.34

1.40

1.15

1.66

.99

. . .

1.82

. . .

1.17

1.72

2.10

2.10

1.99

2.02

1.96

. .

.90

1.82

2.12

2.10

2.01

2.02

1.37

. . .

1.46

. . .

1.26

1.44

1.42

1.54

1.53

1.64

1.50

. . .

1.29

1.47

1.42

1.55

1.55

1.86

1.22

. . .

2.06

. . .

1.38

2.05

2.29

2.44

2.14

2.11

2.12

. .

1.49

2.08

2,42

2.49

2.19

2.13

1.50

. . .

1.62

. . .

1.42

1.56

1.57

1.65

1.77

2.03

1.66

. . .

1.50

1.57

1.60

1.80

1.82

2,03

1.42

. . .

2.42

. . .

1.63

2.35

2.58

2.61

2.46

2.37

2.50

. . .

1.76

2.40

2.73

2.92

2.56

2.53

1.75

. . .

1.94

. . .

1.58

1.79

1.88

2.02

2.06

2.30

1.97

. . .

1.70

1.80

1.88

2.07

2,28

2.29

{.57

. . .

3.22

. . .

2.26

3.10

3.23

3.45

3.27

3.33

3.31

. . .

2.39

3.11

3.33

3.49

3.30

3.34

2.49

. . .

2.59

. . .

2.06

2.37

2.58

2.81

2.92

3.03

2.59

. . .

2.14

2.37

2.59

2.81

2.95

3.03

2.41

. . .

4.03

. . .

3.05

3.82

4.21

4,26

4.04

4.28

4.10

. . .

3.05

3.85

4.23

4.43

4.05

4.33

3.60

.,.

3.43

. . .

2.78

2,93

3.20

3.74

4,01

3.96

3.45

. . .

2.76

2.93

3.21

3.80

3.96

4.04

3.28

. . .

4.55

. . .

3.85

4.34

4.79

4.88

4.55

4.66

4.62

. . .

3.66

4.48

4.93

5.02

4.56

4.87

3.91

.,.

4.01

. . .

3.21

3.41

3.61

4.34

4.36

4.51

4.02

. . .

3.36

3.28

3.61

4.42

4.47

4.61

3.95

. . .

4,94

. . .

4.07

4.71

5.25

5.30

4.85

5.14

5.02

. . .

4,23

4,75

5,34

5.78

4.91

5.14

4.08

.,.

4.38

,,.

3.78

3.85

3.81

4.66

4.82

5.08

4.41

. . .

3.79

3.66

3.80

4.87

4.82

5.09

4.31

. . .

6,46

,.,

*

5.02

6.58

6.22

5.42

5.60

5.57

.,.

*

5.09

5.58

*

5,42

5.60

4.64

,.!

5.02

,,.

4.17

4.32

4.25

5.26

5.08

5.75

5.04

. . .

*

4.32

3.91

5.72

5.08

5,88

5,19

. . .

1Includss data for races not ah own separately.

2Data not given by age because of small sample size.

NOTES LDLcholestsrol = total cholesterol -HDLcholeaterol -triglyceride/5. Equallon from Ffiedew'ald, V~, etal. Cl:n Chem(18):499-502. 1972. Persons with aserum triglyceride value

greater than 400 mgldl were excluded.

21
Table 8. Cumulative percent distribution of serum total cholesterol levels for persons 20-74 years of age, and number of examined

persons, byrace, selected cholesterol Ievelcutoffs, and sex: United States, 1976-80

Both sexes Men Women

Race and se/ected

—

Number of Number of Number of

cholesterol level cutoff examined Cu,mu/ative examined Cumulative

(mg/dl)

examined Cumulative

persons percent persons percent persons percent

—

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . .

Less than 120,.......,...,,,, .

Lessthan 130.,,...,,....,,. . .

Lessthan 140,.,.....,,,,, . . . .

Lessthan 150, . . . . . . . . . . . . ,. .,..,,

Lessthan 160,.......,,,. . . . . . .

Lessthan 170,,.....,,,..

Lessthan 180 . . . . . . . . . . . . . ,. .,,,,,

Lessthan 190. ., .,, . . . . . . . .,, ,,..,

Lessthan 200, .,, . . . . . . . . . . . .,...,

Lessthan 210...,,,....,.. ,,, ,,,,.

Lessthan 220 . . . . . . . . . . . . . . . .

Lessthan 230..,,..,,.,,. . . . . . .

Lessthan 240. . . . . . . . . . . . . . . . . . . .

Lessthan 250, . .,, . . . . . . . . . . . . . . .

Lessthan 260 . . . . . . . . . . . . . . . . . . . .

Lessthan 270,........,,,.. . . . .

Lessthan 280,.....,.,,,,. . . . . . . .

Lessthan 290,....,,.,.,,. . . . . .

Lessthan 300,........,,., ... .

Lessthan 325, , . . . . . . . . . . . . ...,,,.

Lessthan 350,....,,,..,.. . . . . .

White

Total, . ., ., . .,, ..,..... . . .

Lessthan 120 . . . . . . . . . . . . . . . . . .

Lessthan 130, ,,, .,....... . . . . . . .

Lessthan 140,,,.......,,. . . . .

Lessthan 150,,....,..,,, . . . . . . . .

Lessthan 160, . ., .,....,.

Lessthan 170,,,,.,..,,,.. ,. ...,,,

Lessthan 180,.....,,,,,.. .,, .,,,,

Lessthan 190...,,,.,..,.. .,, .,,,,

Lessthan 200. . ., ., .,..,... .,,,,,.

Lessthan 210. ,, .,, .,....,. ,,,,,.,

Lessthan 220. . .,, ,, . . . . . . ,,, ,.,,.

Lessthan 230. ,,, ,. .,.,... . . . . .

Lessthan 240. ,,, .,.......

Lessthan 250. ,,, . . . . . . . . . ,, . . . .

Lessthan 260. ,, . . . . . . . . . . . . . . . .

Lessthan 270. . . . . . . . . . . . . . . . . . . .

Lessthan 280,.....,..,,,, ., ..,..,

Lessthan 290,....,..,,,.. . . . .

Lessthan 300, ., . . . . . . . . . . . ..,...,

Lessthan 325....,.,,,,,. ... ..,,,,

Lessthan 350 . . . . . . . . . . . .

11,864

78

187

391

729

1,189

1,839

2,659

3,606

4,623

5,579

6,538

7,451

6,291

9,069

9,692

10,202

10,601

10,914

11,161

11,575

11,730

10,301

58

147

316

606

1,002

1,571

2,257

3,078

3,945

4,798

5,639

6,427

7,162

7,849

8,402

8,845

9,197

9,473

9,693

10,049

10,163

100,0

0.7

1.8

4.0

7.1

11,6

17,8

25.5

33.9

42.9

51.1

59,1

66.4

73,2

79.3

84,1

87,8

90,8

93.3

94.9

97.9

99,1

100.0

0.6

1.6

3.7

6.9

11.3

17.6

25.1

33.6

42,4

50.8

58.8

66.2

72.6

79.0

83.9

87,7

90.7

93.3

94.9

98.0

99.1

5,604

44

108

206

368

602

914

1,337

1,812

2,341

2,815

3,309

3,725

4,119

4,489

4,759

4,988

5,148

5,284

5,369

5,514

5,565

4,883

32

88

166

301

497

775

1,133

1,541

2,005

2,431

2,873

3,243

3,584

3,914

4,154

4,348

4,484

4,606

4,682

4,809

4,851

100.0

0.8

1.9

3.9

6.9

11,7

17.6

25.7

34.4

44.0

52.7

61.1

68.3

75.1

81,3

85.7

89.4

92.1

94.8

96.0

98.4

99.3

100.0

0.6

1,7

3.6

6.5

11.2

17.2

25.2

33.9

43.6

52.4

61.0

68.4

75,0

81,3

85.8

69.4

92.0

94.8

96.1

98.5

99.3

6,260

34

79

185

361

587

925

1,322

1,794

2,282

2,764

3,229

3,726

4,172

4,580

4,933

5,214

5,453

5,630

5,792

6,061

6,165

5,418

26

59

150

305

505

796

1,124

1,537

1,940

2,367

2,766

3,184

3,578

3,935

4,248

4,497

4,713

4,867

5,011

5,240

5,332

100.0

0.7

1,7

4.0

7.4

11,5

17,9

25.3

33.5

42.0

49.7

57.2

64.8

71,5

77.4

82.5

86.4

89.7

91.9

93.9

97,5

98.9

100,()

0:7

1)5

3.9

7.3

11.5

17.9

25.0

33.3

41.4

49,3

56.8

64,1

70,8

76.9

62.3

86.2

89.6

91.9

93.9

97.5

96.8

22
Table 8. Cumulative percent distribution of serum total cholesterol levels for persons 20-74 years of age, and number of examined

persons, by race, selected cholesterol level cutoffs, and sex United States, 1976-80-Con.

Both sexes Men Women

Race and se/ected Number of Number of Number of

cholesterol level cutoff examined Cumulative

(mg/dl)

examined Cumulative examined Cumulative

persons percent persons percent persons percent

Black

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130. . . . . . . . . . . . . . . . . . . . .

Lessthan 140. . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Less than 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . . . . .

Less than 220 . . . . . . . . . . . . . . . . . . . . .

Less than 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan240 . . . . . . . . . . . . . . . . . . . . .

Lessthan250 . . . . . . . . . . . . . . . . . . . .

Lessthan 260 . . . . . . . . . . . . . ... ,,,..

Lessthan 270 . . . . . . . . . . . . . ... ,,,..

Lessthan 280, . . . . . . . . . . . . . ..,,,,.

Lessthan290 . . . . . . . . . . . . . . . . . . . . .

Lessthan300 . . . . . . . . . . . . . . . . . .

Lessthan325 . . . . . . . . . . . . . . . . . . . . .

Lessthan350 . . . . . . . . . . . . . . . . . . . . .

1,336

18

37

68

111

167

234

351

456

563

671

774

875

963

1,043

1,096

1,152

1,196

1226

1250

1300

1,320

100.0

1.5

3.6

6.1

9.7

14.6

20.4

29.6

37.6

47.8

54.6

62.2

68.8

76.2

61.3

64.2

68.0

91.3

92.6

94,2

97.2

98.7

607

11

19

39

62

96

126

18~

235

269

328

376

413

454

465

506

535

557

569

576

591

600

100.0

2.2

4.1

7.7

11.4

18.3

23.0

31.5

40.3

49.5

55.7

63.5

68.7

76.1

81.3

84.0

69.0

92.3

93.5

94.8

97.1

96.4

729

7

16

29

49

71

108

170

221

294

343

398

462

509

556

590

617

639

657

674

709

720

100.0

0.9

3.2

4.8

8.2

11.9

16.2

28.1

35.4

46.4

53.7

61.1

68.6

76,3

81.2

84.3

67.3

90.4

92.2

93.7

97.3

98.9

1Includes data for races not ahown separately.

NOTES To corweti values of serum totsl cholesterol 10 mihmoles per Ibter (mmoliL), multiply by 0.025s6. mgldl IS mil grams per dec,l ter.

23
Table 9. Cumulative percent distribution of serum total cholesterol levels for men 20-74 years of age, and number of examined persons,

byrace, selected cholesterol level cutoffs, and age: United States, 1976-80

20-24 years 25-34 years 35–44 years

Race and se/ected Number of Number of Number of

cholesterol level cutoff examined Cumulative examined Cumulative examined Cumulative

(mg/dl) persons percent persons percent persons percenf

All racesl

Total, ,, .,,,..,.......,,,,. ,,,

Lessthan 120,,,,,......,,,,, ,,, .,

Lesathan 130, ,,, .,.....,, ,. .,.,,,

Lessthan 140. ,,, .,......,

Less than 150. ., . .,..,..,, .,, .,,.,

Lessthan 160, ,,, . . . . . . . . . . . . . . .

Lessthan 170, . . . . . . . . . . . . . . . . . .

Lessthan 180,..,......,,.

Lessthan 190,....,..,,,.

Lessthan 200, . . . . . . . . . . . . . . . .

Lessthan 210,.......,,,.. . . .

Lessthan 220 . . . . . . . . . . . . . .

Lessthan 230,....,..,,,.. . . . .

Lessthan 240, . . . . . . . . . . . . . . . .

Lessthan 250, . . . . . . . . . . . .

Lessthan 260. , . . . . . . . . . .

Lessthan 270, . . . . . . . . . . . .

Lessthan 280, . ., . . . . . . . . . . . . . .

Lessthan 290, , . ., ..,,..... . . .

Lessthan 300 . . . . . . . . . . . . . .,, . . . .

Lessthan325, . . . . . . . . . . . . . . . . .

Lessthan350. ..,,,,,..,.. . . . .

White

Total .,, . . . . . . . . . . . . . . . . . ,,.,,.

Lessthan 120, . .,, ,. .,.... . .

Lessthan 130...,,,..,.,.. ,,, .,,.,

Lessthan 140, . .,, . . . . . . . . ,,, ..,.,

Lessthan 150, ,,, . . . . . . . . . . . . . .

Less than 160, ,,, . . . . . . . . . . . . . . .

Lessthan 170. ,,, . . . . . . . . . . . . . .

Lessthan 180. ,,, ..,....,, ,. ...,..

Lessthan 190.,,..,..,..,.. ,..,,.,

Lessthan 200,,,,.,...,,,, .,, .,...

Lessthan 210,,,......,,,. . . . .

Lessthan 220,.....,..,,,.

Lessthan 230,..,..,,,,,, ., .,,.,,,

Lessthan 240, . . . . . . . . . . . .

Lessthan 250......,.,,,., ... .,,,,

Lessthan 260 . . . . . . . . . . . . .

Lessthan 270 . . . . . . . . . . . . . ...,,,.

Lessthan 280. . .,, ,,, ,..,. ,. .,,,..

Lessthan 290, . . . . . . . . . . . . . . . . . .

Lessthan 300 . . . . . . . . . . . . . ... ,,,.,

Lessthan 325 . . . . . . . . . . . . .

Lessthan 350. ., .,, ,, . . . . . ... . . . .

Black

Total . . . . . . . . . . . . . . . . . . . ,,

Lessthan 120, . . . . . . . . . . . . ,,,

Lessthan 130, , . . . . . . . . . . . . . . . . .

Lessthan 140. ,,, , . . . . . . . . . . . . . . .

Lessthan 150. ,,, . .,.,...., ..,..,.

Lessthan 160. ,, . .,,.,..,, ,. .,.,..

Lessthan 170.,,..,,....,,, . . . .

Lessthan 180. ,, . . . . . . . . . . ,. ...,,.

Lessthan 190, ,, ., . . . . . . . . . . . . . . .

Lessthan 200, . . . . . . . . . . . . . . . . . .

Lessthan 210, . . . . . . . . . . . . . . . . . . .

Lessthan 220,,.......,,,,

Lessthan 230, . . . . . . . . . . . . . . . . . .

Lessthan 240.........,,, .

Lesathan 250,.....,..,,,. . . . . . . .

Lessthan 260, . . . . . . . . . . . . . . . . . . .

Lessthan 270........,.,.. . . . . .

Lessthan 280,,..,...,,,. .

Lessthan 290, . . . . . . . . . . . . .

Lessthan 300. . . . . . . . . . . . . .

Lessthan 325......,..,,. ... ,.,,,,

Lessthan 350. ., ...,,,..,

676

16

43

60

134

207

261

360

426

491

548

584

609

631

649

658

661

667

669

670

675

676

581

11

35

65

112

171

242

306

363

420

469

500

522

543

559

567

569

575

576

577

580

581

79

5

8

15

21

33

36

46

55

61

68

73

75

76

78

78

79

79

79

79

79

79

100.0

2.1

5.2

11.3

18,8

30,3

41.7

54,6

64,1

73.3

81.7

86.9

90.7

93.8

96.3

97.6

97.9

98.7

99.0

99.1

99.9

too.o

100.0

1,7

4.6

10.7

18.4

29.0

41,7

54.6

63.6

73.2

81.8

86.7

90,5

93.9

96.6

97.7

98.0

98.9

99.0

99.2

99.9

too.o

100.0

5.6

11.2

18.7

25,3

43,2

47,0

60,2

72,0

78,2

84.9

94,1

95,7

97.1

99.2

99.2

100,0

100,0

100.0

100,0

100,0

100.0

1,067

14

30

56

100

173

261

365

494

810

718

795

861

905

950

980

1,007

1,019

1,037

1,041

1,054

1,06t

901

8

21

38

75

138

216

309

416

513

602

667

725

764

603

827

852

863

878

882

892

897

t 39

5

8

17

23

33

41

50

67

83

96

106

112

117

122

127

129

130

133

133

135

137

100.0

1,2

2.4

4.8

8.8

15.3

23.2

32.7

44.9

56,7

67.0

74.4

80.1

84.7

89.0

91.7

94.4

95.5

97.4

97.8

98.8

99.5

100,0

0.9

2,0

3,9

7.9

14.6

22.9

33.0

45.1

56.8

66.8

74.3

80.2

85,0

89.1

91.6

94.4

95.7

97.7

98,1

99.1

99.7

100,0

4,2

6.0

13.0

18.2

24.6

29.2

33.9

45.8

58.1

66.5

73.0

76.8

80.7

86.9

90.7

92.8

93.3

94.8

94.8

95.8

97.8

745

3

11

19

38

55

97

156

208

294

345

407

464

540

589

627

658

687

705

719

735

741

653

3

10

16

29

44

79

131

173

251

300

360

412

476

521

556

582

604

619

631

648

651

70

1

3

6

9

16

22

29

36

38

40

44

52

53

53

56

62

64

66

67

68

100,0

0.3

1.5

2.3

4,4

7.3

12.7

20.9

28.1

39.1

45,6

53.6

61.6

72.1

78.7

83,9

88,1

91,8

94.7

96.5

98.6

99.5

1Oo.cl

0.4

1.6

2,4

4.1

6.9

12.3

20.2

27.’[

38.4

45,4

54.1

62,5

72,1

79,2

84.6

88.8

92.1

95.0

96.7

98.9

99,8

100.0

1.0

2.8

6.9

10.5

18.0

28.6

36.5

47,4

52,2

56,6

62,4

75,5

76,4

76.4

79,6

88,0

90.2

93.1

95.2

97.8

llncludes data for races not shown separately,

NOTES:To convert values of serum total cholesterol to milfimoles per liter (mmol/L), multiply by 0,02586, m~)ldl is mi(hgrams per deciliter.

24
Table 9. Cumulative percent distribution of serum total cholesterol levels for men 20-74 years of age, and number of examined persons,

by race, selected cholesterol level cutoffs, and age: United States, 1976-80-Con.

. .

45-54 years 55-64 years 65-74 years

Race and selected Number of Number of Number of

cholesterol level cutoff examined Cumulative examined Cumulative

(mg/dl)

examined Cumulative

persons percent persons percent Deraons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . .

Less than 130 . . . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Less than 170 . . . . . . . . . . . . . . . . . . . . .

Less than 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . . . . .

Less than 220 . . . . . . . . . . . . . . . . . . . . .

Lessthan230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 240 . . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . . . . . .

Lessthan 260 . . . . . . . . . . . . . . . . . . . . .

Lessthan270 . . . . . . . . . . . . . . . . . . . . .

Lessthan280 . . . . . . . . . . . . . . . . . . . . .

Lessthan 290 . . . . . . . . . . . . . . . . . . .

Lessthan300 . . . . . . . . . . . . . . . . . . . . .

Lessthan325 . . . . . . . . . . . . . . . . . . . . .

Lessthan350 . . . . . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . . . . . . .

Lassthan230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 240 . . . . . . . . . . . . . . . . . . . . .

Lessthan250 . . . . . . . . . . . . . . . . . . . . .

Lessthan260 . . . . . . . . . . . . . . . . . . . . .

Lessthan270 . . . . . . . . . . . . . . . . . . . . .

Lessthan280 . . . . . . . . . . . . . . . . . . . . .

Lessthan290 . . . . . . . . . . . . . . . . . . . . .

Lessthan300 . . . . . . . . . . . . . . . . . . . . .

Lessthan325 . . . . . . . . . . . . . . . . . . . . .

Lessthan350 . . . . . . . . . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 240. . . . . . . . . . . . . . . . . . . . .

Lessthan 250. . . . . . . . . . . . . . . . . . . .

Lesathan 260 . . . . . . . . . . . . . . . . . . . . .

Lessthan 270. . . . . . . . . . . . . . . . . . . . .

Lessthan 280 . . . . . . . . . . . . . . . . . . . . .

Lessthan 290 . . . . . . . . . . . . . . . . . . . .

Lessthan300, . . . . . . . . . . . . . . . . .

Lessthan325 . . . . . . . . . . . . . . . . . . .

Lessthan350 . . . . . . . . . . . . . . . . . . .

690

3

11

14

37

55

96

152

204

255

328

384

442

507

553

584

615

638

352

1376

1684

617

2

10

13

31

46

86

135

180

229

297

349

396

453

494

521

548

571

5s3

634

612

62

1

1

1

5

7

10

14

20

22

27

30

39

46

49

53

57

57

5!3

61

61

100.0

0.4

1.8

2.2

5.3

7.2

12.8

20.3

26.0

35.7

46.8

55.3

63.1

71.8

78.9

84.0

88.2

92.2

94.2

97.6

98.6

100.0

0.2

1.8

2.2

5.0

6.7

12.7

20.3

27.9

36.3

47.9

56.5

63.5

71.9

79.2

83.6

87.8

92.3

94.1

97.6

98.7

100.0

2.2

2.2

2.2

6.6

8.9

12.2

19.3

27.9

31.1

39.7

46,3

59.7

70,4

74,7

87.0

91.8

91.8

94.3

97.5

97.5

1,227

6

9

16

34

54

89

154

238

333

432

566

674

785

886

962

1,026

1,074

1,!20

1,147

1,199

1,218

1,086

5

8

15

31

49

78

128

206

288

380

497

594

692

784

852

906

948

990

1,016

1,060

1.078

129

1

1

1

3

5

11

24

30

42

48

64

73

83

91

99

108

114

118

119

127

128

100.0

0.4

0.5

1.0

2.5

4.3

7.2

12.3

18.8

25.9

34.9

45.0

54.7

63.2

72.2

77.5

82.4

86.1

90.6

92.6

97.3

99.1

100.0

0.3

0.4

1.0

2.5

4.2

6.9

11.2

18.1

25.1

34.4

44,3

54,4

62,7

71.8

77.2

82,0

85.7

90.5

92.7

97.2

99.1

100.0

1.2

1.2

1.2

2.9

6.1

12.4

23.9

26.9

35.0

40.0

52.3

58.4

64.7

70.6

75,8

83.3

87.7

89.3

90.9

98.6

99.1

1,199

5

12

24

50

76

131

204

294

409

517

629

733

816

908

979

1,052

1,086

1,115

1,140

1,175

1,165

1,045

5

12

22

41

64

114

171

248

353

451

552

641

713

794

858

918

946

972

993

1,027

1,032

128

2

8

11

15

29

40

47

56

66

79

87

95

100

110

115

118

121

122

127

100.0

0.3

1.0

1.9

3.8

6.2

11.1

16.9

24.0

33.5

43.0

52.3

60.8

68.3

75.4

81.1

87.3

90.2

92.9

94.7

97.9

98.7

100.0

0.4

1.1

2.0

3.8

6.1

11.1

16.4

23.3

33.0

42.8

52,2

60,5

67.6

74,9

80.9

86.9

69.8

92.6

94.4

97.9

96.6

1.4

5.3

8.5

12.4

23,6

32.0

37.2

46.0

54.4

64.8

72.8

77.5

81.3

88.6

91.6

93.6

95.5

96.3

99.3

25
Table 10. Cumulative percent distribution of serum total cholesterol levels for women 20-74 years of age, and number of examined

persons, by race, selected cholesterol level cutoffs, and age: United States, 1976-80

20-24 years 25-34 years 35–44 years

Race and selected Number of Number of Number of

cho/estero/ /eve/ cutoff examined Cumulative exarnlned Cumulative

(mgldl)

exam;ned Cumulative

persons percent persons percent persons percenf

All racesl

Total, . ., . ., .,, ., . . . . . . . . . .

Less than 120. . . . . . . . . . . . . .

Less than 130. . . . . . . . . . . . . . . .

Less than 140. ,,, . . . . . . . . . . . . .

Less than 150 . . . . . . . . . . . . . . . .

Less than 160 . . . . . . . . . . . . . . . .

Less than 170. . ., . ., .,,,,....

Less than 180,..,..,,,,,,.,..

Less than 190 . . . . . . . . . . . . . . . . ., ...

Lessthan 200...,,,,,,,,,,,.. ,., ,,

Lessthan 210. ,, . . . . . . . . . . . . . .

Less than 220,,,,.,,.,,,.,.,,. ,,,

Lessthan 230 . . . . . . . . . . . . . . ,. .,,,.

Lessthan 240, , . .,, ,,, . . . . . ,. .,,,.

Lessthan 250. . . . . . . . . . . . . . . . . .

Lessthan 280, . . . . . . . . . . . . . . . .

Lessthan 270 . . . . . . . . . . . . . . . . .

Less than 280. , ., . . . . . . . . . . . . . .,,

Lessthan 290,,......,,,..,.. ... ,,

Lessthan 300, . . . . . . . . . . . . . . .

Lessthan 325.,...,,,,,,,.,.. ... ,,

Lessthan 350,,......,,,., . . . . .

White

Total . . . . . . . . . . . . . . . . . . . .

Lessthan 120. . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . ..,,,,.

Lessthan 150 . . . . . . . . . . . . ., ..,,,,.

Lessthan 160 . . . . . . . . . . . . . ...,,,.

Lessthan 170 . . . . . . . . . . . . . . . . . .

Lessthan 180. , . .,, ,. ..,... . .

Lessthan 190,,...,....,.. .,, ,,...

Lessthan 200, . . . . . . . . . . . . . . . . . .

Lessthan 210. . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . .

Lessthan 230.....,,...,., ...

Lessthan 240 . . . . . . . . . . . . . .

Lessthan 250. . .,, ,, .,..,. ,,, ,.,,.

Lessthan 260, , .,, ,. . . . . . . ,,, ..,,.

Lessthan 270. . . . . . . . . . . . . . ,,,

Lessthan 280. , .,, ,, . . . . . .,, ,,..,.

Lessthan 290. . . . . . . . . . . . . . . . .

Lessthan 300 . . . . . . . . . . . . . . ,,,..,.

Lessthan 325. . .,, . . . . . . . . ,, .,.,..

Lessthan 350. . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . ,,

Less than 120. ,, . . . . . . . . . .

Lessthan 130. . . . . . . . . . . . . .

Lessthan 140, ,,, .,.....,. . . . .

Lessthan 150. ,,, .,....... . . . . .

Lessthan 160. . . . . . . . . . . . . .

Lessthan 170, . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . .

Lessthan 200.,,,.......,,, . . . . .

Lessthan 210. ,,, . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . . . . . .

Lessthan 230, , ., . . . . . . . . . . . . . . .

Lessthan 240. . . . . . . . . . . .

Lessthan 250. , ., .,..,..,. . . . .

Lessthan 260. ,, . .,.....,, ,. . . . . .

Lessthan 270. . . . . . . . . . . . . . . . . . .

Lessthan 280. ,,, . . . . . . . . . .

Lessthan 290. . . . . . . . . . . . . . . . . . . . .

Lessthan 300. ,,, . . . . . . . . . . . . . . . .

Lessthan 325. . . . . . . . . . . . . .

Lessthan 350. , . . . . . . . . . . . . ,,

738

8

24

66

122

183

263

353

440

511

576

629

657

690

701

708

711

718

723

728

737

738

624

7

19

53

102

151

220

297

376

432

488

535

556

583

593

598

601

808

612

616

623

624

94

3

9

16

25

35

48

54

67

74

79

83

88

89

91

91

91

92

93

94

94

100.0

1,3

3.8

9.9

18.2

25.7

37.1

49,3

60.4

69.6

78,8

86,3

89.4

93,4

94,9

85,9

96,2

96.8

97.6

98.2

99.8

100,0

100.0

1.2

3.1

9.4

18.1

25.2

36.8

48.9

61.1

69.9

79.3

87.0

89.9

93.5

95.1

96.0

96.3

97.1

97.9

98.4

99.7

100.0

100.0

5.4

10.6

17,7

26.3

37.1

53,1

56.4

69.5

77,6

83.7

87.0

93.0

94.2

95.8

95.8

95.8

97.2

98.5

100,0

100.0

1,170

17

37

76

144

227

356

477

607

744

838

911

983

1,040

1,078

1,104

1,125

1,140

1,148

1,153

1,167

1,169

1,000

15

29

64

125

201

309

409

521

633

718

778

833

885

919

945

963

975

982

986

997

999

145

2

8

10

16

23

39

56

71

93

101

113

126

131

135

135

138

141

141

142

145

145

100.0

1,5

3,3

7.1

12.4

19.3

31.0

41.9

52.3

64.4

71.5

77.6

83.4

88.2

91.8

94.2

96.1

97.5

98.2

98.7

99.8

100.0

100.0

1.5

3.1

7.1

12,6

20.0

31.5

42,3

52.6

64.1

71,6

77,5

82,5

87.6

91.4

94.2

96.3

97.6

98.3

98.7

99.7

99.9

100.0

1.8

5.4

6.2

11.7

16.2

28.1

39.1

48.8

66.3

71.8

80.0

87.8

91.3

94.0

94.0

95.3

97.5

97.5

98.0

100.0

100,0

844

2

8

20

45

93

154

234

335

411

480

561

630

676

727

758

784

810

813

821

835

839

726

1

6

15

38

82

138

204

291

351

413

483

546

581

630

657

677

698

699

707

718

722

103

1

2

5

7

11

15

28

40

53

60

68

72

83

85

88

92

97

99

99

102

102

100.0

0.3

1.2

2.8

5.6

11.1

17.9

27.1

38.9

47,6

55.8

65.2

73.7

79,3

85,8

89.7

92.9

96.3

96.5

97,5

98.9

99.6

100,0

0.2

1.1

2.6

5.7

11.5

18.7

27.7

39.1

46.8

55.2

64.9

73.9

78.9

86.2

90.2

93,1

96.3

96.3

97.5

98.0

99.6

100.0

0.7

2.5

4.8

6,3

10,6

14,7

27.4

39.8

53.2

61.4

67.3

71.1

83.1

84.7

86.7

90.0

95.8

97.3

97,3

99.4

9:1’4

1Includes data for races not shown separately.

NOTES:To convert values of serum total cholesterol to milltmoles per liter, mult!ply by 0,025S6. mgldl is milligrams per deciliter.

26
Table 10. Cumulative percent distribution of serum total cholesterol levels for women 20-74 years of age, and number of examined

persons, by race, selected cholesterol level cutoffs, and age: United States, 1976-80– Con.

45-54 years 55-64 years 65–74 years

Race and selected Ntimber of Number of Number of

cho/estero/ /eve/ cutoff examined Cumulative examined Cumulative examined

(mgldl)

Cumulative

p?rsons percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Less than 170 . . . . . . . . . . . . . . . . . .

Less than 180. . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210. . . . . . . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . .

Lessthan 240, . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . . .,,

Lessthan 260 . . . . . . . . . . . . . . . . . .,.

Lessthan 270 . . . . . . . . . . . . . . . . . .

Lessthan 280 . . . . . . . . . . . . . . . . . . . .

Lessthan 290, . . . . . . . . . . . . . . . . . .

Lessthan 300 . . . . . . . . . . . . . . . . . . . . .

Lessthan 325 . . . . . . . . . . . . . . . . . . . . .

Lessthan 350. . . . . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . . . . .

Less than 140 . . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Less than 170. . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200. . . . . . . . . . . . . . . . . . . . .

Lesathan 210 . . . . . . . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . ...,,,

Lessthan230 . . . . . . . . . . . . . . . . . . .

Lessthan 240 . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . ,.....,

Lessthan 260 . . . . . . . . . . . . . . . . . . . . .

Lessthan 270. . . . . . . . . . . . . . . . . . . . .

Lessthan280 . . . . . . . . . . . . . ,., . . . . .

Lessthan 290 . . . . . . . . . . . . . . . . . . . . .

Lessthan300 . . . . . . . . . . . . . . . . . . . . .

Lessthan 325 . . . . . . . . . . . . . . . . . . . . .

Lessthan 350 . . . . . . . . . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 120. ,, . . . . . . . . . . . . . . . . . .

Lessthan 130. . . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . . .

Lessthan 150, . . . . . . . . . . . . . . . . . . . .

Lessthan 160, . . . . . . . . . . . . . . . . . .

Lessthan 170............,,. . . . . . .

Lessthan 180. . . . . . . . . . . . . . . . . . . . .

Lessthan 190, . . . . . . . . . . . . . . . . . . . .

Lessthan200 . . . . . . . . . . . . . . . . . . . . .

Lessthan210 . . . . . . . . . . . . . . . . . . . . .

Lessthan220 . . . . . . . . . . . . . . . . . . . . .

Lessthan230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 240. . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . . . . . .

Lessthan 260. . . . . . . . . . . . . . . . . . . . .

Lessthan270. . . . . . . . . . . . . . . . . . . . .

Lessthan 280 . . . . . . . . . . . . . . . . . . . .

Lessthan 290. . . . . . . . . . . . . . . . . . .

Lessthan300 . . . . . . . . . . . . . . . . . . .

Lessthan325 . . . . . . . . . . . . . . . . . . . . .

Lessthan350 . . . . . . . . . . . . . . . . . . . . .

763

5

6

12

20

31

52

65

128

“194

260

323

369

456

520

578

625

656

686

707

739

747

647

3

3

9

14

24

41

69

107

166

224

275

327

38I3

439

491

559

584

601

627

633

100

2

3

3

6

7

10

14

19

26

34

44

55

60

70

74

80

84

88

92

96

98

100.0

0.7

0.8

1.7

2.7

4.0

6.9

11.1

t 6.8

25.3

33.7

41.6

50.8

59!5

67.7

76.1

62.2

86.1

89.8

92.5

97.0

98.0

100.0

0.6

0.8

1.7

2.5

4.0

6.7

10.7

16.7

25.9

34.6

42.0

50.7

59.4

67.4

76.1

82.2

86.1

89.8

92.5

97.0

97.8

100.0

1.5

2.3

2,3

4.7

5.8

8.0

14.2

18.8

24.4

32.5

41.7

52.7

59.3

69.9

75.0

62.0

86.8

89.9

93.4

96.3

98.5

1,329

4

15

26

36

70

131

189

291

385

504

627

741

867

950

1,027

1,095

1,151

1,247

1,294

1,176

4

14

24

33

56

111

156

249

334

434

547

646

756

835

907

968

1,019

1,102

1,143

135

1

2

4

13

19

27

36

44

62

72

87

97

102

106

111

116

128

133

100.0

0.3

1.3

1.9

2.6

4.8

8.9

13.0

20.8

28.1

37.4

47.1

55.1

64.4

70.4

76.3

81.4

85.1

92.9

97.3

100.0

0.3

1.4

2.0

2.6

4.6

8.8

12.7

20.4

27.7

36.4

46.3

54.5

64.0

70.5

76.7

81.9

85.8

93.4

97.4

100.0

0.8

1.0

2.5

7.4

10.8

15.5

22.9

30.9

44.7

53.5

62.0

67,6

70.3

72.9

76.0

78.4

87.4

96.2

1,416

2

4

7

15

27

62

103

153

233

319

420

563

683

813

918

1,019

1,102

1,165

1,232

1,336

1,378

1,245

2

5

12

23

55

89

131

200

275

361

486

596

708

799

889

966

1,022

1,082

1,173

1,211

152

2

2

2

3

3

5

11

18

28

38

50

64

75

92

105

114

120

126

132

144

148

100.0

0.1

0.3

0.5

1.2

1.9

4.1

6.8

10.2

16.0

21.6

29.1

39.3

48,4

57.5

64.7

71.6

77.6

82.1

66.8

94.6

97.5

100.0

0.2

0.5

1.2

1.8

4.2

6.7

10.0

15.6

21.2

28.5

39,0

47,9

57.0

64.1

70.9

77.2

81.8

86.6

94.4

97.4

100.0

1.0

1.0

1.0

1.7

1.7

2.8

6.2

10.1

16.6

23.6

30.7

39.9

51.6

81.3

70.1

76.6

80.5

64.1

67.1

95.4

97.7

27
Table 11. Cumulative percent distribution of high density lipoprotein (HDL) cholesterol levels for persons 20-74 years of age, and

number of examined persons, by race, selected HDL cholesterol level cutoffs, and sex: United States, 1976-80

Both sexes Men Women

Race and se/ected

—

Number of Number of Number of

HDL cholesterol /eva/ cutoff examined Cumulative examined

(mg/dl)

Cumulative exam;ned Cumu/afive

persans percent persons percent persons percerrt

All racesl

Total .,, . . . . . . . . . . . . . . . . . . .

Lessthan 30 ., ., . . . . . . . . . . . . . ,..

Less than 35 . . . . . . . . . . . . . . . .

Lessthan 37, . . . . . . . . . . . . . . .

Less than 40,,,,,,,,,.,,.,,, ,,, .,

Less than 42 . . . . . . . . . . . . . . . . .

Lessthan 44,,,,,.,...,,. ,,,

Leasthan 46...,,,....,.. .,, .,,..

Lessthan 48 ., .,, . . . . . . . .

Lessthan 51,,.,....,.,.. ,,, .,,,.

Lessthan 53 .,, . . . . . . . . . . .

Lessthan 56,.,,,,.,,,,,, ,,,,,,,

Lessthan 59 . . . . . . . . . . . . . .

Lessthan 60 . ., .,, ..,.,...

Lessthan 62,.,,,.,,.,,,, ,,, ,.,..

Lesathan 64 .,, . . . . . . . . . .

Lessthan 69 . . . . . . . . . . . . . .

Lessthan 74, ,,, ,., ..,.,. ,,, ,.,,,

Lessthan 80 . . . . . . . . . . . . . .

Lessthan 84 . . . . . . . . . . . . . .

Less than 90 . . . . . . . . . . . . . . .

Less than 95, ,, . . . . . . . . . . .

Less than 189. ,,, . . . . . . . . .

White

Total, . ., . .,, . .,.....,, ,. ...,.,

Lessthan 30 . . . . . . . . . . . . . .

Lessthan 35 . . . . . . . . . . . . . . .

Lessttlan 37,..,,....,,, ,., ..,.,,

Lassthan 40, . . . . . . . . . . . . .

Lessthan 42, . . . . . . . . . . . . .

Lessthan 44 . . . . . . . . . . . . . . . .

Lassthan 46, . . . . . . . . . . . . . . .

Lessthan 48 . ., . . . . . . . . . . .

Lessthan 51, ., . . . . . . . . . . ,., .,,,,

Lassthan 53, ., . .,.,.,...

Lessthan 66, .,, , ..,,,.... .,..,,,

Lassthan 59, . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . .

Leasthan 62, . . . . . . . . . . . . .

Leasthan 64,......,,,,., ., .,,,,.

Lessthan 69 . ., ..,,,,... ... .,,,,,

Lessthan 74 . ., ..,,,,... . . .

Leasthan 60 . . . . . . . . . . . . . .

Leasthan 84 . . . . . . . . . . . . . .

Lessthan 90, . . . . . . . . . . . . .

Lessthan 95, . . . . . . . . . . . . .

Less than 189. . . . . . . . . . . . .

9,797

396

1,127

1,642

2,542

3,204

3,540

4,187

4,867

5,791

6,347

6,892

7,584

7,762

8,064

8,352

8,824

9,186

9,445

9,555

9,647

9,694

9,797

8,562

372

1,033

1,509

2,339

2,925

3,213

3,803

4,419

5,224

5,723

6,194

6,776

6,926

7,173

7,414

7,820

8,122

8,317

8,400

8,470

8,504

8,582

100.0

3.8

11,2

16.5

25.8

32.5

35.9

42,5

49,6

59.1

64,6

70,7

77.4

79,3

82.4

85.2

90.1

93.8

96.3

97,5

98.4

98.9

100,0

100.0

4,1

11.6

17.1

26.9

33.7

36.9

43,8

51.1

60.6

66,4

72.2

78.5

80.3

83.3

86.0

90.8

94.4

96.7

97.7

98.5

99.0

100.0

4,562

297

781

1,130

1,666

2,070

2,243

2,584

2,920

3,322

3,540

3,737

3,984

4,042

4,141

4,225

4,334

4,419

4,475

4,501

4,520

4,534

4,562

4,019

283

730

1,058

1,576

1,924

2,075

2,385

2,683

3,027

3,227

3,392

3,568

3,634

3,712

3,774

3,861

3,925

3,963

3,961

3,992

4,000

4,019

100,0

6.3

16.7

24.6

37.3

45,7

49,4

57,0

64,7

73,1

78,0

82.7

87.6

88.9

91.1

92.6

95.2

97.0

98.2

98.7

99.2

99.4

100.0

100.0

6.6

17.5

25.8

39.2

47.8

51.4

59.2

67,0

75.3

80.3

84.7

89.1

90,3

92.3

93.8

96.0

97.7

98.6

99,0

99,3

99,5

100.0

5,235

99

346

512

856

1,134

1,297

i ,603

1,947

2,469

2,607

3,155

3,600

3,720

3,923

4,127

4,490

4,767

4,970

5,054

5,127

5,160

5,235

4,563

89

303

451

763

1,001

1,136

1,416

1,736

2,197

2,496

2,602

3,186

3,292

3,461

3,640

3,959

4,197

4,354

4,419

4,478

4,504

4,563

100.0

1.’7

6.4

9.4

15.8

20.9

24,1

29,8

36.5

46,8

532

60.1

68,5

70.8

74.6

78,6

85.6

90.9

94.7

96,4

97,8

96.4

100.0

100,0

1.7

6.3

9.4

16.1

21,1

24.0

30.1

37.0

47.5

54.0

61,0

69.1

71,5

75.3

79,1

86.2

91.5

94.9

96.6

97,9

96.5

100.0

20
Table ll. Cumulative percent distribution ofhighdt?nsity lipoprotein (HDL) cholesterol leveLsfor persons 20-74 years ofage, and

number of examined Persons, by race, selected HDL cholesterol level cutoffs, and sex United States, 1976-80-Con.

Both sexes Men Women

Race and selected Numb?r of Number of Number of

HDL cho/estero/ /eve/ cutoff exammed Cumulative examined Cumulative examined Cumulative

(mg/dl) persons percent persons percent persons percent

Black

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 30 . . . . . . . . . . . . . . . . . . . . .

Lessthan 35 . . . . . . . . . . . . . . . . . . . .

Lessthan 37 . . . . . . . . . . . . . . . . . . . . .

Lessthan 40 . . . . . . . . . . . . . . . . . .

Lessthan 42 . . . . . . . . . . . . . . . .

Lessthan 44 . . . . . . . . . . . . . . . . . .

Lessthan 46 . . . . . . . . . . . . . . . . . . .

Lessthan 48 . . . . . . . . . . . . . . . . . . . .

Lessthan51 . . . . . . . . . . . . . . . . . . .

Lessthan53 . . . . . . . . . . . . . . . . . .

Lessthan56, . . . . . . . . . . . . . . . . . .

Lessthan59 . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Lessthan 62 . . . . . . . . . . . . . . . . . . . . .

Lessthan 64 . . . . . . . . . . . . . . . . . . . .

Lessthan 69 . . . . . . . . . . . . . . . . . . . .

Lessthan 74 . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . . .

Lessthan 84 . . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . . .

Lessthan 95 . . . . . . . . . . . . . . . . . . . . .

Leasthan 189 . . . . . . . . . . . . . . . . . . . . .

1,043

20

74

106

163

223

271

32o

372

473

520

580

674

696

748

793

845)

904.

962

98E

1,007

1,019

1,043

100.0

1.7

7.3

10.3

15.9

22.3

26.9

31,7

37.1

46,5

51.2

57.0

66.7

68.7

73.6

77.7

82.9

88.2

93.2

95.0

97.2

98.0

100.0

462

12

39

56

89

122

142

168

i 97

246

261

285

331

341

362

382

400

417

433

440

448

454

462

100.0

2.0

9.0

12.7

20.4

27.5

31.9

38.2

44.3

53.9

57.3

63.4

74.1

76.1

79.9

84.4

87.8

91.0

94.3

96.2

97.7

98.4

100.0

581

8

35

50

74

107

129

152

175

227

259

295

343

355

386

411

449

487

529

545

559

565

581

100.0

1.5

6.0

8.5

12.4

18.4

23.1

26.9

31.6

40.9

46.7

52.2

61.1

63.2

68.9

72.7

79.2

86.2

92.4

94.1

96.9

97.6

100.0

i Includes values for rs.ceanot shown aeperalely.

NOTES: To convert values of high density lipoprotein cholesterol to milhmo es per Ihter (mmo!/L), multiply the values by 0.02586. mg/dl is mdfigrams per decll,ter.

29
Table 12. Cumulative percent distribution of high density lipoprotein (HDL) cholesterol levels formen20-74 years of age, and number of

examined persons, by race, HDL cholesterol Ievel cutoffs, and age: United States, 1976-60

20-24 years 25-34 years 35-44 years

Race and se/ected Number of Number of Number of

HDL cho/estero/ /eve/ cutoff examined Cumulative examined Cumulative

(mgldi)

examined Cumulative

persons percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . .

Lessthan 30,,....,..,,.,.. . ...,,

Lessthan 35, . . . . . . . . . . . . . . . . .

Lessthan37, . . . . . . . . . . . . ... .:,,,

Lessthan40 . . . . . . . . . . . . . . . . . . .

Lessthan42 . . . . . . . . . . . . . . ..,,,,.

Lessthan 44 . . . . . . . . . . . . . . . . . .

Lessthan 46 . . . . . . . . . . . . . ...,,.,

Lessthan48 . . . . . . . . . . . . . . . . . . .

Lessthan 51 . .,, . . . . . . . . . . ,, . . . . .

Lessthan53 . . . . . . . . . . . . . . . . . . .

Lessthan 56..,........,,, . . . . . .

Lessthan 59.,,..,.....,., .

Lessthan 60 . . . . . . . . . . . . . . . . . . . .

Lessthan 62 . . . . . . . . . . . . . . .

Lessthan 64 . . . . . . . . . . . . . . . . . . .

Lassthan 89.,........,,, . . . . . . .

Lessthan 74 . . . . . . . . . . . . . . . . . . . . .

Lessthan 80..........,,. . . . . . . .

Lessthan 84, . . . . . . . . . . . . . . . . . .

Lessthan 90, . . . . . . . . . . . . . . . . .

Lessthan 95 . . . . . . . . . . . . . . . . . . .

Lessthan 189. . . . . . . . . . . . . ...,,,.

White

Total, ,, . ., . . . . . . . . . . . . . . . .

Lessthan 30, . . . . . . . . . . . . . . . . .

Lessthan 35 . . . . . . . . . . . . . . . . . . .

Lessthan 37 . . . . . . . . . . . . . . ,, . . . . .

Lessthan 40.,,........,., . . . . . .

Lessthan 42.,.........,., . . . . . . .

Lessthan 44.,........,,. . . . . . . .

Lessthan 46, . . . . . . . . . . . . . .

Lesethan 48, . . . . . . . . . . . . . . . . . . .

Lessthan 51,.......,,.. . . . . . . .

Lessthan 53 . . . . . . . . . . . . . . . . . . . .

Lessthan 56 . . . . . . . . . . . . . . . . . . . .

Lessthan 59 . . . . . . . . . . . . . . . . . . .

Lessthan 60, . . . . . . . . . . . . . . . .

Lessthan 62, . . . . . . . . . . . . . . . . . .

Lessthan 64 . . . . . . . . . . . . . . . . . . . .

Lessthan 69 . . . . . . . . . . . . . . . . . . .

Lessthan 74 . . . . . . . . . . . . . . . . . . .

Lessthan 80 .,, . . . . . . . . . . . . . . . . . .

Lessthan 84 .,, . . . . . . . . . . . . . . . .

Lessthan 90.,........,,, . . . . . . .

Lessthan 95,,........,., . . . . . . . .

Lessthan 189, . . . . . . . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 30 . . . . . . . . . . . . . . . . . .

Lessthan35 . . . . . . . . . . . . . . . . . .

Lessthan37, . . . . . . . . . . . . . . . . . . . .

Lessthan 40, . . . . . . . . . . . . . . . . .

Lessthan 42 . . . . . . . . . . . . . . . . . . .

Lessthan 44.,.,,,.....,.. .,,,,.,

Lessthan46 . . . . . . . . . . . . . . . . . .

Lessthan 48 ., .,, . . . . . . . . ... ,,.,.

Lessthan 51, ,,, . . . . . . . . . . . . . .

Lessthan 53 .,, . . . . . . . . . . . . . . .

Less than 56 . . . . . . . . . . . . . . . . . .

Lessthan 59 . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Lessthan 62 . . . . . . . . . . . . . . . . . . . . .

Lessthan 84,,........,,,. . . . . . . .

Lessthan 69,,.......,,., . . . . . . . .

Lessthan 74,........,,., . . . . . . .

Lessthan 80, . . . . . . . . . . . . .

Lessthan 84, . . . . . . . . . . . .

Lessthan90, . . . . . . . . . . . . . .

Lessthan 95 . . . . . . . . . . . . .

Lessthan 189 . . . . . . . . . . . . . . ..,,,,.

570

18

63

96

172

216

239

291

340

405

436

465

495

505

520

531

542

552

559

562

566

568

570

494

18

61

93

159

199

221

269

311

366

394

414

437

446

458

467

474

461

467

489

492

492

494

65

1

3

10

14

15

19

24

32

35

42

48

49

52

54

58

60

61

62

63

63

65

100.0

3.1

10,7

17,0

30.0

36.0

42.1

52.3

60.1

70.3

75.6

80.8

86.4

88.1

90.3

92,3

94.4

96.2

97.9

98.3

99.2

99.2

100.0

100,0

3.5

11.8

18,5

31.9

40,1

44.7

55.6

63.4

73.3

78.7

82.7

87.6

89.3

91.3

93.3

94.9

96.5

98.2

98.5

99.4

99.4

100,0

100.0

1.5

3.7

13.6

21.2

22.4

29.4

36.7

48.1

53.1

65.2

75.5

77.9

81.8

83,8

90.4

92,8

95.6

96.5

97.5

97,5

100,0

885

52

146

209

312

403

444

516

580

657

695

739

785

797

815

826

642

867

872

874

875

879

885

751

48

135

190

283

364

396

455

510

576

609

648

681

691

704

712

724

741

744

745

745

747

751

112

3

9

15

24

32

40

50

56

64

69

73

85

87

92

95

98

105

107

107

108

110

112

100,0

5.9

16.0

22.7

34.3

45.4

50.0

58.1

S5.7

74.4

78.9

84.3

88.9

90.4

92.7

94.0

95.6

98.1

98.6

98.9

99.0

99.4

100.0

100.0

6.2

16.8

23.5

35.9

47.5

51.6

59.3

67.2

75.9

60.4

86,1

90.1

91.6

93.8

94.9

96.4

98.6

99.0

99.1

99.1

99.5

100.0

100.0

2.6

9.6

14.6

22.5

29.3

37.5

47.7

52.3

59.1

64.8

66.0

78.3

79.4

83.8

87.7

89.5

95.4

96.9

96.9

97.4

98,7

100.0

611

47

113

171

265

313

329

369

418

470

499

522

543

549

564

575

590

594

601

607

609

610

611

545

46

102

159

246

268

303

341

386

433

460

479

494

497

511

518

529

533

539

542

544

544

545

54

1

7

8

14

20

21

22

26

31

32

34

40

42

43

46

49

49

50

53

53

54

54

100.0

7.1

18.3

27,4

43.1

50.5

52.9

60.3

68.0

76.0

80.4

64.8

.98.1

89.4

92.0

94,0

96,3

97.0

98.1

99.3

99.6

99.9

100.0

100.0

7.9

18.6

28,8

44,8

52.3

54.9

82.9

70.8

78.9

83.7

87,6

90.3

90<9

93.7

94.9

96.8

97.6

98.6

99.3

99.9

99.9

“100,0

100.0

1.6

13.0

14.6

26.7

34.9

36.9

38.1

45.9

55.4

56.5

60.4

71,7

74.8

77.5

86,2

91.1

91.1

92.4

98.9

98,9

100.0

100,0

1Includes data for races not shown separately. NOTES: To converi the values in the stub to millimoks per her (mmol/L), multiply the values by 0.02586. mgldl is milligrams per deciliter.

30
Table 12. Cumulative percent distribution of high density lipoprotein (HDL) cholesterol levels for men 20–74 years of age, and number of

examined persons, by race, HDL cholesterol level cutoffs, and age: United States, 1976-80–Con.

45–54 years 55-64 years 65–74 years

Race and selected Number of Number of Number of

HDL cholesterol level cutoff exemined Cumulative examined Cumulative examined Cumulative

(mgldl) p.3rsons percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 30 . . . . . . . . . . . . . . . . . . . . .

Less than 35 . . . . . . . . . . . . . . . . . . .

Lessthan 37 . . . . . . . . . . . . . . . . . . . . .

Lessthan 40 . . . . . . . . . . . . . . . . . . . . .

Lessthan 42 . . . . . . . . . . . . . . . . . . . . .

Lessthan 44 . . . . . . . . . . . . . . . . . . . . .

Lessthan 46 . . . . . . . . . . . . . . . . . . . . .

Lessthan 48 . . . . . . . . . . . . . . . . . . . . .

Lessthan 51 . . . . . . . . . . . . . . . . .

Lessthan 53 . . . . . . . . . . . . . . . . . . . . .

Lessthan 56 . . . . . . . . . . . . . . . . . .

Lessthan 59 . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . .

Lessthan 62 . . . . . . . . . . . . . . . . . . . .

Lessthan 64 . . . . . . . . . . . . . . . . .

Lessthan 69 . . . . . . . . . . . . . . . . . . . . .

Lessthan 74 . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . .

Lessthan64 . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . .

Lessthan95 . . . . . . . . . . . . . . . . .

Lessthan 169 . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . .

Lessthan30 . . . . . . . . . . . . . . . . . .

Lessthan35 . . . . . . . . . . . . . .

Lessthan37 . . . . . . . . . . . . . .

Lessthan40 . . . . . . . . . . . . . . . . .

Lessthan42 . . . . . . . . . . . . . . . . .

Lessthan44 . . . . . . . . . . . . . .

Lessthan 46 . . . . . . . . . . . . . . . . . . . . .

Lessthan46 . . . . . . . . . . . . . . . . . . . .

Lessthan 51 . . . . . . . . . . . . . . . . . . .

Lessthan53 . . . . . . . . . . . . . . . . . . . .

Lessthan56 . . . . . . . . . . . . . . . . . . . . .

Lessthan59 . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Lessthan 62 . . . . . . . . . . . . . . . . . . . . .

Lessthan 64 . . . . . . . . . . . . . . . . . . . . .

Lessthan 69 . . . . . . . . . . . . . . . . . . . . .

Lessthan74 . . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Lessthan 84 . . . . . . . . . . . . . . . . . . . . .

Lessthan90 . . . . . . . . . . . . . . . . . . . . .

Lessthan 95 . . . . . . . . . . . . . . . . . . . . .

Lessthan 189 . . . . . . . . . . . . . . . . . . . . .

Black

Total, . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan30 . . . . . . . . . . . . . . . . . . . . .

Lesathan35 . . . . . . . . . . . . . . . . . . . . .

Lessthan 37 . . . . . . . . . . . . . . . . . . . .

Lessthan40 . . . . . . . . . . . . . . . . . . . . .

Lessthan42, . . . . . . . . . . . . . . . . . . . .

Lessthan 44, . . . . . . . . . . . . . . . . . .

Lessthan46 . . . . . . . . . . . . . . . . . . . .

Lessthan48 . . . . . . . . . . . . . . . . . . .

Lessthan51 . . . . . . . . . . . . . . . . . . . . .

Lessthan53, . . . . . . . . . . . . . . . . . . .

Lessthan56 . . . . . . . . . . . . . . . . . . .

Lessthan59 . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . .

Lessthan 62 . . . . . . . . . . . . . . . . . . . .

Lessthan 64 . . . . . . . . . . . . . . . . . . . . .

Lessthan69 . . . . . . . . . . . . . . . . . . . . .

Lessthan74 . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . . .

Lessthan 84 . . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . . .

Lessthan95 . . . . . . . . . . . . . . . . . . . . .

Lessthan 189 . . . . . . . . . . . . . . . . . . . . .

559

37

101

159

236

273

295

333

374

420

442

465

499

504

510

.516

534

!543

551

553

556

556

559

506

36

95

149

223

256

Z76

310

350

390

411

431

458

462

468

474

430

438

502

503

504

504

506

417

1

4

8

10

12

16

19

20

25

26

29

36

37

37

37

39

33

4.3

4.$

46

46

47

100.0

6.6

16.5

29.2

43.5

50.1

53.8

60.6

68.7

76.0

80.0

64.3

89.7

90,7

91.7

92.7

95.9

97.4

96.7

99.0

99.4

99.4

100.0

100.0

7.1

18,9

30.0

45.3

52.3

55.7

62.4

71.2

76.2

62.4

86.3

90.9

91.6

92.9

94.0

97.1

98.6

99.4

99.5

99.6

99.8

100.0

100.0

2.0

12.4

19,9

22.6

26.1

33.1

39.4

41.9

52.0

53.6

62.4

76.6

80.6

80.6

80.6

82.4

83.8

90.8

93.4

97.2

97.2

100.0

964

76

176

245

339

425

466

525

592

677

731

774

830

840

865

867

914

930

944

947

952

955

964

665

76

167

234

324

403

441

496

555

625

678

716

763

771

768

604

828

840

850

853

855

856

865

92

2

9

11

15

22

25

29

36

49

49

54

62

64

72

76

81

65

67

87

90

90

92

100.0

8.1

16.4

25.9

35.6

43.6

47.1

52.5

60.3

68.7

75.6

79.9

85.1

85.6

68.5

90.7

94.2

96.3

97.7

97.9

96.6

99.2

100.0

100.0

8.6

19.4

27.5

37.7

45.5

49,3

54.8

62.2

70,2

77.3

81.6

66.7

87.3

89.4

91.3

95.0

96.6

98.0

98.2

96.6

99.3

100.0

100.0

1.7

8.9

11.2

16.3

26.7

29.3

33.0

43.3

53.8

53.8

59.2

65.0

66.8

76.6

83.1

85.7

91.1

93.9

93.9

97.9

97.9

100.0

973

65

182

246

362

440

470

550

616

693

737

772

832

847

867

890

912

933

948

958

962

966

973

858

59

170

233

341

412

436

514

571

637

675

704

755

767

783

799

816

832

841

849

852

655

856

92

5

9

11

16

22

25

29

35

45

50

53

60

62

66

72

76

79

65

87

88

91

92

100.0

7.2

19.4

25.9

37.3

45.3

48.2

56.0

62.5

70.2

75.3

78.7

85.4

86.9

89.1

91,6

93.9

96.0

97.7

98.6

98.9

99.4

100.0

100.0

7.5

20,5

27.3

39.5

47,6

50,5

58.7

65.0

72,4

77.6

80.9

67.4

86.9

91.0

93.0

95,2

97.0

98.1

99.0

99.3

99.6

100.0

100.0

5.6

9.1

10.7

16.9

23.6

26.1

32.2

37.8

50.7

55.8

58.6

66.4

68.1

71.7

79.6

83.0

85.5

94.4

96.2

96.9

99.3

100.0

31
Table 13. Cumulative percent distribution of high density lipoprotein (HDL) cholesterol levels forwomen 20-74years ofageandnumbt?r

of examined persons, by race, HDL cholesterol Ievel cutoffs, and age: United States, 1976-80

20–24 years 25–34 years 35-44 years

Race and selected Number of

—

Number of Number of

FfDL cho/estero/ /eve/ cutoff examined Cumu/afive examined Cumulative

(mg/dl)

examined Cumulative

persons percent persons percent persons percent

All races 1

Total ...,,,,.,.,.,....,.. ... ,.,

Lessthan 30 .,, .,, , ..,.,,.,, ,,, .,

Lessthan 35, , .,, ,, .,.... .,, ,,.,.

Lessthan 37, . .,, . . . . . . . . . . . .

Lessthan 40 . . . . . . . . . . . . . .,, ..,.,

Lessthan 42 . . . . . . . . . . . . . ,,, ..,.,

Lessthan 44,,,,,.....,., ., ..,..,

Lessthan 46...,,,....,,, ,, .,....

Lessthan 48 . .,, .,.,,.,,

Less than 51..,,..,,,,,,, ,. .

Lessthan 53,,.,,,..,.,,, ... .,.,,

Lessthan 56..,,.,.,,,,,. ,,, ,,.,.

Lessthan 59, , .,, ...,.... ., ...,,,

Lessthan 60, . . . . . . . . . . . . . . . . .

Lessthan 62..,...,,,.,.. . . . . .

Lessthan 64, , .,, ..,,.... . . . .

Lessthan 69....,.,,,.,,. . . .

Lessthan 74, ., . .,..,,... ,. ...,,,

Lessthan 80, . . . . . . . . . . . . .

Lessthan 84,.......,,.. . . . . . .

Lessthan 90, ,, . .,.,,..,. . . . . . . . .

Lessthan 95, ., ., ..,,.... ., ..,,,.

Lessthan 189, . . . . . . . . . . . . . . . . .

White

Total . .,, . . . . . . . . . . . . . . . . . . .

Lessthan30 . . . . . . . . . . . . . . . . . .

Lessthan 35 . . . . . . . . . . . . . . . . . .

Lessthan 37, . . . . . . . . . . . . . .,,,.,.

Lessthan 40 . . . . . . . . . . . . . . . . . .

Lessthan 42 . . . . . . . . . . . . . . . . . . .

Lessthan 44 . . . . . . . . . . . . . . . . . .

Lessthan46 ...,,......,.,

Lessthan 48, .,, ,. . . . . . . . . . . .

Lessthan 51,.,,.......,., . . . . . . .

Less than 53.,,.......,,,, . . . . . . .

Lessthan 58 . . . . . . . . . . . . . . . . . . . . .

Lessthan 59.,,.......,,, ... . . . .

Lessthan 60.,.......,,,. . . . . .

Lessthan 62,,........,.. .

Lessthan 64, . . . . . . . . . . . . . . . . . .

Lessthan 69, . . . . . . . . . . . . . . . . . .

Lessthan 74,......,,,..

Lessthan 80,......,,,.,.. .,,.,,.

Lessthan 84, . . . . . . . . . . . . . ...,,,.

Lessthan 90 . . . . . . . . . . . . . . . . . .

Lessthan 95 . . . . . . . . . . . . . . . . . .

Lessthan 189. . ., .,.,.....

Black

Total . .,, .,, . .,, .,..... .,, ,,,..

Lessthan 30, ,, .,, . . . . . . . . . . . .

Lessthan 35, , . .,, . . . . . . . . . . . . .

Lessthan 37 . . . . . . . . . . . . . . . . . .

Lessthan 40 . . . . . . . . . . . . . . . . . . .

Lessthan 42..,,,.....,., .,,

Lessthan 44.,.,,....,., .,, ,..,.,

Less than 46 .,, ,, .,...... . . . . . .

Less than 48 . . . . . . . . . . . . . . . . . . . .

Lessthan 51 . . . . . . . . . . . . . .

Lessthan 53 .,, . . . . . . . . . . . . . . . . .

Lessthan 56.,,.......,,,,

Lessthan 59.,........,,., . . . . . . .

Lessthan 60,,........,., . . . . . . . .

Lessthan 62.,........,., . . . . . . .

Lessthan 64,,.......,,., . . . . . . . .

Lessthan 69,,.......,,., . . . . . . .

Lessthan 74,........,,., . .

Lessthan 80, . . . . . . . . . . . . . . . . . . .

Lessthan 64,........,,. . . . . . . . .

Lessthan 90, . . . . . . . . . . . . . . . . . . .

Lessthan 95,......,,,.. . . . . . .

Lesathan 189, . . . . . . . . . . . . . . . . .

634

8

37

60

104

133

159

188

235

303

358

400

453

462

493

517

567

593

613

616

627

628

634

542

8

34

55

97

120

141

167

210

264

313

348

393

400

424

445

489

512

526

529

536

537

542

77

2

3

4

9

12

14

17

30

35

41

48

49

55

58

64

67

72

74

76

76

77

100.0

1.4

6.0

9.0

16.3

20.6

24.9

29.1

36.1

47,6

55.9

62,3

71.0

72.3

76.7

80.2

68.3

92.5

96.3

97.1

98.2

96.5

100.0

100.0

1.6

6.3

9,6

17,4

21.4

25,6

30,0

37.3

48.2

57.0

63.8

72.0

73.0

77.1

80.8

89.0

93.3

96.4

97.0

98.0

98.4

100.0

100,0

2.6

3.5

6.1

11,6

16,7

18,4

23.7

40,1

45,7

50.3

62.1

64.3

70.7

74.0

83.2

87.0

94.4

97.1

99.1

99.1

100,0

1,017

19

74

112

171

212

249

317

391

502

576

652

732

758

796

842

905

955

983

994

1,008

1,011

1,017

875

18

60

92

148

183

212

269

338

439

502

565

637

661

692

731

784

827

651

861

870

872

875

122

1

12

17

18

23

29

38

43

52

63

73

79

81

87

94

101

108

112

113

118

119

122

100.0

1.6

6.7

10,4

16.3

19,8

23.2

29.8

36.8

47.9

55.2

62.8

70.7

73.6

77.6

82.0

87.9

93.5

96.5

97.6

99.3

99.5

100,0

100.0

1.8

6.1

9.9

16.5

20.1

23.1

29.9

37.1

48.8

55.9

63.5

71.8

74,9

78,4

82.8

88,5

94,2

97.2

98.4

99.5

99.7

100.0

100.0

0.4

10.0

13.5

13.9

16.5

21.2

27.2

33.3

41.3

50.2

57.5

61.0

63.3

69.9

75.5

81.2

87.3

90.8

91.3

97.2

97.8

100.0

722

14

47

76

122

163

190

240

269

360

405

444

511

527

557

583

627

665

697

705

709

713

722

626

11

41

67

107

143

168

215

258

321

361

393

447

462

486

509

549

582

607

614

616

620

626

64

3

6

9

14

18

20

23

28

35

39

44

55

55

61

64

68

73

79

79

81

81

84

100.0

2.1

6.3

9.9

16.9

23.1

26,3

33.2

39.6

49,9

56.2

62.2

71.0

73.1

77.’1

60,6

86.6

92.2

96.4

97,7

98.1

98.6

100.0

100,0

1.7

6.3

10.0

17.0

23.2

26.7

34.2

40.6

51.3

57.8

63.6

71.5

73.7

77.3

80.9

87,0

92.6

96.6

97.9

98.1

98.9

100.0

100.0

5.3

7.6

10,6

17.4

22.8

24,5

27.9

33.2

40.1

44.6

51.4

66.3

66.3

74.2

77.1

82.7

90,5

95,5

95.5

97.6

97.6

100.0

1Includes dats for races not shown separately, NOTES To mnvett values of high densiy lipoprotein cholesterol to millimoles per titer (mmoVL), multipv by 0.0258a. mgfdl is milligrams per decititer.

32
Table 13. Cumulative percent distribution of high density lipoprotein (HDL) cholesterol levels for women 2C-74 years of age and number of

examined persons, by race, HDL cholesterol level cutoffs, and age: United States, 1976-80-Con.

45%4 years 5E-64 years 6S74 years

Race and se/ected Number of Number of Number of

HDL cfro/estero/ /eve/ cutoff examined Cumulative examined Cumulative

(m~dl)

examined Cumulative

persors percent persons percent persons percent

All racesl

Total. ..,............,,,.. . . . . .

Lessthan 30 . . . . . . . . . . . . . . . . . . . . .

Lessthan35 . . . . . . . . . . . . . . . . . . . . .

Lessthan37 . . . . . . . . . . . . . . . . . . . . .

Lessthan40 . . . . . . . . . . . . . . . . . . . . .

Lessthan42 . . . . . . . . . . . . . . . . . . . . .

Lessthan44 . . . . . . . . . . . . . . . . . . . . .

Lessthan46 . . . . . . . . . . . . . . . . . . . . .

Lessthan48 . . . . . . . . . . . . . . . . . . . . .

Lesathan51 . . . . . . . . . . . . . . . . . . . . .

Lessthan53 . . . . . . . . . . . . . . . . . . . . .

Lessthan56, . . . . . . . . . . . . . . . . . . . .

Lessthan59 . . . . . . . . . . . . . . . . . . . . .

Lesathan60 . . . . . . . . . . . . . . . . . . . . .

Lassthan62 . . . . . . . . . . . . . . . . . . . . .

Lessthan64 . . . . . . . . . . . . . . . . . . . . .

Lessthan69 . . . . . . . . . . . . . . . . . . . . .

Lessthan74 . . . . . . . . . . . . . . . . . . . . .

Lessthan80 . . . . . . . . . . . . . . . . . . . . .

Lessthan64 . . . . . . . . . . . . . . . . . . . . .

Lessthan90 . . . . . . . . . . . . . . . . . . . . .

Lessthan95 . . . . . . . . . . . . . . . . . . . . .

Lessthan189 . . . . . . . . . . . . . . . . . . . .

Whtie

Total . . . . . . . . . . . . . . . . . . . ,,,...,

Lessthan30 . . . . . . . . . . . . . . . ..,.,,

Lessthan35. . . . . . . . . . . . . . . . . . . . .

Lessthan37 . . . . . . . . . . . . . . . . . . . . .

Lessthan40 . . . . . . . . . . . . . . . . . . . . .

Lesathan42 . . . . . . . . . . . . . . . . . . . . .

Lessthan44 . . . . . . . . . . . . . . . . . . . . .

Lessthan46 . . . . . . . . . . . . . . . . . . . . .

Lessthan48 . . . . . . . . . . . . . . . . . . . . .

Lessthan51 . . . . . . . . . . . . . . . . . . . . .

Lessthan53 . . . . . . . . . . . . . . . . . . . . .

Lessthan56 . . . . . . . . . . . . . . . . . . . . .

Lessthan59 . . . . . . . . . . . . . . . . . . .

Lessthan60 . . . . . . . . . . . . . . . . . . . . .

Lessthan62. . . . . . . . . . . . . . . . . . . . .

Lessthan64 . . . . . . . . . . . . . . . . . . . . .

Lessthan69 . . . . . . . . . . . . . . . . . . . . .

Lessthan74 . . . . . . . . . . . . . . . . . . . . .

Lessthan60 . . . . . . . . . . . . . . . . . . . . .

Lessthan84 . . . . . . . . . . . . . . . . . . . . .

Lassthan90 . . . . . . . . . . . . . . . . . . . . .

Lessthan95 . . . . . . . . . . . . . . . . . . . . .

Lessthan189 . . . . . . . . . . . . . . . . . . . .

Black

Total. . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan30 . . . . . . . . . . . . . . . . . . .

Lessthan35 . . . . . . . . . . . . . . . . . . . . .

Lessthan37 . . . . . . . . . . . . . . . . . . . .

Lessthan40 . . . . . . . . . . . . . . . . . . . . .

Lessthan42 . . . . . . . . . . . . . . . . . . . . .

Lessthan44 . . . . . . . . . . . . . . . . . . . . .

Lessthan46 . . . . . . . . . . . . . . . . . . . . .

Lessthan46 . . . . . . . . . . . . . . . . . . . . .

Lessthan51 . . . . . . . . . . . . . . . . . . . . .

Lassthan53 . . . . . . . . . . . . . . . . . . . . .

Lessthan56 . . . . . . . . . . . . . . . . . . . . .

Lessthan59. . . . . . . . . . . . . . . . . . . . .

Lesathan60 . . . . . . . . . . . . . . . . . . . . .

Lessthan62. , . . . . . . . . . . . . . . . . . . .

Lessthan64 . . . . . . . . . . . . . . . . . . . . .

Lessthan69 . . . . . . . . . . . . . . . . . . . . .

Lessthan74. . . . . . . . . . . . . . . . . . .

Lessthan80 . . . . . . . . . . . . . . . . . . . .

Lessthan84 . . . . . . . . . . . . . . . . . . .

Lessthan90 . . . . . . . . . . . . . . . .,,,..

Lessthan95. . . . . . . . . . . . . . . . . . . . .

Lessthan 189, . . . . . . . . . . . . . . . . . . .

641

11

36

55

87

129

146

180

229

292

327

366

419

433

466

491

532

569

595

609

618

622

641

546

6

30

46

75

110

122

154

198

255

281

317

359

371

401

423

453

488

508

520

528

530

546

81

2

4

7

9

16

21

23

28

33

41

42

49

51

53

56

62

71

74

76

77

78

81

100,0

1.3

5.4

8.2

13.1

19.4

22.4

27.5

35.2

44.6

49.7

56.9

64.6

67.3

72.2

75.7

83.2

88.3

92.0

94.7

96.3

96.6

100.0

1OQ,O

1.0

5.2

8.0

13.0

19.4

21.8

27.3

35.6

45.5

50.3

57.7

64.6

67.0

72.0

75.7

83.3

88.1

91.7

94.6

96.4

96.8

100.0

100.0

1.9

3.9

8,0

10,3

18,0

27,2

29,7

34.5

39.9

48.0

46.9

60.1

64.2

68.5

71.9

79.9

69.6

92.7

94,4

95,2

96.2

100.0

1,086

24

78

98

179

229

250

306

362

469

526

606

669

718

754

793

882

954

1,012

1,031

1,053

1,065

1,086

973

22

68

68

159

203

222

275

327

422

477

552

628

655

686

723

805

868

910

925

945

955

973

99

1

8

8

16

20

22

25

29

37

39

44

50

52

57

59

85

75

88

92

94

96

99

100.0

2.1

7.2

8.6

15.7

20.2

22.4

26.8

32.3

41.9

47.0

54.3

62.1

64.6

67.8

71.5

80.2

86.5

91.8

93.8

96.0

97.6

100.0

100.0

2.3

7.3

8.9

15.7

19.9

21.8

26.3

32.0

41.1

46.7

54.4

62.4

65.1

68.4

72,4

81.7

87.5

91.9

93.8

96.1

97.7

100.0

100,0

0.4

5.2

5.2

15!0

21,7

26.4

31,3

35.4

46.0

46.9

51.1

55.3

56.6

58.6

60.4

64,3

74,3

89.8

92.1

94.0

96.6

100.0

1,135

23

74

111

193

268

303

372

441

543

613

687

796

822

857

901

977

1,031

1,070

1,097

1,112

1,121

1,135

1,001

22

70

103

177

242

273

338

405

496

562

627

724

743

772

809

874

924

952

970

963

990

1,001

118

1

3

6

13

21

25

29

30

40

42

51

62

67

73

80

89

93

104

111

113

115

118

100.0

1.9

6.5

9.6

16.6

23.6

26.5

32.8

38.6

48.2

54.1

60.7

70.3

72.7

75.8

79.5

86.0

90.8

93.7

96.4

98.0

98.7

100.0

100.0

2.1

6.9

10.0

17.3

23.6

26.5

33.2

39.7

49.5

55.7

62.1

71.6

73.9

76.8

80.5

86.9

91.9

94.4

96.5

98.0

96.7

100.0

100,0

0,5

1.8

3.8

9.9

23.6

26,1

29.2

30,0

37.3

39.6

48.6

58.6

61.6

66.0

71,2

77.8

81.8

89.5

95.3

97.2

98.3

100.0

33
Table 14. Cumulative percent distribution of serum non-high density lipoprotein (non-HDL) cholesterol for persons 20-74 years of age by

race and selected cholesterol level cutoffs, according to sex: United States, 1976-80

Both sexes Men Women

Race and selected Number of Number of Number of

nor7-/-/DL cho/estero/ cufoffl examined Cumulative examined Cumulative

(mg/dl)

examined Cumulative

persons percent persons percent persons percent

All racesz

Total . . . . . . . . . . . . . . . . . . . .

Less than 80,......,,,...,.. .,, ,.

Lessthan 90,,....,,,,...,., ,,, ,,

Lessthan 100 . . . . . . . . . . . . . . . . .

Lessthan 110, . . . . . . . . . . . . . . . ,,,

Lessthan 120 . . . . . . . . . . . . . . . . ,., .,

Lessthan 125...,,,,....,.. .,, .,,,

Less than 130 . . . . . . . . . . . . . . ,, ..,..

Lessthan 135. . ., ..,..,..,

Lessthan 140, ,,, . . . . . . . . . . . .

Lessthan 150,,,,,....,,, . . . . . .

Lessthan 160,.....,.,,,,.

Lessthan 170,..,.,...,,. . .

Leesthan 180 . . . . . . . . . . . . . . .

Lessthan 190,.,.,...,,., . .

Lessthan 200,.......,,,.. . . .

Lessthan 210. , . ., ...,,.... . . .

Lessthan 220. ., . ...,..... . . . .

Lessthan 230. , . . . . . . . . . . . . .

Lessthan 240,,,.,,...,,,, . . .

Lessthan 250. . .,, ,, . . . . . . .,, ,.,..

Lessthan 260, . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . .

Lessthan 80, . . . . . . . . . . . . . . . . . . .

Lessthan 90,........,,.. . . . . . . .

Lessthan 100,.....,,,,,.. .,, .,,,,

Lessthan llO. . .,, ,,, . . . . .

Lessthan 120, . . . . . . . . . . . . . . . . .

Lessthan 125, . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . .,, ,.,..

Lessthan 135, . .,, . . . . . . . . . . . .

Lessthan 140, . . . . . . . . . . . .

Lessthan 150. .,, ,. . . . . . . . . . . . .

Lessthan 160,.....,,.,.,.. . . . . .

Lessthan 170,...,,,..,,,. . . . . .

Lessthan 180,.......,,,,.. . . .

Lessthan 190,.......,,,., . . . . .

Lessthan 200. . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . ..,,,,.

Lessthan 220 . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . .,, ,,,.,

Lessthan 240....,,.....,., ,,,.,,.

Lessthan 250,..,..,,,,,., .,, .,,.,

Lessthan 260, .,, , .,,....,, ,...,.,

9,797

160

329

627

1,041

1,603

1,929

2,281

2,633

2,996

3,642

4,639

5,421

6,166

6,818

7,435

7,951

8,411

8,734

9,015

9,230

9,396

6,562

125

253

504

858

1,336

1,621

1,926

2,224

2,547

3,275

3,972

4,667

5,326

5,897

6,455

6,923

7,341

7,623

7,878

6,074

6,227

100,0

2,0

4,0

7.7

12.5

19.0

22.7

26.5

30.5

34.4

43,2

51.3

59,0

66.5

72.5

78,5

83.2

67.5

90.4

93.3

95.2

96.5

100,0

1,8

3.6

7.3

11.9

18.3

22.1

25.9

29,6

33.6

42,5

50,4

58.2

65.7

71,7

77.8

82.8

67.3

90.2

93.2

95.2

96,6

4,562

60

133

246

433

677

823

968

1,150

1,327

1,720

2,117

2,516

2,874

3,206

3,515

3,767

3,976

4,100

4,243

4,339

4,416

4,019

45

97

166

343

552

677

818

952

1,110

1,456

1,810

2,170

2,496

2,799

3,077

3,303

3,492

3,600

3,732

3,821

3,893

100.0

1.5

3.2

5.9

10.3

16,1

19,4

23,1

27,1

31.0

39.7

46.3

56.8

64,6

71.5

76.0

83,2

87,7

90.1

93.7

95.6

96.9

100.0

1.3

2.6

5,2

9.5

15.1

18.4

22.1

25.9

29.9

38.6

47.3

55.8

63.7

70.7

77.4

82.7

87.3

69.6

93.6

95.6

97.0

5,235

100

196

361

608

926

1,106

1,293

1,463

1,669

2,122

2,522

2,905

3,294

3,610

3,920

4,184

4,435

4,634

4,772

4,691

4,980

4,563

80

156

318

515

786

944

1,108

1,272

1,437

1,617

2,162

2,497

2,830

3,098

3,376

3,620

3,849

4,023

4,146

4,253

4,334

100,0

2.4

4.7

9.3

“14.4

21.5

25.5

29.6

33,5

37,5

46,3

!53,8

60.9

66,1

73.4

‘78.9

83.2

87.4

90,7

92.9

94.9

96.2

100.0

2,3

4.3

9.1

14.1

21.2

25,3

29,3

33.3

37.3

46.0

53.2

60.3

67.4

72.6

76.2

82.6

87.3

90.5

92.8

94,8

96.2

34
Table 14. Cumulative percent distribution of serum non-high density lipoprotein (non-HDL) cholesterol for persons 20-74 years of age by

race and selected cholesterol level cutoffs, according to sex: United States, 1978-80-Con.

Both sexes Men Women

Race and se/ected Nu#nber of Number of Number of

non-HDL cho/estero/ cutoff 1 examined Cumulative examined Curnu/ative examined Cumulative

(mgldl) persons percent persons percent persons percent

Black

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . . .

Lessthan 100 . . . . . . . . . . . . . . . . . . . .

Lessthan 110, . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . .,, ,.

Lessthan 125, . . . . . . . . . . . . . . . ... ,,

Lessthan 130, . . . . . . . . . . . . . . . . . . .

Lessthan 135, . . . . . . . . . . . . . . . . . . .

Lessthan 140. . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230............,.. . . . . . .

Lessthan 240. . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . . . . .

Lessthan 260 . . . . . . . . . . . . . . . . . . . . .

1,043

33

72

114

164

237

275

319

364

398

498

587

657

730

794

839

882

917

951

972

369

’999

100.0

3.5

7.7

12.2

18.0

26.0

29.5

33.6

38.0

41.1

50.4

60.1

67.0

73.9

79.2

83.0

86.8

89.2

92.1

94.0

95.2

95.9

462

15

35

57

84

114

133

155

178

193

229

270

299

325

352

371

393

409

424

432

439

443

100.0

4.3

8.3

13.4

20.0

27.0

30.7

84.3

39.9

42.8

50.1

60.2

67.5

72.9

79.1

82.1

88.5

89.5

92.5

94.0

95.2

96.0

581

18

37

57

80

123

142

164

186

205

269

317

358

405

442

468

489

508

527

540

550

556

100.0

2.9

7.2

11.3

16.5

25.1

28.6

33.2

36.7

39.9

50.6

60.1

66.6

74.7

79.3

83.7

86.7

89.0

91.7

94.0

95.2

95.7

lNon-HDL cholesterol = totslcholesterol -HDLcholeserol. Toconvert values ofnon-HDL cholesterol tom! bmolesper l,ler(mmol!L), multiply by O.O2586.

21ncludes data for races not shown SeParalEh/.

NOTE mg/dl is milligrams per deciliter.

35
Table 15. Cumulative percent distribution ofserum non-high density lipoproteirl (non. HDL)cholesterol formen20-74 years of age and

number of examined persons by race and selected cholesterol level cutoffs, according to age: United States, 1976-80

20-24 years 25–34 years 35-44 years

Race and se/ected Number of

—

Number of Number of

non+/DL cho/estero/ cutoffl examined Curnu/ative examined Cumulative examined

(mgldl) persons

Cumulative

percent persons percent persons percent

All racesz

Total . . . . . . . . . . . . . . . . . . . . . . .

Less than t30 . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . .

Less than 100.,,,.......,.,.. . . .

Less than llO. . . . . . . . . . . . . . . . . . . . .

Less than 120, . . . . . . . . . . . . . . . . .

Less than 125 . . . . . . . . . . . . . . . . .

Lessthan 130, , . . . . . . . . . . . . . . . .

Lessthan 135 . . . . . . . . . . . . . .

Lessthan 140, ,, . ...,,.... . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . .

Lessthan 170,,..,,,,.,,..

Lessthan 180...,,.....,.. . . .

Less than 190. , .,, ,, . . . . . . . . . .

Lessthan 200. ,, . . . . . . . . . . ,. ...,..

Lessthan 210,......,..,,. . . .

Leasthan 220,,..,....,,,.. . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . .

Lessthan 240.,....,,,..,,. .

Lesethan 250 . . . . . . . . . . . . . ,. .,,,,.

Lessthan 280, , . ., .,,...., .,, ,.,..

White

Total . . . . . . . . . . . . . . . . . . . . . . . . .

Less than 80 . . . . . . . . . . . . . . . . . . .

Lessthan 90,,.......,,,,. . . . . . . .

Lessthan 100,,....,...,,. . . . .

Lessthan 110, , . . . . . . . . . . . ,. ..,,.,

Lessthan 120. , . . . . . . . . . . ,., ..,,.,

Lessthan 125 . . . . . . . . . . . . . . . . .

Lessthan 130. , . .,, . . . . . . . . . . . .

Lessthan 135 . . . . . . . . . . . . . . . . . .

Less than 140,,.,,.,..,,.. ,,, .,,..

Less than 150. . . . . . . . . . . . . . . . . . .

Lessthan 160. , . . . . . . . . . . . . . . .

Lessthan 170, ,, ...,...., . . . . .

Lessthan 180, . . . . . . . . . . . . . . . . .

Leaathan 190,.......,.,.. . . . .

Lessthan 200. ., . . ...,..... . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . .

Lessthan 220, . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . .

Lessthan 240 . . . . . . . . . . . . . . . . .

Lessthan 250. . . . . . . . . . . . . . . . .

Lessthan 280. . . . . . . . . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . .

Lessthan 100 . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . .

Lessthan 120. . . . . . . . . . . . . . . . . .

Lessthan 125 . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . . . . .

Lesathan 135. ,, . . . . . . . . . . ,,, .,,..

Lessthan 140. . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . .

Lesathan 170.........,,.. . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . .

Lessthan 240 . . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . .

Lessthan 260 . . . . . . . . . . . . . . . .

570

23

54

98

161

224

259

295

330

356

401

449

484

512

524

540

549

553

557

563

565

566

494

15

39

78

132

190

218

250

280

304

344

365

417

441

453

469

478

481

483

488

490

491

65

8

15

20

27

32

37

41

46

47

51

58

60

63

63

63

63

64

65

65

65

65

100.0

4.3

9.8

17.1

27.8

40,1

46,8

52,4

59.6

64.1

71,5

79.4

85.3

90.6

92.4

95,0

96,5

97.2

97.9

99.0

99.2

99.4

100,0

3,2

8,4

15.9

26.5

39.6

45.9

51.7

58.5

63.4

71,0

79,0

85,2

90.2

92.2

95.3

97.0

97.6

96.0

98.9

99.2

99,5

100.0

13.5

22.2

29.5

41.4

49,3

57.5

62.1

74,4

75,2

80,8

89.1

91,1

97.6

97.6

97.6

97.6

99.0

100.0

100.0

100.0

100.0

885

18

38

75

127

194

230

274

319

356

461

544

621

686

722

760

794

819

836

855

863

867

751

12

24

51

96

154

185

221

257

291

381

453

516

576

607

639

669

693

708

727

733

737

112

6

14

23

30

37

42

48

54

56

66

78

87

91

95

99

103

104

106

106

108

108

100,0

1.9

4.0

7.9

13.5

21.2

24.7

29.8

34.7

38.6

50.3

60.1

89.2

76.9

81.3

85.3

89.5

92.4

94.4

97.0

97.7

98.1

100.0

1.6

3.2

6.8

12.4

19.9

23,7

28,6

33.2

37.4

49.4

59.7

68.1

76.5

80.9

84.8

88.8

92.0

94.1

97.2

97.8

98.2

100.0

5.7

12.1

19.5

26.4

34.8

37.7

42.7

48.5

50.0

58.4

66.2

75.5

78.8

82.5

85.3

92.2

93.2

94.7

94,7

96.0

96.0

611

5

11

16

37

59

73

90

109

135

205

258

303

347

405

457

492

529

542

569

582

595

545

5

10

13

29

47

59

75

92

117

178

225

267

305

360

407

440

473

484

508

520

531

54

3

8

11

13

14

16

16

23

28

31

34

37

39

41

44

46

49

50

52

100.0

1.0

1.7

2.4

5.8

9.3

12,0

15,2

18,~,

22.9

33.9

42.3

49,1

56.3

65.2

73,8

80.1

86.0

87.9

93.0

95.5

97.3

100,0

1.’1

1.9

2.3

5.4

8.8

11.5

15.1

18.4

23,0

33.8

41,8

48.6

55,0

64.4

73.2

80.0

85.9

87.7

92.9

95.5

97.2

100,0

1.1

4.7

11.6

15.6

18.6

19.7

21.9

21.8

34,4

46,6

56.8

63.9

70.3

73.7

76.2

81.8

85.7

91.6

93.3

97.1

‘Non-HOL cholesterol = total cholesterol -HOLcholesterol. Toconvefl values ofnon-HOL cholesterol tomlllimoles pertiter (mmol/L), multlplyby O.O2586

‘Includes data forraces not shown separately. NOTE: mgldl is milhgr.ams perdecili[er.

36
Table 15. Cumulative percent distribution of serum non-high density lipoprotein (non-HDL) cholesterol for men 20-74 years of age and

number of examined persons by race and selected cholesterol level cutoffs, according to age: United States, 1976-80-Con.

45-54 years 55-84 years 65-74 yeara

Race and selected Number of Number of Number of

non-HDL cholesterol cutoff 1 examined Cumulative examined Cumulative examined Cumulative

(mg/dl) persons percent persons percent persons percent

All racesz

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . . .

Lessthan 90..........,.,,. . . . . . .

Less than 100 . . . . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120, . . . . . . . . . . . . . . . . . . .

Lessthan 125, . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . .,.

Lessthan 135 . . . . . . . . . . . . . . . . . . . . .

Lessthan 140. . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Less than 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200, . . . . . . . . . . . . . . . . . . . .

Lessthan 210. . . . . . . . . . . . . . . . . . . . .

Lessthan 220. . . . . . . . . . . . . . . . . .,.

Lessthan 230. . . . . . . . . . . . . . ..,.,,,

Lesathan 240. . . . . . . . . . . . . . . . . . . . .

Lessthan 250. . . . . . . . . . . . . . . . . . . . .

Lessthan 260. ,, . . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 80..........,,, . . . . . . .

Lessthan 90...........,.. . . . . .

Lessthan 100 . . . . . . . . . . . . . . ..,,...

Lesathan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 125. . . . . . . . . . . . . . . . . . . . .

Lesathan 130. . . . . . . . . . . . . . . . . . . . .

Lessthan 135. . . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Leasthan200, . . . . . . . . . . . . . . ...,..

Lessthan 210. . . . . . . . . . . . . . . . . . . . .

Lessthan220 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230, . . . . . . . . . . . . . . . . . . . .

Lessthan 240 . . . . . . . . . . . . . . . . . . . . .

Leasthan 250 . . . . . . . . . . . . . . . . . . . . .

Lessthan 260 . . . . . . . . . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 80....,....,,.. . . . . . . . .

Lessthan 90..,....,....,.. . . . . . .

Lessthan 100...........,,. . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . .

Lessthan 125 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . . . . .

Lessthan 135 . . . . . . . . . . . . . . . . . . . . .

Lessthan 140. . . . . . . . . . . . . . . . . . . .

Lessthan 150. . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lesathan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200. . . . . . . . . . . . . . . . . . . . .

Lessthan 210......,.....,.. . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan240 . . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . . . . . .

Lessthan260 . . . . . . . . . . . . . . . . . . . . .

559

2

4

9

20

40

51

65

81

10,3

143

183

235

280

337

384

425

458

483

51 I

524

533

506

2

4

El

15

32

43

56

72

9:

127

161

211

254

303

346

363

412

434

461

474

483

47

1

4

7

7

8

8

14

15

21

23

24

32

35

38

41

44

44

44

44

100.0

0.3

0.5

1.7

3.4

6.5

8.2

10.4

13.1

17.3

23.2

30.1

40.0

48.7

58.8

67.9

74.5

81.1

85.7

91.6

93.7

95.3

100.0

0.3

0.6

1.6

2.8

5.7

7.6

9.8

12.9

16.5

22.7

28.7

39.3

48.6

58.1

67.5

74.1

80.6

85.1

91.3

93.6

95.4

100.0

3.1

7.8

13.2

13.2

15.2

15.2

25.3

29.2

47.1

50.7

53.1

72.1

77.0

81.4

86.3

93.3

93.3

93.3

93.3

964

4

8

16

32

60

85

104

131

158

223

301

406

498

590

658

722

781

815

851

889

915

865

3

7

14

28

48

67

82

105

129

186

258

354

438

524

587

643

696

727

761

796

822

92

1

1

2

4

11

17

21

24

27

35

40

48

56

61

65

73

78

81

83

86

88

100.0

0.6

1.0

1.9

3.3

6.1

8,7

10.2

13.2

18.0

22.0

30.5

41.3

50.6

60.1

68.5

74.9

81.0

83.9

67.7

92.0

94,3

100.0

0.5

0.9

1.9

3.2

5.3

7.6

9.2

11.6

14.4

20.5

29.3

39.9

49,6

59.3

67.8

74,1

80.5

83.5

87.5

91.9

94.4

100.0

1.8

1.8

2.4

5.2

16.4

23.0

25.2

29.5

34.0

40.0

46.1

57.8

64.4

69.1

72.1

80.2

63.7

86.2

87.9

91.6

91.6

973

8

18

32

56

100

125

160

180

214

287

382

466

551

630

716

785

836

867

894

916

940

858

8

13

22

43

81

105

134

146

176

242

326

405

482

552

629

690

737

764

787

808

829

92

4

8

11

16

17

23

30

33

37

45

50

57

64

70

75

78

82

85

86

88

100.0

0.9

1.9

3.1

6.0

10.3

12.8

16.3

18.4

21.6

28.7

39.4

47.8

56.6

64.6

72.6

79.6

85.4

88.2

91.4

93.6

96.5

100.0

1.0

1.5

2.3

5.4

9.7

12.5

15.8

17.2

20.4

27.6

38.5

47.0

55.6

63.8

71,9

78.9

84.9

87.8

91.0

93.4

96.4

100.0

4.5

10.0

12,7

16.9

17.7

24.1

33.8

36.5

40.8

49.5

56.8

67.0

72.8

78.7

83.6

67.1

90.8

93.5

94.6

96.3

37
Table 16. Cumulative percent distribution of serum non-high density lipoprotein (non-HDL) cholesterol for women 20-74 years of age

and number of examined persons by race and selected cholesterol level cutoffs, according to age: United States, 1976-80

20–24 years 25-34 years 35-44 years

Race and se/ected Number of Number of Number of

non-HDL cholesterol cutofft examined Cumu/afive examined Cumulative examined Cumulative

(mg/dl) persons percent persons percent persons percent

All races2

Total . ., .,, . ., .,, .,,..,.,. .

Lessthan 80 . . . . . . . . . . . . . . . .

Lessthan 90,,.,,,,..,.,,,., ,,, ,.

Lessthan 100. , . .,, , .,.....,,

Lessthan llO. ..,,,.......,,, . . .

Less than 120,,.,........,,.,

Less than 125,.,,.,,.,,.,.,,.

Less than 130,,,.,.,,.,,,,. ,, .,.,.

Less than 135,..,.,,.,....,.. ,., ,,

Less than 140, , . . . . . . . . . . . . . . . .

Less than 150. . .,, ,,, . . . . . . . . . ,,,

Lessthan 160. . . . . . . . . . . . . . . .

Lessthan 170..,..,,.....,.,,. ,.,

Lessthan 180, , .,, ,, ..,..,. ,,.,,..

Lessthan 190. . .,, ,, .,.... . .

Lessthan 200. , .,, .,...... . .

Lessthan 210 . . . . . . . . . . . . . . ,, . . . .

Lessthan220, ,,, ..,....., . . . . . .

Less than 230,,,......,., . . . . . . .

Lessthan 240.,,.......,,.. . . . . . .

Lessthan 250,,....,..,,.. . . . . . . . .

Lessthan 260. , . . . . . . . . . . . . . . . .

White

Total, ,, . . . . . . . . . . . . . . . . ,,..,.,

Lessthan 80 . . . . . . . . . . . . . . . . . . .

Lessthan 90,,,,,....,.. . . . . . .

Less than 100. . . . . . . . . . . . . . . . . .

Lessthan 110, . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . .

Lessthan 125, . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . .

Lessthan 135 . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170. ,, . . . . . . . . . . . . . . . .

Lessthan 180. . . . . . . . . . . . . . . . . .

Lessthan 190.........,.,.. . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . .

Lessthan 210. . .,, ..,,..... . . .

Lessthan 220 . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . .

Lessthan 240 . . . . . . . . . . . . . . . . .

Lessthan 250. . . . . . . . . . . . . . . . .

Lessthan 260, ,,, . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . .

Lessthan 100 . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Less than 125. . . . . . . . . . . . . . . . . .

Lessthan 130. . . . . . . . . . . . . . . . . . . .

Lessthan 135. . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . .

Lessthan 200, . . . . . . . . . . . . . . . . .

Lessthan 210.,.......,.. . .

Lessthan 220. . . . . . . . . . . . . . . .

Less than 230 . . . . . . . . . . . . . . . .

Lessthan 240. ,,, . . . . . . . . . . . . . .

Lessthan 250. . . . . . . . . . . . . . . . . . . .

lLessthan 260 . . . . . . . . . . . . . . . . . . .

634

35

66

116

176

250

290

336

368

392

456

514

546

577

594

607

612

619

622

627

629

631

542

29

53

97

148

208

245

287

315

339

393

443

470

497

509

520

524

529

532

536

537

539

77

5

13

18

26

37

39

43

47

47

55

62

65

67

71

73

74

76

76

77

77

77

100,0

5.8

11.8

20.0

29,7

41.7

46,5

55.7

60.7

64.1

73,4

82.1

66.7

91.6

93.7

95.6

96.4

97.6

97,9

98.7

99.1

99.5

100.0

5.8

10.5

19.3

29,0

41,0

48,2

56.1

61,4

65.4

74.4

83.1

87.9

92.6

94.5

96.2

96.8

97,7

98.1

98.6

99.0

99.4

100,0

5,4

18,4

23.7

34.2

47,9

51,5

55.4

59.9

59.9

70,2

78,8

62,3

85.4

89.0

93.0

94.8

98.1

96.1

100.0

100,0

100.0

1,017

39

72

144

222

340

396

436

488

537

659

738

803

856

888

918

954

970

988

995

1,003

1,007

875

31

57

122

169

292

342

376

423

465

566

629

688

731

759

789

823

839

850

856

863

867

122

7

14

20

27

41

46

52

55

61

81

95

99

108

110

110

112

112

118

120

120

120

100.0

3.7

7.1

14.6

22.2

34.3

40,3

44.6

49.6

54.0

65.7

72.7

78.6

83.9

87,2

90.0

93.4

95.1

97.2

97.9

98.7

99.0

100,0

3.5

6.6

14.7

22.0

34.1

40.4

44,8

50.1

54.4

65.8

72.1

78.5

83.2

86.5

89.7

93.5

95,5

97.2

97.8

98.8

99.1

100.0

4.5

10,5

15,2

22,7

35.9

39.7

44.4

46.0

51.6

67.3

78.9

83.1

90.6

92,0

92,0

93,0

93,0

96.3

98.2

98.2

98.2

722

14

30

61

105

167

201

239

268

303

360

420

487

545

587

624

649

668

689

697

705

708

626

11

26

52

92

143

175

206

232

262

311

366

423

471

504

540

563

581

600

607

613

616

84

3

4

8

11

22

24

29

33

37

44

48

56

64

72

73

75

76

77

78

80

80

100,0

1.9

4.2

8.9

‘15.O

;22.7

27.4

32.2

36.2

41,3

49.1

57.2

66.7

75.0

80.4

86.6

90.0

92.7

95.3

96.6

97.8

98.4

100.0

1.9

4.4

8.8

15.2

22.7

27.7

32.5

36.0

41.1

48,8

56.8

66.4

74.4

79.3

86.1

89.8

92.8

95.5

96.9

97.9

98.6

‘100,0

2.8

3.7

10.7

15.0

25.8

28.4

33.6

40.2

44,2

52,3

59.4

68.3

78,4

87.0

89.5

91.1

92.3

93.0

93.9

96.7

96.7

lNon-HDL cholesterol = total choleseterol -HDLcholesterol. TocOnvert values ofncn.HDLcholesterolt omillimolesp erliter( mmoUL),multiplyby O. O2586.

21ncludesdata for races not shown separately. NOTE: mg/dl is milligrams per demllter.

38
Table 16. Cumulative percent distribution of serum non-high density lipoprotein (non-HDL) cholesterol for women 20-74 years of age

and number of examined persons by race and selected cholesterol level cutoffs, according to age: United States, 1976-80-Con.

45-54 years 55-64 years 65-74 yeara

Race and selected Number of Number of Number of

non-HDL cho/estero/ cutoffl examined Cumulative examined

(mgldl)

Cumulative examined Cumulative

persons percent persons percent persons percent

All races2

Total, . . . . . . . . . . . . . . . . . . . . . . . . .

Less than 80.....,,,.,,.,,. . . . . . .

Lessthan 90.....,....,,., . . . . . .

Lessthan 100.....,........,,, . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . .,. .

Lessthan 120 . . . . . . . . . . . . . . . . . ,,. .

Lessthan 125. . . . . . . . . . . . . . . . . ,,,

Lessthan 130. . . . . . . . . . . . . . . . . . .

Lessthan 135. . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . . .

Less than 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . .

Less than 180 . . . . . . . . . . . . . . . . . . . .

Lessthan 190...........,,.. . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lesathan 210 . . . . . . . . . . . . . . . . . . . . .

Lessthan 220, . . . . . . . . . . . . . . . . .,. .

Lessthan 230, . . . . . . . . . . . . . . . . . . . .

Lessthan 240. . . . . . . . . . . . . . . . ...,,

Lessthan 250. . . . . . . . . . . . . . . . . . . . .

Lessthan 260. . . . . . . . . . . . . . . . . .,.

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . . .

Less than 100 . . . . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 125,............,,,, . . . .

Lessthan 130..............,,. . . . .

Lessthan 135.............,,,, . . . .

Lessthan 140, . . . . . . . . . . . . . . . ,,, ,,

Lessthan 150. . . . . . . . . . . . . . . . . . . . .

Lessthan 160. . . . . . . . . . . . . . . . . . . .

Lessthan 170. . . . . . . . . . . . . . . . . . . .

Lessthan 180. , .,, . . . . . . . . . . . . . . . .

Lessthan 190, . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . . . .

Lessthan 220, . . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 240......,.....,,. . . . . . .

Lessthan 250.........,,,,. . . . . . . .

Lessthan 260.........,.,,. . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 80, . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . . .

Lessthan 100, . . . . . . . . . . . . . . . . . .

Lessthan 110, . . . . . . . . . . . . . . ...,..

Lessthan 120, . . . . . . . . . . . . . . ...,,,

Lessthan 125. . . . . . . . . . . . . . . . . . . . .

Lessthan 130. . . . . . . . . . . . . . . . . . .

Lessthan 135, . . . . . . . . . . . . . . . . .

Lessthan 140. . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 210 . . . . . . . . . . . . . . . . . . . . .

Lessthan 220 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230.........,,,. . . . . . . . .

Lessthan240 . . . . . . . . . . . . . . . . . . . . .

Lessthan250 . . . . . . . . . . . . . . . . . . . .

Lessthan 260 . . . . . . . . . . . . . . . . . . . . .

641

6

10

23

35

59

74

98

120

1L4

199

256

3C0

356

3~7

447

492

528

557

580

596

609

543

3

43

18

29

51

62

81

99

12.,

166

213

253

30CI

336

379

417

451

472

493

506

517

81

1

2

5

6

7

11

16

20

22

30

39

43

51

53

57

64

66

73

75

77

78

100.0

1.0

1.6

4.1

5.9

9.3

11.3

15,1

18,7

22.6

31.0

39.6

46.4

55.0

61.4

69.1

76.4

82.2

86.6

90.3

93.0

95.2

100.0

1.0

1.6

4.2

6.1

9.8

11.5

14.7

18.4

22.7

30.9

39.3

46.4

54.6

60,9

68,6

75,8

82.3

86.1

90.0

92.7

94.8

100.0

0.9

1.6

4.7

6.0

6.9

11.5

21.0

25.1

27.3

36,4

45.7

51.8

63.6

65.8

71.0

60.7

82.2

90.7

94.2

96.1

97.0

1,086

4

9

19

36

56

72

91

119

151

234

295

373

471

565

655

724

812

872

922

956

992

973

4

9

18

34

48

60

78

105

133

206

259

325

410

492

575

638

721

778

823

655

889

99

1

4

8

12

12

13

17

26

33

44

55

66

73

79

62

64

87

89

90

100.0

0.5

0.9

2.2

3.7

5.4

6.6

6.2

11.1

14.6

21.8

27.3

34.7

44.6

52.8

60.3

65.9

74.4

79.6

83.9

87.7

90.5

100.0

0.5

1.0

2.3

3.8

5.3

6.4

8.0

11.2

14.6

22.0

26.7

33.8

43.6

52.0

59.6

65.5

74.6

80.1

84.3

86.6

91.3

100.0

0.8

3.4

7.3

10.4

10.4

10.6

14.3

22.4

34.6

46.1

55.9

62.9

69.9

73.2

76.0

77.0

80,3

81.3

81.8

1,135

2

7

16

32

54

73

93

120

142

214

299

396

489

579

669

753

838

906

951

1,002

1,033

1,001

—

3

11

25

44

60

76

98

117

175

253

338

421

498

575

655

728

791

832

879

906

118

2

4

5

6

8

10

12

18

21

33

40

51

60

70

62

85

96

99

103

107

111

100.0

0.1

0.4

1.2

2.5

4.5

6,1

7.9

10.1

12,2

la,6

25.6

34.2

42.3

50.3

59.1

65.9

73.7

80.2

64.2

88.5

91.1

100.0

0,2

1.1

2.4

4.2

5.7

7.5

9.5

11.6

17.6

25,1

33.6

41.9

49.7

57.8

65.0

72.6

79,3

83.5

87.9

90.6

100.0

1.3

2.7

3.3

3.8

5.6

7.6

9.3

13.2

15.1

23.7

30,0

38,2

44.4

52.9

70.0

72.1

82.7

85.2

88.6

91.6

94.8

39
Table 17. Cumulative percent distribution of theratio ofserum total cholesterol tohigh density lipoprotein (HDL)choiesterol for persons

20-74 years of age and number of examined persons by race and selected ratio cutoffs, according to sex: United States, 1976-80

—

Both sexes Men Women

Number of Number of Number of

Race and se/ected examined Curnu/afive examined Cumulative examined Cumu/atlve

ratio cutoff persons percent persons percent persons percent

All racesl

Total, . . . . . . . . . . . . . . . . . . . . . .

Less than 2 . . . . . . . . . . . . . . . . . . .

Less than 2.5, . . . . . . . . . . . . . . . . .

Less than 3.,...,,...,.,.. ... ,,,

Less than 3.25 . . . . . . . . . . . . . . . ,,, .,

Lessthan 3.5 . . . . . . . . . . . . . . . . .

Lessthan 4 . . . . . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . .

Less than 4,5.........,,, . . .

Lessthan 4.75 . . . . . . . . . . . .

Less than 5 . .,, . . . . . . . . . . . . . . . . .

Lessthan 5.25 . . . . . . . . . . . .

Lessthan 5.5 . . . . . . . . . . . . . .

Lessthan 6 . . . . . . . . . . . . . . . . .

Lessthan 7 . . . . . . . . . . . . . . .

Lessthan 8 . . . . . . . . . . . . . . .

Lessthan 21,0 . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . .

Less than 2 . . . . . . . . . . . . . . . . . . .

Lessthan 2,5 . . . . . . . . . . . . . . . . . . .

Lessthan 3.,....,..,,., . . . . . .

Lessthan 3.25.......,,.,.. . .

Lessthan 3.5 . . . . . . . . . . . . . . .

Lessthan 4 . . . . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . . . . .

Lessthan 4.5. . . . . . . . . . . . . . .

Lessthan 4,75 . . . . . . . . . . . .

Lessthan 5 . . . . . . . . . . . . .

Lessthan 5.25 . . . . . . . . . . . . . .

Lessthan 5,5 . . . . . . . . . . . . . . . .

Lessthan 6 . . . . . . . . . . . . . . . .

Lessthan 7 . . . . . . . . . . . . . . . .

Lessthan 8, . . . . . . . . . . . . .

Lessthan 21,0 . . . . . . . . . . . . ...,...

Black

Total, ,,, . . . . . . . . . . . . . . ,,

Lessthan 2 . . . . . . . . . . . . . . .

Lessthan 2,5, . . . . . . . . . . . . . . .

Lessthan 3 . . . . . . . . . . . . . .

Lessthan 3.25 . . . . . . . . . . . . . . .

Lessthan 3.5 . . . . . . . . . . . . . .

Lessthan 4 . . . . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . . . . . .

Lessthan 4.5 . . . . . . . . . . . . . . . .

Less than 4.75 . . . . . . . . . . . . .

Lessthan5 . . . . . . . .

Lessthan 5,25 . . . . . . . . . ...’. . . .

Lessthan 5.5. . . . . . . . . . . . . . . .

Lessthan 6 . . . . . . . . . . . . . . . . . .

Lessthan 7 . . . . . . . . . . . . . . . .

Lessthan 8 . . . . . . . . . . . . . . . .

Lessthan 21.0 . . . . . . . . . . . . . . .

9,797

69

425

1,229

1,818

2,479

3,763

4,434

5,071

5,666

6,245

6,736

7,152

7,898

8,901

9,388

9,797

8,582

47

324

975

1,476

2,034

3,140

3,728

4,281

4,805

5,333

5,780

6,152

6,829

7,753

8,202

8,582

1,043

21

94

233

316

403

557

624

697

755

793

633

867

919

985

1,014

1,043

100.0

0.8

5.0

14.2

20.5

27.6

41.2

46.1

54.4

60.4

66.4

71,0

75.1

82.1

91.6

96,1

100,0

100,0

0.7

4.6

13.2

19.4

26.2

39.8

46.6

53,0

59,0

65.2

70.0

74.1

61.3

91.2

95.8

100,0

100.0

1,5

9.3

24.5

32.6

41.0

55.1

61.5

66.2

73.4

76.5

79.9

83.3

88.1

94.6

97.4

100.0

4,562

26

142

383

552

799

1,339

1,641

1,941

2,231

2,537

2,797

3,003

3,452

4,037

4,315

4,562

4,019

17

97

274

419

620

1,082

1,349

1,611

1,865

2,145

2,385

2,567

2,980

3,527

3,766

4,019

462

8

41

100

122

161

228

258

292

321

337

355

376

401

433

448

462

100,0

0.6

3.3

8.7

12.4

18.1

30.3

37,0

43.8

50.3

57.3

62.8

67.2

76.5

88,9

94,6

100.0

100.0

0.5

2.7

7,3

11.0

16.4

28.3

35.0

41.9

48.3

55.4

60.9

65.6

75,1

68.1

94.2

100.0

100,0

1.1

8.8

22.8

27.3

35.3

49.9

56.4

64.0

69.7

73.2

77.2

82.1

87.1

94.4

97,4

100.0

5,235

43

283

846

1,266

1,680

2,424

2,793

3,130

3,435

3,708

3,939

4,149

4,446

4,864

5,073

5,235

4,563

30

227

701

1,057

1,414

2,058

2,379

2,670

2,940

3,188

3,395

3,565

3,849

4,226

4,416

4,563

587

13

53

133

194

242

329

366

405

434

456

478

491

516

552

566

581

100.0

0.9

6.5

19.0

27.6

3!5.9

50.8

57.8

63.7

69,3

74,5

78.4

81.9

87.1

94.1

97.3

100.0

100.0

0.8

6.2

18.3

26.8

35,0

50,0

56.9

62.8

66.5

74.0

78.0

81.7

86.8

93.9

97.3

100.0

100.0

1.8

9.6

25.8

36.6

45.2

59,0

65,3

71,4

76.2

79.0

82.0

84.1

88.8

94.7

97.4

“100.0

Ilncludes data for races notshowfl separately.

40
This page intentionally left blank

41
Table 18. Cumulative percent distribution of the ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol for men

20-74 years of age and number of examined persons, by race, selected raticl cutoffs, and age: United States, 1978-80

20-24 years 25-34 years 35-44 years

Number of Number of Number of

Race and se/ected examined Cumulative examined Cumulative examined Cumulative

ratio cutoff persons percent persons percent persons percent

All racesl

Total ., ., . . . . . . . . . . . . . . . .

Less than 2...,,,.......,,.. .

Less than 2.5,.,.,....,,,.. .

Less than 3,, . . . . . . . . . . . . .

Lessthan 3,25....,...,,..

Lessthan 3.5 . . . . . . . . . . . . .

Lessthan 4 . . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . .

Less than 4,5.....,...,,.

Less than 4.75 . . . . . . . . . . . .

Lessthan 5 . . . . . . . . . . . . . .

Lessthan 5.25, . . . . . . . . . . .

Lessthan 5,5 . . . . . . . . . . . . . .

Lessthan 6 . . . . . . . . . . . . . .

Lessthan 7 . . . . . . . . . . . . .

Lessthan f l . . . . . . . . . . . . .

Lessthan 21.0 . . . . . . . . . . . . . . .

White

Total . .,, ,, . . . . . . . . . . . . . ,,,,,,.

Lessthan 2.,.,,,,.,,,.. ,., ,,,.,.

Lessthan 2,5, . . . . . . . . . . . . .,, ,,...

Lessthan 3.....,,...,,,. . . . .

Less than 3,25 . ., . . . . . . . . . ,,

Less than 3,5. . . . . . . . . . . . . . . .

Lessthan 4 . . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . . . . .

Lessthan 4.5 . . . . . . . . . . . . . . ...,,.,

Lessthan 4,75 . . . ...,.....

Lessthan 5,...,,,,...,,. . . .

Lessthan 5.25 . .,, . . . . . . . .

Less than 5,5. .,, . . . . . . . . . ,,

Lessthan 6 . . . . . . . . . . . . . .

Lessthan 7,, . . . . . . . . . . . . .

Lessthan 8,, . . . . . . . . . . . . . .

Lessthan 21,0 . . . . . . . . . . . . ...,,,.

Black

Total, . . . . . . . . . . . . . . . . .

Lessthan 2 . . . . . . . . . . . . . .

Lessthan 2.5 . . . . . . . . . . . .

Lessthan 3,, . . . . . . . . . . . . . . .

Lessthan 3.25 . . . . . . . . . . . . . .

Lessthan 3.5 . . . . . . . . . . . .

Lessthan 4 . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . .

Less than 4,5. . . . . . . . . . . . .

Lessthan 4.75....,.....,.. . . . .

Lessthan 5 . . . . . . . . . . . . . . .

Lessthan 5.25, . . . . . . . . . . . . .

Lessthan 5.5.........,,.. . .

Lessthan 6.......,,,..

Lessthan 7 . . . . . . . . . . . . . . . . .

Lessthan 8 . . . . . . . . . . . . . . . .

Lessthan 21.0, . . . . . . . . . . . . . . . . . . .

570

6

39

106

153

201

303

345

392

431

455

481

498

531

557

565

570

494

4

28

79

119

159

250

290

329

365

386

413

428

459

484

489

494

65

2

10

26

32

39

48

49

56

59

60

61

62

63

63

65

65

100.0

1,3

7.5

20.3

27.2

35.7

52.5

60.3

69.6

76,5

80.3

64.9

88.0

93.6

97.9

99.3

100.0

100.0

1,2

6.5

17.6

24.6

32.8

50.4

58.7

67.6

75.1

79.3

64.5

87.4

93.6

98.2

99.2

100.0

100.0

2.4

15.3

44.0

50.2

61.3

73.2

75.4

86.9

91.2

92.3

93.1

96.3

97.6

97.6

100,0

100.0

865

6

42

104

144

198

305

392

457

515

576

620

660

737

818

854

885

751

3

28

71

103

148

235

314

389

416

472

514

551

614

689

722

751

112

3

13

29

37

44

61

69

78

66

67

89

92

102

107

110

112

100,0

0.5

4.3

11.0

15.3

21.5

33.8

43.3

50.6

57.0

64.4

69.6

74,5

63.6

92.4

96.5

100.0

100,0

0.4

3.6

9.3

13.4

19.4

31,7

42.0

49.3

55.3

63.0

66.7

74.0

82.5

91,9

96,2

100,0

100.0

1.8

9.6

24,6

32.4

39.0

51,0

57.0

66.3

74.2

74.6

77,3

79,5

89,9

94.6

96.1

100.0

611

2

9

26

45

75

145

178

222

260

314

350

372

429

529

571

611

545

2

7

18

36

61

121

149

190

221

27t

303

322

375

469

507

545

54

2

8

9

14

22

25

26

33

36

39

41

42

48

52

54

100,0

0.2

1,7

4.3

6.9

12.1

25.2

30,1

36,8

43.1

52.2

57,9

61.6

70.2

86.2

93.3

100,0

100.0

0,2

1,6

3,7

6.6

“11.6

23.7

28.4

35.4

41,0

50.6

56,0

59.2

168.2

85.2

92.7

100.0

100,0

3.6

11.1

12,2

20.3

40.9

45,0

50.9

57.3

64,0

72.4

78.9

80,6

91.7

97.1

100,0

1Includes dsta for races not shown separately.

42
Table 18. Cumulative percent distribution of the ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol for men

20-74 years of age and number of examined persons, by race, selected ratio cutoffs, and age: United States, 1978-80-Con.

4LS54 years 55-64 years 65-74 years

Nurvber of Number of Number of

Race and selected examined Cumulative examined Cumulative

rafio cutoff

examined Cumulative

persons percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 2 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 2.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan 3 . . . . . . . . . . . . . . . . . . . . . .

Leasthan 3.25 . . . . . . . . . . . . . . . ... ,,

Lessthan 3.5, . . . . . . . . . . . . . . . . . . . .

Lessthan 4 . . . . . . . . . . . . . . . . . . . . . .

Less than 4.25 . . . . . . . . . . . . . . . . . . . .

Lessthan4.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan4.75 . . . . . . . . . . . . . . . . . . . .

Lessthan5 . . . . . . . . . . . . . . . . . . . . . .

Lessthan5.25 . . . . . . . . . . . . . . . . . . . .

Lessthan5.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan6, . . . . . . . . . . . . . . . . . . . . .

Lessthan7 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 8 . . . . . . . . . . . . . . . . . . . . . .

Lessthan21,0 . . . . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 2 . . . . . . . . . . . . . . . . . . . . . .

Lessthan2.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan3 . . . . . . . . . . . . . . . . . . . . . .

Lessthan3.25 . . . . . . . . . . . . . . . . . . . .

Lessthan3.5 . . . . . . . . . . . . . . . . . . . . .

Lassthan4 . . . . . . . . . . . . . . . . . . . . . .

Lessthan4.25, ,, . . . . . . . . . . . . . . . . .

Lessthan 4.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan4.75 . . . . . . . . . . . . . . . . . . . .

Lessthan5 . . . . . . . . . . . . . . . . . . . . . .

Lessthan5,25 . . . . . . . . . . . . . . . . . . . .

Lessthan5.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan 6 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 7 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 8 . . . . . . . . . . . . . . . . . . . . . .

Lessthan21.0 . . . . . . . . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . ... ,.,,.

Lessthan 2...........,.. . . . . . . . .

Lessthan2,5, . .,, . . . . . . . . . . . . . . . .

Lessthan3, . . . . . . . . . . . . . . . . . . . . .

Lessthan3.25 . . . . . . . . . . . . . . . . . . . .

Leasthan3.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan4 . . . . . . . . . . . . . . . . . . . . . .

Lessthan4,25, . . . . . . . . . . . . . . . . . . .

Lessthan 4,5 . . . . . . . . . . . . . . . . . . . . .

Lessthan 4.75 . . . . . . . . . . . . . . . . . . . .

Lessthan 5 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 5.25 . . . . . . . . . . . . . . . . . . . .

Lessthan5.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan6 . . . . . . . . . . . . . . . . . . . . . .

Lessthan7 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 8 . . . . . . . . . . . . . . . . . . . . . .

Lessthan21.0 . . . . . . . . . . . . . . . . . . . .

559

1

11

26

41

67

117

146

1,33

214

259

237

319

378

471

5“13

559

506

1

6

18

33

54

1Clo

121

157

1.57

225

251

281

336

422

462

506

47

5

3

3

12

1Ij

24

25

25

3“1

33

35

38

44

45

47

100.0

0.2

1.6

4.0

6.5

11.0

19.7

24.2

30.7

37.0

43.5

46.5

55.0

66.0

83.8

91.6

100.0

100.0

0.2

0.8

2.9

5.8

9.6

18.3

21.6

26.7

35.3

41.4

46.6

53.1

64.8

63.0

91.2

100.0

100.0

9.9

16.2

16.2

22,4

34.4

52.9

54.5

54.5

65.4

69.7

76.4

80.8

93.3

94.5

100.0

964

4

17

49

73

114

216

272

323

384

447

508

560

675

809

888

964

865

3

t3

37

55

86

173

224

266

322

382

436

481

591

716

793

865

92

1

3

11

16

26

39

44

51

58

59

64

72

77

86

88

92

100.0

0.5

1.8

4.8

7.5

11.8

22.6

28.9

33.7

40.3

48.2

53.8

59.1

69.4

83.8

92.0

100.0

100.0

0.5

1.7

4.1

6.4

10.4

20.5

27.2

31.6

36.3

46.0

51.9

57.0

67.9

82.6

91.5

100.0

100.0

0.6

3.3

14.5

20.2

29.6

45.6

46.7

56.1

66.3

66.8

69.9

78.0

81.7

95.7

97.1

100.0

973

7

24

70

96

144

253

308

364

427

466

551

594

702

853

924

973

858

4

15

51

73

112

203

251

296

354

407

466

504

605

747

813

858

92

2

8

16

20

26

42

47

54

60

64

69

74

79

85

88

92

100.0

0.8

2.5

7.2

10.0

15.1

26.3

32.1

37.5

43.9

49.9

56.1

60.3

71.5

67.0

94.0

100.0

100.0

0.6

1.9

6.2

8.9

13.4

24.1

29.8

35,2

41.5

47.8

54.1

56.3

70.0

86.3

93.7

100.0

100.0

1,5

7,8

17.8

22.5

29.2

46.1

53.1

59.1

66.1

69.2

75.2

82.0

87.1

92.5

95.4

100.0

43
Table 19. Cumulative percent distribution of the ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol for women

20-74 years of age and number of examined persons by race and selected ratio cutoffs, according to age: United States, 1976-80

20-24 years 25–34 years 35-44 years

Number of Number of Number of

Race and se/ected examined Cumulative exanrhed Cumulative examhed Cumulative

ratio cutoff persons percent persons percent persons percent

All racesl

Total, ..,,.,.,.,,,.,..,,. ... ,,,

Lessthan 2 . ., . .,, . . . . . . . . . . . .

Less than 2.5 . . . . . ...,...,, ,, .,,..

Less than 3..,.,......,,.. . . . .

Less than 3,25.,.,.,.,,,., ., ..,..,

Lessthan 3,5,..,,,,..,,.. ... ..,,,

Lessthan 4 . . . . . . . . . . . . . . .

Lessthan 4.25, . ., .,.,..., ,,, .,,.,

Lessthan 4.5 . . . . . . . . . . . . .

Lessthan 4.75 . . . . . . . . . . . . . . .

Less than 5.,,........,,. .

Less than 5,25,.,,....,,,. . . . . .

Lessthan 5,5,,........,,. . .

Lessthan 6..,.......,,,. . . . .

Lessthan 7,,,.......,,.. . .

Lessthan 8, . . . . . . . . . . . . . . . . .

Lessthan 21.0, . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . .

Lessthan 2, . . . . . . . . . . . . .

Lessthan 2.5 . . . . . . . . . . . . .

Lessthan 3.,..,..,,..,.. . .

Lessthan 3.25 . . . . . . . . . . . . . . . .

Lessthan 3.5, . . . . . . . . . . . . . . . . . .

Lessthan 4, .,, ,, . . . . . . . . ,, . . . . . .

Less than 4,25 . . . . . . . . . . . . . . . . . . . .

Lessthan 4,5,,...,,,.,,,. . . . . . .

Lessthan 4.75.......,,,.. . . . . .

Lessthan 5, . . . . . . . . . . . . . . . . .

Lessthan 5.25 . . . . . . . . . . . . ... ,,,..

Lessthan 5.5 . . . . . . . . . . . . . . . . .

Lessthan 6 .,, ,,, . . . . . . . . ,,, .,,,.

Less than 7 .,, . . . . . . . . . . . . . . . . . . .

Lessthan 8.,,.......,,,, . . . . .

Lessthan 21.0,.,,,..,,,,. . . . . . .

Black

Total ...,.,..,,,...,,.. .,, ,,..,

Lessthan 2 . . . . . . . . . . . . . . . . . .

Lessthan 2,5,,,,,,...,.,

Less than 3.,,.,,,,..,,,, ., ...,,,

Lessthan 3,25, , .,.....,, . .

Lessthan 3,5, , . ...,...,, . . .

Lessthan 4, ., ., ..,,,...

Lessthan 4.25 . . . . . . . . . . .

Lessthan 4,5...,,,,..,.,.. . .

Less than 4,75 . . . . . . . . . . . . . .

Less than 5 .,, . . . . . . . . . . . .

Lessthan 5.25 . . . . . . . . . . . . .

Lessthan 5.5,....,,,.,,,. .,, ,...,

Lessthan 6,,...,.,,,,,, . . . .

Lessthan 7,, . . . . . . . . . . . . . . .

Lessthan 8 .,, . . . . . . . . . . . . .

Lessthan 21.0 ...,,,,.,,.. . .

634

6

72

175

247

316

425

473

517

544

566

580

597

608

624

632

634

542

3

60

144

204

269

359

402

440

463

482

493

507

517

533

540

542

77

3

11

30

40

46

56

60

65

69

72

75

76

76

76

77

77

100.0

1,3

12,5

26.9

40.6

52,4

69.1

76.5

82.4

66.7

89.7

91.7

94.1

96,1

98.3

99.6

100.0

100.0

1.2

12.7

26.1

39.5

52.2

66.6

76.5

82.1

86.5

89.5

91.1

93.6

95.6

98.3

99.5

100,0

100.0

2.9

13,0

39.2

53.0

61.4

74,9

77.1

84,0

88.7

92.7

97.4

98.2

96.2

98.2

100.0

100.0

1,017

13

60

251

348

444

630

697

753

799

842

667

901

936

986

1,005

1,017

875

7

63

209

294

372

542

600

649

690

728

750

776

606

846

863

875

122

6

16

38

50

64

79

84

90

95

98

100

107

113

120

122

122

100.0

1.0

8.0

26.3

35.7

44.7

63.8

70.0

75.0

79.3

83.5

85.9

86.9

92.2

97.2

99.1

100.0

100.0

0.7

7.4

25.2

35.0

43.2

63.6

69.9

74.9

79.5

83.9

86.4

89.3

92.4

97.0

98.9

100.0

100.0

3.6

12.9

34.9

43.7

56.4

67.7

72.3

77,4

80.1

62.2

63.3

87.0

90.9

96.2

100.0

100.0

722

9

45

140

205

266

367

418

464

509

552

587

607

647

688

706

722

626

8

35

114

173

225

313

358

399

435

474

506

524

562

598

613

626

84

1

9

24

30

37

47

52

56

63

67

70

72

74

78

81

84

100.0

1,3

6.1

19.0

27.8

36.9

50.9

58.2

64.4

70.4

76.4

61.2

84.0

89.3

96.6

97.8

100.0

100.0

1.4

5.5

18.1

.27.4

36.2

50.0

57.2

63.6

69.0

75.5

80.6

83.4

89.3

96.0

98.2

100.0

100.0

0.9

10.8

28.6

34.6

43.1

56.5

64.3

69.3

77.1

80.6

84.1

87.3

68,9

92.2

94.5

100.0

llncludes data for races not shown separately.

44
Table 19. Cumulative percent distribution of the ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol for women

20-74 years of age and number of examined persons by race and selected ratio cutoffs, according to age: United States, 1976-80 – Con.

45-54 years 55-64 years 65-74 years

Number of Number of Number of

Race and selected ex~mined Cumulative examined Cumulative examined

ratio cutoff persons

Cumulative

percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Less than 2 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 2.5...........,,,. . . . . . .

Lessthan 3 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 3.25, . . . . . . . . . . . . . . ,,, ,,

Lessthan 3.5 . . . . . . . . . . . . . . . . .

Lessthan4 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . . . . . . . .

Lessthan 4.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan 4.75 . . . . . . . . . . . . . . . . . . . .

Lessthan5 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 5.25 . . . . . . . . . . . . . . . . . . . .

Lessthan5.5 . . . . . . . . . . . . . . . . . . . . .

Lesathan 6, . . . . . . . . . . . . . . . . .

Lessthan7 . . . . . . . . . . . . . . ... ,,,..

Lesathan 8,, . . . . . . . . . . . . . .,.,,.,

Lessthan 21.0 . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 2 . . . . . . . . . . . . . . . . . . . . .

Lessthan 2.5 . . . . . . . . . . . . . ,. . . . . . .

Lessthan 3..........,,,, . . . . . . .

Lessthan3.25 . . . . . . . . . . . . ,,, . . . .

Lessthan3.5, . . . . . . . . . . . . . ...,,,.

Lessthan 4 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . . . . . . . . .

Lassthan 4.5. . . . . . . . . . . . . . . . . . . . .

Lessthan 4.75 . . . . . . . . . . . . . . . . . . . .

Lessthan 5 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 5.25......,,.,,. . . . . . . . .

Less than5.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan 6 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 7 . . . . . . . . . . . . . . . . . . . . .

Lessthan 8 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 21.0 . . . . . . . . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 2 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 2.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan3, . . . . . . . . . . . . . . . . . . . . .

Lessthan3.25 . . . . . . . . . . . . . . . . . . . .

Lessthan3.5 . . . . . . . . . . . . . . . . . . . . .

Lessthan4 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 4.25 . . . . . . . . . . . . . . . . . . .

Lessthan 4.5. . . . . . . . . . . . . . ,.,,,,.

Lessthan4.75, . . . . . . . . . . . . . . . . . . .

Lessthan 5 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 5,25 . . . . . . . . . . . . . . . . . . . .

Lessthan 5.5. .,, .,....... . . . . . . . .

Lessthan 6 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 7 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 8 . . . . . . . . . . . . . . . . . . . . . .

Lessthan 21.0 . . . . . . . . . . . . . . . . . . . .

641

3

32

86

135

“I69

274

316

355

391

~29

~56

~82

E’31

596

C*2O

641

546

3

27

75

110

155

227

261

295

326

362

336

410

4s3

5115

526

546

81

5

9

23

31

43

50

54

57

58

e!t

62

66

79

80

81

100.0

0.5

5.4

13.9

21.7

29,5

42.6

49,0

54.6

60.9

67.2

71.8

75,8

83.4

92.8

96.6

100,0

100.0

0.6

5.6

14.7

21.7

29.6

42.1

47,9

53.8

59.8

66.8

71.7

75.8

83.4

92.6

96.2

100.0

100,0

5.0

8.9

25.9

33.8

51.3

63.3

67.2

72.2

73.1

76.4

77.4

82.8

96.8

99.1

100.0

1,086

6

33

118

188

240

377

457

528

603

659

717

770

843

963

1,034

1,086

973

6

27

99

159

207

325

397

462

532

584

639

689

753

863

927

973

99

6

18

28

31

49

56

62

66

70

73

75

82

89

93

99

100.0

0.7

3.5

11.9

19.0

23.4

35.5

42.8

49.4

56.8

62.5

67.5

72.0

78.3

88.0

94.2

100.0

100.0

0.8

3.3

11.5

18.2

22.8

34.9

42.3

49.0

56.8

62.9

68.3

72.8

78.6

88.5

94,4

100,0

100.0

6.2

16,9

29.7

31.6

44.7

50.8

57.8

61.5

63.7

65.0

67.0

77.1

83.9

90.6

100.0

1,135

6

21

76

143

223

351

432

513

589

660

730

792

879

1,007

1,076

1,135

1,001

3

15

60

117

186

292

361

425

494

558

619

679

758

883

947

1,001

118

3

6

14

23

33

53

64

78

84

91

99

99

107

110

113

118

100.0

0.5

1.8

6.8

12,4

19,3

30,7

38,1

45,0

51.8

57.9

63.8

69.3

77.5

88.7

95.1

100.0

100.0

0.4

1.7

6.2

11.7

18.6

29.5

36.9

43.0

50.1

56,4

62,2

68.1

75.9

87,9

94.9

100,0

100.0

1.9

3.8

10,2

17.1

24,3

40.6

47.8

60.1

65.7

71,1

77.5

77,5

91,4

94.1

96,4

100.0

1Includas data for racaa not shown separately.

45
Table 20. Cumulative percent distribution ofserum triglycerides forpersons 20-74years of age fasting 12hours ormoreand number of

examined persons byrace and selected serum triglyceride cutoffs, according to sex: United States, 1976-80

Both sexes Men Women

—

Race and selected Number of Number of Number of

serum Ylglycerjde cufot% 1 examined Cumulative examined Cumulative

(mg/dl)

examined Cumulative

persons percent persons percent persons percent

—

All racesz

Total .,, .,, . . . . . . . . . . . . . . . .

Less than 60..,.......,..,..

Less than 80..,.,.....,.. . . .

Lessthan 90 . . . . . . . . . . . . . . . .

Lessthan 100. . .,, . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . .

Lessthan 120,...,.....,., . . . . .

Less than 130. . . . . . . . . . . . . . . . . .

Lessthan 140, ., . . . . . . . . . . . . .

Lesethan 150, . . . . . . . . . . . . .

Lessthan 160, . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . .

Less than 230. ,,, . . . . . . . . . . . . . . .

Lessthan 250,,,.......,.. . . . .

Lessthan 270, . . . . . . . . . . . . . . . .

Lessthan 290 . . . . . . . . . . . . . . . . . .

Lessthan300 . . . . . . . . . . . . . . . . . .

Lessthan 500. . . . . . . . . . . . . . . . . . .

Less than 1,000, . . . . . . . . . . .

Lessthan 2,900........,.. . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . .

Less than 60,...,,.....,,. . . . . .

Lessthan 80 . . . . . . . . . . . .

Lessthan 90, . . . . . . . . . . . . . . . . .

Lessthan 100, . . . . . . . . . . . . . . ...,..

Lessthan 110 . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . .

Less than 130. . . . . . . . . . . . . . . . . . . .

Lessthan 140,........,,.. . . . .

Lessthan 150, . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . .

Lessthan 200, . . . . . . . . . . . . . . . . . . . .

Lessthan 230. . . . . . . . . . . . . . . . . . . .

Lessthan 250,.......,.,,.. . . . .

Lessthan 270 . . . . . . . . . . . . . . . . . .

Lessthan 290 . . . . . . . . . . . . . . . . .

Lessthan 300 . . . . . . . . . . . . . . . . . . .

Lessthan 500 . . . . . . . . . . . . . . . . . . .

Less than 1,000, . . . . . . . . . . . . . . . . .

Lessthan 2,900........,.. . . . . .

2,753

207

600

805

1,009

1,220

1,429

1,605

1,739

1,661

1,972

2,156

2,317

2,461

2,524

2,562

2,598

2,633

2,731

2,749

2,753

2,401

163

489

659

829

1,013

1,197

1,349

1,465

1,576

1,676

1,647

1,998

2,128

2,187

2,222

2,256

2,287

2,381

2,397

2,401

100,0

9.4

25.7

33,7

41.2

48.6

56,0

62,8

67.1

71.3

74.7

61.2

86.2

90.8

92.8

93.6

94.9

95.8

99.2

99.9

100,0

100,0

8.8

24.8

32.3

39.6

47.4

54.6

61.3

65.5

70.0

73.6

80.1

65.5

90.3

92.4

93.4

94.6

95.4

99,1

99.9

t 00.0

1269

71

237

352

441

530

606

694

762

616

861

971

1,045

1,121

1,144

1,166

1,184

1,197

1,253

1,265

1,269

1,111

54

192

290

369

446

513

584

641

666

747

630

902

973

993

1,013

1,031

1,043

1,097

1,107

1,111

100,0

6.4

20.4

30.5

37.7

44.6

50.6

57.3

62.3

66.5

71.3

76.3

83.7

89.0

90.7

92.0

93.1

93.9

96.5

99.7

100.0

100,0

6.0

19.4

29.3

36.4

43.4

49.2

55.6

60.2

64.4

69.4

76.5

62.4

68.2

90.0

91.4

92.6

93.4

96.5

99.7

100.0

1484

136

363

453

568

690

621

911

977

1045

1091

1167

1272

1340

1360

1396

1414

1436

1476

1484

1464

1290

109

297

369

460

567

684

765

824

666

931

1017

1096

1155

1194

1209

1225

1244

1264

1290

1290

100.0

11.6

30.0

36.2

44.1

52,2

60.4

87,3

70.9

75.2

77.5

83.6

88.3

9.2.4

94..4

95.2

96.3

97’.3

99,7

100.0

100.0

100.0

11.2

29.2

34.9

4~,3

50.7

59.1

66.1

69.6

74.6

77,0

83.1

88.2

92.1

94.3

95.1

96,3

97,1

99.7

100.0

100.0

46
Table 20. Cumulative percent distribution of serum triglycerides for persons 20–74 years of age fasting 12 hours or more and number of

examined persons by race and selected serum triglyceride cutoffs, according to sex United States, 1976-80-Con.

Both sexes Men Women

Race and selected Number of Number of Number of

serum triglyceride cutoffs 1 examined Cumu/afive examined Cumulative

(mgldl)

examined Cumulative

persons percent persons percent persons percent

Black

Total, . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . .

Lessthan 100 . . . . . . . . . . . . . . . . . ...

Lessthan llO. . . . . . . . . . . . . . . . . . . .

Less than 120 . . . . . . . . . . . . . . . . . . .

Less than 130 . . . . . . . . . . . . . . . . . . . .

Less than 140 . . . . . . . . . . . . . . . . . . . . .

Less than 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200, . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . .

Less than 270 . . . . . . . . . . . . . . . . . . . .

Less than 290 . . . . . . . . . . . . . . . . . . . . .

Less than 300 . . . . . . . . . . . . . . . . . . . .

Less than 500 . . . . . . . . . . . . . . . . . . . . .

Lessthan 1,000 . . . . . . . . . . . . . . . . .

Lessthan 2,900 . . . . . . . . . . . . . . . . .

299

41

101

132

162

186

209

225

242

251

258

271

277

286

289

290

292

294

297

299

2’99

100.0

15.4

35.9

47.6

56.8

63.7

69.9

76.2

82.2

84.5

87.7

91.6

93.3

96.0

96.7

96.9

97.4

98.1

99.2

100.0

100.0

133

16

41

55

64

74

85

95

105

111

116

121

123

126

i 28

129

129

130

131

133

133

100.0

11.2

30.0

41.7

50.0

57.4

64.9

72.7

81.4

85.5

90.2

93.7

94.8

95.7

96.7

97.0

97.0

97.6

98.1

100.0

100.0

166

25

60

77

98

112

124

130

137

140

142

150

154

160

161

161

163

164

166

166

166

100.0

16.6

40.5

52.1

62.1

68,6

73,7

78.8

82.9

83.7

84.7

90.0

92.2

96.2

96.7

96.7

97.8

98.5

100.0

100.0

100.0

lTO converi valuas of serum triglycenes to mdhmoles per Mer (mmol/L), mulbply by 0.01129.

‘Includes data for races not shown separately,

NOTE: mg/dl IS m!llrgrams per decxker.

47
Table 21. Cumulative percent distribution of serum triglycerides for men 20-74 years of age fasting 12 hours or more and number of

examined persons byrace and selected serum triglyceride cutoffs, according to age: United States, 1976-80

20–24 years 25-34 years 3544 years

Race and se/ecfed Number of Number of Number of

serum triglyceride cutoff examined Cun7u/ative examined Cumulative examined Cumulative

(mg/di) persons ,oercent persons percent persons percent

All racesl

Total ., ., ., . . . . . . . . . . . . . . ,, . . .

Less than 60,,...,,,,,..,,.. . .

Lessthan 80, , . . . . . . . . . . . ., .,,.,,

Lessthan 90, . ., .,.,,,... ,. ...,,,

Lessthan 100, ,, . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . .

Lessthan 120, , .,, ,, . . . . . . . ,, . . .

Lessthan 130, . . . . . . . . . . . . . . . . . .

Less than 140. ,,, . . . . . . . . . . . . .

Lessthan 150. ,, . . . . . . . . . . . .

Lessthan 160, . . . . . . . . . . . . . . . .

Lessthan 180, . . . . . . . . . . . . . . . . .

Lessthan 200, . ., . . . . . . . . . . . . . . . . .

Lessthan 230,,,..,,...,.. . .

Lessthan 250, . .,, ,.,..,, . . . .

Lessthan 270.,.,,.,..,,. . . . . .

Lessthan 290, . ., .,......, ... ..,..

Less than 300,,.......,,.. . . . . . .

Lesathan 500,..,.,..,,,.. ... .,,,.

Lessthan 1,000....,,...,., ..,,,,.

Lessthan 2,900 . . . . . . . . . . . . . . . .

83

9

33

40

50

54

61

69

69

70

71

74

75

82

82

82

82

82

63

83

83

100.0

13,3

40,8

51.6

64.6

68.6

75.4

84,4

84.4

85,3

66.9

90.7

91.4

99.1

99.1

99,1

99,1

99.1

100.0

100.0

100.0

206

23

55

77

91

111

121

133

145

157

165

172

183

191

193

193

197

197

204

206

206

100.0

10.3

26.3

37.4

43.7

54.3

59.0

65.1

70.3

76.4

80.8

84.7

90.2

93.9

94.4

94.4

96.2

96.2

98.9

100.0

100.0

150

8

34

44

53

62

71

78

86

92

98

112

124

132

135

137

137

139

148

149

150

100.0

4.5

23.0

30.5

36.6

43.4

50.1

53.5

59.8

63.4

67.6

76,2

84.7

89,2

91.2

92.0

92.0

92,9

98.6

99.6

100,0

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . 66 100,0 174 100.0 133 100.0

“ Lessthan 60, , ., .,, ,,,,.,. . . . . . 8 15.2 19 10.2 6 4.1

Lessthan 80, . . . . . . . . . . . . . . . . 26 41,9 49 27.6 28 21.1

Lessthan 90, . . . . . . . . . . . ,. .,,,,.. 29 47.9 67 38.7 37 28,3

Lessthan 100. , . ...,..... . . . 37 62.1 80 45.6 45 34.2

Lessthan 110 . . . . . . . . . . . . . . . 41 67.0 96 55.7 52 40.1

Less than 120 . . . . . . . . . . . . . . . . . . . 46 75,2 103 60.4 60 47.3

Lessthan 130, . . . . . . . . . . . . . . . . . . 53 61.4 113 66.6 65 50.1

Lessthan 140,....,...,,.. . . . 53 81.4 120 70.3 72 56.3

Lessthan 150 . . . . . . . . . . . . . . . . . . 54 82.6 129 76.0 77 59.8

Lessthan 160 . . . . . . . . . . . . . . . . . 55 84.5 136 80.4 83 64.5

Lessthan 180, . . . . . . . . . . . . . . . 58 89.3 141 82.9 96 73.4

Lessthan 200...,,.....,.. . . . . . 58 89,3 152 89.2 108 83.1

Less than 230. . . . . . . . . . . . . . . . . . . 65 96.8 160 93.4 116 88.2

Less than 250.........,,.. . . . . . 65 98.8 162 93<9 119 90.4

Lessthan 270 . . . . . . . . . . . . . . . . . 65 98.8 162 93.9 121 91.3

Lessthan 290 . . . . . . . . . . . . . . . . . 65 98.6 166 96.0 121 91.3

Lessthan 300.....,....,.. . . . . 65 98.8 166 96.0 122 92.0

Lessthan 500 . . . . . . . . . . . . . . . . . . . 68 100.0 173 99.1 131 98.4

Lessthan 1,000 . . . . . . . . . . . . . . . 66 100,0 174 100.0 132 99.6

Less than 2,900 . . . . . . . . . . . . . . . . . . . 66 100,0 174 100.0 133 100.0

1Includes data for races not shown separately. Data not given separately for black adults because of small sample alze.

NOTES:To convefl values of serum triglycerides to millimoles per liter (mmol/L), multiply the values by 0,01129. mgldl is milligrams per deciliter.

48
Table 21. Cumulative percent distribution of serum triglycerides for men 20-74 years of age fasting 12 hours or more and number of

examined persons by race and selected serum triglyceride cutoffs, according to age: United States, 1976-80-Con.

45-54 years 55-64 years 65–74 years

Race and se/ected Number of Number of Number of

serum triglyceride cutoff examined Cumulative examined Cumulative examined Cumulative

(mg/df) persons percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . . ,,,

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Less than 80 . . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . . .

Less than 100 . . . . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . .,, . . . .

Lessthan 140 . . . . . . . . . . . . . . ,,, . . . .

Lessthan 150, . . . . . . . . . . . . . ,,.,,,.

Lessthan 160. . . . . . . . . . . . . . . . . .

Lessthan 180. ,,, . . . . . . . . . . . . . . . . .

Lessthan 200. . . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . . . . . .

Lessthan 270........,.,,.. . . . . . . .

Lessthan 290..........,,.. . . . . . . .

Lessthan300 . . . . . . . . . . . . . . . . . . . .

Lessthan 500 . . . . . . . . . . . . . . . . . . . .

Lessthan 1,000 . . . . . . . . . . . . . . . . . . .

Lessthan 2,900 . . . . . . . . . . . . . . . .

White

Total, . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . . .

Lessthan90 . . . . . . . . . . . . . . . . . . . . .

Lessthan 100, . . . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . .

Lessthan 160. . . . . . . . . . . . . . . . . . . . .

Lessthan 180. . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . . . . . .

Lessthan 270 . . . . . . . . . . . . . . . . . . . . .

Lessthan 290 . . . . . . . . . . . . . . . . . . . . .

Lessthan300 . . . . . . . . . . . . . . . . . . . . .

Lessthan 500. . . . . . . . . . . . . . . ,,.,..

Lessthan 1,000 . . . . . . . . . . . . . . . . . . .

Lessthan 2,900 . . . . . . . . . . . . . ,,...,

132

5

18

31

39

44

50

63

69

73

81

92

98

108

112

116

117

119

127

130

132

119

4

12

:26

33

37

42

53

58

62

69

79

85

95

99

103

104

106

114

117

!19

100.0

4.8

11.9

24.1

30.8

34.4

38.7

48.2

52.6

55.0

61.2

71,2

75.0

83.2

85.9

88.8

89.3

90.4

96.6

99.1

100.0

100.0

3.9

9.8

22.8

28.5

31.9

35.6

45.2

49.1

51.8

57.4

67.9

72.2

81.3

84.4

87.4

88,1

89.3

96.2

99.0

100.0

352

14

50

81

108

134

159

176

195

208

227

258

279

297

305

313

320

325

347

351

352

312

10

40

67

90

114

135

151

168

180

196

225

245

262

268

276

283

288

308

311

312

100.0

3.9

12.8

23.2

30.9

38.7

46.1

51.7

56.3

61.4

66.1

74.2

79.5

83.4

86.1

87.9

89.3

91.0

98.2

99.7

100.0

100.0

3.4

12.1

22.6

30.1

38.3

45,0

51.0

55.6

60.9

65.4

73.9

79.4

83.5

85.9

67.9

89.5

91.3

98.6

99.7

100.0

346

12

49

79

100

125

146

175

196

216

239

263

266

311

317

325

331

335

344

346

348

307

7

37

64

84

106

125

149

170

186

208

231

254

275

280

286

292

296

305

307

307

100.0

3.2

15.2

23.3

29.5

36.6

42.3

50.9

58.2

62.7

69.8

77.0

83.3

89.0

91.2

93,8

95.7

96.5

99.4

100.0

100.0

100.0

2.4

12,9

21.5

28,1

35,1

41.1

49.0

56.4

61.0

68.8

76.3

83.3

88.8

90.6

93.1

95.1

96.1

99.3

100.0

100.0

49
Table 22. Cumulative percent distribution ofserum triglycerides forwomen 20-74 years of age fasting 12hours ormoreand number of

examined persons byrace and selected serum triglyceride cutoffs, according to age: United States, 1976-80

20-24 years 2544 years 35-44 years

Race and se/ected Number of Number of Number of

serum triglyceride cutoff examined Cumulative examined Cumulative examined Cumulative

(mg/df) persons percent persons percent persons percent

All races 1

Total . . . . . . . . . . . . . . . . . . . . . . ...

Less than 60 . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . .

Lessthan 100 . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . .

Less than i20. .,,.......,..

Lessthan 130. . . . . . . . . . . . . . . .

Lesathan 140.,,.......,..

Lessthan 150 . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . .

Lessthan 200. . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . .

Lessthan 270 . . . . . . . . . . . . . .

Lessthan 290 . . . . . . . . . . . . . . . . . . .

Less than 300 . . . . . . . . . . . . . . . . . . .

Lessthan 500...........,,. . . .

Lessthan 1,000 . . . . . . . . . . . . . . . .

Lessthan 2,900 . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . .

Less than 60 . . . . . . . . . . . . . .

Less than 80..,........,.. . . . .

Lessthan 90..........,., . . . .

Lessthan 100....,....,,.,

Lessthan llO. , . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . .

Lessthan 160. . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . .

Lessthan 230. . . . . . . . . . . . .

Lessthan 250......,...,,.. . . .

Lessthan 270 . . . . . . . . . . . . . . .

Lessthan 290 . . . . . . . . . . . . . . .

Lessthan 300 . . . . . . . . . . . . . . . .

Lessthan 500 . . . . . . . . . . . . . ...,,..

Lessthan 1,000 . . . . . . . . . . . .

Lessthan 2,900 . . . . . . . . . . . . . . .

123

22

55

62

70

80

88

94

98

102

105

109

115

120

120

121

121

121

123

123

123

104

14

42

47

55

64

72

77

80

84

87

91

97

101

101

102

102

102

104

104

104

100,0

19.3

45,4

49.6

56.2

64.6

71,3

76.6

81.1

84.4

85.9

88.8

94.9

98.5

98.5

98.9

98,9

98.9

100.0

100.0

100.0

100,0

13,7

41.8

45.6

53.3

62.0

69.9

75.0

79.2

83.1

84.9

88.3

95,3

96.2

98.2

98,7

98.7

98.7

100.0

100.0

100,0

230

46

96

114

131

144

162

176

182

193

197

206

212

221

222

223

224

227

230

230

230

208

42

86

103

118

129

146

159

163

174

178

186

192

200

201

202

203

206

208

208

208

100.0

19.9

44.0

52.5

59,2

64.6

72.7

79.5

80.8

85.5

86.8

90.5

92,4

96.3

96.8

97.1

97.5

98.5

100.0

100.0

100.0

100.0

20.6

44.5

53.6

60.2

65.3

73.2

79.2

80.6

85.8

87.3

90.9

93.1

96.6

97.1

97.4

97.9

99.0

100.0

100.0

100.0

194

33

79

92

112

127

141

154

157

161

165

172

178

183

168

190

191

193

194

194

194

161

27

63

74

90

104

116

128

131

135

138

143

149

153

157

158

159

160

161

161

161

100.0

17.7

38.9

45.5

56,7

65,4

72.0

79.0

79.9

81.5

83.8

87.7

91.6

94.4

97.1

98,3

98.8

99,6

100.0

100.0

100.0

100.0

17’.5

3[).3

44.9

55.3

65.1

7“1.2

78.5

79,5

81.5

83.5

67.5

920

95.1

97.9

98.5

99.0

99.5

100.0

100.0

100,0

Ilncludes data for races not shown separately. Data not gwenseparately for black adults because ofsmall s,ample sizes.

NOTES:To corweri valuas of serum triglycerides 10millimoles per Ihter(mmol/L), multiply the values by 0.01129. mg/dl ia milligrams per deciliter.

50
Table 22. Cumulative percent distribution of serum triglycerides for women 20-74 years of age fasting 12 hours or more and number of

examined persons by race and selected serum triglyceride cutoffs, according to age: United States, 1976-80-Con.

45-54 years 55-64 yeare 65–74 years

Race and selected Number of Number of Number of

serum triglyceride cutoff examined Cumulative examined Cumulative

(mg/dl)

examined Cumulative

persons percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 60.......,..,.,,.. . . . . .

Less than 80 . . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . . .

Lessthan 100.............,.. . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . .,. .

Lessthan 130 . . . . . . . . . . . . . . . .,, ,,,

Lessthan 140, . . . . . . . . . . . . . . . . ,,, ,

Lessthan 150. . . . . . . . . . . . . . . . . .,.

Lessthan 160. . . . . . . . . . . . . . . . . . . . .

Lessthan 180. . . . . . . . . . . . . . . . . . . . .

Lessthan 200. . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan 250 . . . . . . . . . . . . . . . . . . . . .

Less than 270 . . . . . . . . . . . . . . . . . . . . .

Less than 290 . . . . . . . . . . . . . . . . . . . . .

Lessthan 300 . . . . . . . . . . . . . . . . . .

Lesathan 500 . . . . . . . . . . . . . . . . . . . . .

Lessthan 1,000 . . . . . . . . . . . . .

Less than 2,900 . . . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . ... ,.,

Leasthan 60 . . . . . . . . . . . . . . . . . . . .

Lessthan 80, . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . . .

Lessthan 100. . . . . . . . . . . . . . . . . . . . .

Lessthan llO. . . . . . . . . . . . . . . . . . . . .

Lessthan 120. . . . . . . . . . . . . . . . . . . . .

Lesathan 130 . . . . . . . . . . . . . . . . . . . . .

Lessthan 140.....,,,..,.. . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . .

Lessthan 180...........,.. . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan 230 . . . . . . . . . . . . . . . . . . . . .

Lessthan250, . . . . . . . . . . . . .,, ,.,..

Lessthan 270 . . . . . . . . . . . . . . . . . . . . .

Lessthan 290 . . . . . . . . . . . . . . . . . . . . .

Lessthan300, . . . . . . . . . . . . . . . . . .

Lessthan 500. . . . . . . . . . . . . . . . . .

Lessthan 1,000 . . . . . . . . . . . . . . . . . . .

Lessthan 2,900 . . . . . . . . . . . . . . . . .

193 100.0

10 5.3

45 22.9

56 29.9

74 38.9

89 48.1

107 57.5

122 65.2

133 70.4

138 73.3

143 75.4

156 83.9

1.58 88.1

175 92.1

130 94.7

130 94.7

1,36 97.1

1!39 96.6

1!32 99.7

1!33 100.0

1!33 100.0

166 100.0

8 5.4

39 24.0

45 27.3

59 35.3

71 44.8

88 55.3

101 63.2

Ill 68.7

116 72.2

121 74.6

133 83.6

1L.5 88.8

150 92.1

1:(5 95.2

1515 95.2

161 97.9

1E’2 96.3

165 99.6

1E6 100.0

1C6 100,0

332 100.0

17 6.2

54 19.4

72 23.8

94 29.6

122 36.4

150 44.5

169 52.5

189 58.0

214 67.0

224 69.0

248 75,8

272 81.9

268 66.2

297 86.1

303 89.9

307 91.4

311 92.0

330 99.3

332 100.0

332 100.0

286 100.0

13 6.0

40 16.6

56 21.4

70 25.9

94 33.2

119 41.4

138 50.6

155 55.9

178 65.9

187 67.6

207 74.1

228 79,8

244 84,7

253 87,0.

259 89,1

262 90.3

266 9t ,0

284 99,2

286 100.0

286 100.0

412

8

34

57

87

128

173

194

218

237

257

296

327

353

373

379

385

395

409

412

412

365

5

27

44

68

105

143

162

184

201

220

257

265

307

327

333

338

348

362

365

365

100.0

1.7

8.1

13.6

21.2

31.9

42.3

48,0

53.5

57.4

62.4

73.1

80.7

86.8

91.3

92.7

94.3

96.1

99.3

100.0

100.0

100.0

1.2

7.5

12.6

19.9

31.1

41.3

47.0

52.7

56.6

62.1

72.2

79.6

85.4

90.5

92.1

93,6

956

99.3

100,0

100.0

51
Table 23. Cumulative percent distribution of calculated values of low density lipoprotein (LDL) cholesterol for persons 20-74

years of age fasting 12 hours or more and number of examined persons by race and selected LDL cutoffs, according to sex:

United States, 1976-80

Both sexes Men Women

Race and selected Number of Number of Number of

/ow derwify /ipoprofein cutoff 1 examined Cumulative examined Cumu/afive examined Cumulative

(mgldl) persons percent persons percent persons percent

All races2

Total . . . . . . . . . . . . . . . . . . . . . . ,,,

Leasthan 60 . . . . . . . . . . . . . . . . .

Lessthan 70, , . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . ,,.

Less than 90 . . . . . . . . . . . . . . . . . ,,.

Lessthan 100. , ., .,, . . . . . . . . . . .

Less than 110 . . . . . . . . . . . . . . . . .

Less than 120 . . . . . . . . . . . . . . . . . .

Less than 125,,.,..,....,,,.. . .

Less than 130, . . . . . . . . . . . . . . . . . . . .

Less than 140, . . . . . . . . . . . . . . . . . .

Less than 150. . . . . . . . . . . . . . . . . .

Less than 160, . . . . . . . . . . . . . . . .,, ,.

Lessthan 170, . . . . . . . . . . . . . . .

Lessthan 180.,............,.. .

Lessthan 190 . . . . . . . . . . . . . . . . . . .

Less than 200.....,,,..,..,., ,, ...

Lesathan 400.....,,,..,.. . . .

White

Total . . . . . . . . . . . . . . . . . . . . ...,..

Lessthan 60,,....,..,,., . . .

Lessthan 70 . . . . . . . . . . . . . . . . .

Lessthan 80, . . . . . . . . . . . . . . . . .

Lessthan 90.,.,,,,,,.,., ., ..,,..

Lessthan 100. . .,, ,,, . . . . . . . . . . . . .

Lessthan 110, , . .,, . . . . . . . . . . . .

Lessthan 120.,..,,,.,..,., ,.,.,..

Lessthan 125. , .,, .,...,.,. . . . . .

Less than 130. ,, . . . . . . . . . . ,. ...,..

Leas than 140.,.,..,.,..,,, . . .

Lassthan 150. ,, . . . . . . . . . . . . . . . .

Lessthan 160, . . . . . . . . . . . . ,. ...,,,

Leaathan 170, . . . . . . . . . . . . . .,.,,,.

Lessthan 180, , . ., .,,,..... . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . .

Lessthan 200, ,, .,, ,. . . . . . . ,,, . . . .

Lessthan 400. . . . . . . . . . . . . . ,,..,.,

Black

Total . . . . . . . . . . . . . . . . . . . . . .

Lesathan 60, , ., . .,..,..,. . .

Lessthan 70, . . . . . . . . . . . . . . . . .

Lasathan 80, , . ., .,,,..,, . ...,,,.

Lessthan 90, ., . . . . . . . . . . . . ...,..

Lessthan 100. . . . . . . . . . . . . . . . .

Lessthan 110, ,, .,, ,..,.,. .

Leesthan 120.....,,....,., ,, . . .

Less than 125. ,, . . . . . . . . . . . . . . . . .

Less than 130..,,.,.....,,. . . . .

Lesathan 140, ,, . . . . . . . . . . . . .

Lessthan 150,.....,...,,., . . . .

Lessthan 160,........,,.. . . . . .

Lasathan 170. ,, . .,,,,,.., ... ..,.,

Leesthan 180 . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . .

Lessthan 200. ,, . .,, ,.,..,. .

Lessthan 400.,..,,,.,..,., ,, . . .

2,283

25

46

92

180

312

477

684

784

894

1,121

1,339

1,548

1,719

1,847

1,954

2,040

2,283

1,990

18

35

89

143

252

392

570

662

760

965

1,161

1,343

1,494

1,604

1,702

1,775

1,990

251

7

10

21

30

50

72

96

104

115

134

153

174

193

207

214

225

251

100,0

1,3

2.3

4,6

8.8

15,1

23.4

33.4

36.4

43,1

53,5

62.8

71.3

78.1

63.0

67.4

90.8

100,0

100,0

1,2

2.1

4.0

8,1

14.3

22.6

32.6

38,0

42,7

53.1

62.8

71.3

76.0

82.7

87.1

90.5

100.0

100,0

3.2

4,4

10.8

13.7

21.6

31.7

40,1

42,6

47,2

57,1

64.9

73.1

79,9

85,5

89.2

92.6

100.0

I 037

11

20

40

83

141

2t6

310

363

420

522

615

716

793

860

910

948

1037

906

9

15

30

64

109

169

249

295

350

440

524

615

687

749

796

829

906

114

2

5

9

16

28

41

52

59

60

72

80

8&1

92

96

98

103

114

100.0

1.5

2.3

4.6

8.8

14.5

22,0

31,4

37.3

42.7

53.2

62.5

71.7

78.0

84.0

86.4

91.7

100.0

100.0

1.5

2.0

3.9

8.0

13.3

20.1

29.3

35.3

41.0

51.4

61.0

70.2

77.1

83.3

88.1

91.4

100.0

100.0

2.0

4.9

11.0

16,5

25.9

38.3

48.1

53.4

54.1

67.6

74.6

83.0

84.4

87.9

89,5

93,3

100,0

1,246

14

26

52

97

177

261

374

421

474

599

724

830

926

987

1,044

1,092

1,246

1,064

9

20

39

79

143

223

321

367

410

525

637

728

807

855

906

946

1,084

137

5

5

12

14

22

31

44

45

55

62

73

86

101

111

116

122

137

100.0

‘1.2

2.4

4,7

8.7

15.5

24.6

3!5.0

39.2

43..4

53.7

63,1

71.0

78,1

82.3

86.6

90.2

100.0

100.0

0,9

2,1

4.0

8.3

15.2

24.6

35.3

40,1

44,0

54,6

64.2

72.2

78.7

82.2

86.3

89.7

100.0

100,0

4.1

4.1

10.6

11.5

18.1

26.4

33.7

33.9

4.1.7

48,6

57.0

65.2

76.3

83,7

89.0

92.4

100.0

lLDL cholesterol = serum total cholesterol -high density lipoprotein chO[esterol -ttiglyceride/5, Equation nom Friedewald, W,etal. Clln Chem (18):499-502, 1972. Persons with eserum

triglyceride value greater than 400 mgldl were excluded,

21ncludes data for races not shown separately. NOTES:To converi LDL cholesterol to millimoleaper Mer(mmoVL), multiply ihe values W 0.025a6. mgldl is milfigramaPar deciliter.

52
This page intentionally left blank
Table 24. Cumulative percent distribution of calculated values of low density Iilpoprotein (LDL) cholesterol for men 20-74 years

of age fasting 12 hours or more and number of examined persons by race and selected LDL cutoffs, according to age:

United States, 1976–80

20–24 years 25-34 years 35-44 years

Race and selected

—

Number of Number of Number of

/ow density lipoprotein cutoff 1 examined Curnu/a/ive examined Cumulative examined Cumulative

(mgldl) persons percent persons percent persons percent

All racesz

Total, . . . . . . . . . . . . . . . . . . . ., .,,.

Less than 60 .,, . . . . . . . . . . .

Less than 70 . . . . . . . . . . . . . . . . ,. .,,

Less than 80 ., . . . . . . . . . . . . . . . ,.,

Less than 90, ., . ., .,, ,, . . . . . .

Less than 100, . . . . . . . . . . . . . . . ,., ,,

Lessthan llO. , . . . . . . . . . . . . . . ,., ,,

Lessthan 120, . . . . . . . . . . . . . . . . .,,

Lessthan 125 . . . . . . . . . . . . . ,. .,,,,.

Lessthan 130. . .,, ,,,,.,. ,, .,,.,,.

Lessthan 140, ,, .,, ,,,..,. ,., ,,,,.

Lessthan 150. ., ., ..,,..,. ,. .,,,..

Lessthan 160. ., .,,,,..,. ,. .,,,,.,

Lessthan 170,....,,...,.. . . . . .

Lessthan 180 . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . ,,,,.,.

Lessthan 200. , . .,, ,....,. .,, ,.,..

Lessthan 400 . . . . . . . . . . . . . ,,, ..,.,

White

Total, . . . . . . . . . . . . . . . . . . ..,.,,.

Lessthan 60..,.......,,,, . . . . . .

Lessthan 70.,,.......,,, ,., . . . .

Lessthan 80..........,,, ,., ..,,,

Lessthan 90, , . . . . . . . . . . . . ,.,,.,,

Lessthan 100,,..,.,..,,,. ,. ...,,,

Lessthan 110, . . . . . . . . . . . . . . . . .

Lessthan 120,.......,,,., ... .,,,.

Lessthan 125, , . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . ...,,,.

Lessthan 150. . .,, .,,..... . ...,,,.

Lessthan 160,....,,,.,,. ,. ..,,,.,

Lessthan 170, ., .,, ,. .,.... ,,,..,.

Lessthan 180. , . .,, ,....,. ,,, ,.,..

Lessthan 190...,,,..,.,.. ,,, ,.,..

Lessthan 200 . . . . . . . . . . . . . . ,..,,..

Lessthan400. , .,,.,...,., ,, . . . . .

72

4

5

12

18

31

39

48

51

54

59

62

65

67

70

70

71

72

57

3

3

9

14

25

31

37

39

42

46

48

50

52

55

55

56

57

100,0

8.9

10.0

19,1

27.0

45,6

58,9

69.2

74.0

76.8

82.6

86.3

91.2

93.6

96.5

96.5

98,6

100.0

100,0

10,0

10.0

19.2

28.3

49.4

62.0

69.6

73.9

77.5

83.3

86.3

88.8

91.8

95.6

95.6

98.2

100.0

174

4

6

10

20

37

50

66

81

96

117

133

145

154

162

166

169

174

146

3

4

7

14

26

37

51

64

77

96

109

121

129

137

140

142

148

100.0

2,0

3.1

5,9

12.2

19.4

26.6

34.0

43.2

52.8

67.4

77.4

83.8

86,6

93,3

95.3

96.5

100,0

100.0

1.7

2.5

5.2

10.8

17.4

24.0

31.3

41,0

50,3

65.6

75.6

82,9

88.2

93.6

95.2

96.3

100.0

130

1

2

4

6

14

22

35

43

50

67

77

90

96

107

13

18

30

15

1

2

2

5

10

16

27

35

42

55

65

77

83

93

99

104

115

100.0

1.3

1,7

3.5

6,5

10,8

16.7

26.8

34.0

38.3

51.0

56.2

66.1

70.3

76.5

83.6

88.5

100.0

100,0

1.5

2.0

2.0

4.7

8.8

14.5

24.4

32.5

37.4

48.6

56.8

64.2

69.0

77.1

62,9

88.4

100.0

lLDLcholasterol = serum to!alcholesterol -tighdens!~ lipoprotein cholesterol -tdglycetide/5. Equation from Frledewald, WT, et al, Clin Chem (18):499-502, 1972, Persons with a serum

triglyceride value greater than 400 mgldl were excluded,

‘Includea data forraces noi shown separately, Oatanot given separately for black adults becauae ofsmall sample size,

NOTES: Toconvartvaluesof LOLcholesterol tomMmolesperl,te r(mmol/L), multlplyby O.02586, mgldlls rnllligrams per deciliter.

54
Table 24. Cumulative percent distribution of calculated values of low density lipoprotein (LDL) cholesterol for men 20-74 years of

age fasting 12 hours or more and number of examined persons by race and selected LDL cutoffs, according to age:

United States, 1976-80-Con.

45-54 years 55-64 years 65-74 years

Race and selected Number of Number of Number of

/ow density /lipoprotein cutoff 1 examined Cumulative examined Cumulative examined

(mg/dl)

Cumulative

persons percent persons percent persons percent

All racesz

Total . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . .

Lessthan 70 . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . .

Lessthan 100 . . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . .

Lessthan 120, . . . . . . . . . . . . . . . . .

Lessthan 125 . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . .

Lessthan 400 . . . . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . .

Lessthan 70, . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . .

Lessthan 100 . . . . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . .

Lessthan 125 . . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . . .

Lessthan400 . . . . . . . . . . . . . . . .

106

1

2

7

15

28

33

35

41

53

65

77

86

91

96

106

$,8

1

2

6

13

25

29

31

33

43

5!3

71

78

83

67

96

100,0

1.1

1.6

5.6

12.5

25.3

29.2

31.0

38.0

51.1

63.2

73.2

79.9

85.2

90.2

100.0

100.0

1.2

1.6

5.4

12.0

24.8

28.5

30.4

36.1

50.7

62.7

73.9

79.9

85.8

89.9

100.0

267

1

3

7

16

26

45

61

73

85

104

t 33

167

187

205

221

234

267

236

1

2

5

13

20

34

49

59

71

89

116

146

165

182

196

207

236

100.0

0.1

1.1

2.5

6.2

9.2

16.6

25.4

29.9

34.7

41.8

52.3

65.8

73.7

79.1

84.6

87.8

100.0

100.0

0.2

0.7

2.0

5.8

7.8

14.4

23.7

28.2

33.3

4t .0

51.5

64.7

73.1

78.9

84.5

87.6

100.0

288

1

4

6

19

26

45

72

82

100

134

157

184

212

230

249

260

288

256

1

4

6

16

22

38

60

69

67

118

138

162

187

204

223

233

256

100,0

0.3

0.8

1.6

6.6

9.1

15,7

24.5

27.4

33.6

45.9

54.2

63.5

71.2

78.0

86.2

90.2

100.0

100.0

0.3

0.9

1.8

6.6

9.1

14.6

22.8

25.8

32.6

45.5

53.1

62.2

69.9

77.2

86.3

90.4

100.0

55
Table 25. Cumulative percent distribution of calculated values of low density lipoprotein (LDL) cholesterol for men 20-74 years of age

fasting 12 hours or more and number of examined persons by race and selected LDL cutoffs, according to sex: United States, 1976-80

20–24 years 25-34 years 35-44 years

Race and se/ected Number of Number of Number of

/ow density /lipoprotein cutoff 1 examined Cumulative examined Cumulative examined Cumulative

(mg/df) persons percent persons percent persons percent

All racesz

Total .,....,..,,,.,..,.,,,, .,, .

Lesethan 60 .,, ,, . . . . . . . . .

Lessthan 70...,,,.....,,. . . . . .

Less than 80,,,,,.....,..,,,

Less than 90..,,,....,...,,,

Less than 100.,,,,........,.. ,., ,.

Less than 110 . . . . . . . . . . . . . . . ,,, ,,,

Less than 120 . . . . . . . . . . . . . . . . . .,,

Lessthan 125, ,, . . . . . . . . . . ., ...,,,

Lessthan 130,,..,.,,,,,.,

Lessthan 140,,..,...,.,.. . . . .

Lessthan 150, . . . . . . . . . . . . . ..,,,,,

Lessthan 160 . . . . . . . . . . . . . ...,,,.

Lessthan 170 . . . . . . . . . . . . . . . . .

Lessthan 180, , . . . . . . . . . . . . . . .

Lessthan 190. . .,, ,, .,.... ,,, ,,.,.

Lessthan 200...,,,,,,,,. ,,, ,..,..

Lessthan 400...,,..,..,., ,., .,,..

White

Total ...,.,,,.,.,,.,,,..

Less than 60, ,,, .,...... .

Lessthan 70,,...,,,,,,.. . .

Lessthan 80,,,.,,.,,,,..

Lessthan 90....,...,.,., ,. ...,..

Lessthan 100, ,, . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . ,. .,,,,.

Lessthan 120. , . ., .,,,..,. ,. .,,,..

Lessthan 125, . . . . . . . . . . . . . . .

Lessthan 130. , ., ..,,...., ... ..,..

Lessthan 140. . . . . . . . . . . . . ... ,.,,.

Lessthan 150 . . . . . . . . . . . . . ,., ,,,..

Lessthan 160. . . . . . . . . . . . . .

Lessthan 170. , . . . . . . . . . . . .,, ,,,,.

Lessthan 180....,....,,. ,,, ,..,..

Lessthan 190. . ., ...,...., ,.

Lessthan 200 . . . . . . . . . . . . .

Lessthan 400. . .,, . . . . . . . .

105

5

11

18

34

52

65

68

71

81

91

96

98

101

102

103

105

89

4

8

15

26

43

54

57

59

68

78

83

84

86

87

87

89

100,0

5.7

12.9

20.4

35.4

53.2

65.4

67.6

70.6

79,2

66.5

92,0

93.7

95.8

96.5

97.6

100.0

100.0

5.3

10.7

19.6

32.8

51.8

64.9

67.5

69.6

78,7

67.2

93.7

95.2

96.3

97.1

97.1

100,0

194

6

9

15

30

56

75

105

113

123

148

158

168

181

183

190

191

194

177

3

6

11

24

50

67

97

105

113

136

146

155

167

169

173

174

177

100.0

2.5

323

6.6

13,8

27,0

37.2

54.6

58.6

62.9

75.4

80.1

85.1

92.1

93.4

97.9

98.3

100.0

100.0

1.1

2.5

5.2

12,4

26,8

37,1

56,0

60.4

64.2

76.2

61.4

66.3

93.0

94.4

97.7

98.1

100.0

166

5

6

10

20

30

50

73

83

88

106

t 22

135

146

151

155

159

166

142

4

5

8

16

25

43

62

72

76

92

106

117

125

129

133

137

142

100.0

2.9

3.5

5.2

10,0

15.5

28,6

42.5

49.8

52,8

63,9

74.4

62.4

88,3

91.6

94.1

96.2

100.0

100.0

2.9

3.6

5.1

9.7

1!5.3

2!3.4

42,1

50,4

53.4

64.3

75.2

63.4

88.4

91.3

94.2

96.5

100.0

lLDLcholesterol = serum toialcholesterol -hlghdensity lipoprotein cholesterol -tr!glycer[de/5, Equation from Friedewald, W7, et al, Clin Chem (18):499-502, 1972, Persons with a serum

triglyceride value greater than 400 mgldl were excluded,

21ncludes dstafor races notshown separately .Datanol given separately for black adults because of small :aamp[e sizes,

NOTES: To convert values of LDL cholesterol to millimoles per liter (mmol/L), multiply the values by 0,02586, mgldl is milligrams per deciliter.

56
Table 25. Cumulative percent distribution of calculated values of low density lipoprotein (LDL) cholesterol for men 20-74 years of age

fasting 12 hours or more and number of examined persons by race and selected LDL cutoffs, according to sex: United States,

1976-80-Con.

45-54 years 55-64 years 65–74 years

Race and selected Number of Number of Number of

/otv densiiy lipoprotein cutoffl examined Cumulative examined Cumulative examined Cumulative

(mg/dl) pe:sons percent persons percent persons percent

All races2

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Lessthan 70 . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . . .

Less than 90 . . . . . . . . . . . . . . . . . . . . .

Lessthan 100 . . . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . . . .

Lessthan 120 . . . . . . . . . . . . . . . . . . . . .

Less than 125 . . . . . . . . . . . . . . . . . . . . .

Less than 130 . . . . . . . . . . . . . . . . . . . . .

Lessthan 140 . . . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . .

Lessthan 200 . . . . . . . . . . . . . . . . . . . .

Lessthan400 . . . . . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan 60 . . . . . . . . . . . . . . . . . . . . .

Lessthan 70 . . . . . . . . . . . . . . . . . . . . .

Lessthan 80 . . . . . . . . . . . . . . . . . . . .

Lessthan 90 . . . . . . . . . . . . . . . . . . . .

Leasthan 100 . . . . . . . . . . . . . . . . . . . .

Lessthan 110 . . . . . . . . . . . . . . . . . . .

Lessthan 120, . . . . . . . . . . . . . . . . .

Lessthan 125. . . . . . . . . . . . . . . . . . . . .

Lessthan 130 . . . . . . . . . . . . . . . . . .

Lessthan 140, . . . . . . . . . . . . . . . . . . .

Lessthan 150 . . . . . . . . . . . . . . . . . . . . .

Lessthan 160 . . . . . . . . . . . . . . . . . . . . .

Lessthan 170 . . . . . . . . . . . . . . . . . . . . .

Lessthan 180 . . . . . . . . . . . . . . . . . . . . .

Lessthan 190 . . . . . . . . . . . . . . . . . . . . .

Lessthan200 . . . . . . . . . . . . . . . . . . . . .

Lessthan400 . . . . . . . . . . . . . . . . . . . . .

166

1

2

6

9

15

25

36

42

54

72

64

104

115

125

132

1,43

1168

143

1

2

4

7

12

20

:’0

:6

46

62

73

90

99

106

112

120

143

100.0

0.5

0.9

2.3

3.6

6.6

13.7

19.1

23.0

29.6

39.7

46.5

58.3

65.6

71.4

76.6

84.4

100.0

100.0

0.5

1.0

1,8

3.4

6.3

13.2

19.2

23.6

30.4

41.3

48.7

60.9

67.5

71.5

76.1

83.0

100.0

282

1

3

4

9

15

25

46

57

70

91

126

155

179

199

215

230

282

244

1

3

4

8

12

21

38

49

59

79

108

131

149

166

161

195

244

100.0

0.1

0.6

0.8

2.7

4.4

8.2

16.1

20.3

25.3

33.1

48.4

56.9

63.9

70.4

76.7

82.4

100.0

100.0

0.1

0.7

0.9

3.0

4.3

6.2

15.7

20.6

25.2

33.3

47,1

54,7

61.2

67.7

74.5

80.9

100.0

331

1

1

6

11

21

34

49

56

66

101

143

172

207

226

250

266

331

289

4

9

‘la

29

40

48

57

88

126

152

183

199

220

233

289

100.0

0.2

0.2

1.7

3.5

6.4

10.5

14.2

16.9

19.4

30.2

43.1

51.4

65.2

71.5

77,3

81.2

100.0

100,0

1.5

3.5

6.6

10.5

13,8

16,7

19.3

31.0

44.5

53.5

66.0

71.2

77.4

61.1

100.0

57
Table 26. Cumulative percent distribution of the ratio of calculated values of ICIWdensity lipoprotein (LDL) cholesterol to high density

lipoprotein (HDL) cholesterol for persons 20-74 years of age fasting 12 hours or more and number of examined persons by race and

sex: United States, 1976-60

Both sexes Men Women

Number of Number of Number of

Race and se/ected examined Cumulative examined Cumulative examined Cumuktive

ratio cutoffl persons percent persons percent persons percent

All racesz

Total . . . . . . . . . . . . . . . . . . . .

Less than l.OO ., . . . . . . . . . . . . .

Lessthan l.50 . ., ..,.,... . . .

Lessthan l.70 . . . . . . . . . . . .

Lessthan 2.00 . . . . . . . . . . . .

Lessthan 2.50 . . . . . . . . . . . .

Lessthan 2.90 . . . . . . . . . . . . . . . .

Lessthan 3.00 . .,, . . . . . . . .

Lessthan 3.30 . . . . . . . . . . . .

Lessthan 3,50 . . . . . . . . . . . .

Lessthan 3.80 ., . . . . . . . . . .

Lessthan 4.00 ., . .,, . . . . . . . ,,,..,.

Lessthan 4.50 . . . . . . . . . . . . .,, ..,,.

Lessthan 5.00 . . . . . . . . . . . . . . . .

Lessthan 5.50 . . . . . . . . . . . . .

Lessthan 6.00 . . . . . . . . . . . . . . . . .

White

Total, ,, ., . . . . . . . . . . . . . . . . .

Lessthan l.OO . . . . . . . . . . . . .

Lessthan l.50 . . ...,..... . . . . . .

Lessthan l.70 . . . . . . . . . . . . . . . .

Lessthan 2.00 . .,, . . . . . . . . . ,, . . . . .

Lessthan 2.50 . . . . . . . . . . . .

Lessthan 2.90 . . . . . . . . . . . .

Lessthan3.00 . . . . . . . . . . . . . . . .

Lessthan 3.30 . . . . . . . . . . . . . . . . . .

Lessthan 3.50 . . . . . . . . . . . . . . . .

Lessthan3.80 . . . . . . . . . . . . . . . . . .

Lessthan 4,00 . . . . . . . . . . . . . . .

Lessthan 4,50 . . . . . . . . . . .

Lessthan 5,00 . . . . . . . . . . . . . . . . .

Lessthan 5.50 . . . . . . . . . . . . . . . . . .

Lessthan 6.00 . . . . . . . . . . . . . . . . . .

Black

Total . . . . . . . . . . . . . . . . . . . .

Lessthan l.OO . .,, . . . . . . . . . . . . . .

Lessthan l.50 . . . . . . . . . . . . . . . . .

Lessthan l.70 . . . . . . . . . . . . . . . . . .

Lessthan 2.00 . . . . . . . . . . . .

Less than 2.50 . . . . . . . . . . . . . . . . . . .

Less than 2.90 . . . . . . . . . . . . . . . . .

Lessthan 3,00 .,, , .,......, . . .

Lessthan 3,30 . . . . . . . . . . . .

Lessthan 3,50, , . ...,...,, .

Lesathan 3,80 . . . . . . . . . . . . . . . . . .

Lessthan 4,00 . . . . . . . . . . . . . . . .

Lessthan 4,50 . . . . . . . . . . . . . . . . . . . .

Lessthan 5,00 .,, . . . . . . . . . .

Lessthan 5.50 . . . . . . . . . . . . . . . . . .

Less than 6.00 . . . . . . . . . . . . .

2,283

35

164

258

441

810

1,119

1,198

1,395

1,525

1,687

1,781

1,978

2,101

2,178

2,221

1,990

22

119

194

343

663

936

1,008

1,185

1,301

1,448

1,533

1,706

1,823

1,892

1,933

251

11

39

56

86

127

160

166

183

195

206

214

230

236

244

246

100.0

1.7

8.5

13.0

21,5

37.9

51.4

54.4

63.2

69.2

759

80.0

87.9

92.9

96.1

97.6

100.0

1.3

7.3

11,7

19.5

36.1

50.3

53.3

62,1

68,3

75,2

79,2

87.2

92.4

95.7

97,3

100.0

4,6

18,6

24.8

38.7

52.4

62.2

65.2

73,7

77,4

80,8

86,8

93.3

96,1

98.8

99.2

1,037

11

49

75

126

287

412

449

540

603

704

755

859

938

983

1,009

906

6

34

53

91

222

330

366

450

509

598

644

737

813

855

879

114

4

12

19

31

57

72

73

80

84

93

97

105

108

111

113

100.0

1.6

5.5

7.9

12,7

27,8

40,5

43,2

51.8

59.5

68.7

73.7

83.6

90.5

95.1

97.0

100.0

1.3

4.4

6.6

10.7

25.0

37.6

40.9

49.8

56.2

67.3

72.0

82.1

89.4

94.6

96.7

100.0

4.1

14.5

19.8

30.7

50.3

62.3

62.7

70.2

73.2

79.9

88.1

94.2

97.9

98.9

99.7

1,246

24

115

183

315

523

707

749

655

922

983

1,026

1,119

1,163

1,195

1,212

1,084

16

85

141

252

441

606

642

735

792

850

889

971

1,010

1,037

1,054

137

7

27

37

55

70

88

93

103

111

113

117

125

128

133

133

100.0

1.8

10.8

17.1

28.3

45.0

60.0

63.2

72.1

76,8

81,5

84.9

91,3

94.8

969

98.0

100.0

1,4

9.6

15.8

26.5

45.0

60,3

63.2

71,9

76,4

81.5

84.9

91.3

94.7

96.6

97.9

100.0

5.1

2“1.9

28.7

44.1

54.1

62.1

67.2

76,5

80.8

81.6

85.8

92,7

94.7

98.7

96,7

lLOLchole$terol = serum total cholesterol -tighdensi~ lipoprotein cholesterol -ttiglycetide/5. Equation from Friedewald, WT, etal. Clin Chem(l L3):499-5O2, 1972. Persons with a serum

triglyceride value greater than 400 mgldl were excluded.

‘Includes data for races not shown separately.

58
This page intentionally left blank

59
Table 27. Cumulative percent distribution of the ratio of calculated values of low density lipoprotein (LDL) cholesterol to high density

lipoprotein (HDL) cholesterol for women 20-74 years of age fasting 12 hours or more and number of examined persons by race and LDL

cutoffs, according to age: United States, 1976-80

20-24 year? 25-34 years 35-44 years

Number of Number of Number of

Race and se/ecfed examined Cumulative exarnhed Cumu/at/ve examined Cumulative

ratio cutoff persons percent persons percent persons percent

All races~

Total .,, , . . . . . . . . . . . . . . . . . .

Less than l.OO . . . . . . . . . . . . . . .

Lessthan l.50 ..,,.,,.,,., ,,, .,,.,

Lessthan l.70 . . . . . . . . . . . .

Lessthan 2.00..,,......,,,

Lessthan 2.50..,.......,,.

Less than 2.90.,....,..,,, ... .,,.,

Lessthan 3,00.,,....,.,,, ... .,,,,

Lessthan 3.30 .,, . . . . . . . . .

Lessthan 3.50 . . . . . . . . . . . .

Lessthan 3,80 . . . . . . . . . . . . .,, .,..,

Lesathan 4.00 . . . . . . . . . . . . .

Lessthan 4,50 . . . . . . . . . . . . . . . .

Lessthan 5.00..,..,,.,,., ,,, .,,,,

Lessthan 5,50 . . . . . . . . . . . . . .

Lessthan 6.00 . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . ,,.,..,

Lessthan 1,00, ,, .,.,..,, ,. .,.,,.,

Lessthan 1,50, , . . . . . . . . . . . . . . .

Lessthan 1,70 ., . . . . . . . . . . . . . . .

Lessthan 2,00,,.,....,,,,.

Lessthan 2,50,,.......,,.

Lassthan 2,90,,,...,,,,,,. .,.,,,,

Lasathan 3,00,,.,,,,.,,,. ,. .,.,,,

Lessthan 3.30.....,..,,.

Lessthan 3,50, . . . . . . . . . . . . . . .

Lessthan 3.80, . . . ...,,,.., . . . .

Lessthan 4.00,.,.,..,,,..

Lessthan 4.50 . . . . . . . . . . . . . . . . .

Leasthan 5,00 . ., . . . . . . . . . . . . .

Lessthen 5.50 . . . . . . . . . . . . .

Lesathan 6.00 ., . . ...,..... . . . .

72

5

11

16

22

37

49

51

55

58

61

64

68

69

70

70

57

3

7

10

15

27

37

39

42

45

4a

50

53

54

55

55

100.0

10.0

19.3

27.3

35.4

55.9

71.0

73.3

78,5

81.9

84.7

89,9

94.5

96.6

97,4

97,4

100,0

10.0

16.2

23,6

33.1

53.7

70,2

73.1

78.0

82.3

86.0

68.8

93.0

95.6

96.7

96.7

174

10

16

28

55

85

87

100

110

132

137

152

165

172

173

146

7

12

21

42

68

70

eo

90

107

112

124

137

144

145

100,0

0.8

5,7

8.4

13.9

29.5

46.9

47.7

55.0

61.9

73.9

77.8

87.2

94.0

96.8

99.4

100.0

0.9

5.2

7.8

12.3

27.3

45.6

46,5

53,3

61.2

72.0

76.4

85.3

93.2

98.6

99.3

130

2

4

5

11

28

43

48

65

72

86

92

106

114

120

125

115

3

4

8

20

33

38

54

61

74

79

92

99

105

110

100.0

2.4

3.8

4.7

8.8

22.5

34.5

37.6

51,4

57.8

68,0

72,0

81.5

67,1

93.4

96.4

100.0

1.5

0.1

4.1

5.9

18,6

3’1.0

34.5

48.6

56.0

66.8

70.1

80.3

85.4

926

95.9

llncludes data forracea not shown separately, Data notgiven separately for black adults becauae ofsmallsampleslze.

NOTES:LDLcholesterol = serum total cholesterol -high density lipoprotein cholesterol -tflglyceride/5. EqJationfromFfledewsld,W,e ial.ClinC hem(l8):499-5O2, 1972. Persons witha

aerumttiglycetide value greater than 400mg/dl were excluded. mgldl ismilligrams perdecilker.

60
Table 27. Cumulative percent distribution of the ratio of calculated values of low density lipoprotein (LDL) cholesterol to high density

lipoprotein (HDL) cholesterol for women 20-74 years of age fasting 12 hours or more and number of examined persons by race and LDL

cutoffs, according to age: United States, 1976-60-Con.

45-54 years 5S64 yeara 65–74 years

Number of Number of Number of

Race and se/ected examkred Cumulative examfned Cumulative examined Cumulative

ratio cutoff persons percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . 106 100.0 267 100.0 288 100.0

Less than l.OO . . . . . . . . . . . . . . . . . . . .

Lessthan l.50 . . . . . . . . . . . . . . . . . . .

Lessthan 1,70 . . . . . . . . . . . . . . . . . . . .

Lessthan 2.00 . . . . . . . . . . . . . . . . . . .

Lessthan 2,50 . . . . . . . . . . . . . . . . . . .

Lessthan 2.90 . . . . . . . . . . . . . . . . . . .

Lessthan 3.00 . . . . . . . . . . . . . . . . . . .

Lessthan 3.30 . . . . . . . . . . . . . . . . . . . .

Lessthan 3.50 . . . . . . . . . . . . . . . . . . . .

Lessthan 3.80, . . . . . . . . . . . . . . . . . . .

Lessthan 4.00 . . . . . . . . . . . . . . . . . . .

Lessthan 4.50 . . . . . . . . . . . . . . . . . . . .

Lessthan 5.00 . . . . . . . . . . . . . . . . . . .

Lessthan 5.50 . . . . . . . . . . . . . . . . . . . .

Lessthan 6.00 . . . . . . . . . . . . . . . .

5

7

9

20

31

33

41

54

63

68

83

93

96

100

0.0

4.6

6.4

8.3

17.6

27.2

28.1

35.2

51.0

56.9

65.2

76.0

66.3

90.1

93.1

2

6

16

28

69

100

112

137

151

177

192

216

236

251

260

0.3

2.8

5.0

10.6

27.5

39.4

44.2

52.3

59.5

68.3

73.9

63.3

91.2

95.6

96.1

1

11

15

26

76

104

116

142

158

185

202

232

259

274

261

0.2

3.4

4.9

9.0

27.0

35.1

40.6

49.5

54.0

62.6

66.4

79.9

86.6

94.1

96.6

White

Total . . . . . . . . . . . . . . . . . . . . . . . . . . 96 100.0 236 100.0 256 100.0

Lessthan l.OO . . . . . . . . . . . . . . . . . . . .

Lessthan l.50 . . . . . . . . . . . . . . . . . . . .

Lessthan l.70 . . . . . . . . . . . . . . . . . . . .

Lessthan 2,00 . . . . . . . . . . . . . . . . . . . .

Lessthan2.50 . . . . . . . . . . . . . . . . . . . .

Less than 2.90, . . . . . . . . . . . . . . . . .

Lessthan 3.00, . . . . . . . . . . . . . . . .

Lessthan 3.30, . . . . . . . . . . . . . . . .

Lessthan3.50 . . . . . . . . . . . . . . . . . . . .

Lessthan 3.60 . . . . . . . . . . . . . ,, . . . . .

Lessthan 4.00 . . . . . . . . . . . . . .,,.,.,

Lassthan4.50 . . . . . . . . . . . . . ,, . . . . .

Lessthan5.00 . . . . . . . . . . . . ., ...,..

Lessthan5.50 . . . . . . . . . . . . . . . . . . .

Lessthan 6.00 . . . . . . . . . . . . . . . . . . . .

3

5

7

16

26

28

36

46

56

60

74

63

86

90

0.0

2.6

4.7

6.6

15.6

24.9

25.9

33.8

49.9

57.9

62.6

76.4

64.6

89.0

92.3

1

6

11

19

53

60

91

115

129

153

166

191

210

222

230

0.2

2.6

3.7

8.9

24.9

36.6

41.7

50.1

57.9

67.0

72.7

62.6

90.9

95.6

98.0

8

11

23

64

66

100

123

136

160

177

203

230

243

249

0.0

3.0

4.3

6.7

24.8

32.8

36.9

48,5

52.6

61.1

67.5

78.6

68.5

93.9

96.4

61
Table 28. Cumulative percent distribution of theratio ofcalculated values of Iow density lipoprotein (LDL)cholesterol to high density

lipoprotein (HDL) cholesterol for women 20-74 years of age fasting 12 hours or more and number of examined persons by race and

selected ratio cutoffs, according to age: United States, 1976-80

20-24 years 25-34 yeare 35-44 years

Number of Number of Numbar of

Race and selected examined Cumulative examined Cumulative examined

ratio cutoff

Cumulative

persons percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . .

Less than 1,00 . . . . . . . . . . . . . .

Less than 1,50, . . . . . . . . . . . . . . . . . .

Less than l.70 . . . . . . . . . . . . . . . .

Less than 2,00.,........,,.. . . . . .

Less than 2,50 . . . . . . . . . . . . . . . . . .

Lessthan 2,90, . . . . . . . . . . . . . . . . .

Lessthan 3,00.,...,,,,,,..

Lessthan 3.30,...,,,,,,,..

Lessthan 3.50 . . . . . . . . . . . . .

Lessthan 3.80.......,.,,..

Lessthan 4.00 . . . . . . . . . . . .

Lessthan 4.50 . . . . . . . . . . . .

Lessthan 5.00 . . . . . . . . . . . . .

Lessthan 5,50 . . . . . . . . . . . . . . . . . .

Lessthan 6.00 . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan l.OO, . . . . . . . . . . . . . . . . .

Lessthan l.50 . . . . . . . . . . . . . . . . . . .

Lessthan l.70 . . . . . . . . . . . . . . . . . .

Lessthan 2.00 . . . . . . . . . . . . . . . . . .

Lessthan 2.50 . . . . . . . . . . . . . . . . .

Lessthan 2.90,.,....,,,.. . . . .

Lessthan3.00 . . . . . . . . . . . . . . . .

Lessthan 3,30 . . . . . . . . . . . . . . .

Lessthan 3.50 . . . . . . . . . . . . . .

Lessthan 3.80 . . . . . . . . . . . . . . . . .

Lessthan4.00 . . . . . . . . . . . . . . . . . .

Lessthan 4.50 . . . . . . . . . . . . . . . . .

Lessthan 5.00 . . . . . . . . . . . . . . . .

Lessthan 5.50 . . . . . . . . . . . . . . . . .

Lessthan 6.00 . . . . . . . . . . . . . . . . .

105

1

16

28

46

65

80

65

89

92

96

97

100

102

103

103

89

1

10

20

35

53

68

71

75

77

81

82

85

87

87

87

100.0

0.6

17.7

29.0

45,5

64,7

77,6

82.6

85.2

88.2

91.6

92,3

95,0

96,2

97,3

97.3

100.0

0.7

13.7

24.7

41.1

63.0

78.2

81.4

84.4

87.4

91.5

92.3

95.5

96.8

96.8

96.8

194

5

26

41

65

108

141

149

165

169

174

179

188

193

193

194

177

2

21

35

57

99

130

138

152

155

160

165

172

176

176

177

100.0

2.1

12.1

20.7

32.9

56.5

72.5

75.9

84.7

86.6

89.5

92.1

96.1

98.6

98.8

100.0

100.0

0.6

10,8

19,8

32.4

57.0

73.4

77.1

85.5

87.0

90.2

93.0

96.6

98.7

98.7

100.0

166

9

23

34

54

82

104

112

133

140

149

156

159

162

163

164

142

6

17

25

43

68

90

95

114

120

128

134

137

139

139

140

100,0

4,0

13.1

18.5

32.5

47.7

61.2

65.1

78.0

82.8

89.3

94.8

96.4

98.4

98.8

99.4

100.0

3.3

12.4

17.1

30.6

46.7

61.9

64.6

77.9

82.5

89.6

95.4

97.2

98.8

98.6

99,3

llncludes data lorracea notshown separately. Data notgiven separately for black adults bemuse ofsmallsampleaize.

NOTES:LDLchoiesteroi = serum total cholesterol -high densi~lipoprotein cholesterol -tdglycerlde/5. Equation from Fdedewald,~,etal. Clin Chem(18):499-502, 1972. Pemons witha

serum triglyceride value greater than 400 mgldl were excluded. mgldl is milligrams per deciliter.

62
Table 28. Cumulative percent distribution of the ratio of calculated values of low density lipoprotein (LDL) cholesterol to high density

lipoprotein (HDL) cholesterol for women 20-74 years of age fasting 12 hours or more and number of examined persons by race and

selected ratio cutoffs, according to age: United States, 1976-80-Con.

45-54 years 55-64 yeare 65-74 years

Number of Number of Number of

Race and se/ected examir!ed Cumulative examined Cumulative examined Cumulative

ratio cutoff perso,w percent persons percent persons percent

All racesl

Total . . . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan l.OO . . . . . . . . . . . . . . . . . . . .

Lessthan 1,50 . . . . . . . . . . . . . . . . . . . .

Less than l.70 . . . . . . . . . . . . . . . . . . . .

Less than 2.00 . . . . . . . . . . . . . . . . . . . .

Lessthan 2.50 . . . . . . . . . . . . . . . . . . . .

Less than 2.90 . . . . . . . . . . . . . . . .

Lessthan 3.00 . . . . . . . . . . . . . . . . . . .

Lessthan 3.30 . . . . . . . . . . . . . . .

Lessthan 3.50 . . . . . . . . . . . . . . . . . . .

Lessthan 3.80 . . . . . . . . . . . . . . . . . . . .

Lessthan 4.00 . . . . . . . . . . . . . . . . . . .

Lessthan 4.50 . . . . . . . . . . . . . . . . . .

Lessthan 5.00 . . . . . . . . . . . . .

Lessthan 5.50 . . . . . . . . . . . . . .

Lessthan 6.00 . . . . . . . . . . . . . . . . . . .

White

Total . . . . . . . . . . . . . . . . . . . . . . . .

Lessthan l.OO, . . . . . . . . . . . . . . . . . .

Lessthan l.50 . . . . . . . . . . . . . . . . . .

Lessthan l.70 . . . . . . . . . . . . . . . . . . . .

Lessthan 2.00 . . . . . . . . . . . . . . . . . . . .

Lessthan 2.50 . . . . . . . . . . . . . . . . . . .

Lessthan2.90 . . . . . . . . . . . . . . . . . . .

Lessthan3.00 . . . . . . . . . . . . . . . . . . . .

Lessthan3.30 . . . . . . . . . . . . . . . . . . .

Lessthan3.50 . . . . . . . . . . . . . . . . . . . .

Lessihan3.80 . . . . . . . . . . . . . . . . . . . .

Lessthan4.00 . . . . . . . . . . . . . . . . . . . .

Lessthan4.50 . . . . . . . . . . . . . . . . . . . .

Lessthan5.00 . . . . . . . . . . . . . . . . . . . .

Lessthan 5.50 . . . . . . . . . . . . . . . . .

Lessthan 6.00 . . . . . . . . . . . . . . . . . . . .

168

3

17

28

41

73

94

97

110

122

128

133

147

154

159

162

143

3

12

21

32

60

79

82

92

102

107

112

124

130

134

137

100.0

1.6

8.5

15.9

23.2

42,2

53.2

54.5

63.1

71.5

76,0

78.5

87.5

92.0

95.1

96.7

100.0

1.9

7.3

14.9

22.2

42.0

53.8

55.4

62.2

70.0

74.5

77.5

66.4

91.1

94.2

96.1

262

2

19

31

61

99

135

143

166

165

202

215

245

259

270

274

244

2

15

25

46

80

112

120

143

158

174

166

211

224

234

238

100.0

0.4

9.7

12.6

23.2

33.9

49.7

52.6

62.5

66.2

71.5

74.9

87.3

93.1

97.2

96.2

100.0

0.5

9.4

12.4

19<3

30.3

47.6

51.3

61.6

65.5

71.4

75.2

66.4

92.6

97.1

98.3

331

4

14

21

48

96

153

163

190

214

234

246

280

293

307

315

289

2

10

15

39

81

127

136

159

180

200

210

242

254

267

275

100.0

1.4

4.3

6.3

14.1

30.1

46.6

49.4

58.5

64.4

70.1

75.9

84.8

69.1

93.4

95.4

100.0

1,1

4.0

5.7

14.0

30.4

46.3

49.3

57.8

64.0

70.5

74.4

84.0

68.4

93.1

95.4

63
Table 29. Serum total cholesterol levels forwomen 20–44years of age, number of examined persons, mean, standard error of the mean,

and selected percentiles, by race, oral contraceptive use, and age: United States, 1976-60

Number of Standard F’ercenMe

Race, era/ contraceptive examined error of —

use, and age persons Mean the mean 5th 10th 15th 25th 50th 75th 85th 90th 95th

Serum total cholesterol in milligrams per deciliter (mg/dl)l

All racesz

Nonusers:

20-44 years . . . . . . . . . . . . . . . . .

20-44 years, age adjusted,

20–29 years...,,,...,..,,, ...

30=14 years . . . . . . . . . . . . . . . .

Recently discontinued users:

20–44 years . . . . . . . . . . . . . . . .

20–44 years, age adjusted.

20-29 years...,,,,.....,,,.

30-44 years . . . . . . . . . . . . . . .

Users:

20–44 years . . . . . . . . . . . . . . . ,, ..,.

20–44years, age adjusted.

20-29 years...,,....,..,,,.

30-44 years . . . . . . . . . . . . . . . .

White

Nonusers:

20-44 years . . . . . . . . . . . . . . . . .

20-44 years, age adjusted.

20-29 years.,,.,..,,..,,,. ,..

30-44 years . . . . . . . . . . . . . . .

Recently discontinued users:

20-44 years, . . . . . . . . . . . . . . .

20-44 years, age adjusted.

20-29 years . . . . . . . . . . . . . . .

30G44 years . . . . . . . . . . . . . . .

Users:

20-44 years..,..........,..

20-44 years, age adjusted.

20–29 years.,,.,,..,..,,..

30–44years . . . . . . . . . . . . . . . . .

Black

Nonusers:

20-44 years, .,, , ., . . . . . . . . . .

20–44years, age adjusted.

20-29 years, ,, . . . . . . . . . . . .

30–44years . . . . . . . . . . . . . . . . .

Users:

20–44 years..,.....,..,.,..

20-44 years, age adjusted.

20-29 years, , . . . . . . . . . . . . .

1,693

746

947

160

,..

118

42

504

,..

378

126

1,441

628

813

134

.,.

98

36

433

318

115

209

. .

94

115

64

55

190

189

180

198

188

191

184

’197

200

203

197

208

189

188

179

197

168

192

184

’199

201

204

197

211

196

i 95

188

202

192

187

194

1.3

1.3

1.5

1,6

4,6

5.2

5,0

‘9.4

2.4

2.8

2.5

4.7

1.4

1,4

1.7

1.7

5.2

5.9

5.4

‘10,4

2.5

2.7

2.7

*4.3

3.0

3.2

4,5

‘4.0

‘7.4

*8.9

‘7.8

135

131

143

133

,,,

“114

*

142

.,.

143

142

136

. .

131

143

134

.

*

*

146

,.,

146

149

135

*

138

*

*

144

,..

137

154

143

.,.

136

*

153

.,.

152

159

143

137

152

143

. .

137

*

154

. .

153

164

144

. .

140

156

142

. . .

144

152

. .

143

159

152

149

153

161

. .

160

166

151

143

158

153

.

149

160

164

. .

160

167

156

. .

152

169

154

. .

156

163

. .

154

170

161

,..

161

161

173

. . .

172

180

162

. . .

153

169

161

. . .

161

166

175

. . .

173

185

170

. .

160

175

168

.

168

186

. .

176

192

179

. .

176

185

195

193

210

184

. .

175

191

179

. . .

176

187

196

. . .

193

211

192

. . .

187

194

192

. .

192

213

. .

200

222

208

206

229

223

. .

220

235

212

. .

199

221

207

. . .

202

227

225

.

220

237

220

. . .

209

230

210

. .

213

229

. . .

215

236

229

218

251

240

. . .

237

250

229

. . .

212

236

229

222

246

242

. . .

237

250

234

. . .

224

236

225

.,.

225

240

. .

225

249

246

232

*

250

. . .

245

254

240

.,,

224

248

246

. . .

235

*

251

. .

245

264

246

. . .

235

259

237

. . .

237

260

. .

239

268

260

. . .

255

*

266

. .

264

268

258

.,.

238

268

260

,..

*

*

265

. .

261

275

274

. . .

*

274

●

*

lTO converl to mllljmoles per liter (mmol/L), multrply by 0.02586.

‘Includes da!afor races not shown separately.

NOTES: Data are presented neither for black recently discontinued users nor for black oral contraceptveu sers3044y earsofa gebecauseo fsmalls amplesizes, Excludes pregnant, lactating,

and menocmusal women.

64
Table 30. Serum high density lipoprotein (HDL) cholesterol for women 20-44 years of age, number of examined persons, mean, standard

error of the mean, and selected percentiles, by race, oral contraceptive use, and age: United States, 1976-80

Number of Stancfttrd percentile

Race, oral contraceptive examined error of

use, and age persons Mean the mean 5th 10th f5th 25th 50th 75th 85fh 90th 95fh

All races2

Nonusers:

20-44 years . . . . . . . . . . . . . . . . ,., ,.

20-44 years, age adjusted. . . . . . . . . . .

20-29 years . . . . . . . . . . . . . . . . . .

30-44 years . . . . . . . . . . . . . . . . . .

Recently discontinued users:

20-44 years . . . . . . . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . . . . . . . .

20-29 years . . . . . . . . . . . . . . . . . . .

30-44 years . . . . . . . . . . . . . . . . . . .

Users:

20-44 years . . . . . . . . . . . . . . . . . . . . .

2C!-44 years, age adjusted. . . . . .

20-29 years . . . . . . . . . . . . . . . .

30-44 years . . . . . . . . . . . . . . . . . . .

White

Nonusers:

20-44 years . . . . . . . . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . .

20–29years . . . . . . . . . . . . . . . . . . .

30-44 years . . . . . . . . . . . . . . . . . ,.

Recently discontinued users:

20-44 years . . . . . . . . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . . . . . .

20–29years, . . . . . . . . . . . . . . . . . .

30-44 years . . . . . . . . . . . . . . . . . . .

Users:

20-44 yeara . . . . . . . . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . . . . . . . . .

20-29 years . . . . . . . . . . . . . . . . . . .

3044years . . . . . . . . . . . . . . . . . . .

Black

Nonusers:

20-44 yeara . . . . . . . . . . . . . . . . . . . .

20-44 years, age adjusted. . ., . . . . .

20–29 years . . . . . . . . . . . . . . . . . . .

30-44 years . . . . . . . . . . . . . . . . . . .

Users:

20-44 years . . . . . . . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . . . .

20-29 years . . . . . . . . . . . . . . . . . . .

1,469

. . .

656

813

133

,..

98

35

436

329

107

1,262

. . .

561

701

114

. .

83

31

375

. .

276

99

172

. .

76

94

55

. . .

48

52.4

52.4

52,1

52.6

53.6

53.4

53.9

*52.8

53.2

53.6

52.9

54.2

52.0

52.0

51.7

52.3

53.6

53.5

53.6

‘53.5

52.8

53.2

52.5

53.8

55.7

55.8

56.0

55.5

55.5

56.6

55.1

Serum HDL cholesterol in milligrams per deciliter (mg/dl)l

0.5

0.5

0.7

0.6

1,5

1,5

2,0

●2.5

0.9

0.9

1.1

1.2

0.5

0.5

0.8

0.6

1.8

1.7

2.4

*2.7

1.0

1.0

1.2

1.4

1,1

1,1

*2. 1

*1,7

*2.2

*1.4

*2.6

33.0

. . .

33.0

34.0

34.0

. . .

*

*

34.0

. .

34.0

36.0

33.1

. .

33.0

34.0

34.0

. . .

*

*

34.0

. . .

33.1

*

32.0

. .

*

*

*

. . .

*

36.0

. . .

36.0

37.0

35.0

. . .

35,0

*

38.0

38.0

40.1

36.1

. .

36.0

37.0

35.0

. . .

34.1

*

38.0

. .

37.1

40.0

35.0

. . .

35.0

36.0

40,0

*

39,0

. . .

39.0

39.0

37.0

. . .

37.0

37.0

40.0

. .

40.0

41.1

39.0

. . .

39.0

39.0

37.0

. . .

36.0

*

40.0

. . .

39,1

41,0

41,0

.,.

43.0

39,0

41.0

. . .

40.0

43.0

. . .

43.1

43.0

41.0

. . .

41.0

45.0

45.0

. . .

44.0

45,0

43.0

. . .

43.0

43.0

41.0

.,.

40.0

45,1

45.0

. . .

44.0

45.0

45.0

. . .

47.0

45.0

47.0

. .

47.0

51.0

. . .

51.0

51.0

51.0

. . .

51.0

51.0

51.0

. . .

51.0

52.0

51.0

. . .

50.1

51.0

52.0

. . .

51.0

52.0

51.0

. .

51.0

50.0

55.0

,.,

55.0

57.0

52.0

. . .

50.0

60.0

. . .

60.0

60.0

60.0

. . .

60.0

60.1

60.1

. . .

60.0

61.0

60.0

. . .

59.1

60.0

60.0

. . .

60.0

63.0

60.0

. . .

59.1

61.0

64.0

. .

64.1

63.0

62.0

. .

70.0

65.1

. . .

65.0

66.0

68.0

. .

68.1

66.1

66.1

. . .

66.0

68.1

65.0

. . .

64.1

65.1

68.1

. .

68.1

*

65.1

. . .

65.1

68.1

70.0

. . .

70.0

70.0

74.1

. . .

76.1

70.1

. .

69.1

71.0

75.1

. . .

77.0

*

72.0

. . .

72,1

70.1

70.0

. . .

66.1

70.1

76.0

. . .

77.0

●

69.1

. . .

68.1

70.1

73,0

.,.

74.1

71.1

77.1

. .

*

75.1

. . .

75,0

76.1

84.0

. . .

*

*

77.0

. . .

76.1

77.0

75.0

,..

74.1

76.0

77.1

. .

*

*

76.0

. .

73,1

*

84.1

. .

*

*

*

,.,

*

1To COMWt to milhmoles per hter (mmollL), mulbply by 0.02586,

21ncludes data for races not shown Separately.

NOTES Data are presented neither for black recently discontinued users ncr for black oraf con!mceptiw users W-44 years of age because of small sample szes.

Excludes pregnant, lactetmg, snd menopausal women,

65
Table 31. Ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol for women 20-44 years of age, number

of examined persons, mean, standard error of the mean, and selected percentiles, by race, oral contraceptive use, and age:

United States, 1976-80

Number of Standard Percentile

Race, ord contraceptive examined error of

use, and age persons Mean the mean 51h 70th 15th 25th 50th 75th 85th 90th 95th

All racesl

Nonusers:

20-44 years, .,, , ., . . . . . . . . .,, .,,

20–44 years, age adjusted.

20–29years, . . . . . . . . . . . . . . .

30-44 years, . . . . . . . . . . . . . . . .,,

Recently discontinued users:

20-44 years, . . . . . . . . . . . . . . .,, ,,,

20-44 years, age adjusted.

20-29 years . . . . . . . . . . . . . . . ...

30-44 years..,,,.,.....,,, .,,

Users:

20-44 years . . . . . . . . . . . . . . . .

20–44 years, age adjusted.

20–29 years...,,,,,....,,,,

30-44 years . . . . . . . . . . . . . . . ,.,

White

Nonusers:

20-44 years..,,,,......,,. ... .,,

20-44 years, age adjusted.

20-29 years, . . . . . . . . . . . . . .

30-44 years, . . . . . . . . . . . . . .

Recently discontinued users:

20-44 years . . . . . . . . . . . . . . . . . . .

20-44 years, age adjusted. .

20-29 years . . . . . . . . . . . . . . . ,., .

30-44 years . . . . . . . . . . . . . . . . .,.

Users:

20-44 years . . . . . . . . . . . . . . . ,. .,,.

20-44 years, age adjusted. . . . .

20-29 years .,, ., . . . . . . . . . . . . .

30-44 years . . . . . . . . . . . . . . . ...

Black2

Nonusers:

20-44 years, . . . . . . . . . . . . . . . . .

20-44 years, age adjusted, .

20–29 years . . . . . . . . . . . . . . . ,,,

30-44 years . . . . . . . . . . . . . . . ,,. .

Users:

20–44 years . ., . .,, ..,.,.., ,., .,,

20-44 years, age adjusted.

20–29 years..,,..,,....,,. .,,

1,469

656

813

133

98

35

436

,,.

329

107

1,262

.,.

561

701

114

83

31

375

276

99

172

76

94

55

,..

48

3.87

3.85

3.68

4,02

3,74

3.77

3.69

*3.65

3.97

4.01

3.93

4.09

3,67

3.65

3.67

4.02

3.76

3.81

3.70

‘3.90

4.01

4,07

3,95

4,20

3.80

3.79

3.64

3.93

3.71

3.45

3.79

0.05

0.05

0.06

0.06

0.09

0,10

0.09

‘0,17

0.07

0.08

0.09

0.12

0.06

0,06

0,07

0,06

0.10

0,12

0.10

‘0.19

0.08

0.08

0.09

0.11

0.11

0.11

‘0.17

‘0.14

“0.19

‘0.20

‘0.22

2,29

,..

2,26

2.36

2.36

. . .

*

*

2.:30

,..

2,:31

z,:~l

,z,;z9

. . .

2.:26

2.38

2.38

. . .

*

*

2.32

2.40

*

2.33

*

*

●

*

2.52

,..

2,43

2,60

2.52

.,.

2.44

*

2.58

. .

2,59

2,44

2.53

.,.

2.44

2.60

2.52

2.50

*

2.59

. .

2.62

2.50

2,45

. .

2.36

2.52

2,30

.

●

2.67

. .

2.57

2.79

2.66

. .

2.59

2.72

2.80

2.82

2.69

2.68

.

2.56

2.79

2.68

. .

2.59

*

2.84

2.84

2,93

2.62

. .

2.40

2.79

2,58

,..

2.63

2.97

2.63

3,04

2,90

2.90

2.86

3.11

. .

3.11

3.10

2.98

. .

2.66

3.05

2.91

. .

2.91

3.00

3,12

. . .

3.11

3.19

2.82

,..

2.66

2.98

2.84

,..

3,00

3.57

. . .

3.42

3.74

3,46

. .

3.50

3.47

3.80

3.75

3.96

3.57

. . .

3.40

3.72

3.50

. .

3.51

3.47

3.84

. . .

3.79

4.24

3.45

. .

3.41

3.46

3.59

. . .

3,63

4.46

4.15

4.73

4,37

,..

4,30

4,56

4.71

. .

4.53

5.01

4.44

. . .

4.15

4.75

4.46

. .

4.34

4.73

4,75

. . .

4.57

5.08

4.47

.

4,21

4.57

4.35

. . .

4,46

5.05

4.69

5.26

4.74

. .

4,74

4,94

6.12

.

5.05

5.29

5.04

. . .

4,58

5.26

4.61

. .

4,74

*

5.14

. .

5,05

5.40

5.05

. .

4.89

5.09

4.72

. .

5.04

5.54

. .

5.36

5.74

5.40

. .

5.34

*

5.58

. . .

5.51

5.58

5.54

. . .

5,29

5.72

5,36

. .

4.90

*

5.65

,..

5.60

5.79

5.71

. .

5.55

5.87

5.05

.,,

*

6.52

. . .

6.48

6.77

5.62

. .

*

*

6.33

. . .

8.44

6.19

8.48

6,21

6.77

5.61

. . .

*

*

6.30

. .

6.34

*

6.53

. .

*

*

*

. .

*

1Includes data for races not ahown aepsrately.

2Data are presentsd neither for black recently discontinued users nor for black oral contraceptive users 313-44 years of age because of small sampla aizas.

NOTE: Excludes pregnant, Iacating, andmenopausal women,

66
Table 32. Percent of persons 20-74 years of age with ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol

greater than or equal to 4.5, number of examined persons, and standard error of the percent, by race, age, and sex: United States,

1976-80

Both sexes Men Women

Number of Standard Number of Standard Number of Standard

examined error of the examined error of the

Race and age

examined

persons Percent

error of the

percent Denons Percent percent persons Percent percent

All racest

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65–74years . . . . . . . . . . . .

White

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

3544years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Black

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

9,797

. . .

1,204

1,902

1,333

1,200

2,050

2,106

45.6

45.5

23.7

36.5

48.5

56.6

57.9

58.3

1.2

1.1

1.7

1.5

1.6

2.0

1.6

1.7

4,562

.,.

570

885

611

559

964

973

56.2

56.1

30.4

49.4

63.2

69.3

66.3

62.5

1.4

1.3

2.3

2.2

2.7

2.2

1.9

2.2

5,235

,..

634

1,017

722

641

1,086

1,135

36.3

38.1

i 7.6

25.0

35.6

45.4

50.6

55.0

1.2

1.1

1.7

1.4

1.9

2.5

2.4

1.8

4,563

..!

542

875

626

546

973

1,001

37,2

36.7

17.9

25.1

36.4

46.2

51.0

57.0

1.2

1.2

1.6

1.6

2.2

2.9

2.2

1.7

8,582

. . .

1,036

1,626

1,171

1,052

1,636

1.859

47.0

46.7

24.6

37.2

49.7

58.2

59.1

60.4

1.2

1,2

1.9

1.6

1.8

2.3

1.8

1.6

4,019 58.1

57.9

32.4

50.7

64.6

71.3

68.4

64.8

1,5

1.4

2.7

2.3

2.9

2.4

2.1

2.2

. . .

494

751

545

506

665

858

36.0

37.3

13.1

33.7

49.1

45.5

41.9

40.9

2.8

2.7

●4.1

*4.6

*6.5

*9.2

●5.O

*5.8

561

. . .

77

i 22

64

81

99

118

1,043

. .

142

234

136

128

191

210

31.8

32.8

14.7

27.4

38.4

38.2

42.1

40.3

2.0

2.0

2.8

2.9

3.9

● 6.4

*5.2

4.7

462 28.6

29.5

16.0

22.6

30.7

32.8

42.2

39.9

2.5

2.5

*4.8

*4.3

*4.3

*7.3

*8.9

‘6.4

. . .

65

112

54

47

92

92

1Includee data for races not shown separately.

67
Table 33. Percent of persons 20-74 years of age with high density lipoprotein

number of examined persons, and standard error of the percent, by race, age,

(HDL) cholesterol less than 35 milligrams per deciliter,

and sex: United States, 1976-60

Both sexes Men Women

Number of Standard Nbmber of Standard Number of Standard

examined error of the examine d error of the examined

Race and age persons Percent percent

error !of the

persons Percent percent persons Percent percent

All racesl

20-74 years.,,......,,,.. 9,797 11.2 0.7 4,562 16.7 1.0 5,235 6.4 0.6

20–74 years, age adjusted, 11.2 0.7 16.7 0.9

20–24 years . . . . . . . . . . . . 1,204 8.2 1.1 570 10.7 1.6

25–34 years . . . . . . . . . . . . 1,902 11,1 0.9 sa5 16,0 1.4

35-44 years . ., ..,,..... 1,333 11.9 1,3 611 18.3 2,3

45–54 years,........,., 1,200 11,5 1,0 559 18,5 1,8

55–64 years . . . . . . . . . . . . 2,050 12.4 0,9 964 18.4 1.5

65–74 years . . . . . . . . . . . . 2,106 12.1 1.1 973 19.4 2.1

White

20-74 years,..,,,,...,,,,

20–74 years, age adjusted.

20–24 years,,,......,,,

25–34years, , ..,,...,,,

35-44 years, , . . . . . . . . . .

45–54 years,,,.,,,..,,,

55–64 years, ,, . . . . . . . . .

65–74 years ., . . . . . . . . . .

Black

20–74years .,.......,,,..

20-74 years, age adjusted. .

20-24 years.......,,,..

25–34years . . . ...,,,...

35-44 years . . . . . . . . . . . .

45-54 years . ., ..,,,....

55–64 years.....,,..,.,

65–74 years.....,,..,..

6,582

1,036

1,626

1,171

1,052

1,636

1,659

1,043

142

234

136

126

191

210

11.6

11.6

9.0

11.2

12.1

11.6

13.0

12.8

7,3

7,3

2,1

9.8

9.9

7,5

6.7

4.8

0.7

0.7

1.3

1.0

1.4

1.0

1,0

1.2

1,2

1,3

1,1

2.0

1.6

*2.7

*2,3

1.6

4,019

.

494

751

545

506

665

858

462

.

65

112

54

47

92

92

17.5

17.5

11.6

16.6

16.6

18.9

19.4

20,5

9.0

9.3

1.5

9.6

13.0

12.4

8.9

9.1

1.1

1.1

1.8

1.6

2.5

1.8

1.8

2.2

1.8

1.8

*1.4

*2.6

*3.5

*5.5

*3.6

*3.5

. . 6,4 0.6

634 6,0 1.1

,017 6.7 0.8

722 6.3 0.7

641 5.4 0.6

,066 7.2 1.0

,135 6.5 0.6

4,563

542

675

626

546

973

1,001

561

. . .

77

122

84

81

99

118

6.3

6.3

6.3

6.1

6.3

5,2

7.3

6.9

6.0

5.9

2.6

10.0

7.6

3.9

5.2

1.8

0.6

0.8

1.3

0.9

0,9

1,0

1,0

0.7

1,2

1.2

*1 .6

*2,7

*1 ,4

*1,8

*2.2

*1.1

1Includes data for races not shown separately,

NOTE:35 milligram per deciliter (mg/dl) = 0,9051 millimoles per liter (mmol/L)

68
Table 34. Percent of persons 20-74 years of age with desirable, borderline-high and high serum total cholesterol levels, number of

examined persons, and standard error of the percent, by sex, race, and age: United States, 1976-80

Borderline-high 200-239 mg/d12

Desirable No CHD and no CHD or 2 GHD High

(.:200 mg/dl) 1 2 CHD risk factors risk factors (2240 mg/dl)3

Number Standard Standard

of

Standard Standard

error error error error

examined of the of the

Sex, race, and age

of the

Percent

of the

persons percent Percent percent Percent percent Percent percent

Both sexes

All races:4

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20–24years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20–74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years, . . . . . . . . . . .

3544years . . . . . . . . . . . .

45-54 years, . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . .

20-74 years, aga adjusted. . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Men

AH races:4

2C-74years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54years . . . . . . . . . . . .

55–64years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. , , , .

20-24 years . . . . . . . . . . . .

25-34 years, . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

11,864

. . .

1,414

2,237

1,589

1,453

2,556

2,615

t 0,301

. . .

1,205

1,901

1,379

i ,264

2,262

2,290

1,336

. . .

173

264

173

162

264

260

5,604

,..

676

1,067

745

690

1,227

1,199

4,863

. . .

561

901

653

617

1,066

1,045

42.9

43.5

71.4

60.6

435

26.6

19.1

23.8

42.4

43.3

71.6

60.5

42.8

26.<)

18.6

23.2

47.8

46.5

73.3

62.7

50.7

26.0

24.L

25.~

44,(I

44.3

73.3

56.7

39.1

28.CI

25.9

33.5

43.Ci

44.CI

73.2

56.8

364.

27.SI

25.1

33.cl

1.0

0.9

1.5

1.4

1.5

1.7

1.0

1.1

1.0

0.9

1.6

1.5

1.6

2.1

1.1

1.2

2.5

2.3

5.1

3.6

3.7

4.1

3.9

2.2

1.2

1.1

1,7

2.0

2.2

2.2

1.6

1.6

1.2

1.1

1.9

2.1

2.2

2.4

1.8

1.6

16.4

16.4

16.5

16.2

16.7

17.2

15.6

12.6

16.5

16.5

16.1

16.0

19.4

17.3

16.1

13.0

12.9

12.7

17.4

15.0

12.6

10.6

10.1

8.0

10,8

10.8

10.3

12.0

13.3

10.3

10.0

6.0

10.8

10.8

9.3

11.9

13.7

10.3

10.5

6.2

0.5

0.5

1.1

0.8

1.4

i .3

0.7

0.8

0.4

0.4

1.1

0.8

1.5

1.3

0.6

0.8

1.4

1.4

4.1

2.7

3.5

3.0

3.3

1.5

0.6

0,6

1.3

1,2

1.8

1.4

1.0

0.7

0.7

0.7

1.4

1.3

1.7

1.5

1.1

0.9

13.9

13.8

5.7

9.7

13.7

17.5

19.9

20.9

13.9

13.7

6.1

9.6

13.5

17.2

19.4

20.3

15.5

16.0

4.1

9.0

16.5

22,8

24.1

27.3

20,3

20.3

10.2

16.0

19.7

24.9

27.3

28.7

20.7

20.6

11.4

16.3

20.0

25.2

27,1

28.5

0.4

0.4

0.7

0.7

1,0

0.9

0.9

0.9

0.5

0.4

0.8

0.8

1.0

1.0

1.1

0.9

0.9

0.8

2.3

1.3

3.5

3.6

2.6

3.4

0.6

0.6

1.2

1.4

1.5

1,5

1,4

1.3

0.7

0.7

1.5

1.6

1.6

1.5

1,6

1.4

26,8

26,3

6,4

13.5

24.1

38,7

45.3

43.0

27.2

26.5

6.3

13.6

24.4

38,6

45.9

43,6

238

24,7

5.2

13,4

20.3

405

414

39,3

24.9

24,6

6.2

15,3

27,9

36,9

36,8

31.7

25.0

24.6

6.1

15,0

27.9

36.5

37.3

32.4

0.8

0.8

0.8

0.9

1.3

1.6

1.5

1.5

0.9

0.8

0.9

1.0

1.4

1.6

1.6

1.5

2.1

1.9

1.2

2.2

4,4

5.5

3.3

2,9

0,9

0,9

1.2

1.3

1.9

1.9

1.8

1.8

0.9

0.9

1.3

1,5

1.8

1.9

2.0

1.9

69
Table 34. Percent of persons 20-74 years of age with desirable, borderline-h!lgh and high serum total cholesterol levels, number of

examined persons, and standard error of the percent, by sex, race, and age: United States, 1976-80–Con.

Borderline-high 200-239 mg/d/2

Desirab/e No CHD and no CHD or 2 r3HD High

(<200 mg/d/) i 2 CHL) risk factors riskfactors (> 240 mgldl)3

Number

—

Standard Standard Standard Standard

of error error error

examined

error

of the of the

Sex, race, and age

of the

persons

of the

Percent percent Percent percent Percent percent Percent percent

—

Men–Con,

Black:

2&74 years, . . . . . . . . . . . . .

20-74 years, age adjusted,

20-24 years, . . . . . . . . . . .

25-34 years ., . .,,,....,

35-44 years, . . . . . . . . . . .

45–54 years ., .,, ,. ...,.

55–64 years,,,.,,,..,.,

65–74 years...,,....,..

Women

All races:4

20–74 years,,,,,....,.,,,

20-74 years, age adjusted.

20-24 years,....,..,,,.

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54 years . ., ..,,....,

55–64 years,.,..,,..,.,

65–74 years, .,, ...,..,.

White:

20–74 years .,, ,, . . . . . . . . .

20-74 years, age adjusted.

20–24 years,,.......,,.

25-34 years..,.....,,,.

35-44 years . . . . . . . . . . . .

45-54 yeara . . . ...,,,..,

55–64 years, . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

Black:

20-74 yaars. ,,, ,, . . . . . . . .

20-74 yaars, age adjusted. .

20–24 years . . . . . . . . . . . .

25-34 years, , . . . . . . . . . .

35-44 years,,.......,,.

45–54 years,,..,,...,,.

55-64 years,....,...,..

65-74 years........,,..

607

79

139

70

62

129

128

6,260

736

1,170

844

763

1,329

1,416

5,418

.,.

624

1,000

726

647

1,176

1,245

729

94

145

103

100

135

152

49.5

48.7

78.2

58.1

47.4

27.9

35.0

37.2

42.0

43.0

69.6

64.4

47.8

25.3

13,0

18,0

41.4

42.6

69.9

64.1

46.8

25.9

12.7

15.6

46,4

44,8

69.5

66.3

53.2

24,4

15.5

16.6

2.5

2.4

‘5.1

*4.4

*6.7

*6,3

*4,3

4,6

1,1

1.0

2.2

1.6

2.1

2,3

1,0

1.2

1.2

1.0

2.2

1.7

2.4

2.7

1.1

1,3

3.3

2.9

*6.4

*4.5

‘4.6

*5.5

*5.O

3.6

8,1

7,7

15,8

8.0

8.0

7.6

2.0

3.8

21.5

21,5

22,3

20.2

23.7

23,7

20.6

17.6

21,8

21,6

22.6

20.0

24.6

24.0

21.2

18.1

16.6

16.7

18.6

20,5

16,2

13,2

16.9

11.2

1.2

1,2

*3.5

●2.4

*3.8

*3.2

*1.1

2.1

0,7

0,7

1.7

1.0

1,6

1.9

1.4

1.3

0.7

0.7

1,9

1.2

2.0

2.0

1.5

1.3

2.1

2.1

‘6.1

*4,0

*5.6

*3,7

*6.O

2.6

18.6

19.2

3.1

14.5

20.1

24.2

27,7

31.9

8.1

7.9

1.5

3.7

8.1

10,5

13.4

14.9

7.6

7.3

1.0

3.6

7.5

9.6

12.5

14.1

13.0

13.5

4.9

4.6

13.7

21.7

21.2

23.8

1.5

1.6

*2.3

*2.3

‘8.0

*4.3

*3,8

3.8

0.5

0.5

0.5

0.6

1,0

1.1

1.2

1.2

0.5

0.5

0.4

0.8

1.0

1.1

1.3

1.0

1.6

1.4

*2.8

*1 .7

*4.6

*5.2

*3.7

6.0

23.9

24,4

2,9

19.3

24.5

40.3

35.3

27.2

28.5

27.6

6.6

11.8

20,7

40.5

52.9

51.6

29,2

28.0

6.5

12.4

21.1

40.6

53.7

52.1

23.7

25.0

7,0

8.7

16.9

40.7

46.5

46.4

2.2

2.2

*1 ,6

*3.6

*7.5

*9. O

*4.8

3.9

1.0

0,9

1.0

1.0

1.8

2,3

2,0

1.8

1.0

0.9

1.2

1.1

1,9

2,7

1,9

2.0

2.7

2.5

*2.3

*3.1

*5.5

*7.3

*6.2

4.9

1Less than 5.17 mmol/L,

25.17-6,20 mmol/L.

3Greater than or equal to a.21 mmoUL.

41ncludes data for races not shown separately.

NOTES:Groups based on National Cholesterol Education Program Guidelines published in Arch, Int, Med.: 148(1):35-69, 1988, 6ee appendix IV for definition of risk variables. CHD IS coronary

heart disease; mgldl Is milligrams per declllte~ mmol/L is millimoles per titer. Excludes prsgnant, Iaclating, and menopausal females.

70
Table 35. Percent of women 20-44 years of age with desirable, borderline-high and high serum total cholesterol levels, number of

examined persons, and standard error of the percent, by race, oral contraceptive use, and age: United States, 1976-80

Borderline-high 200–239 mg/d12

Desirable No CHD and no CHD or 2 f2HD High

(<200 mgldo 1 2 CHD risk factors risk factors (2240 mgldl)3

Number Standard Standard Standard Standard

of error error error error

Race, oral contraceptive use, examined of the of the

and age

of the of the

persons Percent percent Percent percent Percent percent Percent percent

All races4

Nonusers:

20-44 years . . . . . . . . . . . . . .

20-44 years, age adjusted. .

20-29 years . . . . . . . . . . . .

30-44 years . . . . . . . . . . . .

Recently discontinued users:

20-44 years . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . .

20-29 years . . . . . . . . . . . .

30-44 years . . . . . . . . . . . .

Users:

20-44 years . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . .

20-29 years . .’ . . . . . . . . . .

30-44 years . . . . . . . . . . . .

White

Nonusers:

20-44 years . . . . . . . . . . . . . .

20+4 years, age adjusted. . . . .

20-29 years . . . . . . . . . . . .

3044years . . . . . . . . . . . .

Recently discontinued users:

20-44 years . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . .

20–29 years . . . . . . . . . . . .

30+4yeara . . . . . . . . . . . .

Users:

20-44 years . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . .

20–29years . . . . . . . . . . . .

30-44 years . . . . . . . . . . . .

Blacks

Nonusers:

20-44 years . . . . . . . . . . . . . .

20-44 years, age adjusted. . . . .

20–29years . . . . . . . . . . . .

30-44 years . . . . . . . . . . . .

Users:

20-44 year3. . . . . . . . . . . . . .

20-44 years, age adjusted. . . . .

20-29 years . . . . . . . . . . . .

1,693

,..

746

947

160

. .

118

42

504

. . .

378

126

1,441

. . .

628

813

134

. .

98

38

433

. .

318

115

209

. .

94

115

64

. .

55

64.7

65.6

74.2

57.5

66.4

64.6

68.6

‘60.8

54.5

50.5

58,0

43,4

65.3

66.4

75.4

57.9

66.6

64.5

69.3

*60.O

52.8

48.2

57.3

39.6

61.8

62.3

68.4

56.5

64.8

66.9

64.1

1.3

1.2

1.4

2.0

4.5

4.6

5.9

*7.9

2.6

3.2

2.7

5.4

1.4

1,4

1.7

2.1

5.1

5.4

6.3

●9.1

2.7

3.0

3.0

*4.9

3.6

3.9

4.8

*4.5

9.4

11.6

*9.4

20,2

20.1

18,4

21.6

1.0

0.9

1.4

1.4

4.8

4.6

2.6

6.6

0.5

0.5

0.6

0.9

10.2

9.7

4.8

14.3

0.6

0.8

0.9

1.3

3.1

4.2

2.7

*7.7

18.6

16.7

21.1

*12.5

3.5

3.1

4.6

*4.2

3.8

4.5

3.0

*5.9

1.6

2.3

1.3

‘4.3

11.2

14.2

7.3

*20.7

15.1

17.6

12.8

22.2

1.8

3.0

1.4

5.7

27.3

27.3

27.3

27.4

2.3

2.9

2.4

4.7

3.1

4.5

1.6

7.1

0.6

1.3

0.7

2.1

1.1

1.1

1.7

1.6

4.4

4.2

2.2

6.0

0.6

0.5

0.7

0.9

10.1

9.5

4.6

14.2

0.9

0.6

0.9

1.4

20.1

19.9

17.8

21.9

3.6

4.7

3.3

*8.7

16.3

17.1

19.9

●14.4

3.7

3.4

4.6

●4.6

4.0

4.9

2.6

*6.8

1.7

2.6

1.4

*5.O

11.2

13.5

8.0

*1 8.7

0.8

1,3

0.6

*2.3

16.0

18.8

13.3

24.1

2.1

3.2

1.7

‘6.0

28.1

28.3

28.0

26.5

2.4

2.9

2.7

*5.O

3.0

4.7

1.4

7.9

17.7

17.7

17.7

17.8

3.3 9.0 2.6 11.5 2.6

3.3 8.8 2.6 11.2 2.7

3.9 6.0 2.7 7.8 2.7

*3.9 11.3 *3.7 14.4 *4.5

23.1

23.3

23.1

7.6 4.1 3.0 6.0 3.7

10.7 2.3 1.7 7.5 4.6

*7.4 4.7 *3.4 8.1 *3.8

1Less than 5.17 mmol/L

25.17_3.20 ~mOI/L

3Greaterthan or equal to 6.21 mmoVL.

41ncludes data for races not ahown separately.

5Data not given separately for black recently discontinued users nor for black oral contraceptive users 30-44 years of age because of small sample size.

NOTES: Groups basad on National Cholesterol Educalion Program Gu]delinea published in Arch. lnt. Med.: 148(1):36-69, 1988. See appendix IV for definition of risk variables. CHD is coronary

heart disease; mgldl is milligrams per decilitec mmol/L ia millimoles per Mer. Excludes pregnant, lactating, and menopausal females.

71
Table 36. Percent of persons 20-74 years of age with desirable, borderline-high-risk, and high-risk low density lipoprotein (LDL)

cholesterol values as a percent of the total number needing lipoprotein analysis, number of examined persons, and standard error of the

percent, by sex, race, and age: United States, 1976–80

Borderline-high risk (130– 159 mg/dl) 2

Desirable No CHD and no CHD or 2 CHD High-risk

(< 130 mg/dl) 1 2 CHD risk factors risk factors (2 160 mg/dl)3

Number .SWndard Standard Standard Starrcfard

of error error error error

examined of the of the of the

Sex, race, and age Percent

of the

persons percent Percent percent Percent percent Percent percent

Both sexes

All races:4

20-74 years .,, , . . . . . . . . . .

20-74 years, age adjusted.

20-24 years.,..,,.,,,,,

25–34years ...,,,,,,,,.

35-44 years, . . . . . . . . . . .

45–54years, , .,,,.,,,,.

55–64years ., .,, ...,..,

65-74 years . . . . . . . . . . . .

White:

20-74 years, . ., . .,,,,..,.

20-74 years, age adjusted, .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54 yeara . . . . . . . . . . . .

55-64 years.....,...,..

65–74 years . . . . . . . . . . . .

Black:s

20–74 years . . . . . ...,,..,,

20-74 years, age adjusted.

Men

All races:4

20-74 years..,,..,.,,.,,.

20–74 years, age adjusted.

20–24years . . . . . . . . . . . .

25-34 years,.......,,..

35+4 years.......,,,..

45-54 years,....,,,,,,,

55-64 years,......,.,..

65-74 years . . . . . . . . . . . .

White:

20–74 years . . . . . . . . . . . . . .

20–74 years, age adjusted,

20-24 years . . . . . . . . . . . .

25–34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54 years...,,,,,,,,.

55–64 years, .,, ,. .,..,.

65–74 years . .,, ,, . . . . . .

Black:5

20-74 years . .,, ,, . . . . . . . .

20-74 years, age adjusted.

1,084

17

83

105

146

339

394

953

.,.

16

73

94

126

297

347

115

526

11

50

63

61

167

174

476

,..

11

44

59

55

150

157

44

.

6.1

6.2

*

4.6

5.2

5.4

8.4

5.2

5.8

6.2

*

5,0

4,4

4.2

8.3

5.6

9.6

7.2

7,0

7.7

*

4.1

5.1

5.6

10.3

6.9

6,5

7,3

*

*4,5

3,4

3,8

10,6

7.5

‘14.1

*12.2

0,9

1.3

.

2.0

2,4

2,2

2,3

1,4

0.8

1,3

*

‘2.2

2,2

1,7

2.5

1.5

*6.2

*4.8

1.5

2,1

*

*2,3

3,0

3,0

3,8

1.8

1.4

2.0

*

*2.4

2.5

2.2

4.1

1.9

*1O.7

*6.2

5.7

6.3

*

3.4

7.7

6.8

6,2

3,1

5.9

6.8

*

3.7

8.5

7.4

5.9

3.0

2,9

1,6

2.0

2,6

*

1.2

3.0

0.0

4,0

0,6

1.9

2.5

*

‘1.3

3.2

0.0

3,1

0.6

●4, 1

‘2.9

0.6

1.3

*

1.9

3,2

2,3

2,0

0.9

0,9

1.4

*

‘2.1

3.5

2.9

1.9

0.9

*1.4

‘0.8

0.6

0.9

*

‘1.1

2.1

0.0

2,2

0.6

0,7

0.9

*

‘1.2

2.2

0.0

2.2

0.6

*3.2

*2.O

25.5

24.8

*

34.5

25.1

22.2

24.5

27.4

25.8

25.2

*

35,1

24.9

23.7

23.6

28.2

24.9

25.1

33.0

31.5

*

39,6

27,6

35.3

31.3

35,0

32,9

31,6

*

‘40.0

27.3

36.8

30.9

34.0

*33. 1

*33,8

1.5

1.9

*

5.2

4.1

2.9

3.0

3.0

1,7

2.1

*

‘6,0

3.8

3.6

3.2

3.1

*3.8

*5.8

2,4

3.0

*

*6.2

4,4

6.4

4,4

4,0

2.6

3.2

*

*9.2

4.4

7.0

4.9

4.2

‘9.0

*9.7

62.7

62.6

*

57,6

61.9

65,6

61.0

64.4

62.4

61.9

*

56.2

62.2

64.7

62.2

63.2

62.6

66.1

58.1

56.2

*

55.0

64.3

59.1

54.4

57.5

56.7

58.6

*

*54.3

66.1

59.4

55.4

57.9

*48,7

‘51.1

1.9

2.3

*

5.0

5.9

3,8

4.0

3.1

2.0

2.4

*

*5.7

5.8

4.4

4.2

3.1

*5,7

*7,4

2.3

3.4

*

*7,3

5.7

5.9

4.4

4,2

2,5

3.5

*

*8.3

5.7

6.4

4.8

4.5

*1O.O

‘11.3

72
Table 36. Percent of persons 20-74 years of age with desirable, borderline-high-risk, and high-risk low density lipoprotein (LDL)

cholesterol values as a percent of the total number needing lipoprotein analysis, number of examined persons, and standard error of the

percent, by sex, race, and age: United States, “1976-60-Con.

Borderline-high risk (130- 159 mg/dl) 2

Desirable No CHD and no CHD or 2 CHD High-risk

(< 130 mg/dl) 1 2 CHD risk factors risk factors (> 160 mg/dl)3

Number Standard Standard Standard Slandard

of error error error error

examined of the of the of the

Sex, race, and age Percent

of the

persons percent Percent percent Percent percent Percent percent

Women

All races:4

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20–24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

558

,.,

6

33

42

85

172

220

477

. .

5

29

35

71

147

190

5.2

4.6

*

*5.2

*5,4

5.2

6,8

3.8

5.2

4.7

.

*5.9

*6.1

4.6

6.2

4.1

1.1

1.2

*

●3.7

‘4.0

2.4

2.3

1.6

1.1

1.4

*

*4, 1

‘4,4

2.5

2,5

1,7

9.2

10.7

*

*6.7

●15.O

11.8

8.0

4.9

10,1

12.1

*

‘7.5

*1 8.9

13.3

8.4

4.9

1.4

2.8

*

*4.6

*6.5

4.0

3.0

1.6

1.7

3.2

*

●5.2

●7.5

5.3

3.1

1.6

16.5

17.8

*

●26.7

*2 I .4

12.7

18.7

21.8

18.7

17.9

*

*27.2

*21.1

13.1

17.1

23.5

1.8

2.2

*

*8.O

*6.8

3.0

4.4

3.6

2.1

2.5

*

*8.3

‘7.0

3.3

4.7

3.9

67.1

67.0

*

*6 I .4

*58.3

70.4

66.5

69.4

66.1

65.2

*

*59.4

*55.9

69.0

66.3

67.5

2.3

3.5

*

*10.6

*8.6

4.7

5.5

3.6

2.6

3.9

*

‘11.5

‘8.5

5.6

5.9

3.5

Black:5

20-74 yeara . . . . . . . . . . . . . . 71 7.2 *3.9 2.2 ‘1.3 20.3 *4.2 70.3 *5.4

20-74 years, age adjusted. ,,. 4.0 *2.2 1.0 ‘0.6 24.2 *7,5 70.8 *8,5

lLess than 3.36 mmol!L

23,36-4.13 mmol/L

3Grea!er lhan or equal to 4.14 mmoliL

41ncludes da!a for races not shown separately.

5Dala not gwen separately for black adults by age because of sm$ II sample S!ZC.

NOTES: Groups based on Natronal Cholesterol Educalmn Program Gu,dehnes publshed n Arch. M Med.: 148(1):36-69, 1988, See append~ IV for de!:rutmn of risk var(ables. mg!dl E

mill! grams per dec!hlen mmollL IS m!lhmo!es per hter. LDL cholesterol = serum total cholesterol - high densty hpcprotem cholesterol - tr,glycendei5, Equa! ton from Friedewalcf, Wr, et al, Clm.

Chem (18):499-502, 1972. Feraons v:lh a scum triglyceride value greater Ihan 400 mgldl (4.52 mmol/L) were excluded. Excludes pregnant, lac!atmg, and menopausal females.

73
Table 37. Percent of persons 20-74 years of age with desirable, borderline-high-risk, and high-risk low density lipoprotein (LDL)

cholesterol levels as a percent of the total U.S. population and number of examined persons, by sex, race, and age:

United States, 1976-80

Borderline-high-risk

(130-159 mg/dl)2

Number of —

examined Desirable No CHD and no CHD or 2 CHD High risk

Sex, race, and age persons (c 130 mg/d!) 1 2 CHD risk factors risk factors (Z 160 mg/dl)3

Both sexes

All races:4

20–74years, , .,,,.,,,,.,,,,. .,, ,,,

20-74 years, age adjusted.

20–24years . . . . . . . . . . . . . . . .

25-34 years.,.,,,,,,.,.,,., ,,, ,.

35-44 years . . . . . . . . . . . . . . . . . .

45-54 years .,, ,, . . . . . . . . . . . . .

55–64 years, . . . . . . . . . . . . . . .,, ,,.

65-74 years . . . . . . . . . . . . . . . .

White:

20–74years . . . . . . . . . . . . . . . . . .

20-74 years, age adjusted,

20-24 years......,,....,.. . . .

25-34 years, . . . . . . . . . . . . . . . ,,,

35-44 years . . . . . . . . . . . . . . . . . .

45–54years, . . . . . . . . . . . .

55–64years . . . . . . . . . . . .

65-74years . . . . . . . . . . . . . . ..,,...

Black:3

20–74years, . . . . . . . . . . . . . . . .

20–74years, age adjusted,

Men

All races:3

20–74years . . . . . . . . . . . . . . . . . . . .

20-74 years, age adjusted..

20–24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . .

45–54 years,.,,,,..,.,., ,,

55–64years . . . . . . . . . . . .

65–74years . . . ...,,,...

White:

20–74yaars. . . . . . . . . . . . . .

20–74years, age adjusted.

20–24years ..,,,....,.,,,

25–34years . .,, ,. ...,.,, . . . . . . .

35-44years . .,, ,. . . . . . . . . . . . . . .

45-54years . . . . . . . . . . . . .

55–64years . .,, ,. . . . . . . . . . . . . . .

65–74years . . . . . . . . . . . . . . . . . . .

Black:4

20-74years. .,, . . . . . . . . . . . . . . . . . .

20-74 years, age adjusted..

1,084

17

63

105

146

339

394

953

16

73

94

126

297

347

115

,,.

526

,..

11

50

63

61

167

174

476

11

44

59

55

150

157

44

,,.

2,5

2.5

,,

1,”1

2.0

3.0

5.5

3.3

2,4

2,4

*

1,2

1.7

2,4

5.4

3.6

3.8

4.0

3.2

3.2

*

1.3

2,4

3,5

6.6

4,2

3,0

3,0

*

*I ,4

1.6

2,3

6.8

4.6

‘6.0

*6.O

2.3

2,3

*

0.8

2.9

3.8

4.0

2.0

2.4

2,5

*

0.9

3,2

4,1

3.8

1.9

1.1

1.0

0.9

0.9

*

0.4

1.4

0.0

2.5

0.3

0.9

0.9

*

*0.4

1.6

0.0

2.0

0.4

*I .7

*1 .5

10.4

10.2

*

8.0

9.5

12.5

16.0

17.5

10.6

10,3

*

8.2

9.4

13.2

15.4

18.0

9.a

10.5

14.9

14.7

*

12.4

13.1

21.8

20.0

21.2

15.0

14.8

*

*12.5

13.1

22.7

19.9

20.7

*14.O

*14.4

25.5

25.1

*

13.3

23,4

36.9

39.8

41.1

25.6

25.0

*

13.2

23.6

36.1

40.6

40.4

24.6

25.0

26.2

26.1

*

17.2

30.6

36.5

34.9

34.8

26.8

26.5

*

*1 7.0

31.6

36.7

35.7

35.2

*20.7

*21 .2
Table 37. Percent of persons 20-74 years of age with desirable, borderline-high-risk, and high-risk low density lipoprotein (LDL)

cholesterol levels asapercent of the total U.S. population and number of examined persons, by sex, race, and age:

United States, 1976-60-Con.

Borderline-high-risk

(130-159 mg/dI) 2

Number of

examined Desirable No CHD and no CHD Of 2 CHD High risk

Sex, race, and age persom (< 130 mg[dl) 1 2 CHD risk factors risk factors (2 160 mg/dl)3

Women

All races:4

20-74 years . . . . . . . . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . . . . .

20-24 years . . . . . . . . . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . . . . . . . . . .

65-74years . . . . . . . . . . . . . . . . . . . . .

White:

20-74years . . . . . . . . . . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . . . . . . .

20-24years . . . . . . . . . . . . . . . . . . . . .

25-34years . . . . . . . . . . . . . . . . . . . . .

35-44years . . . . . . . . . . . . . . . . . . . . .

45-54years . . . . . . . . . . . . .

55-64years . . . . . . . . . . . . . . . . . . . . .

65-74years . . . . . . . . . . . . . . . . . . . .

Black:s

20-74years, . . . . . . . . . . . . . . . . . . .

20-74years, age adjusted. . . . . . . .

558

6

33

42

85

172

220

477

,.,

5

29

35

71

147

190

71

1.9

1.8

*

‘0.8

*1.5

2.6

4.5

2.6

1.9

1,8

*

●0.9

*1.7

2,3

4,1

2.7

2.6

2,6

3.4

3.3

*

*1 .0

*4.3

6.0

5.3

3.3

3.7

3.7

*

*1.2

*4.8

6.7

5.6

3.3

0.8

0.7

6.7

6.6

*

*4. 1

*6.1

6.5

12.4

14.5

6.9

6.6

*

*4.3

●6.O

6.6

11.3

15.5

7.4

8.5

24.5

23.7

*

*9.5

*1 6.7

35.9

44.1

46.2

24.3

23.2

*

*9.5

*1 6.0

34.6

45.1

44.7

25,8

26.6

1Less than 3.36 mmol/L.

23.3s-4. 13 mmol/L

3Greaterthan or equal to 4.14 mmoVL

41ncludes data for races not shown separately.

5Date not gwen separately for black adults by age because of small SamPle SZe.

NOTES+ Groups based on National Cholesterol Educatmn Program Gudelines pubI,shed m.4rch. lnt. Med.: 148(1):3-69, 19E8. Seeappend[x i`Jfordefinlt onofr4sk varables.C HDiscoronav

heafld!sease; mg/dl!s m!ll!grams perdectl!!ec mmol)Lls ml[l!moles perlzler. LDL cholesterol = serum lotalcholesterol -h!ghdensi~ lpoprofe!nc holesterolt rlglycer!dei5. Equahon from

Friedewa[d, WT,etal. Clm Chem (18]:499-502, 1972. Persons \,/,tha serum trigfycerdev aluegreatert hzn4GOm g/dl(4.52m mof'L)wereexcluded

75
Table 38. Percent of persons 20-74 years of age who did not need lipoprotein analysis with desirable, borderline-high-risk, and high-risk

low density lipoprotein (LDL) cholesterol levels, and number of examined persons, by sex, race, and age: United States, 1976-80–Con.

Borderline-high-risk (130-159 mg/dl) 2

Desirable No CtfD and no CHD or 2 CHD High-risk

(c 130mg/d/71 2 CHD risk factors risk factors (2 160 mg/di)3

Number Standard Stendard Standard Standard

of error error error

examined

error

of the of the of the

Sex, race, and age

of the

persons Percent percent Percent percent Percent percent Percent percent

—

Both sexes

All races:4

20-74 years, ., ., ..,.,....

20–74 years, age adjusted,

20-24 years...,,,,,,,,,

25-34 years, . . . . . . . . . . .

35-44 years...,,,,..,.,

45-54 years.........,.,

55–64 years . . . . . . . . . . . .

65–74 years ., . . . . . . . . . .

White:

20-74 years .,, . . ...,.....

20–74 years, age adjusted. .

20–24 years ., .,, ,. ...,.

25–34 years..,,,.,..,.,

35-44 years, .,, ,., . . . . .

45-54 years...,,.,..,.,

55–64 years . . . . . . . . . . . .

65–74years ., . . . . . . . . . .

Black:5

20-74 years, . . . . . . . . . . . . .

20-74 years, age adjusted.

Men

All races:4

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted,

20-24 years . ., ..,,,..,.

25-34 years, .,, .,,,,...

35S44 years . . . . . . . . . . . .

45-54 years.,.,,,,.,,,.

55-64 years . . . . . . . . . . . .

65-74 years . .,, ,, .,,.,.

White:

20-74 years . . . . . . . . . . . .

20-74 years, age adjusted

20-24 years . ., .,,.,..,,

25–34 years .,, . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years, . . . . . . . . . . .

55-64 years, . . . . . . . . . . .

65–74 years,...,,...,,.

Black:s

20-74 years.........,,,..

20-74 years, age adjusted,

1,199

,..

160

285

191

128

210

225

1,037

.,,

130

250

163

113

183

198

136

511

61

124

67

45

100

114

430

46

102

56

41

86

99

70

69.2

68.3

78.7

73.2

68.5

61.6

61.9

61.1

69.2

68.4

78.7

72.9

70.1

62.3

61.8

58,8

70.8

70,7

72.6

72.5

85.8

71.4

68.4

65.7

71,7

75.2

72.4

72,9

89.6

69.3

71,6

“66.9

69.0

74,8

72,1

72.3

1.7

1.6

3.5

2.7

4,0

4.5

4.0

3.3

1.6

1.7

3.7

2.8

4,0

4,8

4,2

3,5

*6.9

“7.0

2,2

1.9

4.6

4,4

6,4

‘6.1

5.9

4.4

2.7

2,5

*3.8

4,5

6.9

*6,1

6,3

4,8

*8,7

*7,6

22.7

23,2

16,0

20,3

23.2

29.8

27.8

24.4

23.3

23.7

16,2

20,9

24.0

31.4

26.8

24.9

17,1

17.1

17.6

17.4

9.0

21.7

17.5

23.5

16.2

8,3

18,3

17.6

3.4

23.7

17.9

*26.1

20.2

6.1

13,1

10,7

1,4

1.4

3.2

2.5

2,8

4.3

4,4

3.2

1.4

1.4

3.3

2.6

3.1

4,5

4,1

3.3

‘4,1

*4,4

2,0

1.9

4.2

4.2

4.4

‘5.6

4.5

3.0

2.3

2.1

●2,4

4,6

4,6

“6,0

4,8

2,6

*4,6

*3,6

3.5

3.6

2.6

2.9

3.5

1.7

4.7

7.8

3.1

3.2

3.2

2.8

1,8

0.0

6,0

8.7

7.6

8.7

6.5

6.5

4.1

5.6

7.7

4.5

6.7

12.9

5,8

5,8

5.5

5.4

5,2

‘0.0

7.0

14.9

12.0

14.3

0.6

0,6

1,0

1,1

1,3

1.7

2.1

2.4

0.6

0.7

1,2

1.1

1.3

0.0

2,3

2,7

*3,6

*3,9

1.3

1.2

2.4

2.3

3.6

*4.3

3.5

3.9

1.4

1.3

*3.2

2.4

3.6

‘0.0

3.9

4.5

*6.5

*5,6

4.6

4,8

2,7

3.5

4,9

6.9

5.6

6.8

4.4

4.6

1.9

3.4

4.0

6.3

6.4

7.6

4.6

3.5

3.4

3.6

1.1

1.3

6.4

6.4

3.5

3.6

3.5

3.7

1.5

1.6

5.2

“7.1

3.8

4.2

2.8

2.6

0.7

0.7

1.3

0.8

1.9

2.5

1.8

1.8

0.7

0.7

1,2

0,9

1,5

2A

2.1

1.!3

*2.1

*1 .6

1,0

1.1

1.2

1.0

4.1

*3.6

1.4

1.6

1.0

1.0

*1 ,6

1.2

2.9

*3,9

1.5

1.9

*2.8

“2.4

76
Table 38. Percent of persons 20-74 years of age who did not need lipoprotein analysis with desirable, borderline-high-risk, and high-risk

low density lipoprotein (LDL) cholesterol levels, and number of examined persons, by sex, race, and age: United States, 1978-80-Con.

Borderline-high-risk (130- 159 mg/df) 2

Desirab/e No CHD and no CHD or 2 CUD High-risk

(< 130 mg/d~ 1 2 CHD risk factors risk factors (> 160 mgldi)3

Number Standard Standard Standard Standard

of error error error error

examined of the of the of the

Sex, race, and age

of the

persons Percent percent Percent percent Percent percent Percent percent

All races:4

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

2S34years . . . . . . . . . . . .

3544years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

688 66.9

65.2

75.1

74.7

6&5

58.9

53.6

4&7

1.8

1.7

4.2

2.8

4.1

5.7

6.3

4.9

26.2

27.5

19.5

19.2

26.4

33.8

36.0

38.5

1.7

1.8

4.2

2.9

3.5

5.4

6.7

4.4

1.4

1.5

1.9

0.8

1.1

0.0

3.1

3.3

0.5

0.5

1.3

0.8

1.1

0.0

2.0

2.0

5.5

5.9

3.5

5.3

4.0

7.3

7.3

9.5

1.1

1.1

1.9

1.4

1.8

3.3

3.0

3.6

. . .

99

161

124

83

110

111

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20–24years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

3544years . . . . . . . . . . . .

45–54years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

607

...

84

148

107

72

97

99

67.2

65,3

73.7

75.6

69.3

5$1.3

55.3

45.6

1.8

1.8

5.0

3.2

4.2

6.1

6.5

5.2

26.6

27.8

22.0

18.8

27.3

34.9

32.9

40.4

1.8

1.9

4.9

2.9

3.8

5.9

6.2

4.6

1.2

1.4

2.2

0.8

0.0

0.0

3.1

3.6

0.5

0.5

1.6

0.8

0.0

0.0

2,3

2.2

5.0

5.5

2.1

4.8

3.4

5.6

8.7

10.4

1.1

1.4

1.6

1.2

1.7

3.0

3.5

3.8

Black5

20-74 years, . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

66 6~).4

7G.7

*9.5

*7.O

21,1

20.8

*6.4

●5.3

3.2

2.6

*2.4

*1.6

6.3

4.3

*3.O

*1.9

1Less thsn 3.36 mmol/L

23.3w,13 mmo1/L

3Gree,ter than or equal to 4.14 mmol/L

41ncludes data for races not shown separately.

5Data not given separately for blacks by age because Of Small SamPle Size.

NOTES Groups besed on National Cholesterol Edusetion Program guidelines published in Arch. Int. Med.: 148(1):36-69, 19S8. See appendix IV for definition of risk variables. CHD is coronary

heart disease. mgidl is milligrams par dac{litec mmol/L is millimoles per titer. LDL cholesterol = serum total cholesterol - high density hpoprotein cholesterol - triglyceride/5. Equation from

Friedawald, WT. et al. Clin Chem (18):498-502, 1972. Persons with a serum triglyceride value greater than 400 mg/dl (4.52 mmol/L) were excluded.

77
Table 39. Percent of persons 20-74 years of age in the desirable, borderline-high and high serum total cholesterol categories with

hypertension, number of examined persons, and standard error of the percent, by sex, race, and age: United States, 1978-80

.

florcfer//ne-h/gfr Border//ne-high

200-239 mg/dl 200-239 mg/dl

Desirable no CHD and CHD or 2 CHD

(<200 mg/dl) 1 no 2 CHD risk factors2 risk factors2 (22%!ng/dl)3

Number Standard Number Standard Number Standard Number Standard

of error of of error of of error of of error of

examined the examined the examined the examined the

Sex, race, and age persons Percent percent persons Percent percent persons Percant percent persons Percent percent

Both sexes

All races:4

20–74 years . . . . . . . . . . . . . .

20-74 years, age adjusted.

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

White:

20-74 years, . . . . . . . . . . . . .

20-74 years, age adjusted. . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54 years . . . . . . . . . . . .

55–64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . .

20-44 years . . . . . . . . . . . .

45-84 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

Men

All races:4

20–74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. .

20-24 years . . . . . . . . . . . .

25-34 years . . . ...,.....

35-44 years . . . . . . . . . . . .

45–54 years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20–24 years . . . . . . . . . . . .

25–34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54 years . . . . . . . . . . . .

55–64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

Black:

20–74years . . . . . . . . . . . . . .

20–74 years, age adjusted. . . . .

20-44 years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65–74 yeara . . . . . . . . . . . .

4,496

,..

969

1,316

668

365

511

627

3,838

. .

828

1,114

586

334

435

541

565

379

114

72

2,304

464

606

289

198

327

400

1,972

415

509

246

174

262

346

285

178

62

45

20.4

27.6

8.7

10.6

20.1

39.4

49.0

58.9

19.0

25.6

8.5

10.0

16.5

36.8

44.7

50.1

30.1

39.7

20.6

65,7

68.1

25,5

30.4

14.1

16,1

25,5

37.5

51,8

54.5

24,3

28,7

15,0

15,9

21,0

35,6

48,1

53.2

34.4

39,9

25,5

58.8

63.3

1.1

1.1

1.2

1.0

1.9

3.1

2.5

2.3

1.2

1.2

1.4

1.0

1.9

3.3

2.7

2.5

2.6

2.6

2.6

*5.4

●5.7

1.4

1.3

2.1

1.9

2.9

4.0

3.2

2.9

1.6

1.6

2,4

1.9

3.0

4.5

3.4

3.2

3.6

3.3

4.8

*7.5

*7.4

1,741

222

351

272

239

363

294

1,553

186

299

245

213

340

270

141

. .

68

35

18

521

.,.

71

116

90

67

108

69

465

. .

57

98

82

61

103

64

39

. .

29

7

3

9.3

9.7

1.1

0.7

5.3

13.2

17.6

34.1

9.1

9.2

0.8

0.4

5.2

12.0

16.6

34.2

13.1

17.5

4.5

*33.9

*

1.0

0.9

0.6

0.4

1.5

2.6

2.6

3.3

1.1

0.9

0.6

0.3

1.6

2.4

2.6

3.5

*2.5

*3.2

‘2.1

*9.5

*

1,821

76

219

222

252

507

545

1,578

. . .

71

187

195

219

435

471

221

. .

58

97

66

1,218

. . .

66

171

152

168

331

330

1,084

. . .

64

148

139

154

290

289

118

. . .

33

49

36

60,8

55,0

37.9

42.1

49.1

59.4

76.0

82.6

59.4

53.4

34.5

41.9

47.5

57.6

74.6

81.9

69.0

64.4

54.6

75.6

84.6

54.1

50.6

34.6

41.2

46.0

52.4

67.6

76.2

53.6

50.6

34.1

42.0

46.7

51.5

66.5

76.3

52.8

47.6

*34.9

63.9

*69.3

1.8

2.2

5.6

4.7

3.4

3.7

2.3

1.8

1.9

2.3

5.2

5.2

3.7

4.1

2.5

1.9

4.8

5.7

*9.O

*4.5

*5.9

2.0

2.2

*5.5

5.3

4.6

4.3

3.0

3.0

2.0

2.3

*5.7

5.7

4.7

4.5

3.2

3.0

6.1

5.8

*8.6

*8.5

*I 0.2

3,487

. . .

84

266

364

546

1,125

1,096

3,066

. . .

70

229

314

477

1,007

969

362

. . .

al

167

114

1,464

. .

45

159

201

245

435

379

1,265

.,.

38

134

174

218

390

33t

148

. .

42

66

40

47,1

38.8

24.8

25.0

30.9

46.6

56.3

67.5

46.1

37.8

25.9

24.4

28.4

45.3

55.4

66.1

59.3

51.3

37.3

66.9

82.6

48.4

44.7

40.7

33.5

33.8

54.5

57.2

63.0

48.4

45.1

*44.6

34.5

32.3

53.9

57.9

61.3

55.4

51.2

*36.9

63.7

*82.O

1.3

1.9

6.7

3.1

2.6

2.1

2.3

1.9

1.5

2.0

7.0

2.5

2.7

2.1

2.5

2.0

2.3

3.3

*6.3

4.6

3.6

2.2

2.9

*6.5

5.0

3.8

3.5

3.6

3.0

2.3

3.1

*9.5

5.8

4.0

2.9

3.8

3.2

4.7

4.1

*7.7

*9.3

*4.1

78
Table 39. Percent of persons 20-74 years of age in the desirable, borderline-high and high serum total cholesterol categories with

hypertension, number of examined persons, and standard error of the percent, by sex, race, and age: United States, 1976-80-Con.

Borderline-high Borderline-high

200-239 mg/dl 200–239 mg/dl

Desi{ab/e no CHD and CUD or 2 CHD High

(<200 mgldl) 1 no 2 CHD risk factorsz risk factors2 (2 240 mg/df)3

Number Standard Number Standard Number Standard Number Standard

of error of of error of of error of of error of

examined ‘he examined the examined the examined the

Sex, race, and age persons Percent percent persons Percent percent persons Percent percent persons Percent percent

Women

All races:d

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20–74years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55–64years . . . . . . . . . . . .

65–74years . . . . . . . . . . . .

Black

20-74 years . . . . . . . . . . . . . .

2C!-74 years, age adjusted. .

20-44 years . . . . . . . . . . . .

45–64years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

2,192

.

485

710

399

187

184

227

1,866

. .

413

605

340

160

153

195

280

. . .

201

52

27

15.5

25.2

3.3

5.9

15.9

41.5

44.1

66.0

13.8

22.8

1.6

4.9

13.1

38.0

36.7

66.1

26.3

41.0

16.7

74.6

*76.1

1.2

1.4

0.9

1.0

2.1

4.3

3.5

3.4

1.1

1.2

2.7

1.0

2.1

4.0

3.7

3.8

3.1

2.6

3.0

*5,7

*6.7

1,220

. . .

151

235

182

172

255

225

1,068

. . .

129

201

163

152

237

206

102

. . .

59

26

15

13.7

13.3

1.6

1.1

&1

18.6

25.3

43.2

13.3

12.7

1.2

0.6

8.0

17.0

24.0

43.1

18.5

22.7

6.6

*42.9

*

1,4

1.2

0.9

0.6

2.3

3.4

3.4

4.3

1.4

1,2

0.8

0.4

2.4

3.1

3.4

4.6

‘3.3

*3.8

3.2

●12.5

*

603

. . .

10

48

70

64

176

215

494

. . .

7

39

56

65

145

182

103

. . .

25

48

30

76.1

65.4

*

46.4

56.2

74.6

91.3

91.9

73.5

60.3

*

●41 .5

49.4

72.9

90.6

90.4

86.8

64.3

*79.9

87.0

●1OO.O

2.4

4,0

*

*8.5

6.6

5.1

2.6

2.0

2.9

4,5

*

*9.4

*6.6

5,7

3.0

2.3

*4. 1

*6.1

‘10.3

*5.6

*0.O

2,023

.

39

109

163

303

690

719

1,781

. .

32

95

140

259

617

638

214

. .

39

101

74

46.1

31.8

*8.2

12.9

27.4

39.9

55.8

69.7

44.3

29.2

*5.4

10.6

23.6

36.0

53.8

68.4

62.4

51.0

‘35.3

69.4

62.6

1.2

1.3

*5.8

2.6

3.2

2.4

2.6

2.0

1.4

1.4

*3.8

3.2

3.1

2.9

2.9

2.0

4,2

4.4

*6.6

5.1

4.5

1Less than 5.17 mmol/L

26,17-6.20 mmol/L.

3Greater than or equal to a.21 mmollL

41ncludes data for racas not shown separately.

NOTES Groups based on National Cholesterol Edueatmn Program Gu.calines published m Arch. In!. Med.: 148(1):38-69, 1988. See append,x IV for defml]on of risk variables. A person w[th

hypertension is defined by either hawng elevated blood pressure (systohc pressure of at least 140 mmHg or dlastol: pressure of at least 90 mmHg) or taking anl!hypertenswe medication.

Percents are based on the average of three blood pressure read~ngs. Persons missmg any blood pressure read ngs or information on rnedmahon usage were excluded Vom th]s analysis

(n =222). Pregnant women (not missing any blood pressure readings on information on medcatmn usage) were also excluded (n= 97).

79
Table 40. Percent of persons 20-74 years of age in the desirable, borderline-high-risk, and high-risk low density lipoprotein (LDL)

cholesterol categories with hypertension, as a percentage of the total number needing lipoprotein analysis, number of examined

persons, and standard error of the percent, by sex, race, and age: United States, 1976-80

Borderline-high-risk 130-159 mg/d12

Des/rab/e

(< 130 mg/di) 1

Standard

error of

Examined the

Sex, race, and age persons Percent percent

Total

20–74 years, ,, . . . . . . . . . . . 66

20-74 years, age adjusted,

Male

20-74 years, , . . . . . . . . . . . . 36

20–74 years, aga adjusted, . .

Female

2f2-74years . . . . . . . . . . . . . . 30

20-74 years, age adjusted. .,

White

20-74 years, , . . . . . . . . . . . . 59

20-74 years, age adjusted. .,

Black

20–74 years . . . . . . . . . . . . . . 7

20–74 years, age adjusted.

All races

Both sexes:

20-44 years . ., . . . . . . . . . . . 12

45–64 years .,, . .,, ,. .,.., 30

65-74 years . . . . . . . . . . . . . . 24

62,0

49,5

‘60,9

*57.5

*63,4

*33.9

68.8

55.3

*

*

*

*69.7

*

No CHD and no 2 GHD

risk factors

Standard

error of

Examined the

persons Percent percent

*9,8 51 25.4 7.9

*6.9 20.7 6.3

*12.2 9

. *

*3.9 .,

● *

‘13,0 42 ‘30.6 *8.9

*3.9 ,.. *24.4 *7.6

*6.2 44 *25.2 *8,7

‘7.0 ,.. ‘21.1 *7,3

* 5

* *

* * *

CHD or 2 CHD

risk factors

High-risk

(> 160 mg/dl) 3

Standard

error of

Examined the

persons Percent percent

Standard

error of

Examined the

persons Percent percent

265

.

176

109

. .

252

.,.

30

. .

*

12 * *62

*11.6 27 *26.2 *12.2 116

*

12 * *107

67.8

61,7

57.0

52.4

85.9

79.4

67.4

61.2

*69.7

*6 I .2

53,0

69.4

66,3

3,1 669

4,6

4.4 300

5.1

4.6 369

8.0 . .

3.2 587

4.6

‘1 0.2 71

*4.6 ,.,

7.7 117

5.5 307

3,4 245

45.8

38.1

46,0

42.1

45.6

32.2

44.3

38.1

64.1

40.0

28.0

47.5

65,4

2.1

2.6

3,3

3.i3

2.9

3.6

2.’2

2.6

9.9

7,4

4.1

2.8

4.5

lLess than 3.3a mmol/L,

.

23,3a-4.13 mmol/L.

3Greater than or equal to 4.14 mmol/L.

NOTES: Groups based on National Cholesterol Education Program guidelines publlshed In Arch, Int. Med.: 148(1):36-69, 19a6, See appendix IV for de firvtion of risk variables. CHD is coronary

heart disease, mg/dl is millgram$ per decilitec mmol/L is millimoles per liter, LDL cholesterol = serum lob Cllolestero[ - high density lipoprotein cholesterol - triglyceride/5, Equation from

Ftiedewald, WT, et al, Cfin Chem (18):499-502, 1972. Persons wtth a serum triglyceride value greater than 400 mg/dl (4,52 mmol/L) were excluded,

80
Table 41. Percent of hypertensive persons 20-74 years of age with desirable, borderline-high, and high serum total cholesterol levels,

number of examined persons, and standard error of the percent, by sex, race, and age: United States, 1976-60

Borderline-high 200–239 mg/d12

Desirab/e No CFID and no 2 CHD CHD or 2 CUD High

(<200 mg/dl)l risk facfors3 risk factors (2 240 mg/dl)4

Number of Standard Standard Standard Standard

examined error of the error of the error of the

Sex, race, and age

error of the

persons Percent percent Percent percent Percent percent Percent percent

Both sexes

All races:5

20–74years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65–74years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-S4years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20–24years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65-74 yeara . . . . . . . . . . . .

Men

All races5

20-74 years c . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 yeara . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

4,447

.

141

313

368

593

1,346

1,666

3,736

. .

119

255

304

491

1,141

1,426

637

. . .

20

55

73

95

163

211

2,202

. . .

113

221

220

289

643

716

1,690

. . .

103

190

181

254

552

610

27.9

36.6

61.9

46.6

36.6

25.1

17.7

21 .L

26.5

35.3

61.8

45.3

24.7

16.2

21.1

35.2

42.?

*

50,~

53.7

24J?

27.2

22.7

32.8

37.7

62.9

44.1

35.1

23.6

25.2

30.1

31.3

36.0

62.2

43.0

30.5

23.1

23.2

29.5

1.2

1.3

4.2

3.0

2.4

2.3

1.0

1.4

1.4

1.4

4.5

3.3

2.7

2.7

1.1

1.5

3.4

4.2

*

*7.7

*6.1

●4.8

*5.1

2.6

1.5

1.6

4.2

3.8

3.7

3.1

1,8

2.0

1,6

1.7

4.7

3.8

3.6

3.5

1.8

2.1

4.6

3.5

1.7

0.8

4.0

5.5

5.2

6.7

4.9

3.5

1.3

0.5

4.6

5.3

5.2

7.0

3.9

3.6

*

2.6

2.4

4.4

5.1

4.3

0.5

0.4

1.0

0.5

1.2

1.1

0.8

0.8

0.5

0.4

0.9

0.3

1.4

1.1

0.6

0.6

0.9

1.1

●

*2.5

*1 .7

●1.7

*2.3

1.3

27.2

27.0

21.5

29.5

28.4

25.4

26.6

26.7

27.4

27.6

21.6

31.0

30.2

25..3

28.3

26.1

26.2

25.0

*

22.7

21.8

26.7

28.1

30.6

32.1

30.9

21,5

31.5

32.0

30.0

34.6

36.2

33.0

32.0

22.2

32.8

35.5

30.7

34.6

36.4

0.8

1.1

2.6

3.3

2.2

1.6

1.3

1.1

0.9

1.3

3.3

3.7

2.4

1.7

1.5

1.1

2.1

2.8

*

●5.6

‘5.3

●4.8

*3.5

4.3

1.2

1.5

3.5

4.1

3.0

2.1

2.0

1.9

1.3

1.6

3.7

4.5

3.2

2,2

2.3

2.2

40.1

32.6

14.9

23.1

31.1

44.0

48.6

45.2

41.2

33.6

15.4

23.2

32.2

44.7

50.2

45.8

34.6

28.7

*

24.5

22.1

44.2

39.7

42.4

352

31.4

15.7

244

329

46.1

40.1

33,6

35.8

31.9

15.6

24.3

34,0

46.2

42.1

34.0

1.4

1.4

3.6

3.0

2.6

2,6

1.9

1.7

1.6

1.6

4.4

3.2

3.0

3.1

2.0

1.8

2.7

2.2

*

*5.5

*5.6

*7.4

*3.7

3.5

1,6

1.7

4,0

3.5

3.6

2,9

2.4

2.3

1.6

1.6

4.3

3.7

4.0

3.0

2.6

2.3

81
Table 41. Percent of hypertensive persons 20-74 years of age with desirable, borderline-high, and high serum total cholesterol levels,

number of examined persons, and standard error of the percent, by sex, race, and age: United States, 1976-80 – Con.

Borderline-high 200–239 mg/d/2

Desirable No CHD and no 2 CHD CUD or 2 CHD High

(c,200 mg/dI) 1 risk facfors3 risk factors (2 240 mg/d/)4

—

Number of Standard Standard Standard Standard

examined error of the error of the error of the

Sex, race, and age

error of the

persons Percent percent Percent percent Percent percent Percent percent

—

Men–Con.

Black:

20-74 years,,...,,,,,,,,,

20-74 years, age adjusted,

20-24 years . . . . . . . . . . . .

25–34 years.........,.,

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55–64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

Womer+

All races:5

20-74 years.....,,.,,.,..

20-74 years, age adjusted.

20–24 years..,.,,,..,.,

25–34 years.,,.,,...,..

35$44 years, ,, ..,.....,

45–54 years, ,, . . . . . . . . .

55–64 years....,,,..,,,

65-74 years.....,,,.,,.

White:

20-74 years,....,.,,,,,,.

20-74 years, age adjusted.

20-24 years . ., .,,,,,.,.

25-34 years . ., .,,......

35-44 years . . . . . . . . . . . .

45-54 years ., .,, ,, .,...

55-64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

Black:

20-74 years.,,..,,,,,.,.,

20-74 years, age adjusted.

20-24 years.,.,,,,..,,,

25–34 years.,.,....,,,,

35-44 years....,,,,.,,,

45-54 years.,..,,.,,,,.

55-64 years,.,.,,.,,,..

65-74 years....,,,,,,,,

274

10

30

32

31

82

89

2,245

26

92

168

304

703

950

1,846

16

65

123

237

569

816

363

10

25

41

64

101

122

43.2

46.2

.

*46.1

*65.5

“23.0

40,8

34,4

22.6

37.1

‘57.8

54.2

38.5

26.4

10.9

15.4

21.0

36.3

*

53.8

36.6

26,4

9.7

15.4

29.0

38.9

*

‘52.9

‘43.0

26.0

17.3

15.4

4,8

4,6

*

“10.0

“7,0

*7.9

5.6

4,2

1,5

2.5

●9.1

5.1

3,6

2,8

1.2

1,4

1.5

2.2

*

6.6

4,0

3.2

1,2

1.5

4,0

5,8

*

‘1O,8

‘10.2

‘7.0

‘6.0

3.9

—

10.1

6.1

*8.4

3.0

9.4

11.2

9,6

11,2

10,6

8.8

*

2.2

11.4

11.3

10.1

11,8

7.0

6.6

*

*5.8

*4,6

7,5

8,7

6,9

1.0

1.2

*4.8

1.8

2.6

2,1

1.5

1.3

1,1

1,4

*

1,5

3,3

2.1

1.6

1.4

1.5

1.9

*

‘5.1

*3.2

*3. 1

*3.6

2.3

23.8

21,9

*

*23.9

‘12.1

*24.8

29.9

32.6

21,8

22,3

*2 I ,8

23.7

23,4

20,5

23.2

20.2

20.8

21.3

*

24.6

22,4

19,4

22,5

19,1

28.1

27.2

*

*21 ,2

‘30,6

28.1

26.7

29,2

2.6

3.9

*

*9.1

‘6.0

*8.3

5,7

3.5

1.1

1.P

*6.1

4.2

3.7

1,9

1.7

1.5

1.2

1.9

*

5.3

3.7

2.1

2.0

1.3

2.6

4,2

*

*8,3

‘10,6

‘4,9

*4,7

7,0

33.0

29,9

*

*28,0

*22,4

*52.4

29.3

32,8

45.6

32.5

“12,0

19.1

28.7

41,8

56.2

53.1

47.6

33.6

*

19.4

29,6

43,0

57.7

53.7

35.8

27.3

*

‘20.1

’21.8

38.3

47.2

48.4

4.4

3.9

*7.9

*7,4

*13. ”1

4.5

4.7

1.9

2.0

‘7.’1

4.7

4,2

3,6

2.6

2,1

2,2

2.9

.

6.”1

4.4

4,:3

2.”7

2.2

2.9

2.5

*

*7,f3

*8.7

*7.2

‘5,!3

6.”1

1Lass than 5,17 mmol/L,

25.17-8,20 mmol/L.

3CHD is coronary heart disease.

4Greater than or equal to a.21 mmol/L

‘Includes data for races not shown separately,

6Excludes 95 pregnant women.

NOTES: A person with hypertension is defined by either having elevated blood pressure (systolic pressure of at least 140 mmHg or diastolic pressure of at least 90 mmHg) or taking

antihypartensive medication, Percents ara based on the average of three blood pressure readings, Groups based on National Cholesterol Educalion Program Guidelines published in Arch. Int.

Med.: 148(1 ):36-69, 1988. See appendix IV for definition of nsk factor variables, Women m,ssing blood pressure readings or information on medication usage were excluded from this analysis

(n= 125).

82
Table 42. Percent of normotenaive persons 20-74 years of age with desirable, borderline-high, and high serum total cholesterol levels,

number of examined persons, and standard error of the percent, by sex, race, and age: United States, 1976-60

Borderline-high 200-239 mg/d12

Desirable No CHD and no 2 CHD CHD or 2 CHD High

(<200 mg/dl) 1 risk factors3 risk facfors3 (2240 mg/d/)4

Number of Standard Standard Sfandard Standard

examined error of the

Sex, race, and age

error of the error of the

persons Percent percent

error of the

Percent percent Percent percent Percent percent

Both sexes

All races:5

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

3544years . . . . . . . ...<.

45–54years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

3544years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20-24 years...,.....,..

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Men

All races:4

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years, . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years

20-74 years, age adjusted. . . . .

20–24years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-84 yeara, . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

7,098

. . .

1,210

1,841

1,158

831

1,160

898

6,299

. . .

1,036

1,574

1,036

752

1,076

625

652

. . .

141

221

96

59

76

59

3,305

. . .

553

831

512

389

558

462

2,916

,.,

471

899

460

353

513

420

49,9

45.4

73.5

6:.6

46.0

27.1

20.6

27.1

49.4

45.3

73.7

63.6

45.7

27.5

20.8

26.2

57.1

48.1

75.3

65.7

49.7

30.3

18.8

33.9

50.0

46.9

75.4

60.5

41.0

30.6

26.4

379

496

472

756

607

41.4

310

26.6

37.5

1.0

1.0

1.6

1.5

1.6

2.1

1.7

1.5

1.0

1.0

1.7

1.6

1.7

2.4

1.6

1.5

2.5

2.4

4.6

3.7

*5.5

*8.O

*4,4

7.2

1.5

i .3

1.7

2.4

2.5

2.7

2.7

2.1

1.5

1.4

2.0

2.4

2.7

3.1

3.0

2.3

21.4

22.1

17.3

18.6

22.7

25.3

27.2

23.3

21.3

22.1

16.8

18.5

22.8

25.3

27.2

23.3

18.2

18.5

18.3

18.3

18.2

14.4

22.5

19.8

16.3

16.6

12.1

14.9

18.3

18.2

21.3

15.3

16.2

16.5

11.0

15.0

18.3

16.2

21.7

16.1

0.6

0.6

1.2

0.8

1.5

2.0

1.4

1.6

0.6

0.6

1.3

0.9

1.6

2.1

1.3

1.6

1,9

1.6

4.1

3.0

●4.7

*4.9

*9.1

4.4

0.9

0.8

1.5

1.4

2.1

2,4

1.8

1.9

0.9

0.9

1.6

1.6

2.0

2.6

1.9

2.1

8.0

6.4

4.0

6.6

9.3

12.2

10.1

10.2

8.2

8.5

4.5

6.7

9.2

12.1

10.0

10.0

8,2

10,9

1,0

5.1

13.7

18.5

14s3

17,8

14,2

14,9

6.0

11,9

15,0

21.1

18.6

17.0

14.5

15.0

9.2

12.0

14.6

21.5

18.7

16.3

0.3

0.4

0.6

0.7

0.7

1.4

1.0

1.1

0.4

0.4

0.7

0.7

0.7

1.4

1.2

1.0

1.3

1.5

0.7

1.4

*5.1

*5.6

*3.5

5.9

0.6

0.6

1.2

1.4

1.4

2.4

1.9

2.2

0.6

0.7

1.4

1.5

1.6

2.5

2.2

2.0

20.7

24.0

5.2

11.2

22.0

35.5

42.2

39.4

21.1

24.1

4.9

11.2

22.3

35.1

42.0

40.5

16.6

22.5

5.4

10.9

18.5

36.8

44.4

26.5

19.6

21.5

4.5

12.8

25.7

29.9

33.7

29.8

19,5

21.3

4,1

12.3

25.7

32.6

31.1

0.8

0,6

0.9

0.9

1.4

1.7

2,1

2.3

0.9

0.9

0.9

1.0

1.5

1.7

2.2

2.3

2.1

2.3

1,4

2.4

●4.3

*7.5

*6.8

5.4

1.0

1,0

1.1

1.5

1.9

2.4

2.7

2.5

1.1

1.1

1.2

1.7

1.8

2.3

3.2

2,7

83
Table 42. Percent of normotensive persons 20-74 years of age with desirable,, borderline-high, and high serum total cholesterol levels,

number of examined persons, and standard error of the percent, by sex, race, and age: United States, 1976-80 – Con.

i30rder//ne-high 200–239 rrrg/d/2

L7es/rab/e No CHD and no 2 CHD CHD or 2 CUD High

(<200 mg/dl) 1 risk factorss risk factors3 (> 240 mg/dl)4

Number of

—

Standard Standard Standard Standard

examined error of the error of the error of the

Sex, race, and age

error of the

persons Percent percent Percent percent Percent percent Percent percent

Men–Con.

Black:

20-74 years

20-74 years, age adjusted.

20-24 years . .,, ,, . . . . . .

25-34 years .,, ..,.....,

35-44 years .,, ..,..,..,

45-54 yeara .,, ,,, . . . . . .

55–64 years . . . . . . . . . . . .

65–74 years . .,, ,. . . . . . .

Womer+

All races:5

20-74 years..,........,,,

20-74 years, age adjusted. .

20-24 yeara . . . . . . . . . . . .

25-34 years.....,.,.,..

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-84 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

White:

20-74 years

20-74 years, age adjusted. .

20–24 years . .,, . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years .,, ..,.....,

45–54years . . . . . . . . . . . .

55-84 years, , . . . . . . . . . .

65–74years . . . . . . . . . . . .

Black:

20–74 years

20-74 years, age adjusted, . , .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years...,,,...,..

55-64 years . . . . . . . . . . . .

65–74 years . .,, . . . . . . . .

316

66

107

37

29

42

35

3,793

657

1,010

646

442

602

436

3,383

565

875

576

399

563

405

336

.

75

114

59

30

34

24

54.9

48,2

79,1

62,5

*34.6

*35,9

*26.6

*42,0

49.9

43.9

71.9

66.3

50.3

23.6

15.4

16.7

49,1

43.6

72.2

66.0

49.3

24.6

15.6

15.7

56.9

46.6

72.0

68.1

60.6

*23,2

*1 0,3

*

2,5

2.5

“4.8

‘5.1

*7.3

*9.4

*5.9

*11.7

1,2

1.1

2.3

1,6

2.3

2.8

1.5

2.0

1.3

1.1

2.3

1.8

2.5

3.0

1.7

2,1

3.6

2.8

‘6.2

●4.5

●6.7

*7.9

*5.3

*

13,3

12.3

18.4

10,6

‘14.7

●12.7

*6.O

*1 2.2

25.7

26.9

21.8

21.6

26.4

31.5

32.4

31.0

25,8

26,8

21.8

21.5

26.6

31.3

32.1

30.9

22.4

24.5

16,2

23.8

20.7

‘1 6.6

●40.4

*

2.2

2.2

*3.9

‘3.0

“6,8

*6.2

‘3.1

*6.7

0.8

0.8

1.7

1.1

1.9

2.6

2.3

3.0

0.9

0.9

1.8

1.3

2.3

2.7

2.1

3.2

2,9

3.1

*5.9

*4,1

●7.6

*6.3

*1 6.6

*

14.2

17,6

1,1

9.7

‘27.3

*22.6

*22.7

*30.6

2.8

2,9

0.6

2.1

4.5

4.4

2.5

3.7

2.8

2.9

0.6

2.2

4.7

4.1

2,4

4,0

3.1

4.1

1.0

1.8

3.8

*1 3.3

*5.1

*

2.2

2.7

“1.1

*3.O

‘11.0

*6.4

*4.9

‘11,3

0.3

0.s

0.3

0.5

0.8

1.1

0.8

0.9

0,3

0.3

0.3

0.6

0.8

1.0

0.8

0.9

1.0

1.5

*0.8

*1.2

*2.7

*8.7

●4.1

*

17.7

21.7

1.4

17.1

*23,3

*28.8

*44.6

*15.1

21.6

26.3

5.7

9.8

18,8

40,3

49.7

48.6

22.4

26.6

5.5

10.3

19.4

40.0

50.0

49.4

15,6

24,6

6.9

6.4

14.9

*46.9

*44.3

*

2.2

2.3

*1.4

‘3.8

*7.6

‘1 0.8

*8.9

*4.7

0.9

1.0

1.2

1.1

1.9

2.2

2.4

2.9

1.0

0.9

1.2

1.2

2.1

2.4

2.2

3.0

3.3

3.9

*2.6

*2.8

*5.9

“11.1

*1 5.3

*

i Less than 5.17 mmol/L.

25.17-6.20 mmol/L.

3CHD ia coronary heart disease.

4Greaterthan or equal to 6.21 mmol/L

‘Includes data for racea not shown separately,

6Excludes95 pregnsnt women.

NOTES:A person who ia normotenaive doea not have elevated blood preaaura (systolic pressure lass than 140 mmHg and diastolic leaa than 90 mmHg) and is not taking antihypetiensive

medication. Percents are basad on the average of three blood preaaure readings, Personawith missing information on blood pressure reading or medication usage as well as pregnant women

were excluded from the numerator and the denominator of the percents (n-222), Groups based on National Cholesterol Education Program Guidelines published in Arch. fnt, Med.:

148(1):3S-69, 1988. See appendix IV for definition of risk factor variables, Women miaaing any blood praasure readings or Information on medication usage were excluded from thla analysis

(n=125).

84
Table 43. Percent of hypertensive persons 20-74 years of age with desirable, borderline-high-risk, and high risk low density

lipoprotein (LDL) cholesterol levels, number of examined persons, and standard error of the percent, by sex, race, and age:

United States, 1978-80

Borderline-high-risk 130-159 mg/d12

Desirab/e No CUD and no 2 CHD CHD or 2 CHD High-risk

(e 130 mg/dl) 1 risk factors3 risk fsctors3 (2 160 mg/dl)4

Number of Standard Standard Standard Standard

examined error of the error of the error of the error of the

Sex, race, and age persons Percent percent Percent percent Percent percent Percent percent

Both sexes

All races:5

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

2044years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted, . . . .

2044years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Black:5

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjuated. . . . .

Male

All races:5

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

2044years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-44 years . . . . . . . . . . . .

45-64 years, . . . . . . . . . . .

65-74 years, . . . . . . . . . . .

Black:6

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

Female

All races5

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-44 years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20–74 years, age adjusted. . . . .

20-44 years . . . . . . . . . . . .

45-64 years, . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

611

. . .

70

263

278

526

. . .

64

224

238

76

. . .

265

46

125

114

256

. . .

45

112

99

24

. . .

326

. . .

24

138

164

270

.

19

112

139

7.3

6.4

5.2

9.1)

5.,3

7.!3

6.9

5.5

9.7

6.4

3.,3

1.,3

8.4

8,,2

7.7

9.7

6.7

8.7

8.4

7.!3

9.!3

7.5

*

●

6.4

3.2

*

8.5

5.1

7.”1

3.6

●

9.6

5.6

1.4

1.4

2.1

2.3

1.9

1.5

1.5

2.3

2.4

2.0

*2.1

‘1,2

2.1

2.2

●3.2

3.5

2.2

2.2

2.3

*3,3

3,7

2.4

*

*

1.8

0.9

*

3.0

2.2

1.9

1.0

*

3.1

2.3

2.9

2.3

1.6

3.2

3.0

3.0

2.4

1.7

3.4

3.2

1.5

0.6

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

●

*

5.4

5.2

*

5.8

4.9

6.0

5.9

●

6.4

5.4

1.0

1.1

1.6

1.7

1.1

1.2

1.0

1.7

1.9

1.3

●1.1

*0.5

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

*

*

2.0

2.9

*

2.9

1.7

2.4

3.3

*

3.5

2.0

33.8

33.4

43.4

30.0

32.7

34.5

37.9

41.9

31.6

34.3

29.0

51.2

37.7

37.5

37.6

35.8

42.2

37.9

37.3

36.6

36.9

41.9

●

*

30.4

43.5

*

27.1

26.8

31.0

43.0

●

26.6

29.2

2.0

3.2

5.4

3.1

3.5

2.0

3.4

5.6

3.6

3.5

*4,9

*11 .5

3.4

4.1

‘7.0

5.3

4.7

3.6

4.1

‘7.0

5.9

5.2

*

*

2.6

5.7

*

5.0

4.4

3.3

6.4

*

5.8

4.6

56.0

52.9

49.8

56.9

58.5

54.6

52.8

50,9

55.3

56.1

65.9

46.3

53.9

54.3

54.7

54.8

51.1

53.3

54.3

55.5

53.3

50.6

*

*

57.9

48.1

*

58.6

63.2

55.9

47.5

●

57.2

59.6

2.4

3.3

5.1

3.8

3.3

2.6

3.3

5.1

4.3

3.3

*5.8

*1 2.0

3.2

3.6

*5.9

4.9

5.3

3.4

3.6

*5.9

5.5

6.9

*

*

3.4

7.1

*

5,7

4.4

3.7

7.4

*

6.3

4.1

85
Table 43. Percent of hypertensive persons 20-74 years of age with desirable, [borderline-high-risk, and high risk low density

lipoprotein (LDL) cholesterol levels, number of examined persons, and standard error of the percent, by sex, race, and age:

United States, 1978-80 -Con.

Borderline-high-risk 130-159 mg/d/2

—

Desirab/e No CHD and no 2 CHD CHD or 2 CHD High-risk

(< 130 mg/d/) 1 risk factors3 risk factors3 (> 160 mg/dl)’l

Number of Standard Standard Standard

examined

Standard

error of the

Sex, race, and age

error of the error of the

Percent

error of the

persons percent Percent percent Percent percent Percent percent

Female-Con,

Black:6

20–74years, . . . . . . . . . . . . . 52 3.3 ‘2.3 1.9 ‘1.4 28.4 *6.O 66.3 ‘7.1

20–74 years, age adjusted. . . . . 1.6 *1.3 0.8 *0.6 47.7 *1 2.9 49.9 *1 3.5

1Less than 3,36 mmol/L.

23,36-4.13 mmol/L

3CHD iS coronary h6art disease,

4Greater than or equal to 4,14 mmol/L

5[nc[udes data {or races not shown separately.

6Data “ot given by age because Of WM SafIIP!e SiZeS.

NOTES: A person with hypertension is defined by either having elevated blood pressure (systofic pressure of at least 140 mmHg or diastolic pressure of at least 90 mmHg) or taking

sntihypertensive medication, Percents are baaed on the average of three blood pressure reedings. Groups baaed on National Cholesterol Education Program Guidelines published In Arch. In!.

Med.: 148(1 ):36-69, 19a8. See appendix IV for definition of risk factors. mgldl is milligrams per deciiitec mmol/L ia millimoles per lifer. LDL cholesterol = serum total cholesterol - high deneiO/

lipoprotein cholesterol - triglyceride/5. Equation from Friedewald, WT, et al, Clin Chem 18:499-502, 1972, Persons with a serum triglyceride value greater than 400 mg/dl (4,52 mmoUL) were

excluded.

86
Table 44. Percent of normotensive persons 20-74. years of age with desirable, borderline-high-risk, and high-risk low density

lipoprotein (LDL) cholesterol levels, number of examined persons, and standard error of the percent, by sex, race, and age:

United States, 1976-80

Borderline-high-risk 130-159 mg/d12

Desirable No CHD and no 2 CHD CUD or 2 CUD High-risk

(< 130 mg/d/) 1 risk factors3 risk factors3 (> 160 mgld~3

Number of Standard Standard Standard Standard

examined error of the error of the error of the

Sex, race, and age

error of the

persons Percent percent Percent percent Percent percent Percent percent

Both sexes

All races:4

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. .

20-44 years.........,,.

45-64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-44 years, . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years, . . . . . . . . . . .

Black:6

20-74 years . .,, . . . . . . . . . .

20-74 years, age adjusted. . . . .

Male

All races:4

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

2044 years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-44 years, . . . . . . . . . . .

45-84 years, . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Black:6

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

Female

All races:5

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted,

2044 years . . . . . . . . . . . .

45–64 years.........,..

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20-44 years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

458

131

217

110

414

. . .

115

194

105

37

. .

236

. . .

77

101

58

215

. . .

66

91

56

20

222

.,.

54

116

52

199

. . .

47

103

49

(..7

4.9

5.4

4.4

4.0

: ,7

4.1

5.0

2.5

4.2

‘1s.1

*15.7

5.4

5.1

4.3

5.9

7.6

4.1

3.6

2.9

4.1

7.8

*

*

4,1

4.9

7.0

3.2

0.0

3.3

4.8

79

12

0.0

1.5

1.6

2.0

2.0

1.9

1.0

1.3

2.0

1.0

2.0

*I 4.4

*11.5

2.1

2.1

2.4

3.1

*3.4

1.5

1.5

2.0

2.5

●3.5

●

●

1.6

2.1

*3.4

1.8

‘0.0

1.5

2.3

*3.8

0.9

‘0.0

8.8

8.6

8.8

10.2

3.5

9.1

9.1

9.9

10.1

2.8

*5.1

*4.2

4.0

4.0

4.2

4.5

1.7

3.8

4.0

4.6

3.6

1.7

*

*

13.7

13.6

15.1

14.6

5.4

14,6

14.6

17.1

15.4

3.9

1.4

1.4

2.7

3.1

1.7

1.6

1.6

3.1

3.7

1.6

*3.5

*2.9

1.3

1.3

1.9

2.5

*1 .7

1.4

1.4

2.1

2.5

●1.8

*

*

2.2

2.6

‘5.1

4.0

‘3,0

2.6

3.0

*5.7

5.0

*2.8

16.9

17.7

20.1

15.2

13.3

17.2

18.1

20.8

15.3

13.0

*19.3

‘1 8.7

28.1

28.0

28.4

30.6

18.6

27.7

27.8

28.5

30.1

17.2

*

●

5.6

6,9

9.1

3.0

7.5

6.3

7.8

10.3

3.4

6.1

1.8

2.0

3.3

3.0

3.0

1.9

2.0

3.4

3.2

3.3

*8.6

*7.9

3.3

3.2

4.6

5.8

*5.3

3.4

3.4

4.6

6.2

*5.8

●

*

1.9

2,6

‘4.0

1.8

●3.7

2.2

2.9

*4.5

2.0

*3.9

69.5

68.8

65.6

70.3

79.3

70.0

68.7

64.3

72.1

60.1

*56.5

*61 .4

62.5

62,9

63.2

59.0

72.1

64.4

64.4

64.0

62,2

73,2

*

*

76.6

74.5

68,8

79.2

87.1

75,8

72,6

64.7

80.0

88.0

2.1

2.6

4.3

2.6

4.4

2.2

2.6

4.3

3.2

4.5

*14.0

*12.0

3.1

3.2

4.8

4.7

*7.8

3.2

3.4

5.1

4.8

*8.2

*

*

2,7

3.7

*6.5

3.7

*4.3

3.0

4.0

*7.O

4.6

*4.3

87
Table 44. Percent of normotensive persons 20-74 years of age with desirable, borderline-high-risk, and high-risk low density

lipoprotein (LDL) cholesterol levels, number of examined persons, and standard error of the percent, by sex, race, and age:

United States, 1978-80– Con.

lBorderline-h/gh-risk 130-159 mg/d12

Desirable No CHD and no 2 CUD CHD or 2 CHD High-r;sk

(c 130 mg/dJ T risk factors3 risk factors3 (2 160 mg/dJ3

Number of Standard Standard Standard

examinad

Standard

error of the error of the error of the

Sex, race, and age

error of the

pereons Percent percent Percent percent Percent percent Percent percent

Female–Con.

Black:6

20-74 years..,........,,. 17 . * ● * * ● * *

20-74 years, age adjusted. * * * * * ● * *

1Less than 3,36 mmoi/L.

23.36-4.13 mmol/L.

3CHD is coronary heart disease.

4Greater than or equal to 4.14 mmol/L.

‘Includes data for races not shown separately,

6Dat6 not given by age because of Small samPle Wes

NOTES: A person who is normotenwe does not have elevated blood pressure (systolic pressure less than 140 mmHg and diastolic preaaure less than 90 mmHg) and is not taking

antihyperlensive medication. Percents are based on the average of three blood pressure readinga, Groups based on National Cholesterol Education Program Guidelines published in Arch. Int.

Med.: 14a(l ):36-69, 1988. See appendix IV for definition of risk factors. mgldl is milligrams per decilitec mmol/L is millimoles per liter. LDL cholesterol = serum tOtal cholesterol - high density

lipoprotein cholesterol - triglyceride/5. Equation from Friedewald, WT, et al. Clin Chem 1e:499-502, 1972,Persons with a serum triglyceride value greater than 400 mgldl (4.52 mmol/L) were

axcluded.

88
Table 45. Percent of persons in the desirable, borderline-high and high serum total cholesterol categories with a value for high density

lipoprotein (HDL) cholesterol less than 35 milligrams per deciliter (mg/dl), number of examined persons, and standard error of the

percent, by sex, race, and age: United States, 1976-80

Desirable

(<200 mg/dl)”

Borderline-high

200-239 mg/d/ no CHD and

no 2 Ch’D risk factors 2

Borderline-high

200–239 mg/d/ CHD or

2 CHD risk factors2

High

(2240 mg/dl)3

Number Standard

of error of

examined the

Sex, race, and age persons Percent percent

Number Standard

of error of

examined the

persons Percent percent

Number Standard

of error of

examined the

persons Percent percent

Number Standard

of error of

examined the

persons Percent percent

Both sexes

All races:4

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . ...,.....

55-64 years.....,..,,..

65-74 years . . . . . . . . . . . .

White:

20-74 years...........,,.

20-74 years, age adjusted.

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years, . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65–74years . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . . .

20-44 years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

Men

All races:4

20-74 years, ,,, ,,, . . . . . . .

20-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years ., . . . . . . . . . .

35-44 years..,......,..

45–54 years . . . . . . . . . . . .

55–64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Black:

20-74 years . . . . . . . . . . . . . .

20-74 years, age adjusted. .

20-44 years . . . . . . . . . . . .

45–64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

3,654

.

671

1,151

588

322

415

507

3.322

. .

751

976

511

284

363

437

459

. . .

320

62

57

1,927

. .

426

512

243

160

260

326

1,664

. .

367

430

213

144

226

264

227

.,.

147

46

34

11.0

12.5

6.5

10,2

10,7

11.8

19.1

17.6

11.1

12.5

9.5

9.9

10.0

10,8

20.5

18,8

8.7

9.5

8.1

12.3

8.8

16,9

18,6

11.7

15.1

19.2

20.3

25.8

22.9

17.3

18.9

13.5

15.0

17.0

19,8

28.0

24.7

11.7

12.6

10.6

17.4

*9.6

0.7

0.8

1.4

1,1

1,4

1,7

2.0

2.3

0.8

0.9

1.6

1.2

1.4

1.8

2.3

2.5

1.7

1.8

1.8

●4.3

*3.6

1.0

1.2

1.6

1,9

2.7

3.1

3.2

3.0

1.2

1.3

2.0

2.3

2.9

3.2

3.4

3.2

2.8

3.2

3.2

*8.8

*4.O

1,531

.,.

197

315

252

209

310

248

1,366

. . .

165

274

226

184

290

229

126

. .

76

36

14

444

59

100

78

60

90

57

399

. . .

48

65

72

56

86

52

33

. . .

23

7

3

7.9

7.9

7.5

6.9

9.1

8.6

7.2

8.5

8.3

6.1

8.2

5.9

10.1

9.4

7.4

9.2

4.1

3.5

5.9

‘0.0

*

12.6

12.5

5.6

9.3

14.3

17.6

15.8

14.5

14,1

‘13.8

7,3

10.5

15.8

19.0

16.3

16.7

*0.O

‘0.0

*

●

*

0.8

0.7

2.1

1.3

2.3

2.2

2.1

1.5

0.8

0.8

2.3

1.3

2.6

2.4

2.2

1.6

2.6

2.2

‘3.8

*0.O

*

2,1

7.8

*3.6

3.0

5.7

‘5.8

5.8

*4.9

2.3

1.9

●4.7

3.4

6.3

*6.O

6.1

*5.3

●0.O

‘0.0

*

*

●

1,502

. . .

57

183

187

208

409

458

1,307

. . .

53

155

163

180

356

400

178

,..

50

77

51

1,007

. . .

47

141

124

141

268

286

903

. . .

46

122

112

128

242

253

91

. . .

27

36

28

16.2

15.9

6.4

21.4

18.9

12.7

15.3

16.3

17.4

17.3

7.0

23.9

20.3

13.4

16,4

17.4

6.9

7.5

9.0

5.0

7.0

18.6

16.1

6.0

22.9

23,9

15.1

16,4

20.3

20.0

19.6

6.1

25.0

27.6

15.Fi

17.5

20.9

5.0

6.2

*4.7

*2.O

●14.1

1.4

1.6

‘3.3

3.0

4.0

2.1

2.6

2.2

1.6

1.8

*3.7

3.3

4.4

2.2

2.9

2.4

1.4

1.7

●3.3

*2.4

*4.1

1,9

2,0

3.6

3.4

6.1

2.6

3.4

2.5

2.1

2.2

*3.7

3.8

6.6

2.6

3.8

2.7

1.8

2.3

●3.4

*1.4

*7.7

2,910

. . .

79

253

306

461

916

895

2,585

. . .

67

221

271

404

829

793

280

. . .

68

124

88

1,184

. .

38

132

166

198

346

304

1,053

. . .

33

114

148

178

311

269

111

. . .

34

50

27

10.9

11.1

8.4

12.7

12.6

12.1

10.1

8.1

11.5

11.4

6.0

14.2

13<1

12.8

10.5

8.6

6.4

6.4

6,6

7.8

1.7

16.7

16.2

*13.4

17.0

15.0

19.8

15.4

15.8

17.4

16.3

*7.2

19.1

16.2

20.5

16.0

16.4

9.8

8.5

*7.2

13.9

*3.6

1.1

1.3

3.7

2,6

2.1

1.6

1.4

1.2

1.2

1.5

3.1

3.0

2.2

1.9

1.5

1.3

2.2

2.1

*3.1

*3.9

*1.2

1.6

1.9

*6.3

3.7

3.0

3.7

2.4

3.2

1.8

2.0

*3.8

4.1

3.4

4.0

2.5

3.5

4.0

3.7

*3.8

7.5

*3.3

89
Table 45. Percent of persons in the desirable, borderline-high and high serum totai cholesterol categories with a value for high density

lipoprotein (HDL) cholesterol less than 35 milligrams per deciliter (mg/dl), number of examined persons, and standard error of the

percent, by sex, race, and age: United States, 1976-80–Con.

Borderline-high Borderline-high

Desirable 200-239 mg/dl no CHD and 200-239 mg/dl CHD or High

(<200 mg/dl) 1 no 2 CHD risk factors2 2 CHD risk factors 2 (> 240 mg/dl)3

Number Standard Number

—

Standard Number Standard Number

of error of of

Standard

error of of error of of

examined the examined the examined

errclr of

Sex, race, and age

the examined

persons Percent percent

the

persons Percent percent persons Percent percent persons Percent percent

Women

All races:4

2G74 years.,,....,..,,..

20-74 years, age adjusted,

20-24 years.,...,,,,,,.

25-34 years.....,,,,,.,

35-44 years......,,,,..

45-54 years . ., .,.,.,.,.

55–64 years..,..,,..,..

65-74 years . . . . . . . . . . . .

White:

20-74 years

20–74 years, age adjusted. .

20–24 years .,, .,.....,,

25–34 years, , . . . . . . . . . .

35-44 years,,.,...,,,,.

45-54 years..,..,.,.,..

55-64 years,....,.,,,.,

65-74 years .,, ,,, ,, ..,.

Black:

20–74 years,,,...,,...,,.

20–74 years, age adjusted.

20-44 years, ., ...,....,

45–64 years,,...,,,,,,.

65-74 years,,.......,,,

1,927

.,.

445

639

345

162

155

181

1,658

. .

384

546

298

140

137

153

232

.,.

173

36

23

5.7

6.1

5.5

6.3

4,4

3,7

6,2

9.4

5.4

5.7

5.6

5.7

4.6

2.2

8.6

8,6

6.3

6.3

6.2

‘6.0

*

0.8

0.8

1.6

0.9

1,2

1.5

1.9

2.4

0.8

0.8

1.7

0.8

1,4

1,3

2.1

2.3

1.8

1.9

2.1

*4.6

*

1,067

136

215

174

149

220

191

969

. .

117

189

154

128

204

177

93

53

29

1‘1

5.9

5.9

8,2

5.6

6.5

5.1

3.7

7.0

5.7

5.6

8.5

3.6

7.3

5.1

3.5

7.6

5.6

4.9

8.3

‘0.0

*

0.6

0,6

2.3

1.3

2.0

1.5

1.4

2,1

1,1

0.7

2.5

1.3

2,4

1.6

1.5

2.2

3.6

3.1

5.3

‘0.0

*

495 10.5 1.5 1,726

. . . 10.9 2.3 .,.

10 * * 41

42 *1 5.2 *5.4 121

63 9.0 3.1 140

67 6.9 2.8 263

141 13.4 3.4 570

172 9.8 2.9 591

404 10.9 1.9 1,532

. . 12,6 3.3 .,.

7

* *

34

33 ‘18,6 *6.6 107

51 4.8 2.9 123

52 7.6 3.3 226

114 14.0 4.0 518

147 11.6 3.3 524

87 6.9 1.7 169

. 10.8 2,5 . . .

23 * *

34

41 *7.6 *4.5 74

23 * *61

6.6

6.9

*3.9

8.3

9.5

6.1

6.8

4.4

7,0

7.4

*4.9

9.2

9.2

6.7

7.0

4.6

3.9

4.8

*6.O

3.9

1.1

1.0

1.3

*3.8

3.2

2.6

1.4

1.4

0.9

1.0

1.4

*4,8

3.6

2,9

1,6

1,5

1,0

1.9

3.5

*5,9

2.0

“1,2

1Less than 5.17 mmol/L,

25.17-6.20 mmollL.

3Greater than or equal to 6.21 mmol/L,

41ncludes data for races not shown separately,

NOTES: Groups based on Nstional Cholesterol Education Program Guidelines published in Arch, Int. Med.: .146(1):36-69, 19W. See appendix IV for definition of risk faclors, mg/dl is milligrams

per deciliter: mmol/L is millimolea per liter. 35 mgldl = 0.91 mmol/L. CHD IS coronary heari disease,

90
Table 46. Percent of persons in the desirable, borderline-high-risk, and high-risk low density lipoprotein (LDL) cholesterol categories

with a value for high density lipoprotein (HDL) cholesterol iess than 35 rniiligrams per deciiiter (mg/di), number of examined persons,

and standard error of the percent, by sex, race, and age United States, 1976-80

Borderline-high-risk Borderline-high-risk

Desirable 130-759 mg/dl no CHD and 130-159 mg/d/ CHD or High-risk

(e 130 mg/d~ 1 no 2 CHD risk factorsz 2 CHD risk factors2 (> 160 mgld~3

Number Standard Number Standard Number Standard Number Standard

of error of of error of of error of of

examined the

error of

examined the examined the examined the

Sex, race, and age persons Percent percent persons Percent percent persons Percent percent persons Percent percent

Both sexes4

20-74 years . . . . . . . . . . . . . . 68 13.2

20-74 years, age adjusted. . . . . . . . 12.8

2@14years . . . . . . . . . . . . 12 *

45-84 years . . . . . . . . . . . . 32 *1 6.7

65-74 years . . . . . . . . . . . . 24 *

Male

20-74 years, . . . . . . . . . . . . . 38 *23.8

20-74 years, age adjusted. . . . . . . . *22.O

Female

20-74 years . . . . . . . . . . . . . . 30 *0.O

20-74 years, age adjusted. . . . . . . *0.O

White

20-74 years . . . . . . . . . . . . . . 61 15.5

20-74 yeara, age adjusted. . . . . . . . 14.9

Black

20-74 years . . . . . . . . . . . . . . 7

●

20-74 years, age adjusted. . . , . . . .

*

*5.6 51 6.7

*6.2 . . . 3.6

● 12 *

*9.1 27 *1 1.7

*

12 *

*9.6 9

*

●1O.O . . .

*

*0.O 42 *6.O

*0.O ●4.2

*6.6 44 *7.2

*7.O . . . *4.O

*

5

*

* ●

. . .

*6.2 287 14.5 2.8 678 11.1

*3.3 . . . 18.5 4.1 . . . 12.6

*

62 24.5 6.9 119 14.5

*1O.5 116 11.3 3.9 310 10.2

*

109 7.1 3.1 249 8.7

* 178 19.6 4.1 301 16.1

*

. . . 24.8 5.4 . . . 15.9

●7.4 109 5.7 2.9 377 7.0

●3.7 . . . 5.3 3.0 . . . 9.9

*6.8 254 15.3 3.0 594 12.2

●3.7 . . . 19.5 4.2 . . . 13.8

●

30 *7.6 *4.2 73 3.2

*

,.. *1 0.4 *7.3 . . . 2,0

2.0

3.4

3.6

3.1

1.8

2.7

2.6

1.9

3.6

2.2

2.6

*1.6

*1.2

1Less than 3.36mmol/L

23,3e_.$,13mmOwL

3Greaterthan or equal to 4.14rnrndlL

41ncludesdata for races not shown separately.

NOTES: Groups baaed on National Cholesterol Education Program Gmdefines published in Arch. lnt, Med.: 148(1):38-59, 198S. Sae appendix IV for definition of risk factors. LOL cholesterol =

serum total cholesterol - high density lipoprotein cholesterol - triglyceride/5. Equation from Friedewald, W, et al. Clin Chem 18499-502, 1972. Persons with a serum triglyceride value greater

than 400 mgfdl (4.52 mmoVL) were excluded. mg/dI ia mi[figrams per ceciliter; mmoVL is ml[limolea per liter. 35 mg{dl = 0.91 mmol/L CHO is coronary heart disease.

91
Table 47. Percent of persons in the desirable, borderline-high, and high aerurn total cholesterol categories with a value for the ratio of

serum total cholesterol to high density lipoprotein cholesterol greater than or equal to 4.5, number of examined persons, and standard

error of the percent, by sex, race, and age: United States, 1975-80

.

Borderline-high Borderline-high

Desirab/e 200-239 mg/dl no CHD and 200–239 mg/dl CHD or High

(<200 mg/dl) 1 no 2 CHD risk factors2 2 CHD risk factors2 (> 240 mg/dl)3

Number Standard Number

.

Standard Number Standard Number Standard

of error of of error of of error of of

examined the

error of

examined the examined

Sex, race, and age

the examkred

persons Percent percent

the

persons Percent percent persons Percent percent persona Percent percent

Both sexes

All races:4

20-74 years, ,, . . . . . . . . . . .

20-74 years, age adjusted,

20–24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54 years . . . . . . . . . . . .

55–64 years . .,, ,. . . . . . .

65–74 years . . . . . . . . . . . .

White:

20-74 years.,........,,..

20-74 years, age adjusted.

20–24 years . . . . . . . . . . . .

25-34 years ., . ...,,,.,.

35-44 years . . . . . . . . . . . .

45–54 years.,.,,.,..,.,

55-64 years ., .,, ,., ,., .

65-74 years.,,,,.,..,.,

Black:

20-74 years...........,..

20-74 years, age adjusted,

2044 years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years...,,....,.,

Men

All races:4

20-74 years.,,.,....,.,,,

20-74 years, age adjusted.

20-24 years,...,,,,,,,.

25-34 years.....,.,,,.,

35-44 years . . . . . . . . . . . .

45-54 years,.,..,,.,,,,

55–64 years...,,....,.,

65–74 years . . . . . . . . . . . .

White:

20-74 years...,,,,,...,,,

20-74 years, age adjusted.

20-24 years,,..,,...,,,..

25-34 years.,,,,,,,,,,,,,

35-44 years, , . . . . . . . . . . . .

45-54 years, ,,, ,,, ,, .,...

55-64 years, ,, . . ...,.,..,

65–74 years . . . . . . . . . . . . . .

Black:

20-74 years .,, ., . . . . . . . . .

20-74 years, age adjusted,

20–44 years,,.,,....,,,

45-64 years, . .,, . . . . . . .

65-74 years.....,..,,,,

3,654

,..

871

1,151

588

322

415

507

3,322

.

751

976

511

2a4

363

437

459

320

82

57

1,927

.

426

512

243

160

260

326

1,664

.,.

367

430

213

144

226

284

227

.,,

147

46

34

21,5

24.3

14.5

18,9

25.2

27.7

33.8

31.5

22,3

25,2

15.a

19.3

24,8

29.2

35.4

32.9

13,5

14,2

13.0

14.5

19,6

31.9

35.1

19,2

30.1

40.8

40,9

44.2

36.0

33.5

36.7

21,4

31,4

39,6

43.4

47.5

40.6

15.8

16.5

15.1

20.0

*13,5

1.0

1,1

1,5

1.5

1.9

3,0

2.3

2,4

1.2

1,2

1,6

1,7

1.8

3.4

2,5

2.6

1,5

1,9

1,6

‘5,0

*5.3

1.5

1.7

2.0

2,4

3.6

4.9

3.2

3.5

i.a

1,9

2.3

2,7

3,7

5,2

3.7

3.7

2.4

2.7

2.4

*6.6

*5.1

1,531

.,.

197

315

252

209

310

246

1,366

.

165

274

226

184

290

229

126

. . .

76

36

14

444

.,.

59

100

78

60

90

57

399

46

85

72

56

86

52

33

. .

23

7

3

42.2

41.8

37.4

40,7

47,6

45.0

39.5

39.8

42,5

42.0

35.8

40,0

48,7

45,8

40.3

40,9

33.6

31.8

37.1

*27.5

*

58.8

58.7

50.4

51.0

62,0

72,4

57.9

63.9

59.9

59.6

54.2

51.1

62.8

72,1

58.8

66.8

‘43.4

‘47.9

*

●

*

1.4

1.4

3.9

3.0

3.6

3.2

4,6

2.9

1.5

1.5

4.4

2.7

3.7

4,0

4,7

3.0

4.3

4.4

5.6

●9.4

●

2.7

2.5

●5.7

5.5

6.3

7.5

7,0

7,4

2.6

2.4

‘7.2

5.8

6.2

8.1

7.0

7.8

*9.4

●8.6

*

*

*

1,502

. .

57

183

187

208

409

458

1,307

53

155

183

180

356

400

178

. . .

50

77

51

1,007

. .

47

141

124

141

268

286

903

46

122

112

128

242

253

91

. . .

27

36

28

63.5

63.9

54.3

72.6

68.0

62.8

58.1

59.9

67.1

67.7

58.3

75.6

74.2

67.8

60.9

60.7

36.6

37.3

39.0

29.4

50.9

71.1

70.5

56.8

78.0

74.8

74.0

66.0

66.0

74,1

73.4

56.1

79.7

83.0

77.5

68.3

67.7

41.6

42.2

*44.3

*35.9

*48.7

1,6

1.7

*8.O

3.0

6.0

4.5

3.3

2,4

1.6

1.8

*8.5

2.7

5.2

4.1

3,6

2.7

3.6

3.6

*5.2

*5.4

*9.6

1.9

1.9

*8.7

3.2

5.3

4.4

4,1

3,9

2.0

2.0

*8.9

3.0

4,2

4.1

4.4

3.1

5.2

5.0

*7.6

*1 0.4

*11 .0

2,910

. . .

79

253

306

461

916

895

2,585

. . .

67

221

271

404

829

793

280

. .

68

124

88

1,184

. . .

38

132

166

198

346

304

1,053

. .

33

114

146

178

311

269

111

. . .

34

50

27

76.1

76.5

71.7

84.1

80.7

78,2

74.5

77.4

79.2

80.1

77.5

64.5

81.3

76,9

74.9

80.5

66.6

68.3

71,9

67.6

51.2

86.8

86.8

*98,4

90,8

67.0

85.8

84.0

84.5

87.6

89.6

98.2

91.6

87.4

87.1

85.0

86.1

75.9

77.9

*84.8

87.7

*70,2

1.0

1.1

4.!9

1.9

2,3

1.9

2.1

1.9

1.0

1.1

5<4

1.’7

2,4

2.;3

2.2

1.8

2,!3

2.3

*6.6

*5. O

*6.6

0.9

1.0

*1, !5

3.0

2.6

2.0

2.7

2,1

1,0

1,2

*1.8

3.0

2.8

2.2

2.9

2.:2

3.8

3.9

*6.,2

7.9

*9.8

92
Table 47. Percent of persons in the desirable, borderline-high, and high serum total cholesterol categories with a value for the ratio of

serum total cholesterol to high density lipoprotein cholesterol greater than or equal to 4.5, number of examined persons, and standard

error of the percent, by sex, race, and age: United States, 1976-80-Con.

Borderline-high Borderline-high

Desirable 200-239 mg/dl no CHD and 200-239 mg/dl CHD or

(c200 mg/d/)’ no 2 CHD risk factors 2 2 CHD risk factorsz (22%%mg/dl)3

Number Standard Number Standard Number Standard Number Standard

of error of of error of of error of of error of

examined the examined the examined the examined the

Sex, race, and age persons Percent percent persons Percent percent persons Percent percent persons Percent percent

Women

All races:4

20-74 years . . . . . . . . . . . . . .

2C!-74 years, age adjusted. . . . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

.35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

White:

20-74 years . . . . . . . . . . . . . .

20–74 years, age adjusted. . .

20-24 years . . . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 ye.srs . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Black:

20-74 years, . . . . . . . . . . . . .

20-74 years, age adjusted. . . . .

20-44 years . . . . . . . . . . . .

45-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

1,927

445

639

345

162

155

161

1,658

384

546

298

140

137

153

232

. .

173

36

23

12.0

13.6

9.6

9.9

13.6

15.3

16.5

20.9

11.9

13.5

10.4

9.5

13.7

15.7

16.2

19.8

11.6

12.2

11.5

*7.8

●

0.9

1.1

1.5

1.2

1.9

3.5

3.2

2,0

1.0

1.1

1.6

1.3

2.1

3.9

2,6

2.6

2.2

2.6

2.4

*6.2

*

1,087

,..

136

215

174

149

220

191

969

. . .

117

189

154

128

204

177

93

. . .

53

29

11

35,0

34.9

32.2

35.4

40.5

33.5

32.0

34.1

34.8

34.6

29.1

34.3

41.6

33.9

32.3

35,2

30.0

27.6

37.5

●16.3

*

1.6

1.6

4.1

3.4

4,2

4.2

4.9

3.3

1.6

1.6

4,5

3.1

4.2

4.6

4.9

3.6

4.4

4.4

6.4

*7.7

●

495

. . .

10

42

63

67

141

172

404

. . .

7

33

51

52

114

147

67

. . .

23

41

23

46.0

46.2

*

●49.5

54.5

35.5

43.6

50.1

49.4

54.9

*

*56.4

55.6

41.5

45.9

46.9

31.6

32.1

*

●23.6

*

2.9

3.9

*

*8.6

7.7

6.3

5.1

4.3

3,2

3,6

*

*0.7

8.7

7.3

6,3

4,1

5,8

5.7

*

*5.9

*

1,726

. . .

41

121

140

263

570

591

1,532

. . .

34

107

123

226

518

524

169

. . .

34

74

81

7~ .5

69.6

*47.7

77.0

73.0

72.3

66.7

74.1

72.7

71.7

*57.6

77.2

73.6

72.4

68.7

77.8

59.9

59.2

*57.5

67.6

44.7

1.4

2.0

*8,0

3.9

5.0

2.6

2.6

2.3

1.6

2.2

*9.O

3.9

5.0

3.2

2.9

2.3

4.1

5.0

*9.2

*5.6

‘7.3

1Less than 5.17 mmoliL

25. I 7-6.2o mmol/L.

3Greater than or equal to 6.21 mmoVL.

41ncludes data for races not shown separately.

NOTES: Groups baaed on National Cholesterol Education Program Guidelines published in Arch. Int. Med.: 148(1):36-69, 1988. See appendix IV for defm!ion of risk factors. mg{dl is milhgrams

per decilitec mmol/L is milhmoles per Itler. CHD IS coronary heart d,sease.

93
Table 48. Percent of persons in the desirable, borderline-high-risk, and high-risk low density lipoprotein cholesterol categories with a

value for the ratio of serum total cholesterol to high density lipoprotein (HDL) cholesterol greater than or equal to 4.5, number of

examined persons, standard error of the percent, by sex, race, and age: United States, 1976-80

Borderline-high-risk Border/ine-hjgh-risk

Desirab/e 130-159 mg/d/ no CHD and 130-159 mg/dl CHD or Hjgh-risk

(< 130 mg/dl) 1 no 2 CHD risk factors 2 2 CHD risk factors2 (2 160 mgldi)3

—

Number Standard Number Sfandard Number Standard Number

of

Standard

arror of of error of of error of of

examined the examined the

error of

examined the examined the

Sex, race, and age persons Percent percent persons Percent percent persons Percent percent persons Percent percent

Both sexes4

20–74 years . . . . . . . . . . . . . 68

20–74 years, aga adjusted.

20-44 years,........,.. 12

45-64 years . . . . . . . . . . . . 32

65-74 years . . . . . . . . . . . . 24

Male

20–74 years,.,,,,,...,,,. 38

20-74 years, age adjusted.

Female

All races:

20-74 years . . . . . . . . . . . . . . 30

20-74 years, age adjusted.

White:

20-74 years, , . ., . . . . . . . . . 61

20–74 years, age adjusted. .

Black:

20-74 years . . . . . . . . . . . . . . 7

20-74 years, age adjusted. .

34.5

39.9

*

‘32.0

*

‘46.0

‘58.7

‘17.7

‘9.4

40.4

45.8

*

*

*7.5 51

*9,2

* 12

‘11,3 27

* 12

*1 0.9 9

‘12.0 . .

‘8.1 42

‘4,1

‘9.0 44

*7.8 . . .

*

5

*

. .

46.1

54.0

*

‘36.5

*

*

*

‘38.0

’45.2

*49,9

‘56,0

*

*

●8.6

‘10.1

*

‘11.3

*

*

*

*9.6

●11.3

*8,7

‘7.7

*

*

287

62

116

109

178

.

109

254

. . .

30

. . .

59.5 2.8

60.1 3,7

65.5 6.8

60.1 5.3

49.6 5.5

68,9 3.6

70.0 4.0

43.7 5.2

47,7 7.7

63.5 2.5

65.7 3.5

*19.2 *7.9

*27.4 *1 2.3

678

. .

119

310

249

301

. .

377

.,.

594

. .

73

. . .

81.6 1.6

81.5 2.0

81.6 3.2

81.7 2.6

81.1 3.0

87.8 1.9

81.8 2.5

76.5 2.8

74.7 3.7

82.7 1.7

82.9 2,0

66.1 *4.7

62.6 *8. O

i Less than 3.36 mmol/L.

23.36&4,13mmol/L.

3Greater than or equal to 4.14 mmd/L.

41ncludesdata far races not shown separately,

NOTES: Groups based on National Cholesterol Education Program Guidelines published in Arch. Int. Med.: 148(1):36-69, 1988. See appendix IVfor definition of risk factors. LOL cholesterol =

serum total cholesterol - high density hpoprotein cholesterol - triglyceride/5, Equation from I’riedewald, W, et al. Clin Chem (18):49S-502, 1972. Persons with a serum triglyceride value greater

than 400 mgldl (4.52 mmoVL)were excluded. mgldl is milligram per deciliter; mmol/L la millimoles per Hter.CFIOIs coronary heari disease.

94
Appendixes

Contents

1, Statistical notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97

Survey design . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97

Estimation procedures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9S

Nonresponse bias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

Missing data and imputation process . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...101

Measures of variability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...101

Variance covariance matrix.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .,...........102

Testing statistical hypotheses.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...102

Age adjustment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...103

H. Data presentation and reliability . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...104

Cumulative percent distributions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...104

HI. Definition of ofdemographic and socioeconomic terms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...105

IV. Definitions of risk factor variables. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ., . . . . . . . ...106

Coronary heart disease (CAD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...106

Sex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .106

Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , . . . . . . . ...106

Overweight . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...106

Smoking . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...106

Stroke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...107

Diabetes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...107

Low HDL-C values . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , . . . . . . ...107

List of appendix figures

I. Stages of selection for sample in the second National Health and Nutrition Examination Survey, 1976-S0 . . . . 97

II. Definition ofprimary sampling units for the second National Health and Nutrition Examination Survey,

1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98

111, Number of examined persons 20-74 years of age in fasting sampleby fasting category: Second National

Health and Nutrition Examination Survey, 1976-80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...102

Listofappendix tables

I. Sampling rates by age: Second National Health and Nutrition Examination Survey, 1976-S0 . . . . . . . . . . . . . . . . 98

H. Sample sizes and response rates for interviewed and examined persons 20-74 years of age byrace, sex,

and age: Second National Health and Nutrition Examination Survey, 1976–S0 .,...,...........,,, ... ..,.. 98

111, Sample sizes and resporwe rates for persons 20–74years ofage in the fasting sample, byage, sex, and race:

Second National Health and Nutrition Examination Survey, 1976-S0 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

IV. Number of examined persons 20-74 years of age, by race, sex, and age of examinee: United States,

1976_S0 ...,.,............,.<,<+, . . . . . . . . . . . . . . .

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99

v. Number of examined persons 20–74 years of age in the fasting sample and estimated population, by sex,

race, and age: United States, 1976-S 0. .,, . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , . . . . . . . . . . . . . . . . . . ...100

95
VI. Estimated population in thousands of persons 20–74 years of a[ge,by race, sex, and age: United States,

1986, . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1.01

VII. Percent distribution ofnonresponse adjustment factors for persons 20–74 years of age, by size of factor:

Second National Health and Nutrition Examination Survey, 1976-80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101

VIII. Percent distribution of nonresponse adjustment factors for persons 20–74 years of age in the fasting

sample by size of factor: Second National Health and Nutrition Examination Survey, 1976–80 . . . . . . . . . . . . . . 101

IX. Number of persons 20–74 years of age with missing serum lipid and lipoprotein determinations:

United States, 1976-80 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...101

x. Variables used indefining corona~heart disease andcoronar~/ risk factors, bysources of data. . . . . . . . . . . . . . 106

XL Values for desirable weight used in defining overweight as a risk factor for coronary heart disease . . . . . . . . . . 107

96
Appendix I

Statistical notes

Survey design

The second National Health and Nutrition Examination Survey (NHANES H) used a stratified, multistage

design that permits selection of samples at each stage with

known probability. In hierarchical order the stages of

selection were: primary sampling units (PSU’S), which are

counties or small groups of contiguous counties; census

enumeration districts; segments (clusters of households);

households; and sample persons (figure 1).

NHANES II is based on a subset of the sample

PSU’S in the National Health Interview Survey (NHIS)

(z7) (figure II) The self-representing PSU’S in NHIS

were first split along county boundaries. Within each

region, each county was classified as either a selfrepresenting or a non-self-representing PSU. The PSU’S

that were non-self-representing were further combined

into homogeneous classes or strata equal in size to the

NHIS strata containing non-self-representing PSU’S.

Subdividing the 156 self-representing PSU’S in NHIS

and redefining the PSU’S by using COUIWboundaries

resulted in a total of 397 PSU’S, of which 198 were defined

as self-representing and 199 were defined as non-selfrepresenting. The latter were used to form 43 non-selfrepresenting strata, which were combined with the other

22(I non-self-representing psu’s in NHIS. The average

population of a self-presenting PSU was reduced from

838,000 to 584,000. The average area of the PSU’S was

reduced more than 60 percent, from 2, 1S5 square miles to

855 square miles.

The 461 first-state units (redefined from NHIS strata)

were further stratified into a total of 64 superstrata, and

one PSU was selected from each of the superstrata using a

modified Goodman-Kish controlled-selection technique (28,29). These 64 PSU’S were the geographic locations visited by the mobile examination centers during the

survey period.

The U.S Bureau of the Census had the major responsibility for seIecting households and sample persons within

each PSU. Three sampling frames of housing units were

used to select the sample within each PSU. The list frame

consisted of all housing units Iocated in the 1970 Census of

the Population (27).

In the second stage, enumeration districts (ED’s)

within each stratum were selected proportional to their

measures of size. An ED is a geographical area that

contains approximately 300 housing units. In order to

oversimple persons with low incomes, the ED’s within

each PSU were stratified into a poverty stratum and a

nonpoverty stratum. The poverty strata contained ED’s

with 13 percent or more of persons below the poverty

level, and the nonpoverty strata contained ED’s with less

than 13 percent of persons below the poverty level, as

determined by the 1970 census.

The third stage of the design consisted of a selection

of clusters of households (segments) within ED’s. To

ensure sampling reliability, clusters of 16 listed addresses

were drawn from the sampling frames and then systematically subsampled at a rate of 1 out of 2 to produce a final

segment of 8 househoId address listings.

At the fourth stage of sampling, a list was made of all

eligible sample persons within each selected segment. For

each sample person selected who agreed to participate in

I

Stage II

(prirnary%$ing unit) (Census

, enumeration district)

I

Stage Ill

(segment) I @am~@L@

I

‘m l$igiiq-+= I

NOTES PSU h pimwy aamphg untt NHIS b NstbMl HealMI Intavlw Survey. ED k a’wmeraticm dksbkt

Figure 1. Stages of selection for sample in the Second National Health and Nutrition Examination Survey, 1976-80

97
NHIS PSU’S I

Redefinition of PSU’s

~

IDI

199 nonseifreprseenting redefined

Psu’s

I ‘cl 43 nonselfrepresenting radefined

Psu’s

NOTES FsU IS@mwy smnpiimJuntt NHIS k NaMoMl Heal!!! Irtervlew SuweY. ED 16

emumeratbn5Mrict

Figure Il. Definition of primary sampling units for the second

National Health and Nutrition Examination Survey, 1976-80

NHANES II, the interviewer conducted a medical history

interview and notified the field office to schedule an

examination. The field oflice staff assigned alternate persons ages 20–74 years to an oral glucose tolerance test

(OGTT) subsample. The sample of persons to be examined was selected so that the younger and older age

groups were oversampled and approximately one person

per sample household was selected. The sampling rates by

age are shown in table 1,

Of the 17,390 persons, 20-74 years of age included in

the NHANES II sample, 15,364 (88 percent) were interviewed and 11,S64 (68 percent) were interviewed and

examined,

Of the 8,686 persons 20-74 years of age in the fasting

sample, 7,691 (87 percent) were interviewed and 5,903

(6$ percent) were interviewed and examined. The

NHANES II sample size and response rates by age, sex,

and race are shown in table II for the total sample and in

table 111for the fasting sample. The number of examined

persons and population estimates for the total sample and

the fasting sample are shown in tables IV and V. The

1986 census population estimates are shown in table VI. A

more complete description of the sample survey design is

included in Viral and Health Statistics, Series 1, No. 15 (8).

Estimation procedures

Because the design of the National Health and Nutrition Examination Survey (NHANES) is a complex multistage probability sampIe, national estimates are derived

through a multistage estimation procedure. The proce98

Table 1. Sampling rates by age: Second National Health and

Nutrition Examination Survey, 1976-60

Age Hate

—

6months-5 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3/4

6–59yaars, . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1/4

60–74 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3]4

Table Il. Sample sizes and response rates for interviewed and

examined persons 20-74 years of age by age, sex, and race:

Second National Health and Nutrition Examination Survey,

1976-80

—

krtervlekved Examined

Total —

Ag,?, sex, and race sample Number Percent Number Percent

Total, ,,, . . . . . . . . .

Age

20-24 years, ..,.,...

25–34 years .,,......

35-44 years . . . . . . . . .

45-54 years . . . . . . . . .

55–64 years . . . . . . . . .

65–74 years . . . . . . . . .

Sex

Female . . . . . . . . . . . .

Male . . . . . . . . . . . . .

Race

White . ., . ...,.,...

Black, . . . . . . . . . . . .

Other . . . . . . . . . . . . .

17,390

1,894

3,031

2,236

2,149

3,868

4,212

9,316

8,074

15,103

1,955

332

15,364 80.4 11,864 68.2

1,758 92.8 1,414 74.7

2,773 91.5 2,237 73.8

2,005 89.7 1,589 7“1.1

1,866 86.8 1,453 67.6

3,330 86.1 2,556 66.1

3,632 86.2 2,615 62.1

8,286 88.9 6,260 67.2

7,078 87.7 5,604 69.4

13,316 88.2 10,301 68.2

1,784 90.2 1,336 68.3

284 85.5 227 68.4

dure has three basic components for both the total sample

and the fasting sample: (a) Inflation by the reciprocal of

the probability of selection, (b) adjustment for nonresponse, and (c) poststratification by age, sex, and race. A

brief description of each component follows:

● Inflation by the reciprocal of the probability of selection.

The probability of selection in the total sample is the

product of the probabilities of selection from each

stage of selection in the design – PSU, segment, household and sample person. The probability of selection

in the OGTT subsample is determined by doubling the

probability of selection of each person in that subsample. This probability is zero for sample persons not

selected for that subsample,

. Adjustment for nonresponse. The estimates are inflated

by a multiplication factor that brings estimates based

on examined persons up to the level that would have

been achieved if all sample persons had been examined. To calculate the nonresponse adjustment factor

for the total sample, the sum of the reciprocals of the

probability of selection for all selected sample persons

within each of five income groups (less than $6,000,

$6,000-$9,999, $10,000-$14,999, $15,000-$24,999, and

$25,000 or more), three age groups (6 months-5 years,

6-59 years, and 60-74 years), four geographic regions,
Table Ill. Sample sizes and response rates for persons 20-74

years of age in the fasting sample, by age, sex, and race: Second

National Health and Nutrition Examination Survey, 1976-60

hterviewed Examined

Total

Age, sex, and race san@e Number Percent Number Percent

Total . . . . . . . . . . . . . 8,686 7,691

Age

20-24 years . . . . . . . . . 914 837

25-34 years . . . . . . . . . 1,520 1,390

35-44 years . . . . . . . . . 1,135 1,025

45-54 years . . . . . . . . . 1,075 926

55-64 years . . . . . . . . . 1,909 1,651

65-74 years. . . . . . . . 2,133 1,862

Sex

Female . . . . . . . . . . . . 4,572 4,073

Male . . . . . . . . . . . . . 4,114 3,618

Race

White . . . . . . . . . . . . . 7,555 6,673

Black . . . . . . . . . . . . . 962 871

Other . . . . . . . . . . . . . 169 147

88.5

91.6

91.5

90.3

86.1

66.5

87.3

89.1

67.9

88.3

90.5

87.0

5,903

650

1,129

795

708

1,261

1,340

3,057

2,648

5,145

646

112

68.0

71.1

74.3

70.0

65.9

67.1

62.8

66.9

69.2

66.1

67.2

66.3

and within or outside a standard metropolitan statistical area (SMSA) was obtained. This sum was then

divided by the sum of the reciprocals of the probability

of selection for examined sample persorls in the same

income, age, region, and SMSA groups. The percent

distribution of the nonresponse adjustment factors is

shown in table VII. The same method was used to

calculate the nonresponse adjustment flctor for persons in the fasting subsample. The calculation was

restricted to persons in the fasting subsample. Two age

groups –.W-59 vears and 6t)-74-years were used in

defining subgro;ps, rather than the three age groups

for the total sample. The percent distribution of the

nonresponse adjustment factors is shown in table VIII.

● Poststratijicotion by age, m-, and rote. Th z estimates of

the number of examined persons were ::atio adjusted

within each of 75 age-sex-race cells ancl estimates of

the number of examined adults 20–74 years in the

fasting sample were ratio adjusted with 24 age-sex-race

cells to independent estimates, provided by the U.S.

Bureau of the Census, of the population as of h4arch 1,

1978, approximate midpoint of the survey. The ratio

adjustment used a multiplication factor in which the

numerator was the U.S. population and the denominator was the sum of the weights adjusted for nonresponse for the specified population subgroup. This

ratio estimation process brings the population estimates into close agreement with the U.S. Bureau of

the Census estimates of the civilian noninstitutionalized population of the United States. h general, it

reduces sampling errors of NHANES II estimates.

Nonresponse bias

In health examination surveys such as NHANES,

there exists the potential for three levels of nonresponse:

Table IV. Number of examined persons 20-74 years of age,

by race, sex, and age of examinee: United States, 1976-80

White Black

Number of Number of Number of

examfned examined examined

Sex and age persons persons persons

Both sexes

20-74 years . . . . . . . . . . . .

18-24 years . . . . . . . . . . . .

20-24 years . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65–74 years . . . . . . . . . . . .

Male

20-74 years . . . . . . . . . . . .

18-24 years . . . . . . . . . . . .

20-24 years . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45–54years . . . . . . . . . . . .

55-64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

Female

20-74 years . . . . . . . . . . . .

18-24 years, . . . . . . . . . . .

20-24 years . . . . . . . . . .

25-34 years . . . . . . . . . . . .

35-44 years . . . . . . . . . . . .

45-54 years . . . . . . . . . . . .

55–64 years . . . . . . . . . . . .

65-74 years . . . . . . . . . . . .

11,864

2,054

1,414

2,237

1,589

1,453

2,556

2,615

5,604

968

676

1,067

745

690

1,227

1,199

6,260

1,066

738

1,170

844

763

1,329

1,416

10,301

1,736

1,205

1,901

1,379

1,264

2,262

2,290

4,683

846

581

901

653

617

1,066

1,045

5,416

692

624

1,000

726

647

1,176

1,245

1,336

268

173

284

173

162

264

280

607

121

79

139

70

62

129

126

729

147

94

145

103

100

135

152

househoId interview nonresponse, examination nonresponse, and item nonresponse. Household interview nonresponsc occurs when the household medical history

questionnaire is not completed. Examination nonresponse

occurs when sample persons w’ho respond to the household questions do not come to the examination center for

an examination. Item nonresponse results when sample

persons, intervie~~ers, or examiners do not complete some

portion of either the household interview questionnaires

or the examination protocol, Intense efforts were undertaken during NHANES H to develop and implement

procedures and inducements that wotdd reduce all types

of nonresponse and thereby reduce the potential for bias

in the survey estimates. These procedures are discussed in

I&d LWd Healtlz Statistics, Series 1, No. 15 (S),

In NHANES II, the medical history interview nonresponse was 12 percent, and, despite intense efforts to

reduce the number of examination nonrespondents, an

additional 20 percent of the 17,390 persons 20-74 years of

age selected for NHANES II \vere not examined (table II).

However, a comparison of the 1976 National Health

Interview Survey and NHANES II (30) suggests that the

nonresponse bias for some health-related variables was

not large because selected interview items in NHANES II

data agree so closely with comparable items in the 1976

99
Table V. Number of examined persons 20-74 years of age in the fasting sample and estimated population, by sex, race, and age:

United States, 1976-80

BoVi sexes Male Female

Number of %firnated

.

Number of Estimated Number of Estimated

examined population examined

Race and age

popu/afion examined

persons

popdation

in thousands persons in thousands persons in thousands

—

All races

20-74 years, ,, . . . . . . 5,903 133,605 2,848 63,611 3,057 69,994.

20-24 years, ,. . . . . . . 650 19,325 323 9,331 327 9,994.

25–34 years. . . 1,129 32,752 546 15,895 583 16,856

35–44years. . . 795 23,651 376 11,367 419 12,284

45-54 years.,,,.,,,. 708 23,032 329 11,114 379 11,918

55-84 years . . . . . . . . . 1,281 20,350 656 9,607 625

65–74 years .,,,,,.,. 1,340

10,743

14,496 616 6,297 724 8,198

White

20-74 years...,,,,,, 5,145 116,696 2,466 56,002 2,659 60,696

20–24years. . 553 16,566 277 8,059 276 8,510

25-34 years ...,,.... 967 26,254 462 13,812 505

35-44 years. . . 684

14,442

20,270 330 9,631 354 10,438

45-54 years .,....... 624 20,335 297 10,011 327 10,324

55–64years ..,....,. 1,131 18,323 579 6,681 552

65-74 years .,,...... 1,166

9,642

12,948 541 5,608 645 7,340

Black

20-74 years,,..,.,,, 648 13,661 305 6,102 341 7,579

20–24 years . . . . . . . . . 64 2,347 36 1,043 46 1,304

25–34 years.....,,,, 132 3,499 69 1,546 63 1,953

35-44 years...,,,,., 91 2,527 36 1,112 55 1,415

4S-54 years .,,,.,.,, 71 2,259 29 1,044 42 1,215

55-64 years ..,,...,, 135 1,760 70 801 65

65–74 years.,,,,,,,. 133

959

1,288 63 555 70 733

—

NHIS data. The 1976 NHIS was used for comparison

because it included data on diabetes, which was also of

interest in NHANES II, and because the nonresponse rate

was 4 percent, It was assumed that the 4-percent nonresponse was randomly distributed,

Data from earlier studies also suggest that no substantial nonresponse bias exists. An analysis of data on examined and nonexamined (but interviewed) persons was

done using the first 35 stands of the first National Health

and Nutrition Examination Survey (NHANES 1) (30). The

two groups were found to be quite similar with respect to

the health characteristics that were compared. In another

study of examined and nonexamined persons selected for

participation in NHANES I, no differences were found

between the two groups with respect to health-related

variables (31). In another study (32), factors relating to

response in Cycle I of the National Health Examination

Survey of 1960-62 were investigated. It was found that 36

percent of the nonexamined persons in that survey viewed

themselves as being in excellent health, compared with 31 percent of examined persons. A self-appraisal of poor health was

made by 5 percent of nonexamined persons and by 6 percent

of those who were examined.

In a different study of Cycle I (33), comparisons

between two extreme groups –those who participated in

the survey with no persuasive effort and those who participated only after a great deal of persuasive effort —indi100

cated that differences between the two groups generally

had little effect on estimates based on numerous selected

examination and questionnaire items. These findings were

interpreted as evidence that no large bias exists between

the two groups for the items investigated, and they were

offered as further support for the belief that Iittle bias is

introduced into the findings because of differences in

health characteristics between examined and nonexa,mined persons, As shown in table II, response rates differ by

age; however, the number of interviewed and examined

sample persons was poststratified to agree with U.S.

Bureau of the Census population estimates to account for

such differences.

For the fasting subsample, 11 percent were not

interviewed and 32 percent were not examined. The

respc~nse rates to the interview and the examination for

adults 20–74 years of age in the total sample and in the

fasting sample are similar (tables II and III, respectively). In addition to interview and examination nonresponse, there was substantial (23 percent) item

nonresponse to the fasting sample (34). This suggests a

potential bias in the estimates for the OGTT sample,

However, comparison of the OGTT subsample for

which the OGTT was completed with the total exa[mined OGTT subsample, the total interviewed sample,

and the 1978 National Health Interview (with respect

to selected demographic and health reIated character-
Table VI. Estimated population 20-74 years of age by race, sex,

and age: United States,l 986

All

Sex and age races White Biack

Both sexes Number ir, thousands

20-74 years . . . . . . . . . . . . . 158,639 136,335 17,633

20-24 years . . . . . . . . . . . . . 20,411 1E,944 2,813

25-34 years . . . . . . . . . . . . . 42,779 3E,045 5,285

35-44 years . . . . . . . . . . . . . 33,070 2E,469 3,499

45-54 years . . . . . . . . . . . . . 22,815 19,703 2,439

55-64 years . . . . . . . . . . . . . 22,232 19,640 2,106

65-74 years . . . . . . . . . . . . . 17,332 15,534 1,491

Male

20-74 years . . . . . . . . . . . . .

20-24 years . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . .

55–64years . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . .

Female

20-74 years . . . . . . . . . . . . .

20-24 years . . . . . . . . . . . . .

25-34 years . . . . . . . . . . . . .

35-44 years . . . . . . . . . . . . .

45-54 years . . . . . . . . . . . . .

55-64 years . . . . . . . . . . . . .

65-74 years . . . . . . . . . . . . .

77,085

10,226

21,390

18,287

11,077

10,456

7,647

81,554

10,163

21,369

16,763

11,736

11,776

9,665

66,726

8,532

18,193

14,172

9,663

9,290

6,876

69,609

6,413

17,852

14,297

10,039

10,351

6,657

6,115

1,356

2,466

1,593

1,092

951

633

9,517

1,454

2,797

1,906

1,347

1,155

856

istics) yielded similar results for most variables considered. This suggests that no substantial bias was

introduced due to item nonresponse. A more detailed

analysis of nonresponse for the OGTT sample is presented elsewhere (34).

There are several published reports related to issues

of nonresponse bias in National Health Examination Surveys (35–37).

Missing data and imputation process

In examination surveys, information is lost not only

through the failure to examine all sample pmsons but also

from the failure to obtain and record all items of information for examined persons. Age, sex, and race were known

for every examined person.

The extent of missing data for serum lipids and

lipoprotein in show in table IX. The 272 missing serum

cholesterol values were imputed using a “hot deck” procedure. An explanation of this procedure is presented in

another publication (20).

The missing HDL-C and serum triglyceride values

were not imputed. Therefore, the missing ratio of serum

cholesterol to HDL-C and missing calculated values of

LDL-C were not imputed. Comparison of examined persons 20–74 years of age with and without HDL-C determinations with respect to related variables such as body mass

index, alcohol consumption, smoking, and physical activity

revealed no substantial differences between the two groups.

Table W. Percent distribution of nonresponse adjustment factors

for persons 20-74 years of age by size of factor: Second

National Health and Nutrition Examination Survey, 1976-80

Percent

Size of factor disfrlbuflon

Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100.0

1.00-1 .24 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26.6

1.25-1 .49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54.6

1,50-1 .74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.9

1.75-1 .99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4.4

2.00-2 .49 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.2

2.50-2 .99 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.9

Table Vlll. Percent distribution of nonresponse adjustment

factors for persons 20-74 years in the fasting sample by size of

facto~ Second National Health and Nutrition Examination Survey,

1976-80

Size of factor Percent distribution

Total . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100.0

1.10-1 .29 . . . . . . . . . . . . . . . . . . . . . . . . . . . 17.6

1.30-1 .44 . . . . . . . . . . . . . . . . . . . . . . . . . . . 44.5

1.45-1 .64 . . . . . . . . . . . . . . . . . . . . . . . . . . . 22.8

1.65-1 .99 . . . . . . . . . . . . . . . . . . . . . . . . . . . 9.2

2.00-2 .49 . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,4

2.50-2 .99 . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.5

Table IX. Number of persons ages 20-74 years of age with

missing lipid determinations: United States, 1976-80

lipid determination Number

Serum total cholesterol (TC). . . . . . . . . . . . . . . . 272

High density lipoprotein cholesterol (HDL-C). . . . 2,067

Ratio of TCto HDL-C . . . . . . . . . . . . . . . . . . . . 2,067

Serum triglyceride . . . . . . . . . . . . . . . . . . . . . . 55

Low densky lipoprotein cholesterol. . . . . . . . . . 74

Figure III is a flow chart showing the progressive 10SS

of data for serum triglyceride and LDL-C. Because half

the examined adults 20–74 years were in the fasting

sample and only half of these sample persons fasted 12

hours or more, a potential source of bias is introduced.

However, the estimates of serum triglyceride and LDL-C

are based on the OGTT weights, which accounts for only

half the examined adults being in the fasting sample.

A comparison of those in the fasting sample with

those who were not with respect to selected health-related

characteristics revealed no substantial differences, other

than what would be expected by chance. A similar analysis

of those fasting 12 hours or more with those in the fasting

sample who did not fast 12 hours or more yielded similar

results. At each stage of this analysis, the age-adjusted

means for TC, HDL-C and non-HDL cholesterol yielded

similar values for fasting versus nonfasting and for fasting

12 hours or more versus fasting less than 12 hours.

Measures of variability

Standard error of estimates

The standard error of an estimated mean or percent is

primarily a measure of the extent to which estimates

101
Total sample (11,864 persons)

Fasting sample (5,903 persons)

Fasting 12 hours or more (2,804 persons)

Fasting 12 hours or more with known serum triglyceride

determinations (2,753 persons)

,

I

Fasting 12 hours or more with known low-density

lipoprotein cholesterol determinations

(2,263 persons)

Figure Ill. Number of examined persons 20-74 years of age in

fasting sample by fasting category: Second National Health and

Nutrition Examination Survey, 1976-80

derived from the many different samples that a sampling

design might produce, would vary from sample to sample.

As estimated in this report, the standard error also reflects

part of the variation that arises in the measurement

process. The possible bias of estimates is not included.

The complex sample design of NHANES II must be

incorporated in estimating standard errors of means or

percents. Methods accounting for the complex sample

design yield estimates different from and generally larger

than those estimated under the assumption of simple

random sampling. The standard errors of the means and

percents were estimated by the method of linearization

(40) –a method that accounts for the sample design by

using the computer program SESUDAAN (41).

Variance

The variance is the square of the standard error of the

mean or percent.

Covariance

The covariance is a measure of the extent to which

two random variables, Xl and Xz vary together and is a

function of the unit of measurement. If Xz increases as Xl

increases, the covariance is positive. If Xz decreases as .Xl

increases, the covariance is negative. If the value of X2 is

independent of Xl, the covariance is zero.

102

The covariance of two random variables from a complex sample design, such as NHANES II, is seldom equal

to zero.

Variance covariance matrix

The variance covariance matrix, 2 of a random vector

~ = (Y1>Y2>. . . . >Yn)

is an n x n matrix of the form

(

U11 U,2 ... .‘1 n

2= U7-~ U22 ... .

‘2n

Crn~ u“~ . . . . u “n

1

where Uii is the variance of yii and Uij (i # j) is the

covariance of yi and yj.

The elements of Z were estimated by using linearization through the computer program SURREGR (42).

Testing statistical hypotheses

To test statistical hypotheses of the form

HO:61 = 62 against the alternative

HI: 01 +(32

where 01 represents a mean or percent of a given subdomain and (3Zrepresents a mean or percent of a different

subdomain, the statistic

z = [e~-OJW [e~- 6*] (1)

is used.

Va,r[O* – 8-J is estimated by the formula

Va.r[O1– 62] = Var (Ell) + Var (62) – 2cov (01, 62)

Because 61 and 62 are estimated from a complex sample,

Cov[el, 02] # o

The statistic given in equation (1) is assumed to be

normally distributed and its square to have X2distribution

with 1 degree of freedom. The numerator and denominator of equation (1) maybe obtained from the SURREGR

(40) and the test statistic computed through GENCAT

(41) (see example below),

Statistical hypotheses were tested using an a level of

0.05. Where multiple comparisons were made, this overall

CYlevel was adjusted using the Bonforroni method by

dividing O .05 by the number of implied comparisons, n.

If the probability of rejecting the null hypothesis when

it is true for a given comparison, P(Ai), i = 1, . . .. n, is less

than 0,05/n, the Bonforroni inequality

P(UAi) < = ZP(Ai) (2)

guarantees that the overall level for the null hypothesis

concerning all n comparisons is less than .05.

I!!any statistical tests conducted for this report involve

tests of the equality of age-adjusted means and percents.

These estimates may be obtained through GENCAT.
For example, assume the objective were to test the

hypothesis that age-adjusted mean LDL-C is the same for

white adults as for black adults.

1) Using SURREGR, estimate the 24 x 1 vector of

mean LDL-C levels for the age (20–24 years, 25–34 years,

35-44 years, 45–54 years, 55–64 years and 65–74 years),

sex, and race subdomains:

~ = (Xl, X?, . . .. X2.4)

(3)

where xi i = 1, 2, 3, 4, 5, 6 represent the 6 age specific mean

LDL-C levels of white men,

xi+~ i = 1, 2, 3, 4, 5, 6 represent the 6 age specific mean

LDL-C levels of white women,

xi+ 12 i = 1, 2, 3,4, 5, 6 represent the 6 age specific mean

LDL-C levels of black men,

xi+ ~~ i = 1, ~, 3, 4, 5, 6 represent the 6 age specific mean

LDL-C levels of black women.

The variance-covariance matrix V can also be

estimated.

2) A and its estimated variance-covaria. nce matrix V,

are then read into GENCAT.

The variance-covariance matrix W4 ~ ~, of (01, 02,03, 6A)

is also obtained as a result of this linear transformation.

3) To test the equality of age-adjusted mean LDL-C

levels of black men versus white men (or black women

versus white women), that is, to test the hypothesis

cle_=o

where Cl = (1, O,-1, O)

or C26=0

where ~ = (0,1,0,-1), the WaId statistic

Q= = ~ ‘ Ci’ [Ci {D’W-l D}-l Ci’] Ci ~ (4)

is employed. D, the design matrix, is set equal to the 4 x 4

identity matrix and, therefore, equation (2) is equivalent

to the square of equation (l).

Age adjustment

The age-adjusted means and percents were calculated

by the direct method and were adjusted to the age

distribution of the 1980 U.S. Bureau of the Census population. These adjusted or standardized values are meaningful only when comparing subgroups of the population

to control for confounding by E age.

103
Appendix II

Data presentation and

reliability

The estimates numerically describe the distribution of

serum lipids and lipoproteins in certain population groups,

Among the descriptive measures are means, percentiles,

percents, percent distributions, and standard errors of the

means or percents.

The mean value for a population group is the sum of

each value times its weight in the group divided by the.

sum of the weights for that group. It is a measure of

central tendency; that is, it indicates where the center of

the distribution of observations for a given subgroup is

located. The prevalence rate for a population is the

proportion of persons believed to be at risk for a particular condition or disease in the population or who exhibit

the condition, disease, or risk characteristic at a given

time. It is estimated using the percent of persons in the

sample with that characteristic. Age-adjusted means and

percents assume that each group has the same age distribution, thus adjusting for the effect of age and allowing

comparison of combined mean values among population

groups.

A percentile is a value that indicates the percent of

people in a population with a value less than or equal to

the percentile value. Of particular interest is the 50th

percentile or median, which has the property that half of

the observations are less than or equal to it and half arc

greater than it. This measure is used instead of the mean

as a measure of central tendency in instances where the

distribution of observations is highly skewed.

The standard error of the mean or percent is a

statistic used in constructing confidence intervals and in

testing statistical hypotheses. The accuracy of the estimate

is directly related to its standard error. The estimates with

smaller standard errors are generally more accurate than

those with larger standard errors. Standard errors estimated from complex sample designs have a x distribution,

with degrees of freedom equal to the number of strata

with observations in both paired PSU’S. For further discussion of these measures, see appendix I.

The statistical guidelines used for reporting means,

standard errors, and percentiles are as follows.

Means and percents:

. If the sample size in the cell was less than 25, the

estimated sample mean or percent is not reported,

. If the sample size was 25–44, the sample mean or

104

percent is reported with an asterisk (*) before it to

indicate that the statistic does not meet the reliability

standard.

. If the sample size was 45 or more, the sample mean or

percent is presented without caveat.

Stand(rrd error of the mean or percenl:

(7.

b.

c.

If the sample size in the cell was less than 25, no

estimated values for the standard error are presented.

If Ithe sample size was 25 or more and the observations

were distributed among the primary sampling units

(PSU’S) so that fewer than 12 pseudostrata had observations in both of the paired PSU’S, then the values are

presented with an asterisk to indicate that the estimate

may be unreliable.

If the sample size was 25 or more and the observations

were distributed among the PSU’S so that 12 or more

pseudostrata had observations in both of the paired

PSU’S, the standard error of the mean are presented

without caveat.

Percentiles:

● The following minimum sample sizes were required

for the presentation of percentile estimates given in

this report:

Sample size Percent//e

10. . . . . . . . . . . . . . . . . . . . . . . . . 50th

20 . . . . . . . . . . . . . . . . . . . . . . . . . 25th and 75th

35 . . . . . . . . . . . . . . . . . . . . . . . 15th and 85th

50 . . . . . . . . . . . . . . . . . . . . . . . . . 10th and 90th

100, . . . . . . . . . . . . . . . . . . . . . .,, 5th and 95th

. If these minimum sample sizes were not met, there is

an asterisk in the cell.

Cumulative percent distributions

If the sample size is less than 25, the cumulative

percent distribution is not presented. Even though cumulative percent distributions are presented when the sample

size is between 25 and 44, percents less than specified

cutpoints are unstable and therefore should be applied

with caution. If the sample size is less than 50 or between

50 and 100, percents of less than specified cutpoints at the

tails of the distribution are unstable,
Appendix Ill

Definitions of demographic

and socioeconomic terms

Age – Recorded mice for each examinee: age at last

birthday at the time of examination and age at the time of

the U.S. Bureau of the Census interview. The age criterion

for inclusion in the sample used in this survey was defined

as age at the time of U.S. Bureau of the Census interview.

The adjustment and weighting procedures used to produce national estimates were based on age at the interview. Data in the detailed tables and text of the report are

also shown by age at time of interview.

Race – Observed and recorded as “white,” “black,” or

“other.” Other includes Japanese, Chinese, American

Indian, Korean, Eskimo, and all races other than white

and black. Persons of Mexican descent were included with

“white” unless definitely known to be American Indian or

of another race. Blacks and persons of mixed bIack and

other parentage were recorded as black. When a person of

mixed racial background was uncertain about his or her

race, the race of the father was recorded.

Sex– Recorded as observed by the intewiewers.

Birth control pilf– The birth control cluestion was

worded as follows:

Only if the answer to this question was yes, was the sample

person asked:

(b) Are you taking them now?

Women 20-44 years of age were classified by oral

contraceptive use as follows:

1) nonusers – those who answered “no” to the first

question,

2) recent discontinues – those who answered “yes”

to the first question but “no” to the second question,

3) users – those who answered “yes” to questions 1

and 2.

Nonpregnant and nonlactating women were excluded

from the estimates of TC, HDL-C and the ratio of TC to

HDL-C. Estimates of mean TC and the percent with

desirable, borderline-high and high TC were based on 504

birth controI users. Estimates of the mean HDL-C and of

the ratio were based on 436 such women.

(a) Have you taken birth control pills during the past

6 months?

105
Appendix IV

Definitions of risk factor

variables

Coronary heart disease (CHD) and the risk factors for

coronary heart disease, as defined by the Adult Treatment

Panel of the National Cholesterol Education Program,

were applied to data collected during NHANES II. These

data have been coded, edited, and released on data tapes.

Definitions of these risk factors are described below.

Sources of the health-related variables used in these

definitions are provided in table X.

Coronary heart disease (CHD)

Sample persons were defined as having CHD if they

had been told by a physician that they had a heart attack

or if they had angina defined as a positive response to the

Rose Questioner (42).

Sex

Being a male was defined as a risk factor for CHD.

Hypertension

Although not expressly stated in the Adult Treatment

Panel Guidelines, hypertension was defined as a systolic

blood pressure of at least 140 mmHg, a diastolic blood

pressure of at least 90 mmHg, or when an individual is

currently taking medication for high blood pressure.

Systolic blood pressure was defined as the mean of

three systolic blood pressure readings and diastolic blood

pressure was defined as the mean of three diastolic blood

pressure readings. Both of these means were defined only

if all three readings had been determined (43,44).

Overweight

Sample persons were classified as overweight if their

actual weight (45) was 30 percent or more above desirable

weight. The 1959 Metropolitan Life Standards (46) were

used to define desirable weight (table XI).

For examined persons whose height was outside the

specified ranges shown in table XI, desirable weight was

calculated by using a sex-specific regression equation of

weight-on-height fitted through the height-weight points

given in table XI. The regression coefficients for these

equations are also shown in table XI.

All values for weight and height were either known or

had been imputed.

106

Smoking

If sampled persons smoked more than half a pack a

day, clefined as 10 cigarettes, they were defined to be at

risk of CHD (44),

Table X. Variables used in defining coronary heart disease and

coronary heart disease risk factors, by sources of data

Tape

Variab/e Tape number positions

Coronary heart disease (CHD)

Ever told by a doctor had

aheiwla ttack . . . . . . . . . . . . . . . . ...5020

Rose CWestionnaire

(used to define angina) . . . . . . . . . 5020

Male sex . . . . . . . . . . . . . . . . . . . . . . . . Any

NHANES II

data release

tape

Hypertension

Systolic blood pressure:

First reading . . . . . . . . . . . . . . . . . ...5305

Secrmd reading . . . . . . . . . . . . . . . . ..5305

Thircl reading . . . . . . . . . . . . . . . . ., .,5305

Diastolic blood pressure

First reading . . . . . . . . . . . . . . . . . . . ...5305

Second reading . . . . . . . . . . . . . . . . ...5305

Third reading . . . . . . . . . . . . . . . . . . ...5305

Now taking medication for high

blood pressure . . . . . . . . . . . . . . . . ...5020

Overweight

Height in inches . . . . . . . . . . . . . . . . ...5301

Weight in pounds . . . . . . . . . . . . . . . ...5301

Smoking

Ever smoked at least 100 cigarettes. . . . 5020

Smoke now . . . . . . . . . . . . . . . . . . . ...5020

Numk~er of cigarettes smoked per day . . . . 5020

Stroke

Told by a doctor had a stroke. . . . . . . 5020

Diabetes

Told by a doctor had diabetes . . . . 5020

495-496

415, 427–436

55

791-793

797-799

803-805

794-796

800-802

806-808

1069

422–424

407–41 1

529

530

531-532

523

534
Stroke

If sampled persons had been told by a cloctor that they

had had a stroke, they were defined to be at risk of CHD

(44).

Diabetes

If sampled persons had been told by a doctor that they

had diabetes, they were defined to be at risk of CHD (44).

Low HDL-C value

A low HDL-C value (that is, HDL-C <35 mg/dl was

used as a risk factor for adults referred for lipoprotein

analysis. This included adults 20–74 years of age with high

TC (TC < = 240 mg/dl) or borderline-high TC (TC: 200-239

mg/dl) and CHD or 2 CHD risk factors (excluding HDLC< 35 mgjdl) and who had known LDL-C determinations

(a total of 1,0S4 adr.dts).

Table Xl. Values for desirable weight used in defining cr~erweight

as a risk factor for coronary heart disease

Men Women

h’e/ghtl Weight2 Heighti Welght2

5’ 1“ (61 “) 121.5 4’ S“ (56”) 99.5

5’ 2“ (62”) 125.0 4’ 9’ (57”) 102.0

5’ 3“ (63”) 128.0 4’10” (58”) 105.0

5’ 4“ (64”) 131.0 4’11 “ (59”) 108.0

5’ 5“ (65”) 134.5 5’ O“ (80”) 111.0

5’ 6“ (66”) 136.5 5’ 1“ (61”) 114.0

5’ 7“ (67”) 143.0 5’ 2“ (62”) 117.5

5’ 6“ (68”) 147.0 5’ 3“ (63”) 121.0

5’ 9“ (69”) 151.0 5’ 4“ (64”) 125.5

5’10” (70”) 155.5 5’ 5“ (65”) 129.5

5’11” (71”) 160.0 5’ 6“ (66”) 133.5

6’ O“ (72”) 164.5 5’ 7“ (67”) 137.5

6’ 1“ (73”) 169.0 5’ 8“ (68”) 141.5

6 2“ (74”) 174.0 5’ 9“ (69”) 145.5

6’ 3“ (75”) 179.0 5’10” (70”) 149.5

1H@~~inU~1i~~hfor men ~“d mjn~~ ,2inches {or women to correct for shoe heels.

2Subtract 2 pounds for clothing for both men and women

NOTES Desirable weight ia defined as midrange of medium frame in Metropolitan Life

Insurance Company Actuarial Tables, 1959. For men and women whose heights

were outside the specified ranges (5’1’’-6’3” for men; 4’6’-5’1 U’ for women),

desirable weight was imputed using finear regression of weight-on-height using the

above sex-specific values. The following parameters were obtained

Intercept Slope

Men -132,2 4.1

Women -106.4 3.6

us. Qovummr Prlntfrq m 1903- 342-327frMwl 107
Vital and Health Statistics

series descriptions

SERIES 1.

SERIES 2.

SERIES 3.

SERIES 4.

SERIES 5.

SERIES 6.

SERIES 10.

SERIES 11.

SERIES 12.

SERIES 13.

Programs and Collection Procedures–These reports

describe the data collection programs of the National Center

for Health Statistics, They include descriptions of the

methods used to collect and process the data, definitions,

and other material necessary for understanding ?he data.

Data Evaluation and Methods Research –These reports

are studies of new statistical methods and incluce analytical

techniques, objective evaluations of reliability of collected

data, and contributions to statistical theory. These studies

aLso include experimental tests of new survey methods and

comparisons of U.S. methodology with those of other

countries.

Analytical and Epidemiological Studies-These reports

present analytical or interpretive studies based on vital and

health statistics. These reports carry the analyses further than

the expository types of reports in the other series.

Documents and Committee Reports–These are final

reports of major committees concerned with vital and health

statistics and documents such as recommended model vital

registration laws and revised birth and death certificates.

International Vital and Health Statistics Reports –These

reports are analytical or descriptive reports that compare U.S.

vital and health statistics with those of other countries or

present other international data of relevance tc the health

statistics system of the United States.

Cognition and Survey Measurement–These reports are

from the National Laboratory for Collaborative Research in

Cognition and Survey Measurement. They use methods of

cognitive science to design, evaluate, and test survey

instruments.

Data From the National Health Interview Survey-These

reports contain statistics on illness; unintentional injuries;

disability use of hospital, medical, and other heath services;

and a wide range of special current health topics covering

many aspects of health behaviors, health status, and health

care utilization. They are based on data COIected in a

continuing nationat household interview survey.

Data From the National Health Examination Survey, the

National Health and Nutrition Examination Surveys, and

the Hispanic Health and Nutrition Examination Survey–

Data from direct examination, testing, and measurement on

representative samples of the civilian noninstitutionalized

population provide the basis for (1) medically defined total

prevalence of spacific diseases or conditions in the United

States and the distributions of the population with respect to

physical, physiological, and psychological characteristics,

and (2) analyses of trends and relationships among various

measurements and between survey periods.

Data From the Institutionalized Population Surveys –

Discontinued in 1975. Reports from these surveys are

included in Series 13.

Data From the National Health Care Survey-These

repotts contain statistics on health resources and the public’s

use of health care resources including ambulatory, hospital,

and Iongterm care services based on data collected directly

from health care providers and provider records.

SERIES 14.

SERIES 15.

SERIES 16.

SERIES 20.

SERIES 21.

SERIES 22.

SERIES 23.

SERIES 24.

Data on Health Resources: Manpower and Facilities–

Discontinued in 1990. Reports on the numbers, geographic

distribution, and characteristics of health resources are now

included in Series 13.

Data From Special Surveys–These reports contain

statistics on health and health-related topics collected in

special surveys that are not part of the continuing data

systems of the National Center for Health Statistics.

Compilations of Advance Data From Vital and Health

Statistics –Advance Data Reports provide early release of

information from the National Center for Health Statistics’

health and demographic surveys. They are compiled in the

order in which they are published. Some of these releases

may be followed by detailed reports in series 10-13.

Data on Mortality–These reports contain statistics on

mortality that are not included in regular, annual, or monthly

reports. Special analyses by cause of death, age, other

demographic variables, and geographic and trend analyses

are included.

Data on Natality, Marriage, and Divorce –These reports

contain statistics on natality, marriage, and divorce that are

not included in regular, annual, or monthly reports. Special

analyses by health and demographic variables and

geographic and trend analyses are included.

Data From the National Mortality and Natality Surveys–

Discontinued in 1975. Reports from these sample surveys,

based on vital records, are now published in series 20 or 21.

Data From the National Survey of Family Growth –These

reports contain statistics on factors that affect birth rates,

including contraception, infertility, cohabitation, marriage,

divorce, and remarriage; adoption; use of medical care for

family planning and infertility and related maternal and infant

health topics. These statistics are based on national surveys

of childbearing age.

Compilations of Data on Natality, Mortality, Marriage,

Divorce, and Induced Terminations of Pregnanc~-

These include advance reports of births, deatha, marriages,

and divorces based on final data from the National Vital

Statistics System that were published as supplements to the

Month/y Vita/ Statistics Repofi (MVSR). These reporta provide

highlights and summaries of detailed data subsequently

published in Vital Statistics of the United States. Other

supplements to tha MVSR published here provide selected

findings based on final data from the National Vital Statistics

System and may be followed by detailed reports in series 20

or 21.

For answers to questions about this report or for a list of reports published

in these series, contact:

Scientific and Technical Information Branch

National Center for Health Statistics

Centers for Disease Control and Prevention

Public Health Service

6525 Belcrest Road, Room 1064

Hyattsville, MD 20782

(301) 43s-6500
DEPARTMENT OF

HEALTH & HUMAN SERVICES

Public Health Service

Centers for Disease Control and Prevention

National Center for Health Statistics

6525 Belcrest Road

Hyattsville, Maryland 20782

1

OFFICIAL BUSINESS

PENALTY FOR PRIVATE USE, $300

DHHS Publication No. (PHS) 93-1692, Series 11, No. 242